reviews of 92 physiolog3~ biochemistry and pharmacology

224
92 Reviews of Physiolog3~ Biochemistry and Pharmacology Editors R. H. Adrian, Cambridge. H. zur Hausen, Freiburg E. Helmreich, Wiirzburg • H. Holzer, Freiburg R. Jung, Freiburg • O. Krayer, Boston R. J. Linden, Leeds. P. A. Miescher, Gen~ve J. Piiper, G6ttingen • H. Rasmussen, New Haven U. Trendelenburg, Wiirzburg • K. Ullrich, Frankfurt/M. W. Vogt, G6ttingen • A. Weber, Philadelphia With 13 Figures Springer-Verlag Berlin Heidelberg New York 1982

Upload: others

Post on 24-Jul-2022

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

92 Reviews of

Physiolog3~ Biochemistry and Pharmacology Editors R. H. Adrian, Cambridge. H. zur Hausen, Freiburg E. Helmreich, Wiirzburg • H. Holzer, Freiburg R. Jung, Freiburg • O. Krayer, Boston R. J. Linden, Leeds. P. A. Miescher, Gen~ve J. Piiper, G6ttingen • H. Rasmussen, New Haven U. Trendelenburg, Wiirzburg • K. Ullrich, Frankfurt/M. W. Vogt, G6ttingen • A. Weber, Philadelphia

With 13 Figures

Springer-Verlag Ber l in H e i d e l b e r g N e w York 1982

Page 2: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

I S B N 3 - 5 4 0 - 1 1 1 0 5 - 0 S p r i n g e r - V e r l a g B e r l i n H e i d e l b e r g N e w Y o r k I S B N 0 - 3 8 7 - 1 1 1 0 5 - 0 S p r i n g e r - V e r l a g N e w Y o r k H e i d e l b e r g B e r l i n

Library of Congress-Catalog-Card Number 74-3674

This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically those of translation, reprinting, re-use of illustra- tions, broadcasting, reproduction by photocopying machine or similar means, and stor- age in data banks. Under § 54 of the German Copyright Law where copies are made for other than private use, a fee is payable to 'Verwertungsgesellschaft Wort', Munich.

@ by Springer-Verlag Berlin Heidelberg 1982 Printed in Germany.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant pro- tective laws and regulations and therefore free for general use.

Offsetprinting and Binding: Konrad Triltsch, Wt~rzburg 2121/3130-543210

Page 3: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Contents

Cardioactive Substances that Prolong the Open State of Sodium Channels. By P. HONERJAGER, Mfinchen/Federal Re- public of Germany. With 12 Figures . . . .

Factors Influencing Renal Sodium Reabsorption in Volume Expansion. By F. G. KNOX and J. A. HAAS, Rochester, MN/USA . . . . . . . . . . 75

Hormonal Coordination of the Immune Response. By J. COMSA, H. LEONHARDT, and H. WEKERLB, Homburg/Federal Republic of Germany. With 1 Figure . . . . : . . 115

Author Index . . . . . . . . . . . . . . . . 193

Subject Index . . . . . . . . . . . . . . . 219

Indexed in Current Contents

Page 4: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Rev. Physiol. Biochem. Pharmacol., Vol. 92 © b y Springer-Verlag 1982

Cardioactive Substances that Prolong the Open State of Sodium Channels

P E T E R H O N E R J A G E R *

Contents

1 I n t r o d u c t i o n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

C h e m i s t r y o f Na Channe l -Ga te T o x i n s . . . . . . . . . . . . . . . . . . . . . . . . . . 4 2.1 Alkalo ids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 2.2 Di t e rpeno ids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 2.3 Po lypep t ides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

Mode 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3 .10

o f A c t i o n o f Na Channe l -Ga te Tox in s . . . . . . . . . . . . . . . . . . . . . . 7 Me th o ds of Analys i s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 C e v e r a t r u m Alkalo ids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 B a t r a c h o t o x i n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Aco n i t i ne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 G r a y a n o t o x i n s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Scorp ion T o x i n s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Sea A n e m o n e T o x i n s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Coral T o x i n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Silent Na C h a n n e l s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 A n t a g o n i s t s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

4 Cardiac A c t i o n of Na Channe l -Ga te T o x i n s . . . . . . . . . . . . . . . . . . . . . . . 15

4.1 Role of Na Channe l s in the Cardiac Ac t i on Po ten t i a l . . . . . . . . . . . . 15 4 .2 C e v e r a t r u m Alkalo ids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 4.3 B a t r a c h o t o x i n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 4.4 Aco n i t i ne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 4.5 G r a y a n o t o x i n s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 4.6 Scorp ion T o x i n s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 4.7 Sea A n e m o n e Tox in s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 4.8 Coral Tox in . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50

Sa rco l em m al Na Permeab i l i ty and Myocard ia l Force of Con t rac t ion : Na-Ca E x c h a n g e . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 5.1 I n t r o d u c t i o n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 5.2 Na-Ca E x c h a n g e in the Squid Giant A x o n . . . . . . . . . . . . . . . . . . . 51 5.3 Nai-Ca o E x c h a n g e in Cardiac P repara t ions . . . . . . . . . . . . . . . . . . . 53

C o m p a r i s o n of Cardiac Ac t i ons o f Na Channe l -Ga te Tox in s wi th Those of O th e r Posit ive Ino t rop ic Drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 6.1 I somet r i c C o n t r a c t i o n Curve . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 6.2 Blockade of Sa r co l emmal Na Channe l s by T e t r o d o t o x i n . . . . . . . . . . 58

* l n s t i t u t fiir Pha rmako log ie u n d Tox iko log ie der T e c h n i s c h e n Universit~it Mfinchen, Bieders te iner StratSe 29, D-8000 Mtinchen 40, Federa l Repub l i c of G e r m a n y

Page 5: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

2 P. Honerj~iger

6.3 Contraction Frequency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 6.4 Reduction of Extracellular Na Concentration . . . . . . . . . . . . . . . . . 60 6.5 Variation of Extracellular K Concentration . . . . . . . . . . . . . . . . . . 61 6.6 Inhibition of the Na Pump by Dihydro-Ouabain . . . . . . . . . . . . . . . 61 6.7 Propranolol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62

7 Summary and Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62

References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64

Abbreviations and Symbols

ATXII cAMP

D 600

ScTXII

STX TTX

Toxin II fromAnemoniasulcata h Cyclic adenosine 3',5'-mono- phosphate m o~-Isopropyt-c~- [(N-met hyl-N- homoveratryl)-'),-amin opropyl]- I K 3,4,5-trimethoxyphenylaceto- INa nitrile (gallopamil) Toxin II from Androctonus Isi australis Hector Saxitoxin PNa Tetrodotoxin

*max F c AF c

Peak force of contraction Change in peak force of con- [ ]a traction [ 1;

Inactivation variable of Iqa channels Activation variable of Na channels Transmembrane/( current Transmembrane Na current through Na channels Transmembrane slow inward (Ca, Na) current Membrane permeability to Na ions Maximal rate of depolarization during the upstroke of the action potential Extraeellular concentration Intracellular concentration

1 Introduction

It is now recognized that m a n y tox ic substances evolved by plants or ani-

mals act by interfer ing with the exc i ta t ion process o f nerve and muscle cells. Specifically, these c o m p o u n d s alter the rapid and t ransient increase in m e m b r a n e permeabi l i ty to Na ions (PNa), tha t initiates the ac t ion potent ia l . Accord ing to the general m o d e by which toxins m o d i f y the Na permeabi l i ty mechanism, or Na channels, two groups can be distinguished. The first group o f substances, including t e t r o d o t o x i n (TTX) and saxi- t ox in (STX), blocks the f low o f Na ions t h rough Na channels. The second group o f toxins mainta ins an open fo rm o f the Na channel , t he r eby pro- longing the t ime during which Na ions f low into the cell. This group com- prises alkaloids (cevera t rum alkaloids, ba t r acho tox in , aconi t ine) , the diter- peno id g rayanotox ins , and po lypep t ides f rom scorpions, sea anemones and coral and contains the most p o t e n t and mos t specific substances k n o w n to increase the Na permeabi l i ty o f exci table membranes . Toxins

Page 6: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 3

which prolong the open state of Na channels will be referred to as Na channel-gate toxins to denote the specific function of the Na channel affected by these agents, i.e. the gating mechanism which controls the activation and inactivation of Na channels.

While the general pharmacology of one subgroup of Na channel-gate toxins, the ceveratrum alkaloids, has been studied for more than a cen- tury, the basic mechanism of their action, as outlined above, has been elucidated only during the last 2 decades following the discovery of the ionic permeability changes responsible for membrane excitation (Hodgkin and Huxley 1952). For methodological reasons we possess more detailed information concerning the effect of Na channel-gate toxins on nerve fibres and nerve cells in culture than on myocardial and other excitable cells. This review, therefore, includes a brief description of effects on the type of preparation which yielded most information on the mechanism of action at the level of Na channels. For in-depth information of the effects of toxins on Na channels, the reader is referred to the reviews by Ulbricht (1969, 1974), Hille (1970), Narahashi (1974), Khodorov (1979), Ritchie (1979), Catterall (1980), and Lazdunski et al. (1980), and to the original literature cited in connection with individual toxins.

This review deals with the direct cardiac effects of Na channel-gate toxins observed in isolated cardiac preparations. The main effects are a positive inotropic effect without a significant chronotropic effect and an arrhythmogenic effect. Early references to the direct cardiac effects of ceveratrum alkaloids are given in the reviews by Krayer and Acheson (1946) and Trautwein (1963). Trautwein (1963) also reviewed the litera- ture concerning the cardiac effects of aconitine. The Benforado review (1967) includes a chapter on the direct cardiac effects of ceveratrum alkaloids and concludes that "the mechanism by which the veratrum alkaloids exert their positive inotropic action on the heart is not known". The last 15 years have brought considerable progress in our understand- ing of the basic membrane action of ceveratrum alkaloids and other Na channel-gate toxins and of the relationship between ion fluxes through the sarcolemma and myocardial force of contraction. Perhaps the most impressive result is that the large group of chemically diverse Na channel- gate toxins represents a single class of inotropic agents. They possess a characteristic mode of action that differs from that of other cardioactive drugs, e.g., cardioactive steroids, catecholamines, and other agents thought to act by influencing the cellular concentration of cyclic nucleo- tides.

In the intact animal organism, the direct cardiac effects of Na channel- gate toxins may not be recognized because of cardiovascular or cardio- cardiac reflexes following the stimulation of sensory nerves by the toxins. The Bezold-Jarisch effect exemplifies this action for many ceveratrum

Page 7: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

4 P. Honerjfiger

alkaloids (Krayer 1961). The hypotensive and other circulatory effects of ceveratrum alkaloids were reviewed by Benforado (1967), Kupchan and Flacke (1967), and Krayer and Meilman (1977). The older literature on this subject was surveyed by Krayer and Acheson (1946) in their com- prehensive review of the pharmacology of veratrum alkaloids. Notably, certain Na channel-gate toxins lack a hypotensive effect; for example, some natural and semi-synthetic ceveratrum alkaloids (Kupchan and Flacke 1967) and at least one of the polypeptide toxins, namely antho- pleurin A, which has a direct positive inotropic effect on the myocardium in conscious dogs (Blair et al. 1978).

2 Chemistry of Na Channel-Gate Toxins

2.1 Alkaloids

2.1.1 Ceveratrurn Alkaloids

The veratrum alkaloids are steroid alkaloids that occur in liliaceous plants belonging to the genera Veratrum, Zygadenus, Stenanthiurn, and Schoenocaulon. These genera comprise a section of the suborder Melan- thioideae (Kupchan et al. 1961). The terms ceveratrurn and jerveratrurn alkaloids were introduced to distinguish two chemically and pharmaco- logically different groups of veratrum alkaloids (Fieser and Fieser i 959). The jerveratrum alkamines are secondary amines, contain only one to three atoms of oxygen, and are found in unhydrolyzed plant extracts in part as the free alkamines and in part in combination with one molecule of D-glucose as glucoalkaloids. Jerveratrum alkaloids do not prolong the open state of Na channels. Somej erveratrum alkaloids, such as veratramine, antagonize the effect of ceveratrum alkaloids (Krayer and George 1951), probably because they block Na channels (Ohta et al. 1973). The ceverat- rum alkamines are tertiary amines, are highly hydroxylic, and contain seven to nine atoms of oxygen. They usually occur esterified with various acids as ester alkaloids, but are sometimes unconjugated. They have never been found as glycosides. The ceveratrum alkaloids can be formally derived from (22 S, 25 S)-5/3-cevanine. Their chemistry has been reviewed by Kupchan and By (1968). The structures of the monoester veratridine and the triester germitrine are shown in Fig. 1. The name veratrine is usually used for the total alkaloids of the seeds of Schoenocaulon offici- nale, it does not refer to a well-defined preparation of constant composi- tion (Krayer and Acheson 1946; Kupchan et al. 1961). The use of this and other mixtures of veratrum alkaloids for scientific purposes is dis- couraged. Jerveratrum alkaloids may antagonize the effect of ceveratrum

Page 8: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 5

Fig. 1. Chemical structures of the ceveratrum alkaloids vera- tridine and germitrine. (Drawn after Kupchan and By 1968)

CH3H

N?H/N~IH3

OCHa / ~ / ; " - H I ~ / "OH

OH^O-( / ')-CO" ~ J ~ /

Verat ridine

CH3 H

N ? / N ~ c H 3

0 r/ "4/ ~ "~/ i " / "OH .L - ° l ° " i o,

CH 3 0 0 CH 3

Germitrine

alkaloids, and there are more subtle differences between the effects of individual ceveratrum alkaloids (veratridine versus cevadine; Reiter 1963; veracevine and germine and their esters, Sect. 3.2; veratridine versus ger- mitrine, Sect. 4.2.5).

2.1.2 Batrachotoxin

Batrachotoxin is the most toxic of the steroid alkaloids extracted from the skin of the Columbian arrow poison frog (Phyllobates aurotaenia). It is a pyrrolecarboxylate ester o f the pregnane derivative batrachotoxi- nin A (Tokuyama et al. 1969).

2.1.3 Aconitine

Aconitine is the main alkaloid of Aconitum napellus of the plant family Ranunculaceae (List and HOrhamrner 1969). Like the ceveratrum alkalo- ids, aconitine is an ester o f an alkamine with organic acids. The alkamine,

Page 9: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

6 P. Honerj~iger

aconine, contains two cyclopentane rings, one piperidine ring, and three cyclohexane rings. In aconitine, aconine is esterified with benzoic acid and acetic acid. The structure of aconitine was reported by Wiesner et al. (1969).

2.2 Diterpenoids

Gyanotoxins are the toxic principles found in the leaves of various spe- cies of Rhododendron, Kalmia, and Leucothoe (Ericaceae). They are diterpenoids with a perhydroazulene skeleton and their chemical struc- tures have been determined (Kakisawa et al. 1965; Kumazawa and Iriye 1970).

2.3 Polypeptides

2. 3.1 Scorpion Toxins

Toxins of North African scorpions were first purified, characterized, and sequenced by Rochat, Miranda, Lissitzky, and colleagues (Miranda et al. 1970; Rochat et al. 1970; Kopeyan et al. 1979). These toxins are basic polypeptides with molecular weights of approximately 7000. Each scor- pion species studied contained multiple toxins having extensive sequence homology (Rochat et al. 1970). The molecular weight of toxin II from Androctonus australis HECTOR (ScTXII) is 7249 (Miranda et al. 1970).

2.3.2 Sea Anemone Toxins

Anemone toxins were first isolated in pure form from Anemonia sulcata, shown to be basic polypeptides of 2500-5000 molecular weight and sequenced by Bdress, Wunderer, and their colleagues (BOress et al. 1975a,b, 1977; Wunderer et al. 1976). The sequences of three toxins from Ane- monia sulcata and one from Anthopleura xanthogrammica were deter- mined (Wunderer et al. 1976; B~ress et al. 1977; Martinez et al. 1977; Wunderer and Eulitz 1978; Tanaka et al. 1977). Toxins I and II from Anemonia sulcata and anthopleurin A fromAnthopleura xanthogrammica consist of 47-49 amino acid residues and have substantial sequence homology. None of the anemone toxins has detectable sequence homol- ogy when compared to the scorpion toxins.

2. 3. 3 Coral Toxin

Goniopora toxin, a polypeptide with a molecular weight of 12 000, was isolated and purified from the coral Goniopora spp. (Hashimoto and Ashida 1973).

Page 10: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 7

3 Mode of Action of Na Channel-Gate Toxins

3.1 Methods of Analysis

Different methods have been employed to study the effects of drugs on Na channels; electrophysiologic analysis of membrane voltage and mem- brane current, isotopic flux measurements of ion permeability, and direct binding studies of radiolabelled toxins. The results obtained with the latter two methods were recently reviewed (Catterall 1980), and have helped significantly to elucidate molecular aspects of the effects of toxins on the Na channel. The electrophysiologic approach, with its advantage of high time resolution, provides information allowing us to predict how the Na channel-gate toxins modify the transmembrane elec- trical activity of cells. This is particularly important for an understanding of the cardiac effect of these agents. The effects on the kinetics of Na channels are therefore reviewed in some detail. It has become customary to analyse the effects of drugs on Na channels in terms of the conceptu- alization introduced by Hodgkin and Huxley (1952) to describe the nor- mal Na permeability changes in the squid giant axon. According to this theory, two voltage- and time-variant parameters, the activation variable rn and the inactivation variable h, govern the changes of the Na perme- ability during excitation. The Na permeability is turned on because of an increase of rn if the membrane is depolarized, and the turning off during maintained depolarization is due to a decrease of h. Repolarization turns off PNa because of a decrease in rn. This analysis was also used with some modifications to describe the behaviour of Na channels in other types of excitable cells, including cardiac cells (see Trautwein 1973). The hypo- thetical subunit of the Na channel, which gives adequate kinetics of opening and closing, is referred to as the gating mechanism, consisting of the rn gate and the h gate.

3.2 Ceveratrum Alkaloids

The veracevine ester veratridine has received the most attention among the various ceveratrum alkaloids. A detailed analysis of the effect of vera- tridine on the frog node of Ranvier was performed by Ulbricht (1969, 1972a,b) using the voltage-clamp technique. Normally, the Na permeabil- ity of nerve fibres exhibits a fast and transient rise of about 1 ms dura- tion during a voltage-clamp depolarization. In contrast, the PNa observed in the veratridine-treated node, in addition to the normal Na permeability, develops over a period of several seconds during depolarization and is maintained as long as the membrane is clamped at the depolarized level.

Page 11: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

8 P. Honerj~iger

The veratridine-induced PNa was quantitatively described by introducing an activation variable s (analogous to m) exhibiting the potential- and time-dependence observed and by omitting an inactivation term corres- ponding to h (UIbricht 1969). For a stepwise depolarization, the time course of s follows the equation s(t ) = s(t = ~o) (1 - e - t/rs), where t is the time after the start of the depolarization and r s is a time constant. The time constant of activation of the veratridine-induced PNa (~-s) is of the order o f seconds, i.e. about 104 -times larger than rm, the time constant of the normal PNa activation. The voltage-dependence of the veratridine- induced PNa activation is less steep and shifted to more negative mem- brane potentials compared to that of normal PNa"

Veratridine seems to modify some of those Na channels participating normally in the production of the action potential rather than to create new channels (Ulbricht 1969). This would explain why the appearance of the alkaloid-induced PNa is accompanied by a decrease in the normal transient PNa" Furthermore, normal and modified channels distinguish to comparable degrees between Na, Li, choline, and tromethamine, and both are blocked by TTX at rates and to extents that are very similar (Ulbricht 1974). The concentration of veratridine appears to determine the proportion of Na channels that is modified, while at the level of the single Na channel the interaction with veratridine appears to be a rever- sible all-or-none event (Ulbricht 1972a).

At concentrations exceeding about 10 pmol/litre veratridine induces a sustained depolarization of the node of Ranvier due to an increase in PNa (Ulbricht 1969). It is caused by the two effects of veratridine on Na channels; block of inactivation and shift o f activation to more negative potentials, thus allowing the spontaneous opening of Na channels at the level of the normal resting potential. Some pharmacologically important effects of veratridine occur at lower concentrations when the resting membrane potential shows very little, if any depolarization. At this stage of veratridine action, the presence of modified Na channels is apparent as a distinct delay in the final phase of repolarization of the action poten- tial (after-depolarization). The effect reflects the large value of r s that determines the rate at which modified Na channels deactivate after repolari- zation (Ulbricht 1969). By this mechanism, veratridine greatly prolongs the phase of increased PNa and Na influx associated with each action potential.

Other ceveratrum alkaloids are similar to veratridine in producing after- depolarizations in nerve fibres, but individual alkaloids differ with respect to duration (Graham and Gasser 1931; Shanes 1952;Honerfiiger 1973). The alkamines germine and veracevine induce after-depolariza- tions of relatively short duration in crustacean nerve axons. The half-life of after-depolarization decay is 6 8 ms (Honer]alger 1973). In the same

Page 12: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 9

study it was shown that number and nature of the ester groups attached to the alkamine modify the duration of after-depolarization. For example, replacement of the 3~-hydroxyl in veracevine by an acetyl (cevacine), angeloyl (cevadine), or veratroyl group (veratridine) causes a progressive prolongation of the after-depolarization up to about 3 s (half-life) in the case ofveratridine. Even longer-lasting after-depolarizations were observed with the di-, tri-, and tetraester alkaloids in guinea-pig papillary muscle (Sect. 4.2.5). The semisynthetic germine ester germine-3-acetate produces an after-depolarization in curstacean nerve fibres that decays with a half- life of 4 0 - 7 0 ms. Voltage-clamp experiments on squid axons showed that this alkaloid induces a TTX-sensitive slow component of Na perme- ability (Honer]alger 1973). After repolarization this component of PNa deactivates about 20-times faster than the PNa induced by veratridine. This may indicate that all the various ceveratrum alkaloids react with Na channels, but differ in the degree to which they slow the m-gating process.

3.3 Batrachotoxin

A detailed voltage-clamp analysis carried out on the frog node of Ranvier showed that batrachotoxin alters both the gating mechanism and ion selectivity of Na channels (Khodorov and Revenko 1979). The Na chan- nels lose the ability to inactivate, and the voltage-dependence of activa- tion is shifted by about 50 mV to more negative voltages. Therefore, a fraction of Na channels is permanently activated at the normal level of resting potential, resulting in depolarization. The time constant of activa- tion is also affected by batrachotoxin, but to a much lesser extent than by veratridine. Batrachotoxin increases the relative permeability of the Na channels toward larger ions, including Ca ions. This finding, by Kho- dorov and Revenko (1979), is of particular interest with regard to the positive inotropic effect on myocardial cells of batrachotoxin, as well as other Na channel-gate toxins (Chap. 4). If myocardial Na channels were to lose their ionic selectivity and become significantly permeable to Ca ions, this would explain a positive inotropic effect of the Na channel-gate toxins. It seems, however, that this effect of batrachotoxin on neural Na channels cannot be extended to cardiac Na channels, at least as far as the action of veratridine and ScTXII is concerned. The Ca influx induced by these Na channel-gate toxins in cardiac cells in culture does not occur through Na channels, but by way of Na-Ca exchange (Sect. 5.3.2).

Khodorov and Revenko (1979) further showed that the modification of Na channels by batrachotoxin requires a specific functional state of the Na channels, namely their open configuration. Thus the effect develops

Page 13: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

10 P. Honerj~iger

much more rapidly if the node of Ranvier is stimulated repetitively in such a way that the Na channels are not inactivated by the holding poten- tial and the pulses are large enough to activate Na channels. The concen- tr~ition-effect relationship suggests that each channel receptor binds only one molecule of batrachotoxin. A study of the effect of batrachotoxin on the action potential of guinea-pig papillary muscle led to the same conclusion (Sect. 4.3.2).

3.4 Aconitine

The mode of action of aconitine on Na channels was elucidated in voltage- clamp experiments on the frog node of Ranvier (Schmidt and Schmitt 1974; Mozhayeva et al. 1977), and was found to be very similar to that of batrachotoxin. Aconitine-modified Na channels lose the property of inactivation and open at more negative potentials than the normal resting potential. These channels open with a time constant about twice as large as normal Na channels. As with batrachotoxin, the development of the effect is speeded up by periodical depolarizations if they lead to an activation of Na channels. This suggests that the open configuration of the Na channel gate is more favourable for the interaction with aconitine. Aconitine, like batrachotoxin, reduces the selectivity of Na channels for monovalent cations (Mozhayeva et al. 1977).

3.5 Grayanotoxins

Grayanotoxins have been found to depolarize the membranes of various excitable cells (see Starkus and Narahashi 1978). As shown on the squid giant axon, this is due to a selective and TTX-sensitive increase in resting PNa (Narahashi and Seyama 1974). The effect of grayanotoxins on the time- and voltage-dependence of activation and inactivation of Na chan- nels has not been published in detail.

3.6 Scorpion Toxins

Venom of Leiurus quinquestriatus delays the repolarization of the action potential, reduces the resting membrane potential and induces spontane- ous activity in myelinated nerve fibres (Adam et al. 1966). Voltage-clamp experiments on the frog node of Ranvier showed that the main effect of the venom is to slow the inactivation of Na channels (KoppenhOfer and Schmidt 1968a,b). Venoms or toxins of other North African scorpions

Page 14: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 1 1

(Buthus thamulus, B. eupeus, Androctonus australis HECTOR) have the same principal effect on nerve fibres (see Khodorov 1979). In the squid giant axon, which allows application of substances to either side of the axolemma, venom of B. thamulus is effective only if applied from the extracellular side (Narahashi et al. 1972). More recently, Catterall (1980) showed that a toxin purified from L. quinquestriatus venom increases the fraction of Na channels activated by veratridine, aconitine, or gray- anotoxin I in cultured neuroblastoma cells: His findings indicate that scorpion toxin and the group of alkaloidal and diterpenoid toxins (lipid- soluble toxins) bind to separate receptor sites of the Na channel which interact allosterically.

In contrast to the venoms of North African scorpions, which modify Na inactivation, venom of the American scorpion Centruroides sculptura- tus alters the activation gate without modifying the h gate in the frog node of Ranvier (Cahalan 1975). This venom causes a shift of the activa- tion voltage-dependence by 40-50 mV in the hyperpolarizing direction, while the modification of the Na channel requires depolarization.

While many Na channel-gate toxins alter the function of isolated car- diac muscle by modifying sarcolemmal Na channels, scorpion toxins seem to act mainly by releasing neurotransmitters from intracardiac nerve fibres, i.e. by their effect on neural Na channels (Sect. 4.6).

3.7 Sea Anemone Toxins

3. 7.1 Toxin H from A nemonia sulcata (A TXII)

In the crayfish giant axon, ATXII has little or no effect on resting poten- tial, but produces a marked prolongation of the falling phase of action potentials (Rathmayer and B~ress 1976). As shown in the frog node of Ranvier, and crayfish giant axons, the main effect of ATXII is to slow the rate of the Na channel inactivation (Bergman et al. 1976; Romey et al. 1976). The activation of Na channels is not markedly altered. The curve relating steady-state inactivation to membrane potential shows a decrease in slope under the influence of ATXII, so that moderate depo- larizations inactivate a larger than normal fraction of Na channels. The receptor for ATXII does not seem to be accessible from inside the axo- lemma. Like scorpion toxin, ATXII increases the fraction of Na channels modified by veratridine (Catterall 1980). Scorpion toxin and ATX n appear to act at a common receptor site associated with the Na channel (Catterall 1980).

Page 15: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

12 P. Honerj~iger

3. Z2 Anthopleurin A

Low concentrations of anthopleurin A produce slow transient depolariza- tions and a prolongation of the repolarization phase in the crayfish giant axon, while high concentrations induce a sustained depolarization (Low et al. 1979). Voltage-clamp experiments show that anthopleurin A alters the kinetics of Na channels (Low et al. 1979). Modified Na channels are activated at more negative membrane potentials, and the inactivation is slowed as is the removal of activation after repolarization.

3.8 Coral Toxin

Goniopora toxin prolongs the falling phase of the action potential in rabbit myocardium (Fu]iwara et al. 1979), and this effect is abolished by TTX. This is so far the only available evidence indicating that the toxin slows the kinetics of Na channels.

3.9 Silent Na Channels

The basic effect of the various Na channel-gate toxins was discovered in excitable membranes that produce their action potential by the activa- tion of Na channels. However, it is becoming increasingly evident that neither the presence of a Na channel-dependent mechanism of excitation, nor excitability as such are prerequisites for Na channel-gate toxins to cause the appearance of persistently activated Na channels. Veratridine opens Na channels in the pancreatic I3-cell membrane which normally pro- duces impulses by the activation of Ca channels (Donatsch et al. 1977). The action potential of chick embryonic heart cells in an early stage of development is due to the activation of TTX-insensitive, slow Na-Ca chan- nels. Nevertheless, veratridine depolarizes these cells and the effect is blocked by TTX (Sperelakis and Pappano 1969; Bernard and Couraud 1979; Romey et al. 1980). Polypeptide toxins also produce bioelectric effects that are blocked by TTX in slow cells of the chick embryo heart (Bernard and Couraud 1979; Romey et al. 1980). These effects are de- scribed in detail in Chap. 4. Veratridine produces a TTX-sensitive depolari- zation in non-spiking sensory dendrites of the crab (Lowe et al. 1978). In an inexcitable cell line derived from a rat brain tumor, veratridine or polypeptide toxins open TTX-sensitive Na channels (Romey et al. 1979). When exposed to Na channel-gate toxins, fibroblasts exhibit an increased uptake of Na that is blocked by TTX (Munson et al. 1979;PouyssOgur et al. 1980). There are conflicting reports as to whether Na channel-gate toxins open Na channels in glial cells (Villegas et al. 1976; Tang et al. 1979).

Page 16: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 13

As it is highly unlikely that the Na channel-gate toxins create Na-selec- tive and TTX-sensitive ionic channels in these membranes, it is generally assumed that Na channels pre-exist in a state which under normal condi- tions precludes their electrical activation. The term silent Na channels has been suggested by Romey et al. (1979). If these Na channels were in a state characterized by faster inactivation kinetics than activation kinet- ics, this would explain why they are normally electrically silent, but able to open in the presence of a toxin that specifically slows the inactivation (Romey et al. 1979).

3.10 Antagonists

3.10.1 Non-Competitive Antagonists

TTX and STX are potent and selective blockers of Na channels and they have no other known action (Narahashi 1974). TTX and STX also block the flow of Na ions through Na channels modified by Na channel-gate toxins, and thus are specific antagonists of Na channel-gate toxins. The blockers and the gate toxins modify different properties of the Na chan- nel. TTX and STX, in partially blocking concentrations, reduce the total available Na permeability, but do not alter the kinetics of the unblocked Na channels. In contrast, the gate toxins alter the kinetic (m and/or h) behaviour of the Na channels. This difference suggests different receptor sites at the Na channel for blockers and gate toxins respectively, and thus a non-competitive type of antagonism. Catterall (1975) investigated the nature of this antagonism by using the initial rate of Na influx into cul- tured neuroblastoma cells to quantify the effect of veratridine or batra- chotoxin. He has shown that activation of Na influx by the Na channel- gate toxins is non-competitively inhibited by TTX. Further proof that the receptors for TTX and Na channel-gate toxins are not identical was obtained in experiments on the specific binding of labelled TTX to nerve membrane preparations. This binding (and that of labelled STX) was unaffected even by high concentrations of Na channel-gate toxins (see Catterall 1980).

Although the TTX-sensitivity of biological effects points to the involve- ment of Na channels, there are some instances in which the lack of sen- sitivity to TTX does not rule out the participation of Na channels. Examples of cells possessing TTX-insensitive Na channels are denervated skeletal muscle fibres (Redfern et al. 1970) and giant neurons of the snail Helix aspersa (Chamberlain and Kerkut 1969). These TTX-insensitive Na channels are susceptible to the action of Na channel-gate toxins such as veratridine (Leicht et al. 1971) or batrachotoxin (Albuquerque and Warnick 1972).

Page 17: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

14 P. Honerj~iger

Normal Na channels and those modified by veratrine are blocked by the local anaesthetic lidocaine (frog node of Ranvier; Hille 1968). Lido- caine and tetracaine inhibit veratridine-induced Na uptake by embryonic cardiac cells (Fosset et al. 1977).

An increase in external Ca concentration is known to reduce the depolarizing effect of veratridine (Ulbricht 1969). To understand this antagonism it is necessary to recall the effect of external Ca ions on nor- mal Na channels. An increase in [Ca]o shifts the voltage dependence of both activation and inactivation to less negative membrane potentials (Frankenhaeuser and Hodgkin 1957). Varatridine-modified Na channels lose the inactivation gate, but their activation gate is similarly sensitive to changes of [Ca]o as that of normal Na channels (frog node of Ranvier; Ulbricht 1969). Thus, increasing [Ca]o at a given level of depolarization reduces the fraction of activated veratridine-modified Na channels and may lead to repolarization. This may also explain why concentrations of external Ca higher than 2 mmol/litre inhibit the veratridine-induced Na uptake by embryonic cardiac cells (Fosset et al. 1977). It is not necessary to assume a specific, e.g. competitive, interaction between Ca ions and veratridine to account for this antagonism. However, the inhibition by external Ca ions of the veratridine-induced Na influx into neuroblastoma cells (Catterall 1975) and cardiac cells in culture (Galper and Catterall 1979) appears to be of the competitive type.

3.10.2 Competitive Antagonists

The clarification of a pharmacological antagonism usually requires estab- lishing complete concentration-effect relationships in systems where the effect is a more or less direct measure of the degree of receptor occupancy by the drug. In the case of Na channel-gate toxins, Catterall (1975)was the first to obtain complete concentration-effect relationships for their effect on Na permeability by using the stimulation of 22 Na influx in cultured neuroblastoma cells. With this system he showed that there are competitive interactions among veratridine, batrachotoxin, aconitine, and grayanotoxin I (see Catterall 1980). The effect of saturating concen- trations of batrachotoxin is reduced by each of the other lipid-soluble toxins, suggesting that batrachotoxin is a full agonist, whereas veratridine, aconitine, and grayanotoxin are partial agonists acting at a common receptor site of the Na channel. A competitive antagonist without notice- able intrinsic effect on the Na channels has apparently not yet been found.

Page 18: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 15

4 Cardiac Action of Na Channel-Gate Toxins

4.1 Role of Na Channels in the Cardiac Action Potential

4.1.1 Na Channels in Different Cell Types of the Heart

During the last 15 years the application of voltage-clamp techniques to cardiac tisssues has provided much information on the transmembrane ionic currents underlying the action potential of cardiac cells, which is important for an understanding of the cardiac action of Na channel-gate toxins. The reader is referred to the reviews by Trautwein (1973) and Reuter (1979) and to the articles by McAllister et al. (1975) and by Beeler and Reuter (1977). In the case of mammalian ventricular myocar- dium, the action potential has been shown to result from the sequential and transient activation of a fast inward Na current (INa), a secondary, slow inward current carried by Ca and Na ions, (Isi), and an outward K current (IK) (Trautwein 1973; Reuter and SchoIz 1977; McDonald and Trautwein 1978). The fast PNa system responsible for INa is very similar to that of nerve cells and the term Na channels, originally applied to the ionic pathwahs of the Na conductance mechanism of nerve cells (Hille 1970), is now also used for that of cardiac cells (Hondeghem and Katzung 1977). The rapid upstroke of the action potential is caused by the rapid increase of INa , and the first time derivative of membrane potential dur- ing the upstroke (V) provides an indirect estimate of INa (Reuter 1979; Walton and Fozzard 1979). The electrotonic current resulting from the potential change during the upstroke is the stimulus for excitation of adjacent cells. Therefore, INa is the basis for conduction of the action potential, and conduction velocity is largely determined by the Vma x of the action potential. INa subsides completely within a few milliseconds after its activation, but the membrane potential remains at a positive level because of the now-apparent activation of Isi. The subsequent repolariza- tion process is determined by the inactivation of Isi and the activation of I K . As in ventricular myocardial cells, a fast, inward Na current is respon- sible for the upstroke of the action potential in Purkinje fibres and atrial muscle fibres (Trautwein 1973). The action potential of Purkinje fibres exhibits a higher value of Vmax than the fibres of the working myocar- dium. This allows the Purkinje fibre to play its physiological role in dis- tributing excitation, leading to the nearly simultaneous contraction of the different parts of the ventricles. In Purkinje fibres, INa is not com- pletely inactivated after the upstroke and participates in the ionic cur- rents flowing during the plateau phase (Attwell et al. 1979). Thus, the action potential duration of Purkinje fibres, but not of ventricular muscle fibres, is markedly shortened by the specific Na channel blocker TTX

Page 19: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

16 P. Honerj~iger

(Coraboeuf et al. 1979). The slowly rising action potentials of cells of the sinoatrial node are insensitive to TTX (Yamagishi and Sano 1966) indicating that Na channels are not involved in producing the rising phase of the action potential. Yet the presence of Na channels in this cell type is indicated by the observation that hyperpolarization of pacemaker cells by application of carbachol produces an increase in Vmax of the action potential that is entirely suppressed by TTX (Kreitner 1975). Hyperpolar- ization by the voltage-clamp technique also reveals a fast Na current that is inactivated by depolarization and blocked by TTX (Noma et al. 1977). The upstroke of the action potential of atrioventricular nodal fibres shows two components (Ruiz-Ceretti and Ponce Zurnino 1976). The first of these is attributed to the activation of Na channels because it depends strongly on [Na]o and is inhibited by TTX. Its relatively low Vmax of about 13 V/s is accounted for by the low resting potential of nodal cells causing inactivation of the Na channels. The voltage-dependence of Vrnax of atrioventricular nodal action potentials corresponds to that of Na channels (Shigeto and Irisawa 1974). The second component of the action-potential upstroke is attributed to the slow inward current (Ruiz- Ceretti and Ponce Zumino 1976).

In summary, electrophysiologic experiments revealed the presence of Na channels in the plasmalemma of cells of the sinoatrial and atrioventri- cular nodes, atrial and ventricular myocardium, and of Purkinje fibres. Na channel gate toxins are expected to modify the electrical activity of all cells possessing Na channels unless the Na channels lack the pharma- cologic receptor for alteration of the gating mechanism by the toxin.

The effects of Na channel-gate toxins on membrane currents of cardiac cells under voltage-clamp conditions are largely unknown. However, there is substantial indirect evidence obtained by intracellular potential recording suggesting that these toxins affect the kinetics of INa in a way similar to their effect on neural Na channels. A slowing of INa inactiva- tion, as produced in the nerve membrane by sea anemone or scorpion toxins, or the removal of inactivation combined with a slowing of activa- tion in a fraction of Na channels, as produced by veratridine in the node of Ranvier, would add a component of Na current to the membrane cur- rents flowing during the plateau and repolarization phases of the cardiac action potential. This should drive the membrane potential from the normal level determined by the balance of Isi and I K towards the equilib- rium potential for Na ions (approx. + 50 mV) until the delayed inactiva- tion of the modified Na channels and normal repolarizing mechanisms allow a return of the membrane potential to the normal resting level. Indeed, a prolongation of the repolarization phase is the characteristic effect on cardiac cells of many Na channel-gate toxins. Strong evidence for a selective modification of INa by these agents is the prevention of

Page 20: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 17

their effect on the action potential in Na-poor medium or in the presence of TTX, i.e. under conditions where INa is absent and the action poten- tial occurs through the activation of Isi.

4.1.2 Delayed Repolarization and Oscillatory After-Potentials

The repolarization of the cardiac action potential proceeds in certain phases that are affected differently by individual Na channel-gate toxins. The first or early phase of repolarization to be distinguished in Purkinje fibres occurs immediately after the rapid upstroke and extends from the spike to the beginning of the plateau phase. This early repolarization, which is absent or much less pronounced in atrial and ventricular muscle fibres, has received scant attention in the study of Na channel-gate toxins and seems to be little affected by these agents (Schmidt 1960; Heistracher and Pillat 1962; Hogan and Albuquerque 1971 ; Ar bel et al. 1975; Shimizu et al. 1979). The early phase of repolarization is followed by the plateau phase and a phase of rapid repolarization during which the resting poten- tial level is approached. In purely descriptive terms, there are two ways in which the course of repolarization following the plateau phase may be prolonged, and Na channel-gate toxins can be classified on this basis. First, repolarization can be slowed by a prolongation of the plateau phase, i.e., by a broadening of the action potential at nearly all potential levels between the peak of the plateau potential and the resting potential. Second, repolarization can be slowed, more or less abruptly, at any point during the fast phase of repolarization which follows the plateau phase; the latter and a variable, initial part of the former then remain unaffected. This second modification is usually called depolarizing after-potential or after-depolarization. These terms should replace the term negative after- potential (e.g., Fig. 1 in Shanes 1958), which was introduced when elec- trical activity was measured with extracellular electrodes. The intracellu- lar potential is changed in the positive direction during an after-depolar- ization.

It should be noted that a slowing of the rate of repolarization may have either an anti-arrhytl~mic or an arrhythmogenic effect, depending upon the level of membrane potential at which the slowing occurs. A broaden- ing of the plateau phase at near-zero membrane potential, where both INa and Isi are inactivated in the course of the action potential and unable to recover from inactivation, will make the cell refractory against premature action potentials for as long as the membrane is kept at this depolarized level. If, however, the rate of repolarization is slowed at more negative levels of membrane potential (negative to about - 20 mV), spontaneuous action potentials often arise from the prolonged repolariza- tion phase (Cranefield 1977). This is probably the most important cause

Page 21: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

18 P. Honerj~iger

of the arrhythmias produced by Na channel-gate toxins. The coupling interval and the shape of the triggered action potential depend on the recovery kinetics of INa and Isi during the after-depolarization. As shown by Gettes and Reuter (1974) this recovery is voltage dependent, the time constant for recovery OfVma x increasing from less than 20 ms at - 8 0 mV to more than 100 ms at - 6 0 mV. When the membrane is further depolar- ized to - 9 mV, INa is completely inactivated and the time constant for recovery of" Isi ificreases from about 60 ms to about 250 ms. The critical toxin-induced prolongation of the repolarization phase which leads to re-excitation will therefore depend on the level of membrane potential at which the individual agent slows repolarization. In the case of aconitine (see following sections), which slows repolarization at about - 6 0 mV, triggered activity occurs as soon as the action potential is prolonged by only about 30 ms (cat papillary muscle; Heistracher and Pillat 1962). In contrast, veratridine (see following sections), which prolongs the repolarization phase already at - 2 0 mV, induces spontaneous activity after prolonging the action potential by more than 400 ms (guinea-pig papillary muscle; Honer]alger and Reiter 1975).

After-depolarizations, which result from a delay of the repolarization process, have to be distinguished from oscillatory after-potentials, which occur after the membrane has repolarized completely (Bozler 1943; Ferrier 1977). The latter phenomenon is frequently observed in cardiac cells under conditions of Ca overload and in association with after-con- tractions (Reiter 1962; Kaufmann et al. 1963). Oscillatory after-poten- tials result from an oscillatory inward current that is thought to be trig- gered by a phasic release of Ca ions from an intracellular store (Kass et al. 1978a,b). Thus, an oscillatory Ca release from an intracellular store is regarded as the cause for both after-contractions and oscillatory after- potentials. Kass et al. (1978b) suggested that the oscillatory inward cur- rent may represent either the flow of cations through a non-selective ion channel or the inward movement of Na ions via an alectrogenic Na-Ca exchange mechanism activated by the rise in free intracellular Ca concen- tration. Although oscillatory after-potentials are inhibited by the specific Na channel blocker TTX (Kass et al. 1978b; Rosen and Danilo 1980), oscillatory after-potentials are not likely to be mediated by a delayed reopening of Na channels. The work by Kass et al. (1978b) suggests that any intervention which suppresses the intracellular Ca release responsible for the oscillatory after-potentials will also inhibit oscillatory after-poten- tins. TTX has a negative inotropic action (Sect. 4.2.5) and may thus inhibit oscillatory after-potentials indirectly by reducing intracellular Ca release.

Cranefield (1977) has extended the term after-depolarization to include oscillatory after-potentials. He distinguishes between "early after-depolari-

Page 22: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 19

zations", which interrupt the repolarization phase of the action potential, and "delayed after-depolarizations", which follow complete repolariza- tion.

4.2 Ceveratrum Alkaloids

4. 2.1 Sinoatrial Node

There are no reports on the effects of ceveratrum alkaloids on intracellu- lar potentials in the sinoatrial node, but there is some information on the effects on atrial rate in the dog heart-lung preparation and in isolated guinea-pig atria. Benforado (1957) investigated the effects of nine cevera- trium ester alkaloids (veratridine, cevadine, veratroylzygadenine, vanillo- ylzygadenine, germbudine, neogermitrine, germitetrine, protoveratrine A, and protoveratrine B) on the dog heart-lung preparation by means of electrocardiographic (ECG) recording. Only cevadine produced a consis- tent chronotropic effect, i.e. a sinus tachycardia. The general lack of chronotropic activity shows clearly that the marked bradycardia seen following administration of ester alkaloids to the intact animal has no direct cardiac component (Benforado 1957). The mechanism of the posi- tive chronotropic effect of cevadine is unknown. Cevine, the 3-~-hydroxyl isomer of the alkamine veracevine, causes a bradycardia in the dog heart- lung preparation (Moe and Krayer 1943) by an unknown mechanism. Germine-3-acetate (31 -540 umol/litre) has a positive chronotropic effect on isolated guinea-pig atrium that is abolished by 0.5 t~mol/litre propra- nolol (Seifen 1969). This may indicate that germine-3-acetate affects the sinoatrial node by releasing catecholamines from intracardiac nerve fibres.

4.2.2 Atrium

Horackova and Vassort (1973, 1974) analysed the effect of the alkaloid mixture veratrine (veratrine sulphate, Sigma) on small atrial bundles of the frog heart. They used the double sucrose-gap technique to record both membrane potential and membrane current under membrane-poten- tial control. Veratrine prolongs the repolarization phase of the action potential, which agrees with the earlier findings that veratrine and one of its constituents, cevadine, prolong the action potential in isolated dog and rat atrial tissue (Brooks et al. 1955; Matsuda et al. 1953). The addi- tion of TTX (3 umol/litre) completely suppresses the effect of veratrine on the action potential of frog atrial preparations. Under voltage-clamp conditions, veratrine prolongs the phase of inward current associated with moderate step depolarizations from the normal resting potential, and this induced inward current decays only slowly after repolarization

Page 23: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

20 P. Honerj/iger

(inward "tail" current). The veratrine-induced inward current is abolished by TTX (3 pmol/litre), and veratrine fails to modify the remaining inward current (Isi) if external Na ions are replaced by sucrose. If Na ions are replaced by Li, veratrine increases inward current, as in the presence of external NA. These findings indicate that veratrine prolongs the open state of Na channels in frog atrial fibres. During a depolarizing pulse, the decay of INa is slowed by veratrine, indicating that the h gate closes more slowly in a fraction of Na channels. In the modified channels, the time constant o f inactivation (rh) during depolarization by 40 mV from the normal resting potential is increased to 1 .1 -1 .9 s (18° -20°C) , i.e. by 3 orders of magnitude. There is no obvious effect on the activation of Na channels upon depolarization, but the removal of activation after repolarization is slowed, as indicated by the inward tail currents that decline exponentially with time constants of 0 . 4 -0 .7 s. This shows that veratrine has little or no effect on the rate constant am, but markedly reduces ~m 1. These effects are not identical to the effect of veratridine on Na channels in the frog node of Ranvier (Sect. 3.2), although in both types of cells, veratridine and veratrine, respectively, increase the Na inward current associated with the action potential. In the frog node of Ranvier, veratridine diminishes both a m and ~m, i.e, ~'m is increased dur- ing depolarization as well as after repolarizatio n 2. Furthermore, veratri- dine completely removes inactivation in the neural Na channels. It is not clear whether this discrepancy reflects a genuine difference 0etween neural and myocardial Na channels or whether the cardiac effects are due to ceveratrum alkaloids other than veratridine present in the alkaloidal mixture veratrine.

Horackova and Vassort (1973, 1974) were the first to show that the effect on sarcolemmal PNa and the positive inotropic effect of veratrine are intimately linked. They found that the positive inotropic effect is abolished by TTX (3 umol/litre), which also blocks the veratrine-induced prolongation of the action potential. The positive inotropic effect of vera- trine on frog atrial muscle develops during identical repetitive depolariza- tions under voltage-clamp conditions indicating that it is related to the change of membrane current and not to the veratrine-induced alteration of the duration of the action potent ial . As shown by Horackova and Vassort (1974) the veratrine4nduced Na inward current does not lead to an increase in the rate of force development of the s imul taneous contrac- tion within a given excitation-contraction cycle. In a previously resting

1 a m and /3 m are the rate constants for the activation and deactivation, respectively, of the m gate of the Na channels (Hod~kin and Huxley 1952). These rate constants are related to the time constant of the m gate by the equation 7rn = 1/(am + ~m)

2 Ulbrieht (1969) uses the symbols c~ s and/3 s for the veratridine-modified Na channels

Page 24: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 21

veratrine-treated muscle, the positive inotropic effect appears only during the course of several excitations above a critical frequency. This shows that the bioelectric and positive inotropic effect of veratrine are linked by a slowly responding accumulative process (Sect. 4.2.5). All the findings suggest that veratrine increases the force of contraction by increasing the intracellular Na concentration through its effect on the Na channels. An intracellular accumulation of Na ions is expected to activate Na-Ca exchange (Chap. 5) which could explain the positive inotropic effect.

4.2. 3 A trioventricular Node

There are no reports on the effect of ceveratrum alkaloids on the trans- membrane electrical activity of cells of the atrioventricular node. Using extracellular recording electrodes, Swain and McCarthy (1957) studied the effect of ceveratrum alkaloids on atrioventricular conduction in the dog heart-lung preparation. Veratrine, its main constituents veratridine and cevadine, and protoveratrine (a mixture of the protoveratrines A and B) each slow atrioventricular conduction. In the case of veratrine this effect is particularly pronounced at high frequencies, while at low frequencies veratrine may even accelerate atrioventricular conduction. At high frequencies the effect of veratrine is characterized by alternation of atrioventricular conduction time. The spontaneous firing rate of the atrioventricular node recorded after elimination of the activity of the sinoatrial node is enhanced by protoveratrine.

4. 2. 4 PurMn]e Fibres

Arbel et al. (1975) studied the effect of veratrine (Sigma) on the isolated ventricular conduction system of the dog heart with intracellular micro- electrodes. They found that superfusion of Purkinje fibres in the right bundle branch with solution containing 0 .1-1 ~g/ml veratrine causes a slowing of repolarization that affects the plateau phase and terminal repolarization phase of the action potential. The latter effect may result in the appearance of a distinct after-depolarization. Higher veratrine con- centrations induce oscillatory responses superimposed on the prolonged repolarization phase. The after-depolarization was followed in some experiments by a slight hyperpolarization. The prolonging effect on the repolarization phase is reversed by washout with veratrine-free solution. In ventricular muscle cells of the anterior papillary muscle dissected together with the bundle branch, the prolongation of the action poten- tial by veratrine is less, both in absolute units and if related to the con- trol duration, than that recorded simultaneouSly from Purkinje fibres.

Page 25: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

22 P. Honerj~iger

The effect on repolarization is interpreted as resulting from the persistent activation of Na channels because it is inhibited by TTX (0.3-3 ~mol/ litre). Arbel et al. (1975) note that TTX abolished the effect of veratrine on repolarization at a time when the Purkinje fibre is still excitable, indi- cating that at least a major fraction of the normal Na channels that medi- ate the upstroke of the action potential is not blocked by that concentra- tion of TTX. One might thus conclude that the Na channels activated by veratrine are more sensitive to TTX than normal Na channels. In this context it is of interest that even during the normal action potential of Purkinje fibres, a component of persistent and TTX-sensitive Na current was detected (Attwell et al. 1979); this explains why TTX has a marked shortening effect on the normal action potential of Purkinje fibres (Cora- boeuf et al. 1979). It appears that, in the absence (Coraboeuf et al. 1979) as well as in the presence of veratrine (Arbel et al. 1975), the effect of TTX on the repolarization phase requires lower concentrations than its inhibitory effect on the rate of rise of the action potential. As pointed out by A ttwell et al. (1979), such a differential sensitivity does not necessarily indicate that the Na channels activated during upstroke of the action potential and those activated during the plateau phase differ in their sensitivity to TTX. Rather, the blockade of the same small frac- tion of Na channels by TTX may result in a larger effect on action potential duration than on upstroke velocity, if the small fraction of the Na current blocked by TTX is a large fraction of the net inward membrane current flowing during the plateau phase. Thus, the different sensitivity to TTX of the two phases of the action potential might be due to the fact that the upstroke is almost entirely the result of net inward Na current through Na channels, whereas during the plateau a considerable fraction of the inward ionic current is balanced by outward K current. This considera- tion applies equally to the situation when the action potential is pro- longed by Na channel-gate toxins. It is therefore not necessary to postu- late that veratrine activates an additional population of Na channels dif- fering by an abnormally high sensitivity to TTX from normal Na chan- nels responsible for the upstroke of the action potential. In the frog node of Ranvier, normal and veratridine-modified Na channels were identical in their sensitivity to TTX (Ulbricht 1974).

Veratridine (0.1 umol/litre) has recently been shown to increase the force of contraction of canine Purkinje fibres stimulated at 1 Hz (Vassalle and Bhattacharyya 1980). The positive inotropic effect, as well as the prolongation of the action potential observed in the same study, are antagonized by the local anaesthetics procaine or benzocaine.

Page 26: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 23

4.25 Ventricular Muscle

Although the direct positive inotropic effect of ceveratrum alkaloids had already been discovered at the beginning of this century (see Krayer and Acheson 1946), analytical and quantitative studies of this effect were per- formed only in recent years (Reiter 1963; Koch-Weser 1966; Horackova and Vassort 1973, 1974; Honerjdger and Reiter 1975, 1977a; Honerjdger 1977, 1980). An understanding of the cardiac effects of these alkaloids was only possible after Ulbricht (1969) had shown that veratridine alters the Na channels of the excitable membrane. Detailed information on the effects of individual ceveratrum alkaloids on ventricular myocardium was obtained in the isolated isometrically contracting papillary muscle of the guinea pig (Honerj~iger and Reiter 1975, 1977a;Honerjdger 1977, 1980).

In this section, various aspects of the positive inotropic effect are described including the concentration-effect relationships, the modifica- tions of individual phases of the isometric contraction curve and the differentiation of the direct from a neurally mediated positive inotropic effect. Effects on transmembrane electrical activity are also described. Finally, the mechanism of positive inotropic action is discussed, as well as arguments suggesting that the positive inotropic effect is an indirect consequence of the modification of sarcolemmal Na channels leading to increased Na influx, intracellular Na accumulation and increased Na-Ca exchange.

Positive Inotropic Effect The positive inotropic effect of ceveratrum alkaloids on the isometrically suspended guinea-pig papillary muscle results from an increase in the rate of force development, while the time to peak force is unaltered or slightly shortened (Figs. 2, 3). The term klinotropic was introduced to denote influences on the steepness of the contraction curve (Bohnenkamp 1922; Reiter 1972a). The positive inotropic effect of ceveratrum alkaloids is thus of the positive klinotropic type. With respect to their influence on the relaxation phase, two types of effect can be distinguished. Veratri- dine (Fig. 2), as well as cevadine (Reiter 1963; Honerjgiger 1977), verace- vine, zygadenine, and veratroylzygadenine (Honerjdger 1977)markedly prolong relaxation time and thereby total contraction time. In contrast, no major effect on total contraction time is observed under the influence of germitrine (Fig. 3), other germine di- and triesters or the protovera- trines A and B (Honerjdger 1977). This varied effect on the relaxation phase is probably due to the different modifications of the repolarization phase by these alkaloids. Furthermore, TTX inhibits the effect of veratri- dine on relaxation in addition to that on the repolarization phase sugges- ting a causal connection (see Fig. 9). A direct effect on the rate of Ca sequestration by sarcoplasmic reticulum thus seems to be ruled out.

Page 27: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

24 P. Honerj~iger

/ 1.6 pM (F) 20 ~ 0 . 8 pM ' ~ 1-6HM

°NTR°'

0L/ I I I I

200 ms 200 ms

Fig. 2. The positive inotropic effect of veratridine. Isometric contraction records from an isolated guinea-pig papillary muscle contracting at 1 Hz and exposed to cumulatively increasing concentrations of veratridine. Note the prolongation of the relaxation phase. (From Honerjiiger and Reiter 1975)

F c

(g)

2.0

1.5

1.0

0.5

~1 80 nM 40 nM

60 nM 20 nM 10 0 .

/ Z / / / ~ C50 2T~O L ;Yf \\ f 'M_

i ! 200 ms

Fig. 3. The positive inotropic effect of germitrine. Isometric contraction records from an isolated guinea-pig papillary mus- cle contracting at 1 Hz and exposed to cumulatively increasing concentrations of germitrine. Note that this ceveratrum alkaloid does not markedly alter the dura- tion of contraction. (From Honerf~'ger and Reiter 1977a, by permission of American Heart Association)

Indeed, veratridine (1 #mol/1 to 1 mmol/1) is reportedly without effect on Ca uptake by sarcoplasmic reticulum isolated from rabbit skeletal muscle (Johnson and Inesi 1969).

The positive inotropic activity resides in the alkamine part of the ceve- ratrum alkaloids, but esterification increases the potency. The alkamines zygadenine and veracevine (each at 0.5 mmol/litre) produce a positive inotrpic effect, while germine (0.8 mmol/litre) and protoverine (5 mmol/ litre) are inactive (Honer]iiger 1977). Graded, steady-state positive ino- tropic effects can be obtained with different concentrations of cevera- trum alkaloids, suggesting a reversible binding reaction with the receptor for the positive inotropic effect. In fact, the positive inotropic effect of

Page 28: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State 6f Sodium Channels 25

Positive inotropic effect,AF c (% of maximum)

100

90

60

70

60

50

','-0

30

20

10

010-9

I

I

10 -8

Y / I

10 -7

I I

!1 I I I

10 -6 tO -5 tO -4 10 -3

Alkaloid concentration (mol/I)

Fig. 4. Concentration-effect relationships for the positive inotropic effect of cevera- trum ester alkaloids: Abscissa, molar concentration of alkaloid, logarithmic scale; ordinate, positive inotropic effect expressed as percent of the maximum increase in force of contraction obtained with each alkaloid. Means of at least six guinea-pig papillary muscles for each alkaloid (SEM < 7%).Germitetrine (1), protoveratrine A (2), germitrine (3), protoveratrine B (4), neogermitrine (5), desacetylgermitetrine (6), germerine (7), germbudine (8), veratroylzygadenine (9), neogermbudine (10), vera- tridine (11), cevadine (12), zygacine (13), and germine-3-acetate (14). (From Honer- ]iiger 1977)

veratridine disappears during washout with alkaloid-free medium, although only very slowly (Honer]dger and Reiter 1975). The concentration-depen- dence of the positive inotropic effect obtained with 14 different cevera- trum ester alkaloids is shown in Fig. 4. The absolute maximum increase in force of contraction, corrected for cross-sectional area of individual muscles, does not differ significantly among the various alkaloids. The concentration-effect relationships are nearly parallel and relatively steep. Each curve extends over approximately 1.5 logarithmic units. The con- centration-effect relationship for the increase of PNa by veratridine is less steep and compatible with a reversible one-to-one binding reaction between veratridine molecules and the receptor at the Na channel (Carte- rall 1975). Presumably, the concentration-effect curve for the positive inotropic effect of ceveratrum alkaloids is limited by the capacity of the muscle to increase force development and not by the ability of cevera- trum alkaloids to increase sarcolemmal PNa (Honer]dger and Reiter 1975, 1977a). The maximum positive inotropic effect o f veratridine and

Page 29: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

26 P. Honerj~iger

germitrine was found to be 68% and 81%, respectively, of that of the car- dioactive steroid dihydro-ouabain tested on the same papillary muscle (Honerjdger and Reiter 1975, 1977a).

Like other depolarizing interventions, veratridine causes a release of noradrenaline from intracardiac adrenergic nerve endings (Moss et al. 1974). The release is mainly of the exocytotic type (Thoa et al. 1975; Ross and Kelder 1979). In addition, veratridine has a TTX-resistant, reser- pine-like noradrenaline-depleting effect on the storage vesicles, but this effect does not normally lead to increased release of noradrenaline from the nerve ending (Bdnisch et al. 1980). The positive inotropic effect of ceveratrum alkaloids, including veratridine, persists in muscles that have been depleted of noradrenaline by reserpine pretreatment (I£och-Weser 1966; Honerjiiger and Reiter 1975, 1977a). This argues against the par- ticipation of a neural mechanism in the positive inotropic action under normal conditions (1 Hz contraction frequency). In contrast, concentra- tions of veratridine or cevadine exceeding those maximally effective at a frequency of 1 Hz increase the force of the rested-state contraction entirely by a neurally mediated mechanism (floner]iiger 1980). This posi- tive inotropic effect is absent in the presence of a neuroactive, but not yet cardioactive concentration of TTX (100 nmol/litre) and in muscles from reserpine-pretreated animals. It is inhibited by 50 nmol/litre ( - )p ro - pranolol, but not by the same concentration of the dextrorotatory enan- tiomer. The concentration-effect relationships for the direct and the neurally mediated positive inotropic effect of veratridine are illustrated in Fig. 5. While all these findings demonstrate that ceveratrum alkaloids affect isolated ventricular mammalian myocardium normally by a direct myotropic action, Basseches and Bianchi (1976) conclude, on the basis of their experiments on the perfused frog ventricle, that veratridine acts by enhancing transmitter release from cholinergic and adrenergic nerve fibres. The discrepancy may in part be due to the fact that Basseches and Bianchi (1976) used a field stimulus on their preparations which also excited both cholinergic and adrenergic nerve terminals. Under these con- ditions the frog ventricle may be more sensitive to the neural effects of veratridine.

Transrnembrane Electrical Activity Veratridine prolongs the repolarization phase of the action potential in guinea-pig papillary muscle (Honerjiiger and Reiter 1975) and the effect of a relatively high concentration (2 umol/litre) is illustrated in Fig. 6. For this experiment the papillary muscle was stimulated only once every 5 rain which, because of the frequency-dependence of the inotropic action, prevents the positive inotropic effect of veratridine. Secondary superimposed effects on the action potential expected to result from

Page 30: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 27

25 dEc

2O

10

I I i i I I |

Contractions t at 1Hz ~ / T ~

/÷ .e2.,a, contraction / (9)

, 0.1 0.3 1.0 3.0 1() 310

Veratridine concentration (pmoFI)

Fig. 5. Concentration-effect relationships for the direct (left curve) and neurally mediated (right curve) positive inotropic effect of veratridine on guinea-pig papillary muscle. The direct (reserpine-insensitive) effect was measured on muscles contracting at 1 Hz and exposed to cumulatively increasing concentrations. The presynaptic (reserpine-sensitive) effect was obtained on muscles that were incubated at rest with a single concentration of veratridine to determine its effect on the subsequent rested- state contraction. Number of muscles is given in parentheses. The inset shows a con- trol rested-state contraction and a second one amplified by exposure of the resting muscle to 30/lmol/litre veratridine (V); calibration: 5 mN (vertical), 0.2 s (horizon- tal). (From Honerja'ger 1980)

NO DRUG VERATRIDINE

TETRODOTOXIN

["1 200 [

-8

I 2 0 q m s 200

Fig. 6 A--C. Effect of veratridine on the transmembrane action potential of guinea- pig papillary muscle and blockade of the effect by TTX. Before (A), 25 min after addition of 2 #mol/litre veratridine (B), and 7 rain after additonal application of TTX (10 #mol/litre) 1(C). Continuous microelectrode impalement. Stimulation fre- quency was 0.2 min- . The broad trace is the differentiation of the upstroke of the action potential and was obtained at the faster sweep speed. (From Honerjiz'ger 1977)

increased in t racel lu lar Ca, n o t a b l y an abbrev ia t ion o f the ac t ion p o t e n t i a l (Isenberg 1975; Bassingthwaighte et al. 1976), are hence avoided. Vera- t r id ine does no t a f fec t the rest ing m e m b r a n e po t en t i a l or Vma x (Fig. 6). The o v e r s h o o t o f the ac t ion po t en t i a l is sl ightly r educed (by 4 mV) . The

p la t eau phase assumes an u p w a r d concave c o n t o u r in con t ras t to the con- vex shape p resen t u n d e r con t ro l condi t ions . The repo la r i za t ion phase is

Page 31: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

28 P. Honerj~iger

slowed particularly as it proceeds from +16 mV to 20 mV and from - 6 0 mV to the resting potential level. Additional application of TTX (10 gmol/litre) completely restores the original action potential duration while reducing Vma x by about 50% (Fig. 6C). The sensitivity of the vera- tridine effect to TTX strongly suggests that it is mediated by Na channels. As discussed in Sect. 4.2.4, the stronger effect of TTX on repolarization than on Vma x does not argue against the identity of the Na channels responsible for the upstroke with those activated by veratridine during the plateau phase. A prolongation of the cardiac action potential may lead to an extracellular accumulation of K ions resulting in an after- depolarization (Cleeman and Morad 1976). In the presence of veratridine such an effect may play an additional role during the final phase of repolarization.

Reiter (1963) pointed out that the monoesteralkaloids veratridine and cevadine differ in their effect on the repolarization phase. Cevadine pro- longs the plateau phase of the action potential whereas veratridine pre- dominantly slows the subsequent phase of normally fast repolarization. This difference is reflected by the relaxation phase of the isometric con- traction. Cevadine slows the initial part and veratridine delays the final part of relaxation (Reiter 1963).

The effect of the germine triester germitrine on action potential differs from that of veratridine in that only the very final phase of repolariza- tion is prolonged, causing the appearance of an after-depolarization lasting longer than 1 min (Honerj~ger and Reiter 1977a). As shown in Fig. 7, germitrine stops the repolarization process at a level about 6 mV positive to the resting potential. Thereafter the membrane depolarizes again slightly, to a maximum level about 9 mV positive to the resting potential, and then repolarizes very slowly. The original level of the resting poten- tial is eventually reached after a slight hyperpolarization (Fig. 8). The after-depolarization produced by di- and triesters of germine, as well as by the two tetraesters of protoverine, protoveratrine A and protovera- trine B (Fig. 8) must be distinguished from the oscillatory after-potentials observed under conditions of Ca overload. The latter occur after com- plete repolarization and in an oscillatory manner: They are of shorter duration and not mediated by Na channels (Sect. 4.1.2). The germitrine- induced after-depolarization is completely and reversibly blocked by 10 ~mol/litre TTX, suggesting that it results from a delayed activation of Na channels (Honer]alger and Reiter 1977a). The amplitude of the after- depolarization increases with the concentration of germitrine.

The demonstration of the germitrine effect requires a very low stimula- tion frequency (cf. Fig. 7). If a germitrine-treated muscle is stimulated repetitively at intervals shorter than the duration of the germitrine- induced after-depolarization, the resting potential shows a stepwise

Page 32: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels

a b

29

mV 0

0.2gE -80

I I 100 ms/1 ms

10 mV

I , I

0.5 min

Fig. 7 a,b. Effect of germitrine on the transmembrane action potential and contrac- tion of a guinea-pig papillary muscle stimulated once every 10 rain. The upper panels show the action potential and isometric contraction at a slow sweep speed and the upstroke of the action potential at a fast sweep speed. The records shown in the lower panels were obtained simultaneously with the corresponding upper records on a second oscilloscope at higher gain and very slow sweep speed. They show the mem- brane potential before and during a period of 1.5 min after the action potential. The action potential causes the interruption (arrow) of these traces. Records were obtained before (a) and 74 rain after (b) addition of 2/2mol/litre germitrine. Note incomplete repolarization (b, upper panel), which gives rise to an after-depolarization (b, lower panel). (From Honerja'ger and Reiter 1977a, by permission of American Heart Asso- ciation)

decrease (Honer/alger and Reiter 1977a). This phenomenon is analogous to the well-known "summat ion" of after-depolarizations observed ifvera- tridine-treated nerve fibres are subjected to high-frequency stimulation (Ulbricht 1969). In the presence of high germitrine concentrations, the repetitive stimulation leads eventually to arrhythmic activity of the papil- lary muscle if the after-depolarization reaches the threshold to eficit an action potential. At 80 nmol/litre germitrine, the maximally effective inotropic and non-arrhythmic concentration at 1 Hz frequency, the sum- mation of after-depolarizations results in a decrease of the resting poten- tial by about 10 mV in the steady-state (Honer]alger and Reiter 1977a).

Mechanism o f the Positive Inotropic Effect Studies of the effects of veratridine (Reiter 1963; Honerjdger and Reiter 1975) and germitrine (Honer]ager and Reiter 1977a) revealed a close association o f the bioelectric and inotropic effects in guinea-pig papillary muscle that strongly suggests a causal relationship. The results may be summarized as follows:

Page 33: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

30 P. Honerj~iger

I__~ No drug

E~-

E ~

E_

[_

Germerine

Neogermbudine

Germbudine

Desacetylgermitet fine

Neogermitrine

E m

E_ [_

E_

~ e r m i t r i n e

~. Protoveratrine A

~ rotoveratrine B

~ ~ = ~ . . . _ . ~ Germitetrine

I I I I 1 2 3 4 min

Fig. 8. After-depolarizations induced in guinea-pig papillary muscle by various ceve- ratrum ester alkaloids. High-gain records of transmembrane potential immediately before and after the stimulation of an action potential. The action potential causes the interruption of the traces at the time marked 0. Experimental procedure as in Fig. 7. The following alkaloid concentrations were used (/~mol/litre): germerine (4); neogermbudine (10); germbudine (8); desacetylgermitetrine (4); neogermitrine (2); germitrine (2); protoveratfine A (3); protoveratrine B (12); and germitetrine (4). Vertical calibration was 5 mV. (From Honer]alger 1977)

1. Inotropically effective concentrations of veratridine or germitrine also produce changes of the transmembrane electrical activity attributable

to an increased PNa" 2. TTX inhibits the bioelectric as well as the positive inotropic effect of

veratridine or germitfine. 3. While the bioelectric and inotropic effects appear to occur simultane-

ously in repetitively stimulated preparations, a closer analysis reveals that the positive inotropic effect is in fact delayed with respect to the phase of increased PNa produced by either veratridine (Honer]alger 1977) or germitrine (Honer]alger and Reiter 1977a)and decays slowly

in the non-excited muscle.

Page 34: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 31

4. As a consequence of the delayed and transient inotropic response to the alkaloid-induced PNa' the positive inotropic effect does not mani- fest itself when contractions are separated by long rest intervals (e.g., 5 min). The inotropic effect appears and grows as the frequency is increased from 0.004 Hz to 0.5 Hz.

5. The positive inotropic response to the combination of a ceveratrum alkaloid with dihydro-ouabain is much larger than the sum of the responses to either drug alone. This synergism points to the impor- tance of the intracellular Na concentration in mediating the positive inotropic effect of ceveratrum alkaloids. The extent of the alkaloid- induced increase in [Nail must be enhanced by an additional inhibi- tion of the Na pump.

TTX has proved a valuable tool in identifying the mechanism of the positive inotropic action of ceveratrum alkaloids and Na channel-gate toxins in general. The selective action of TTX in blocking Na channels of excitable membranes at an extracellular membrane site has been exten- sively documented (see Narahashi 1974). While suppressing INa, TTX does not significantly affect the slow inward current in frog atrial myo- cardium (Tarr 1971) or, at 47 gmol/litre, in dog ventricular myocardium (Beeler and Reuter 1970b). With regard to the analysis of changes in con- tractile activity it is important to note that TTX does not appear to penetrate through the plasmalemma as shown in studies on the squid giant axon (Narahashi et al. 1966; Ro]as and Rudy 1976). Thus, TTX is unlikely to interfere directly with any intracellular process of excitation- contraction coupling or the contraction of the contractile proteins. TTX may affect myocardial force of contraction by two recognized mecha- nisms 3. It abolishes the positive inotropic effect associated with field stimulation by blocking the excitability of intracardiac adrenergic nerve fibres (Feinstein and Paimre 1968). This effect requires very low concen- trations (31-63 nmol/litre) that have virtually no effect on the Na chan- nels of guinea-pig myocardial ceils as judged by the upstroke of the action potential (Baer et al. 1976). Similarly low concentrations of TTX likewise abolish the presynaptic (or "indirect") positive inotropic effect of veratridine or cevadine (see p. 26). The second mechanism by which TTX affects myocardial force involves the blockade of sarcolemmal Na channels. At a frequency of 1 Hz, 10 #mol/litre TTX reduces 9max by about 50% and peak force of contraction by about 30% in noradrenaline- depleted guinea-pig papillary muscle (Honerjiiger and Reiter 1975). This direct negative inotropic action has to be taken into account when TTX is used as an antagonist of positive inotropic agents.

3 The citrate buffer present in the commercial preparation of TTX does not cause a significant inotropic effect of its own when tested at a concentration correspond- ing to 15/~mol/litre TTX (Honer]iiger and Reiter 1975)

Page 35: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

32 P. Honerj~iger

The antagonistic effect of TTX against both the bioelectric and ino- tropic effects of veratridine is illustrated in Fig. 9. TTX completely and reversibly abolishes the positive inotropic effect of veratridine. The negative inotropic effect of TTX in the presence of veratridine is much larger than that observed in its absence, showing the specific nature of the antagonism. As Fig. 10 shows, TTX antagonizes the positive ino- tropic effect of ceveratrum alkaloids selectively. The effects of represen- tatives of three other classes of inotropic agents, a cardioactive steroid, a catecholamine and a methylxanthine are not, or much less, inhibited by TTX. Interestingly, the positive inotropic effect of dihydro-ouabain, which also depends critically on Na influx (Reiter 1972a), is less sensi- tive to TTX than that of the ceveratrum alkaloids veratridine, cevadine, and germitrine. In the case of the steroid, the increase in intracellular Na concentration results from inhibition of the Na pump, and the extent of this increase is diminished if passive Na influx is inhibited by TTX. This might explain the slight antagonism observed (Fig. 10). TTX is expected to be more effective in reducing the alkaloid-induced Na influx than the normal Na influx, on which the inotropic action of the steroid may depend, for the following reasons: Firstly, the normal Na influx probably occurs through TTX-sensitive Na channels as well as through TTX-insensitive ion channels such as slow (Ca, Na) channels (Reuter and Scholz 1977). Secondly, the Na influx induced by Na channel-gate toxins during the repolarization phase is probably more strongly inhibi- ted by TTX than the Na influx occurring during the upstroke, as sug- gested by the higher TTX sensitivity o f the repolarization phase (Sect. 4.2.5).

l ~ - V e r a t r i d i n e , 1.6 FN I Control

TTX, 16 I~H

m V

0

-100

\ / "

I,

\ \ \

l t . 0 g

I I I 0 2 0 0 &00 m s e c

Fig. 9. Reversible inhibition of the effects of veratridine on action potential and con- traction by TTX in guinea-pig papillary muscle. The records were obtained (from left to right) before drug application, 50 min after addition of veratridine ( 1.6 gmol/litre), 5 rain after additonal application of TTX (16/~mol/litre), and after washout of TTX during maintained exposure to veratridine. Muscle was from a reserpine-pretreated animal. Contraction frequency was 1 Hz. (From Honer]iiger and Reiter 1975)

Page 36: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 33

i

100 r CEVADINE "~

I- ~G ®

el 2

> no

VERATRIDINE / ° -'~

/ / ,/), /" jJ

GERMITRINE /°_ //')/"/'~

/ i " sl, ]f

DIHYDRO-OUABAIN ,0.~/o

N O R A D R E N A L I N ~

[/TX] = 0

[TTX] = 10 pM

5 I THEOPHYLLINE Z / J J ~ {raN)

0 L i 4.1 1

i i

10 100 x EC50

Fig. 10. Specificity of TTX as an antagonist of inotropic drugs. Concentration-effect relationships obtained in the absence and presence of TTX (10//mol/litre) by cumu- lative drug additions. Ordinate: positive inotropic effect expressed as percent of the maximum effect obtainable under each condition, except in the case of theophylline where the absolute increase of force of contraction is given; abscissa: drug concentra- tion in logarithmic scale expressed in units of half-maximally effective concentrations in the absence of TTX. Means -+ SEM {vertical bars] of at least six guinea-pig papillary muscles. For the ceveratrum alkaloids (cevadine, veratridine, and germitrine) control and TTX experiments were done on separate muscles. Each of the other drugs was tested, both in the absence and presence of TTX on the same muscle. Contraction frequency was 1 Hz. (From Honer]iiger 1977)

Page 37: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

34 P. Honerj~iger

The inhibitory effect of 10 tsmol/litre TTX is fully surmountable by increases in the concentration of the ceveratrum alkaloids (Fig. 10). This should not be taken as evidence for a competitive type of antago- nism between the alkaloids and TTX. The antagonism between Na chan- nel-gate toxins and TTX at the level of Na channels is non-competitive (Sect. 3.10.1). The inotropically effective range of alkaloid concentra- tions probably modifies only a small fraction of Na channels, and this fraction can still be affected by the gate toxins at a TTX concentration (10/~mol/litre) that blocks only about 50% of the Na channels (Honer- ]iiger and Reiter 1975).

Although the inhibition of veratridine effects by TTX suggests a causal relationship between the bioelectric and the inotropic effect of veratri- dine, it remains uncertain whether veratridine increases force of contrac- tion by increasing Na influx or by prolonging the repolarization phase (thereby indirectly prolonging the phase of Ca influx through slow chan- nels). However, the prolongation of the action potential, under the con- ditions of Fig. 9, is restricted to negative levels of membrane potential where a prolongation of repolarization per se produces little positive ino- tropic effect (Wood et al. 1969). In the case of germitrine the positive inotropic effect is even associated with a marked shortening of the action potential duration, in addition to the reduction of the resting membrane potential reflecting the increased PNa (Honer]iiger and Reiter 1977a). This rules out a secondary effect on Isi as a cause of the positive inotropic effect for this ceveratrum alkaloid. The strongest evidence in support of the hypothesis that ceveratrum alkaloids act by increasing inward Na cur- rent is provided by the voltage-clamp experiments of Horackova and Vassort (1973, 1974) on frog atrial muscle (Sect. 4.2.2).

The germitrine4nduced after-depolarization is particularly suitable for a study of the temporal relationship between the phase of increased PNa and the positive inotropic effect. By choosing an appropriate alkaloid concentration, the amplitude of the after-depolarization can be adjusted to a level which is well below the activation threshold for Isi ( - 40 mV; New and Trautwein 1972) and which leaves the muscle electrically excit- able throughout the course of the after-depolarization. Test contractions elicited at various times during or after the alkaloid-induced after-depolari- zation (Fig. 11) reveal a phase during which the ability of the muscle to develop force is increased. This positive inotropic influence reaches its maximum 1 min after the conditioning stimulus and thereafter decays with a half-life of 2.5 min. In contrast, the after-depolarization attains a peak value about 10 s after the conditioning action potential and decays with a half-life of 32 s. Thus the phase of increased PNa clearly precedes the phase of increased contractility. This is compatible with a role of the intracellular Na concentration in mediating the positive inotropic effect.

Page 38: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 35

100

] [

~E 50

"=:t ]E I L o

o °

TER t \ INOTROPIC DE POL;RIZATION ~ E C T (t, Fe/

I I i 1 2 3 4 5 6

; -: TIME AFTER ACTION-POTENTIAL UPSTROKE o----o REST INTERVAL AFTER RESTED-STATE CONTRACTION

,

200 ms

"ec l,oor.~

I I I --~- 7 8 g 10 (rain)

Fig. 11. Temporal relationship between the germitrine-induced after-depolarization and the germitrine-induced positive inotropic effect as determined by single test con- tractions during and after the after-depolarization. Ordinate: membrane potential dur- ing the after-depolarization which followed an action potential elicited at 0 time ( 100% = 8.1 -+ 0.4 mV) (o) and peak force of test contraction minus peak force of prior rested- state contraction (100% = 79 + 16 rag) (o). The time-course of the after-depolariza- tion is shown by means + SEM of 27-29 records obtained from six muscles incubated with 2 #mol/litre germitrine for at least 1 h. The positive inotropic effect (means + SEM of six to eight muscles) was determined in different muscles. Inset shows enhance- ment of test contraction (trace 2) elicited 1 rain after the conditioning rested-state contraction (trace I), i.e. during the falling phase of the after-depolarization. (From Honer]~'ger and Reiter 1977a, by permission of American Heart Association)

[Na]i will continue to rise during the period of increased PNa and sub: sequently decline owing to the activity o f the Na pump. Direct verifica- tion of this point by the use of an intracellular Na-sensitive micro-elec- trode would be o f great interest.

It is generally accepted that the contraction of cardiac cells is directly linked to the increase in free Ca concentration of the myoplasm. An increased intracellular Na concentration can mediate a positive inotropic effect indirectly by increasing the transsarcolemmal influx of Ca ions, thereby loading cellular Ca stores that release Ca during contraction. I f Na-Ca exchange is enhanced by the depolarization produced by the action potential (Sect. 5.3.4; Mullins 1979), an increased level of [Na]i may not only increase the steady influx of Ca ions but especially that occurring during the action potential. The evidence suggesting the exis- tence of a Na-Ca exchange mechanism in the plasmalemma is discussed in Chap. 5.

Page 39: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

36 P. Honerj~iger

Few attempts have been made to rule out alternative mechanisms of the positive inotropic effect by direct biochemical experiments. The activity of Na, K-ATPase isolated from guinea-pig hearts is not affected by con- centrations of ceveratrum alkaloids (veratridine, cevadine, protoveratrine A and B, germitetrine, desacetylgermitetrine) that are much higher than those causing a maximum positive inotropic effect on guinea-pig papil- lary muscle (Portius and Repke 1964). Veratridine, cevadine, and proto- veratrine lack an inhibitory effect on the active Na-K transport of ery- throcytes (Kahn and Acheson 1955). Sperelakis and Pappano (1969) noted that veratrine did not significantly change the internal K and Na content of intact embryonic chick hearts during 15 min, which argues against inhibition of the Na pump. There is apparently no report on whether inotropically effective concentrations of ceveratrum alkaloids influence the concentration of cyclic nucleotides in myocardial cells. However, it should be noted that many functional characteristics of the inotropic action of ceveratrum alkaloids (and other Na channel-gate toxins) differ clearly from those associated with agents thought to act by increasing the cellular content of cyclic adenosine 3' ,5 '-monophosphate (cAMP) (Sect. 5.1).

4. 2. 6 Cardiac Cells in Culture

During the embryonic development of chick and rat hearts, Vma x of the cardiac action potential and the susceptibility of action potential and contraction to TTX were shown to increase progressively (Bernard and Gargouil 1968; Ishirna 1968; Shigenobu and Sperelakis 1971; Sperelakis and Shigenobu 1972; Pappano 1972; McDonald et al. 1972; DeHaan et al. 1975; McDonald and Sachs 1975; Ii]ima and Pappano 1979). Thus, in the early embryonic stage ( 2 - 4 days in ovo), cardiac cells seem to lack fast Na channels. The action potential is mainly due to the opening of a slow Na channel insensitive to TTX (Sperelakis and Shigenobu 1972). Cardiac cells cultured in the form of monolayers invariably display TTX- insensitive action potentials even if the cells are taken from embryos older than 5 days. Cultured in aggregates, they generally retain the TTX sensi- itivity of the embryonic heart from which they were derived (McDonald et al. 1972;McLean and Sperelakis 1976).

Sperelakis and Pappano (1969) investigated the effects of veratrine and veratridine on ventricular myoblasts obtained from 7-15-day chick embryos, but grown in monolayers. Veratridine (1 .5-15 ~mol/litre) depolarizes the cells within a few minutes to membrane potentials of about - 1 2 mV, and action potentials and beating cease. Before the depolarization begins, the repolarization phase of the action potential is prolonged by veratridine. TTX (63 ~mol/litre), although without effect

Page 40: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 37

on action potential magnitude or Vma x, prevents the depolarization and prolongation of the action potential by veratridine. The depolarization by veratridine also occurs in Na-free Li solution. Veratridine reduces the membrane resistance. This is not prevented by TTX and is attributed to an increased K permeability. In 3- and 16-day aggregates of chick embry- onic heart cells, veratridine produces depolarization and blocks the elec- trical and mechanical activities at concentrations exceeding 10 ~mol/litre (Romey et al. 1980). Romey et al. (1980) suggest that, like other Na channel-gate toxins, veratridine reveals Na channels that are normally in a silent form in monolayers or 3-day aggregates.

The activation of Na channels by veratridine leads to an increase of Na influx into the myoblasts as determined with 22Na (Fosset et al. 1977). The effect is inhibited by TTX, the half-maximally effective concentra- tion being 6.6 nmol/litre at a veratridine concentration of 22 ~mol/litre (Fosset et al. 1977). This degree of TTX sensitivity is similar to that of Vma x in cells at later stages of embryonic development (McDonald et al. 1972; Romey et al. 1980), but much higher than that of Na channels in adult guinea-pig ventricular myocardium (Baer et al. 1976; see also Fig. 6). Veratridine increases the influx of Ca ions in addition to that of Na ions (Sect. 5.3.2). Protoveratrine B also increases the Na uptake by cardiac cells of the chick embryo (Couraud et al. 1976).

4.3 Batrachotoxin

Batrachotoxin belongs to the most toxic substances known. Its lethal effect on mammals, which occurs after parenteral administration of less than 1 pg/kg or 1.86 nmol/kg, appears to be mainly due to its cardiac arrhythmogenic action (Daly and Witkop 1971). A study on anaesthetized rabbits showed that batrachotoxin produces a variety ofventricular arryth- mias, in addition to complete block of atrioventricular conduction (Kay- aalp et al. 1970). Predominant effects are the activation of multifocal ventricular ectopic beats interrupted by transient ventricular fibrillation or tachycardia. The terminal event is ventricular fibrillation.

4.3.1 Purkin]e Fibres

In spontaneously active Purkinje fibres isolated from the dog heart, the initial effect of batrachotoxin on the action potential is a prolongation of the final phase of repolarization (Hogan and Albuquerque 1971). It occurs at the lowest tested concentration of 1.9 nmol/litre at a time when there are no changes in the maximum diastolic membrane potential, Vmax, overshoot of the action potential, or rate of spontaneous diastolic depolarization. With increasing time of exposure to the toxin, the delay

Page 41: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

38 P. Honerj~iger

of repolarization progresses until the membrane fails to repolarize com- pletely during the diastolic interval. At this stage the upstroke velocity and overshoot of the action potential are depressed, as expected from the inactivating influence of depolarization. The membrane potential of fibres depolarized by batrachotoxin is restored if the external Na con- centration is reduced to 1 mmol/litre. At a concentration of 4.7 ~mol/ litre, TTX prevents the effect of batrachotoxin (1.9 nmol/litre) on the repolarization phase for as long as 30 min. These results clearly indicate the involvement of Na channels in the effect of batrachotoxin on the Purkinje fibre membrane. [logan and Albuquerque ( 1971 ) point out that "TTX did not block the action potential of the Purkinje fiber in a con- centration which antagonized BTX [batrachotoxin] action". According to these authors, "resting sodium channels are opened by BTX" and "resting sodium channels in the electrogenic membrane may be function- ally different from the sodium channels for membrane excitation". The TTX concentration used (4.7 ~mol/litre) causes a partial inhibition of Vma x in dog Purkinje fibres (approx. 50%, Coraboeuf et al. 1979). That this concentration causes complete inhibition of the effect of batracho- toxin, as opposed to partial inhibition of Vma x, does not argue against the identity of the Na channels involved in generating the action poten- tial with those modified by batrachotoxin, as discussed in connection with the effect of veratrine on dog Purkinje fibres (Sect. 4.2.4). Hogan and Albuquerque (1971) state that "the same sequence of alterations produced by BTX on the Purkinje fiber membrane was observed whether or not the tissue was being driven". Since their preparations were repor- tedly spontaneously active, this does not rule out a dependency of the effect of batrachotoxin on electrical activity. Such a dependency was reported to exist in the eel electroplaque (Bartels-Bernal et al. 1977), frog node of Ranvier (Sect. 3.3), and guinea-pig papillary muscle (Sect. 4.3.2).

4.3.2 Ventricular Muscle

similar to its effect on Purkinje fibres, batrachotoxin prolongs the repolari- zation phase of the action potential in guinea-pig muscle, and this effect is inhibited by TTX (Honer]iiger and Reiter 1977b). The results indicate that batrachotoxin causes its effect on the ventricular action potential by selectively prolonging the open state of Na channels. At low concentra- tions of the alkaloid (0 .75-60 nmol/litre), the effect on repolarization occurs only after a series of conditioning action potentials. The first action potential after addition of batrachotoxin is unaltered even after prolonged exposure of the resting muscle to the toxin. During repetitive stimulation, the effect on action potential duration develops at a progres- sively increasing rate and eventually gives rise to spontaneous depolariza-

Page 42: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 39

tions arising from the prolonged repolarization phase. For a given effect, measured in terms of the prolongation of the action potential or the first appearance of a coupled extrasystole, the product of batrachotoxin con- centration and number of preceding action potentials during exposure to that concentration of batrachotoxin is virtually constant. The effect thus fits the quantitative requirements of an irreversible one-to-one binding reaction of batrachotoxin molecules with sarcolemmal receptors that are accessible only during the action potential. As in the frog node of Ranvier (Sect. 3.3), the binding of batrachotoxin seems to require specifically the opening of Na channels. Prolonged depolarization by exposure to a high-K solution does not lead to the expression of the batrachotoxin effect in guinea-pig papillary muscle. Removal of batrachotoxin from the bathing solution during continued stimulation of the muscle causes the effect to decrease gradually over several hours, indicating a very slow dissociation of batrachotoxin. The dissociation of batrachotoxin (as manifested by the disappearance of its effect on the repolarization phase) does not require activity and can thus be demonstrated, even in the presence of toxin, simply by resting the muscle.

Concomitantly with the prolongation of the action potential, batracho- toxin produces a positive klinotropic and positive inotropic effect and prolongs relaxation time in guinea-pig papillary muscle (Honer]iiger and Reiter 1977b). These effects persist in preparations from reserpine-pre- treated animals, and are prevented by the presence of TTX ( I0 #tool/ litre). The sensitivity to TTX suggests that the positive inotropic effect results from the increased Na influx induced by batrachotoxin. A reser- pine-resistant, TTX-sensitive positive inotropic effect of batrachotoxin is also observed in the isolated cat papillary muscle (Shotzberger et al. 1976). In guinea-pig papillary muscle (Honer]iiger and Reiter 1977b), the rested-state contraction elicited during incubation of the resting muscle with high concentrations of batrachotoxin (0.6-1.2/~mol/litre) is increased in amplitude and rate of rise. This inotropic effect is absent in muscles from reserpine-pretreated guinea-pigs, pointing to the involve- ment of endogenous noradrenaline as in the case of high concentrations of veratridine or cevadine (Sect. 4.2.5).

4.4 Aconitine

4.4.1 Sinoatrial Node and Atrium

In a preparation consisting of the sinoatrial node and extranodal tissue of the rabbit heart, aconitine (1 ug/ml) produces a bigeminal rythm, fol- lowed by flutter and irregular activity (Matsumura and Takaori 1959b).

Page 43: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

40 P. Honerj~iger

The intracellular records demonstrate that both nodal and extranodal fibres participate in the abnormal rhythm.

4.4.2 Purkinje Fibres

Aconitine produces very similar effects on Purkinje fibres isolated from dog (Schmidt 1960), calf or sheep hearts (Heistracher and Pillat 1962). Aconitine increases the rate of spontaneous depolarization thus causing a positive chronotropic effect on isolated Purkinje fibres. At this stage of action, parameters of the transmembrane action potential are not altered. Subsequently, aconitine selectively slows the terminal part of repolariza- tion (at about - 6 0 mV) which results in the appearance of after-depolari- zation. The duration of the after-depolarization increases from beat to beat until premature action potentials arise from the prolonged repolari- zation phase. Following a stage of bigeminy and trigeminy, a flutter-like activity results and, finally, the preparations are arrested at a reduced membrane potential ( - 5 5 to - 4 5 mV). Decreasing the extracellular Na concentration to 10% of the normal level causes an immediate, though transient, interruption of the aconitine-induced spontaneous activity (Schmidt 1960).

Peper and Trautwein (1967) analysed the effect of aconitine on sheep Purkinje fibres with a voltage-clamp technique. In the presence of aconi- tine (1 ug/ml) the current-voltage relation, obtained by changing the membrane potential at constant and relatively slow rates, shows an abnor- mal inward current with a maximum near - 60 inV. Application of TTX (63 umol/litre) blocks this current as well as the normal excitatory Na current. In Na-free solution, aconitine fails to affect the current-voltage relation. These findings suggest that aconitine abolished the inactivation gate in a fraction of Na channels, thus causing a persistently activated component of PNa"

4.3.3 Ventricular Muscle

Matsuda et al. (1959) describe the effects of amorphous aconitine (Merck) and of the purified alkaloids aconitine and mesaconitine on iso- lated right ventricular tissue of the dog heart. No essential difference was noted among the three alkaloidal preparations. A few minutes after drug administration (0.01-0.1 ug/ml), the muscle suddenly undergoes a flutter- like, automatic and rapid excitation. Non-stimulated, resting preparations do not become spontaneously active if aconitine is added, and aconitine does not affect the resting transmembrane potential in these fibres. The automatic activity is shown to result from one of two mechanisms. Most frequently, the first visible effect is a decrease of the resting potential, followed by oscillatory potential changes following each action potential

Page 44: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 41

and superimposed on the decreased level of resting potential. Schrnidt (1960), in his study on dog ventricular trabeculae, reported no oscillatory after-potentials under the influence of aconitine, but only a slowing of the final repolarization phase, which then led to premature action poten- tials. This mechanism of arrhythmogenesis was observed less frequently by Matsuda et al. (1959).

Heistracher and Pillar (1962) report the effects of aconitine (0 .05- 1.0 gg/ml) on transmembrane potentials of the isolated cat papillary muscle. The initial electrophysiologic effect appears to be a prolongation of the repolarization phase near its end (after-depolarization). The slow- ing ofrepolarization is less abrupt and less pronounced than that observed in dog ventricular muscle (Schmidt 1960). The after-depolarization may escape detection if the arrhythmogenic effect of aconitine develops rapidly. In the second stage of aconitine action, extrasystoles appear in the form of bigeminy or trigeminy. The premature action potentials seem to arise from the aconitine-induced after-depolarization. Subsequently, the papillary muscles show sustained high-frequency activity. The phase of automatic activity is followed by the termination of activity owing to a reduction of the resting membrane potential to about - 5 5 mV in right ventricular muscle isolated from the rabbit heart (Matsumura and Takaori 1959a). An as yet unexplained effect of aconitine is the appearance of spike-like depolarizations arising from the normal resting potential and having an amplitude of up to 40 mV (Heistracher and Pillat 1962).

In the isolated cat papillary muscle, the time to development of aconi- tine-induced automaticity is inversely related to aconitine concentration (0.25-1 ~g/ml), diastolic tension (60%-140% or peak tension) and stimulation frequency ( 1 - 4 Hz) during the preautomatic period (Tanz et al. 1973). As also noted by earlier investigators, the aconitine arrhyth- mia is not reversed by repeated washing of the preparations. The cumula- tive effect of repetitive stimulation may indicate that myocardial Na channels, like neural Na channels (Mozhayeva et al. 1977), interact with aconitine only when they are in the open configuration. The aconitine- induced arrhythmia israpidly abolished by 3/~mol/litre TTX (Tanz 1974).

Although aconitine clearly induces a long-lasting activation of Na channels in Purkinje fibres (Peper and Trautwein 1967) and probably also in ventricular muscle, there is apparently no evidence that aconitine produces a positive inotropic effect. In this respect, aconitine differs from all other cardioactive Na channel-gate toxins reviewed in this chapter. It may seem questionable therefore whether an increase in sarcolemmal Na t~ermeability is strictly linked to positive inotropic action. One pos- sible explanation for the failure of aconitine to produce a positive ino- tropic effect under the conditions used by previous investigators (e.g., Fig. 1 in Tanz et al. 1973) is that the transition to the state ofextrasystoles

Page 45: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

42 P. Honerj~iger

and spontaneous activity occurs without a sufficiently long-lasting phase during which aconitine increases the Na influx associated with each ~iction potential, but does not yet produce extrasystoles. In fact, while the stage of action characterized by the prolonged repolarization phase is easily demonstrated with many other Na channel-gate toxins, this has proven difficult with aconitine (Heistracher and Pillat 1962). A careful analysis o1~ the electrophysiologic and inotropic effect of aconitine in the prearrhythmic phase of action is clearly necessary to settle this point. We have recently observed that the arrhythmogenic effect of aconitine (0.5-1.0 ~mol/litre) is preceded by a small, but distinct positive klino- tropic and inotropic effect in guinea-pig papillary muscle (P. Honerj@er and A. Meissner, unpublished work).

4.5 Grayanotoxins

4.5.1 Sinoatrial Node

In the isolated sinoatrial node preparation of the rabbit heart, grayano- toxin I (0.1 mmol/litre) decreases the maximum diastolic potential, increases the rate of spontaneous diastolic depolarization, thereby caus- ing an increase in firing frequency and, finally, inhibits the action poten- tials (Seyama 1978). These effects are fully reversible by washing with toxin-free medium. TTX (10 umol/litre) abolishes all effects on the trans- membrane potentials, indicating that grayanotoxin I activates Na chan- nels in the sinoatrial node. Thus, although this cell type is characterized by TTX-resistant electrical activity, the presence of Na channels can be demonstrated by pharmacological (Kreitner 1975) or electrical hyper- polarization (Noma et al. 1977) or by applying the Na channel-gate toxin grayanotoxin I (Seyama 1978).

4.5.2 Atrium

In resting right atrial strips obtained from the rabbit heart, grayanotoxin I (0.1 mmot/litre) produces a marked depolarization (by 26 mV), which is reversed by the withdrawal of external Na ions or the application of 10 tamol/litre TTX (Seyama 1978). A less-pronounced depolarization is observed with lower concentrations of grayanotoxin I or a-dihydro-gray- anotoxin II applied to isolated and stimulated left atria of the guinea-pig (Akera et al. 1976; Ku et al. 1977). The addition of TTX (0.8 umol/litre) reverses the depolarization produced by grayanotoxin I (0.5/amol/litre) and partially restores the amplitude of the action potential, which is reduced by grayanotoxin I owing to the reduced resting potential (A kera et al. 1976). Thus grayanotoxin I presumably induces a persistent activa-

Page 46: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 43

tion of Na channels resulting in depolarization of the resting membrane. Concentrations of grayanotoxin I that alter themembrane potential also cause a positive klinotropic and positive inotropic effect under isometric conditions (Akera et al. 1976). This effect is inhibited by TTX (0.8/amol/ litre). The racemic mixture of propranolol (10 ~mol/litre) also inhibits the positive inotropic effect of both grayanotoxin I and a-dihydro-gray- anotoxin II (Ku et al. 1977). These authors state "that a portion of the effects of grayanotoxins on isometric contractile force may be mediated by a beta-adrenergic mechanism". However, the Na channel blocking action of propranolol (Morales-Aguillera and Vaughan Williams 1965) might be responsible for this antagonism. At 5 ~mol/litre, grayanotoxin I produces arrhythmia in isolated guinea-pig left atria (Akera et al. 1976). The grayanotoxins enhance the ouabain-sensitive uptake of the potassium analog rubidium by guinea-pig ventricular slices, which is interpreted as a stimulation of the Na-K pump secondary to the toxin-induced increase of Na influx (Ku et al. 1977). The grayanotoxins do not affect Na, K- ATPase isolated from rat brain or guinea-pig heart (Akera et al. 1976; Ku et al. 1977).

4.5.3 Atrioventricular Node

There are no reports on the effect of grayanotoxins on the transmem- brane electrical activity of cells of the atrioventricular node. In the dog heart-lung preparation, examined with extracellular electrodes, grayano- toxin I (andromedotoxin) prolongs the atrioventricular conduction time and increases the spontaneous firing rate of the atrioventricular node if the faster rhythm of the sinoatrial node is suppressed (Swain and McCarthy 1957).

4. 5. 4 Purkin/e Fibres

Conduction through the Purkinje system is reported to be slowed by grayanotoxin I (andromedotoxin) in the dog heart (Swain and McCarthy 1957). This occurs at a time when ventricular myocardial conduction is not affected. Possibly, the effect on Purkinje fibre conduction is related to a depolarization as observed in atrila cells (Sect. 4.5.2).

4. 5. 5 Ven tricular Muscle

Hotta et al. (1980) studied 18 structurally related grayanotoxins which produced a concentration-dependent reversible positive inotropic effect on isolated guinea-pig papillary muscle.

Page 47: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

44 P. Honerjgger

4.6 Scorpion Toxins

4. 6.1 Isolated Mammalian Heart

Corrado et al. (1968) investigated the effects of crude dried venom of the Brazilian scorpion Tityus serruluatus on the isolated guinea-pig heart. In final concentrations of approximately 1 gg/ml, the venom produces a short-lasting bradycardia followed by an increase of force and frequency of contractions. The effects are reversible and reproducible in the same preparation. The bradycardia is blocked by atropine and potentiated by neostigmine. The positive chronotropic and inotrpic action is abolished by propranolol or bretylium. It is absent in hearts of reserpine-pretreated guinea pigs. Hexamethonium neither affects the bradycardia nor the tachycardia in doses which abolish the nicotine-induced bradycardia and positive inotropic effect. Hence the venom probably acts on the post- ganglionic nerve terminals to cause the release of acetylcholine and nor- adrenaline. Langer et al. (1975) have shown that a purified toxin from T. serrulatus increases the release of 3 H-noradrenaline from guinea-pig atria. Less extensive experiments were performed by other investigators with venoms of Leiurus quinquestriatus, Buthus minax, B. occitanus, and Androctonus australis HECTOR using the isolated heart of rabbits or guinea pigs. Similar to Tityus scorpion venom, the other scropion venoms seem to alter cardiac function mainly through the release of neurotrans- mitters from intracardiac nerve fibres (Zlotkin et al. 1978).

Coraboeuf et al. (1975) used the isolated rat heart to study the effects of pure ScTXIt on contraction and transmembrane electrical activity (at 24°-25°C). ScTXII produces a reserpine-resistant positive inotropic effect that is associated with an increase in the height of the plateau of the ventricular action potential and a prolongation of the repolarization phase. The effect on the action potential persists for hours following a single injection of toxin into the coronary arteries. Resting potential and Vma x are only slightly altered. The lengthening of the action poten- tial produced by ScTXII is greatly diminished by injections of TTX, Ca- rich medium or procaine, and it is prevented during perfusion with low-Na solution. The atrial action potential is also prolonged by ScTXII. According to Coraboeuf et al. (1975), ScTX n increases plateau height by slowing down the inactivation of Na channels or by inducing an incomplete Na inactivation. The effect on the action potential might indirectly favour the penetration of Ca through the slow channel because of a stronger and longer-lasting activation of the potential- and time- dependent slow inward Ca current, and this could explain the positive inotropic effect. The authors do not discuss the possibility of increased Na-Ca exchange.

Page 48: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 45

Confirming earlier investigations, Coraboeuf et al. (1975) find that ScTXII produces a positive inotropic effect also on isolated guinea-pig and rabbit hearts, but that this effect is absent in preparations obtained from reserpine-pretreated animals. Guinea-pig and rabbit ventricular action potentials are insensitive to the scropion toxin in doses that are markedly effective in the rat heart. As pointed out by Coraboeuf et al. (1975), this suggests the existence of species differences in the sensitivity of myocardial Na channels to scorpion toxin.

4.6.2 Cardiac Cells in Culture

ScTXII has marked effects on the mechanical and electrical activity of nerve-free myoblast cultures derived from the chick embryonic heart (Fayet et al. 1974; Bernard and Couraud 1979). ScTXII increases the frequency of the spontaneous contractions, and this effect is followed by cell fibrillation and contracture (Fayet et al. 1974). The bioelectric cause of these phenomena was elucidated by Bernard and Couraud (1979). They used cells from 11-day-old chick embryonic hearts cultured as aggregates in suspension. With their culture technique, they obtain two populations of cells which differ in their value of Vma x ("fast" and "slow" cells). The effect of ScTXII depends on the type of cell.

Fast Cells. This population of cells has resting potentials between - 4 0 and - 7 2 mV. Vma x exceeds 15 V/s and is significantly related to the level of the resting potential, reaching a value of 125 V/s at the most negative resting potential. TTX (0.4 #mol/litre) reduces Vmax by about 90%. ScTXII (30 nmol/litre) causes approximately a tenfold increase in the duration of the action potential, while it does not significantly alter Vma x. TTX (0.1 t~mol/litre) rapidly suppresses the toxin-induced modi- fication of the action potential. D 600, the methoxy derivative of verapa- mil, at a concentration of 1 tsmol/litre, does not prevent prolongation of the action potential by ScTXII. These results suggest that ScTXtI prolongs the open state of Na channels in cultured cells with expressed Na chan- nels, perhaps by slowing inactivation as in neural Na channels (Sect. 3.6).

Slow Cells. This population of cells has resting potentials between - 4 0 and - 62 mV, and Vma x is 10 V/s or less, irrespective of the resting poten- tial, and unaffected by TTX at 0.4 pmol/litre. The low value of Vmax, its lack of correlation with the level of the resting potential, and its insensi- tivity to TTX indicate that the upstroke of the action potential is not mediated by fast Na channels. In these cells, ScTXII (30 nmol/litre), in addition to prolonging the repolarization phase of the action potential, increases Vma x significantly from 8.6 to 36.8 V/s on average, while having

Page 49: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

46 P. Honerj~iger

no effect on the level of the resting membrane potential. Both effects are suppressed by TTX (0.1 #mol/litre). ScTXII restores action potentials in cells when electrical activity was previously reduced by D 600 (0.5 #mol/ litre). Bernard and Couraud (1979) conclude that ScTXII increases Vma x (in slow cells) and prolongs the repolarization phase of the action poten- tial (in both types of cells) by retarding the inactivation of Na channels. The fact that ScTXII conveys TTX sensitivity to the electrical activity of slow cells shows that these normally TTX-resistant cells contain silent Na channels (Sect. 3.9).

Effect on Na and Ca Influx. ScTXII causes a TTX-sensitive increase of Na influx in embryonic cardiac cells (Couraud et al. 1976), as might be expected from the electrophysiological actions described above. The influx of Ca ions is enhanced as well. The effect of Na channel-gate toxins on Ca influx in cultured heart cells is discussed in the section on Na-Ca exchange (Sect. 5.3.2).

4.7 Sea Anemone Toxins

4. 7.1 Toxin H from Anemonia sulcata

Isolated Mammalian Heart. In the heart-lung preparation of the cat, ATXII produces a positive inotropic effect (Alsen et al. 1976). The threshold concentration is approximately 2 nmol/litre, and a maximum positive inotropic effect occurs at around 100 nmol/litre. In the ino- tropic concentration range, ATXII has no significant chronotropic action. Toxic symptoms occur at 160 nmol/litre. They are characterized by periods ofventricular fibrillation alternating with periods of normal spon- taneous rhythm. In the isolated guinea-pig heart stimulated at 3 Hz, ATXII produces a half-maximal positive inotropic effect at about 5 nmol/litre on the ventricle and atrium (Alsen et al. 1976). Arrhythmia occurs at 25 nmol/litre ATXII.

Atrium. In guinea-pig atrium, ATXII (10 nmol/litre) prolongs the repolari- zation phase of the action potential at all levels of membrane potential and produces a positive klinotropic and positive inotropic effect (Ravens 1976). The prolonged phase of repolarization is associated with a pro- longation of the relaxation phase of the isometric contraction.

Ventricular Muscle. Ravens (1976) analysed the effects of ATXII on the transmembrane electrical activity and contraction of the isolated guinea- pig papillary muscle contracting at 1 Hz. At concentrations of 5 -20 nmol/

Page 50: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 47

litre, the toxin produces graded positive klinotropic and positive inotropic effects. They reach steady-state in about 30 rain and disappear within about 1 h of superfusion with toxin-free solution. Inotropic concentra- tions induce a prolongation of the action potential at negative levels of membrane potential. This prolongation is only partially reversed during a 1-h washout period. Concentrations up to 20 nmol/litre leave the rest- ing membrane potential and the amplitude of the action potential unaf- fected. Vma x is slightly reduced by 20 nmol/litre ATXII. The prolonged repolarization phase is associated with a prolongation of the relaxation phase of the isometric contraction. The effects of ATXII are not modi- fied by catecholamine depletion with reserpine. TTX (0.5 t~mol/litre) completely and reversibly inhibits the effect on action potential duration and the positive inotropic effect. ATXII (10 nmol/litre) fails to prolong the action potential and to increase force of contraction if extracellular K is raised from 2.7 to 14.7 mmol/litre, and raising the K concentration after the effects of ATXI! have developed causes their disappearance. The sensitivity to TTX of the toxin-modified repolarization phase sug- gests that it is due to the persistent activation of Na channels. This might result from a delayed inactivation of the Na channels, which is the main effect of ATXII on neural Na channels (Sect. 3.7.1).

Cardiac Cells in Culture. Romey et al. (1980) analysed the effects of ATXII on cardiac cell aggregates in culture obtained from 3- and 1 &day- old chick embryo hearts, respectively. The younger cells exhibit low values of Vma x and their action potential is insensitive to TTX; they will be referred to as slow cells. The older cells show values of Vma x greater than 100 V/s and their action potentials are blocked by TTX (0.1 #tool/ litre); these cells will be called fast cells. Very similar to scorpion toxin (Sect. 4.6.2), ATXI1 produces different effects on slow and fast cells. In fast cells, ATXII only prolongs the falling phase of the action poten- tial and thus produces qualitatively the same effect as observed in adult guinea-pig myocardial cells (Ravens 1976). In slow cells, ATX n produces an increase of Vma x (from 12.5 to 25 V/s on average), in addition to pro- longing the falling phase of the action potential. The increase of Vma x occurs under conditions where any steady-state inactivation of the Na channels is prevented by a long-lasting hyperpolarizing prepulse. In fast cells, TTX (0.1 umol/litre) slows Vma x and abolishes the effect of ATXII on the repolarization phase. The same concentration of TTX blocks the two effects of ATXII on the action pontential of slow cells, namely the increase in Vma x and the prolongation of the falling phase. These results as well as those obtained with scorpion toxin (Sect. 4.6.2) suggest that the polypeptide toxins slow Na inactivation in fast cells, thereby pro- longing the repolarization phase of the action potential. In slow cells,

Page 51: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

48 P. Honerj~iger

the polypeptide toxins cause the appearance of otherwise silent Na chan- nels, as suggested by the TTX-sensitive increase in Vrnax , and these Na channels seem to inactivate only slowly, as shown by the TTX-sensitive prolongation of the repolarization phase. Thus, ATXII reveals Na chan- nels which are not normally expressed in embryonic heart cells derived at an early stage of development. In addition, Romey et al. (1980) showed that ATXII exerts a positive inotropic effect on embryonic car- diac cells along with its effect on the action potential. The inotropic effect is blocked by TTX (0.1 pmol/litre) suggesting that it is causally related to the modification of the Na channels by ATXII. The link may be increased Na-Ca exchange across the sarcolemma, as indicated by the observation that ATXII increases Ca influx as well as Na influx (Romey et al. 1980). The effect of Na channel-gate toxins on Ca influx is dis- cussed in the section on Na-Ca exchange (Sect. 5.3.2).

4. Z2 Anthopleurin A

Sinoatrial Node. At concentrations of 5 or 30 nmol/litre, anthopleurin A has no significant effect on the spontaneous heart rate of isolated atria from the rabbit, cat, guinea pig or rat (Shibata et al. 1976).

Atrium. Anthopleurin A produces a reversible positive inotropic effect on isolated left atria from the rabbit, cat, guinea pig or rat at a contrac- tion frequency of 1.6 Hz (Shibata et al. 1976). Half-maximally effective concentrations are 1 -3 nmol/litre. The effect is not modified by propra- nolol (1 umol/litre). TTX (2 umol/litre) decreases the sensitivity of guinea-pig atria to the positive inotropic action of anthopleurin A (Shibata et al. 1978). Anthopleurin A (50 nmol/litre) does not alter the cAMP content of guinea-pig atria (Shibata et al. 1976).

Purkin]e Fibres. Shimizu et al. (1979) studied the effects of anthopleurin A on the transmembrane electrical activity of isolated canine Purkinje fibres and ventricular muscle fibres in a preparation containing fibres of the right bundle branch and of the anterior papillary muscle. In Purkinje fibres stimulated at 1.67 Hz, anthopleurin A (3 .9 -39 nmol/litre) pro- longs the repolarization phase of the action potential by prolonging the duration of the plateau phase. It has little effect on the subsequent phase of repolarization, i.e. the times to 50% and 90% repolarization are pro- longed to an equal extent. The refractory period is increased along with the prolongation of the plateau phase of the action potential. At high concentrations of the polypeptide (19 -39 nmol/litre), premature action potentials develop from the prolonged repolarization phase at potential levels between - 1 0 and - 5 0 mV. Up to the highest concentration tested

Page 52: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of'Sodium Channels 49

(39 nmol/litre), anthopleurin A does not significantly affect the resting membrane potential, amplitude or Vma x of the action potential. In con- centrations below 19 nmol/litre, anthopleurin A produces no significant change in the firing rate of spontaneously active Purkinje fibres. Shimizu et al. (1979) did not test whether TTX inhibits the effect of anthopleu- rin A on the repolarization phase, as has been observed in the presence of batrachotoxin (Hogan and Albuquerque 1971) or veratrine (Arbel et al. 1975). An inhibition by TTX would be expected if anthopleurin A slows the inactivation of Purkinje fibre Na channels as it does that of neural Na channels (Sect. 3.7.2) and ventricular myocardial Na channels.

Ventricular Muscle. Anthopleurin A increases the force of contraction of isolated papillary muscles and ventricular strips of the guinea-pig heart driven at 1.6 Hz (Shibata et al. 1976). Half-maximally effective concen- trations are 4 .4 -4 .8 nmol/litre. At a threshold concentration near 2 nmol/ litre, anthopleurin A also increases the force of the isolated cat papillary muscle stimulated at 1 Hz (Scriabine et al. 1979): As shown in this study the positive inotropic and positive klinotropic effects of anthopleurin A are associated with a marked prolongation of the relaxation phase (at 64 nmol/litre). Arrhythmia is produced by 120 nmol/litre. As in dog Purkinje fibres, but to a smaller extent, anthopleurin A increases the action potential duration and the refractory period in dog ventricular muscle fibres (Shimizu et al. 1979): The prolongation of the repolariza- tion phase is already manifest at positive levels of membrane potential. In this tissue, anthopleurin A, at concentrations of up to 39 nmol/litre, does not affect the resting potential, Vma x, or the amplitude of the action potential. Using a voltage-clamp technique (single sucrose gap) on the isolated guinea-pig papillary muscle, Hashimoto et al. (1980) have recently shown that anthopleurin A (9 .7-39 nmol/litre) induces a main- tained inward current during depolarizing pulses superimposed on the outward current and reaching a maximum value between - 4 0 and - 2 0 inV. The inward current represents a persistent component of Na flux through Na channels since it is blocked by TTX. TTX likewise abolishes the prolongation of the action potential produced by antho- pleurin A in guinea-pig papillary muscle (Hashimoto et al. 1980). Ochi and colleagues (Hashirnoto et al. 1980) were the first to suggest that anthopleurin A produces its positive inotropic effect by increasing Na influx.

Anthopleurin A (50 nmol/litre) does not affect the activity of Na, K-ATPase isolated from guinea-pig or dog hearts, of phosphodiesterase isolated from guinea-pig hearts, and it does not alter the cAMP content of guinea-pig ventricle (Shibata et al. 1976).

Page 53: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

50 P. Honerjgger

4.8 Coral Toxin

Tbe cardiac action of goniopora toxin was examined in isolated left atrial preparations of the rabbit (Fu]iwara et al. 1979). At 30 nmol/litre, the polypeptide toxin prolongs the action potential at all levels of repolariza- tion, while no significant change is observed either in the resting mem- brane potential, the overshoot or Vmax" The effect on action potential duration persists during superfusion with toxin-free solution for 2 h. TTX (1 #mol/litre) abolishes the effect on the replarization phase. At 3 - 1 0 0 nmol/litre goniopora toxin produces a positive inotropic effect that also persists during washout with toxin-free solution. In line with an irreversible binding reaction, the positive inotropic effect during exposure to a given concentration of the toxin does not reach a steady-state, but progresses and is eventually followed by arrhythmia characterized by coupled extrasystoles. Increasing the concentration of the toxin acceler- ates the development of the positive inotropic effect. Propranolol, phen- ~tolamine or atropine (each at 1 /~mol/litre) do not modify the positive inotropic effect. The positive inotropic and arrhythmogenic effect are both abolished by TTX (1/~mol/litre). In atria depolarized by an elevated extracellular K concentration (27 mmol/litre) and treated with 0 .5/ lmol/ litre isoprenaline to restore excitability (0.25 Hz), goniopora toxin fails to increase force of contraction. The results suggest that goniopora toxin modifies the cardiac action potential by prolonging the open state of Na channels and that the positive inotropic effect is linked to the increase in sarcolemmal PNa"

5 Sarcolemmal Na Permeability and Myocardial Force of Contraction: Na-Ca Exchange

5.1 Introduction

For an understanding of the positive inotropic action of the Na channel- gate toxins it is necessary to consider the role played normally by Na channels in the excitation-contraction cycle of the heart. The most important function of the Na channels is to allow a rapid conduction of the excitation wave, originating in the sinoatrial or atrioventricular node, to all cells of the atrial and ventricular myocardium. The nearly simul- taneous excitation of all atrial and ventricular cells assures the coordinated contraction of these cells, i.e. the function of the heart as a pump. The process which couples sarcolemmal excitation to contraction of the myo- cardial cell does not seem to depend so much on the activation of Na

Page 54: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 51

channels, but seems to be intimately related to events occurring during the plateau phase of the action potential, notably the Ca inward current (Beeler and Reuter 1970a,b,c; New and Trautwein 1972; Trautwein et al. 1975) and electrogenic Na-Ca exchange. Thus, contractions can still be elicited if Na channels are blocked by TTX or completely inactivated by sustained depolarization of the sarcolemma. It is nevertheless very likely that Na channels, in addition to permitting the rapid conduction of the cardiac action potential, influence excitation-contraction coupling, because their activation leads to an influx of Na ions into the cell. Several lines of evidence, reviewed here, suggest that an increased concentration of intracellular Na ions promotes an influx of Ca ions across the sarco- lemma (Na-Ca exchange). This is expected to result in a positive inotropic effect. Na influx through Na channels is greatly enhanced by the Na channel-gate toxins, because they drastically prolong the time during which the Na channels are in the open state.

The intracellular Na concentration may also affect the Ca transport by organelles of the myocardial cell. If exposed to Na ions, cardiac mito- chondria (Carafoli and Crornpton 1978) release Ca. It seems difficult, however, to explain a maintained positive inotropic effect by a mecha- nism that depletes cellular stores and thus, eventually, the cell of Ca ions. A decrease of the [K]/[Na] ratio may impair Ca uptake by cardiac sarco- plasmic reticulum (Katz and Repke 1967).

Ravens (1976) suggested an explanation for the positive inotropic effect of Na channel-gate toxins that does not involve changes of intra- cellular Na concentration. According to this hypothesis, the toxin inter- acts with a sarcolemmal receptor controlling Na channel gating as well as a plasmalemmal Ca store that releases Ca during contraction. However, since TTX, a selective blocker of Na channels, abolishes the postive ino- tropic effect of Na channel-gate toxins (see Chap. 4), it is not necessary to postulate that the positive inotropic effect of these toxins results from a modification of structures other than those regulating Na channel gating.

5.2 Na-Ca Exchange in the Squid Giant Axon

The giant axons of certain species of squid are particularly suitable for studying the role of intracellular Na in regulating Ca flux across an excit- able membrane, because [Na]i can be selectively altered experimentally either by injection of a Na salt into the axoplasm of an intact axon (Baker et al. 1969) or by changing the concentration of Na in the solu- tion used to perfuse an axon intracellularly (Di Polo 1979). Baker et al. (1969) showed that the intraaxonal injection of NaC1 to raise [Na]i by 67 or 120 mmol/litre in axons of Loligo forbesi previously depleted of

Page 55: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

52 P. Honerj~iger

intracellular Na causes an increase in the unidirectional influx of Ca ions by factors of 2 and 4, respectively. These experiments were performed with an external solution in which most of the Na was replaced by Li ions (Li-seawater). In other experiments of their study [Na] i was raised by prolonged stimulation at high frequency. This resulted in an increase of Ca influx irrespective of whether the influx was measured in Na-, Li- or dextrose-seawater. The additional demonstration of a component of Na efflux, which is insensitive to cardioactive steroids, but activated by external Ca ions, led to the hypothesis that the enhancement of Ca influx by internal Na involves a transmembrane ion exchange in which the exit of Na ions is linked to the entry of Ca ions (Baker et al. 1969).

A detailed analysis of the component of Ca influx enhanced by intra- cellular Na ions was performed by Di Polo (1979) using the technique of intracellular dialysis on axons of the tropical squid Dorytheutis plei. The main findings of this study may be summarized as follows: An increase of [Na] i of 0 -120 mmol/litre increases Ca influx, and the Na i- dependent Ca influx requires a threshold level of [Ca2+]i of 40 nmol/litre and increases as [Ca2+]i is raised to 0.8 t~mol/litre. The Nai-dependent Ca influx requires the presence of ATP. The results of Baker et al. (1969) indicate that the entry of one Ca ion may be linked to the exit of more than two Na ions, which would make Na-Ca exchange sensitive to the membrane potential. In line with this prediction, both the Na efflux component (Baker and McNaughton 1976) and the Ca influx component (Di Polo 1979) constituting the Na-Ca exchange under physiological con- ditions, i.e. in the presence of ATP, were found to be augmented by depolarization.

Baker et al. (1969) pointed out that the exchange of external Ca for internal Na which they observed may represent ion movements in a direction opposite to that occurring under normal conditions. The nor- mal function of a Na-Ca exchange system might be to pump Ca out of the cell in exchange for external Na, as suggested by Reuter and Seitz (1968). In this case the energy for the uphill transport of Ca ions from the cell could be provided by the downhill movement of Na ions, and the transmembrane gradient for Na ions would be maintained by the Na pump. Interestingly, although a Ca efflux-Na influx system operates in axons poisoned with cyanide (Blaustein and Hodgl~n 1969), later work has shown that 50%-90% of the Ca efflux from unpoisoned squid axons is independent of external Na ions and requires the presence of ATP (Baker and McNaugh ton 1978; Di Polo and Beaug~ 1979).

The effect of intracellular Na ions on unidirectional Ca efflux has also been examined. Raising [Na]i from 5 to 75 mmol/litre in internally dia- lyzed axons of Loligo pealei inhibits the [Na]o-dependent component of Ca efflux (Blaustein 1977), but the uncoupled Ca efflux, which may

Page 56: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 53

constitute the main part of Ca efflux from intact axons (Baker and McNaughton 1978), is insenstitive to changes in intracellular Na concen- tration (Di Polo and Beaugd 1979). Thus, an increase of [Na]i will affect the intracellular Ca concentration of squid axon through an increase of Ca influx with little effect on Ca efflux.

5.3 Nai-Ca o Exchange in Cardiac Preparations

5. 3.1 Guinea-Pig Atrium

Glitsch et al. (1970) examined the relationship between the intracellular Na concentration and Ca influx in resting left atria of guinea pigs. They produced different levels of [Na]i by equilibrating the resting muscles in K-rich solution ([Na]i = 12.5 mmol/kg fibre water, as determined by flame photometry) , in normal solution ([Na]i = 20 mmol /kg)o r in cold K-poor, Ca-poor solution ([Na]i = 60 mmol/kg). An intermediate level of Na i was established by high-frequency stimulation in K-poor, Ca-poor solution ([Na]i = 40.5 mmol/kg). Subsequently all preparations were placed for 10 min into a medium containing 4s Ca, 0.65 mmol/litre [K]o to prevent a decrease of [Na]i , and 0 .7 -7 ~mol/litre acetylcholine to prevent spontaneous activity of the atria. After the uptake period the preparations were washed for 25 min with inactive solution before the radioactive analysis was performed. Under these conditions, the increase of [Nali was associated with an increase of Ca uptake by the atria. A nearly fivefold increase in [Na]i caused in increase in Ca uptake by a factor of about 2.6.

5.3.2 Cardiac Cells in Culture

To define the relationship between Na fluxes and Ca fluxes in myocardial cells an approach different from that of Glitsch et al. (1970) was used by Fosset et al. (1977). They analysed the Ca influx induced by veratridine in monolayer cultures of cardiac myoblasts obtained from 10-day-old chick embryos. Although these authors did not report the actual changes of [Nali in their experiments, the various concentrations of veratridine which they applied in a medium containing Na ions (140 mmol/litre) and ouabain increased Na influx and presumably caused a graded increase of [Na]i. No information on the transmembrane potential of the myoblasts is given in this article, but the work by Sperelakis and Lehmkuhl (1968) and Sperelakis and Pappano (1969) suggests that either ouabain or the lowest effective concentration of veratridine (1.5 #mol/litre) used by Fosset et al. (1977) caused permanent depolarization and inexcitability and thus eliminated possible complications resulting from spontaneous

Page 57: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

54 P. Honerj~iger

80

. 7 0

~'60 .c_ £

)so

~40 Na influx A

2o 3o * ~ o ~ - Ca influx

25

10 100 ~mot/t

Veratridine concentration

20

"6

c

10- 6

Fig. 12. Concentration-effect relation- ships for the enhancement of Na influx and Ca influx by veratridine in chick embryonic cardiac cells in cul- ture. The experiments were performed in the presence of 0.5 mmol/litre ouabain. (Drawn after Fosset et al. 1977)

activity of cultured heart cells. Fosset et al. (1977) showed that veratri- dine increases Ca influx up to 25-fold (Fig. 12). They could exclude the possibility that this influx uses Na channels opened by veratridine, because veratridine fails to increase Ca influx if external Na is replaced by Li ions, i.e. under conditions where veratridine retains the ability to open Na channels thereby allowing the influx of Li ions (Sperelakis and Pappano 1969). However, because it is abolished by TTX, the veratridine effect on Ca influx does require the opening of Na channels. Veratridine- induced Ca influx is insensitive to manganese or cobalt ions or to the compound D 600 at concentrations at which these substances normally inhibit slow Ca channels. Thus, the veratridine-induced Ca influx is coupled to the presence of an inwardly directed Na gradient and open Na channels, but the Ca ions enter the cell neither through Na channels nor through slow Ca channels. These findings strongly suggest the exis- tence in cardiac cells of a Ca uptake mechanism that is increased by intra- cellular Na accumulation (Fosset et al. 1977).

Results very similar to those of Fosset et al. (1977) were obtained by Couraud et al. (1976) who used ScTXII. The latter authors suggest that the sarcolemma of cardiac cells in culture contains two types of Ca chan- nels, the well-known slow Ca channel and a Ca channel that is "coupled to the passive Na action potential ionophore" and therefore affected by the toxin. This interpretation disregards the observation by the authors themselves that ouabain greatly enhances the effect of ScTXII on Ca influx, an observation which points to the importance of intracellular Na accumulation in linking the effect of the scorpion toxin on Na channels to its effect on Ca influx. It appears that all the results of Couraud et al. (1976) are compatible with the concept that ScTXII increases Na influx

Page 58: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 55

by opening Na channels and thereby indirectly activates an exchange of intracellular Na for extracellular Ca ions. An increase of both Na and Ca influx is also produced by ATXII (Romey et al. 1980).

5. 3. 3 Purkinfe Fibres

The experiments of Glitsch et al. (1970), Couraud et al. (1976) and Fosset et al. (1977) do not clarify whether the activating effect of intra- cellular Na ions on Ca influx involves an actual exchange of internal Na ions for external Ca ions, as in the squid giant axon (Baker et al. 1969). If the cardiac sarcolemma possesses a Na-Ca exchange system, raising the extracellular Ca concentration will increase Na efflux thereby reducing the intracellular Na concentration under conditions where [Na]i is not controlled by the Na pump. Using Na-sensitive glass micro-electrodes, Deitmer and Ellis (1978) indeed showed that raising the bath concentra- tion of Ca produces a decrease in the intracellular Na activity of sheep heart Purkinje fibres even when the Na-K pump is inhibited by strophan- tidin.

5.3.4 Myocardial Contraction in Low Extracellular Na

If extracellular Na is reduced in the presence of extracellular Ca, a con- tracture develops which is associated with a large increase in the influx of Ca into the heart cells (Niedergerke 1963). A study on frog atrial trabe- culae revealed that this contracture is transient and, after spontaneous relaxation, even a 100-fold increase in the bathing Ca concentration (from 0.1 to 10 mmol/litre) fails to induce any increase in tension (Chap- man 1974). The results obtained by Chapman (1974, 1979) stongly sug- gest that the increase in Ca influx resulting from the reduction of [Na] o critically depends on the presence of Na inside the cells. This points to the existence of a Na-Ca exchange mechanism.

Voltage-clamp experiments on frog atrial trabeculae (Benninger et al. 1976; Horackova and Vassort 1979a) indicate that the tonic component of tension (Sect. 6.1) results from a transmembrane Na-Ca exchange that is voltage-dependent and therefore activated by the depolarization used to elicit tonic tension. The tonic component of tension exists in addition to a phasic component that is related to both Is~ and intracellular Ca stores (Horackova and Vassort 1976, 1979b).

5. 3.5 Inotropic Effect of Cardioactive Steroids

If one accepts the view that cardioactive steroids produce their positive inotropic effect by inhibiting the sarcolemmal Na pump, one has to con- clude that the myocardial cell possesses a mechanism that translates some

Page 59: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

56 P. Honerj~iger

consequence of this membrane effect into an enhancement of the intra- cellular Ca transient during contraction (Allen and Blinks 1978) and thus into a positive inotropic effect. One consequence of the Na pump inhibi- tion by cardioactive steroids is an increase in intracellular Na concentra- tion (Lee et al. 1980). A Na-Ca exchange in the sarcolemma would thus provide exactly the mechanism to couple an inhibition of the Na pump to a positive inotropic effect. A kera and Brody (1978) and R eiter (to be published) reviewed the evidence in support of the theory that the posi- tive inotropic effect of cardioactive steroids results from their effect on [Na] i secondary to the inhibition of the Na pump.

5.3. 6 Cardiac Membrane Vesicles

A transmembrane Na-Ca ion exchange was demonstrated in membrane vesicles of presumed sarcolemmal origin. The vesicles were obtained by centrifugation techniques from the ventricle of the heart of the rabbit (Reeves and Sutko 1979), dog (Pitts 1979), and ox (Miyamoto and Racker 1980). Recent studies indicate that this Na-Ca exchange involves the exchange of more than two Na ions with one Ca ion and is thus elec- trogenic (Reeves and Sutko 1980; Philipson and Nishimoto 1980). Na channel-gate toxins have apparently not been used to alter Na fluxes of cardiac membrane vesicles. The demonstration of a toxin-activated and TTX-inhibited Na flux would provide strong evidence for the sarcolem- mal nature of such vesicles. The need for further purification of cardiac sarcolemmal membranes has been stressed by Sulakhe and St. Louis (1980).

6 Comparison of Cardiac Actions of Na Channel-Gate Toxins with Those of Other Positive Inotropic Drugs

As shown in Chap. 4, the cardiac action of Na channel-gate toxins has been analysed and characterized in terms of their influence on mechani- cal and electrical activity and on transsarcolemmal ion movements. The purpose of the following paragraphs is to compare some of these effects with those of other classes of positive inotropic agents on the same aspects of myocardial function. This will serve to reinforce the conclu- sion that Na channel-gate toxins represent a separate class of positive inotropic substances characterized by a distinct mode of action. The dis- cussion deals mainly with effects observed in isolated ventricular prepara- tions of the mammalian heart.

Page 60: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 57

6.1 Isometric Contraction Curve

Na channel-gate toxins increase the force of myocardial contraction by accelerating the rate of force development, i.e. by a positive klinotropic effect (Figs. 2, 3). Hence, they act by increasing the intensity of the "active state" of the contractile elements and differ in this respect from the relatively few interventions which, like the addition of fluoride, pro- duce a positive inotropic effect by prolongation of the active state (Reiter 1972a).

Na channel-gate toxins produce variable effects on the relaxation phase of the isometric contraction. The relaxation time may be prolonged to such an extent that total contraction time is lengthened (Fig. 2, veratri- dine), or the prolongation may just compensate a simultaneous abbrevia- tion of time to peak force resulting in a nearly unchanged total contrac- tion time (Fig. 3, germitrine). The very marked prolongation of relaxation time, causing an increase in total contraction time, is observed in the presence of those toxins which slow repolarization during, or shortly after, the plateau phase of the action potential (e.g., cevadine, veratfidine, batrachotoxin, ATXII , anthopleurin A, goniopora toxin; see Chap. 4 for references). In contrast, relatively little effect on the total contraction time is produced by those toxins inducing a slight depolarization of the resting membrane potential (e.g., germitrine, grayanotoxins). It is well known that an electrical prolongation of the repolarization phase (by injecting a depolarizing current with the sucrose-gap technique), at a level positive to about - 3 0 mV, is associated with prolonged relaxation phase of the contraction (Morad and Trautwein 1968). The resulting component of mechanical activity is maintained as long as the membrane is kept at the depolarized level of membrane potential and is therefore called "tonic" tension (Morad and Goldman 1973). The markedly pro- longed relaxation phase obse~wed with some of the Na channel-gate toxins can thus be explained in terms of the known dependence of mechanical activity on membrane potential. Recent studies indicate that Na channel- gate toxins may prolong relaxation time by an additional mechanism related to the increase in intracellular Na concentration rather than to the prolonged repolarization phase. Vassort and colleagues (Roulet et al. 1979) have shown that veratrine prolongs the relaxation time of frog atrial trabeculae even if the preparation is activated by voltage-clamp depolarizations of constant duration, i.e. if the prolongation of the action potential produced normally by veratrine is prevented. According to Roulet et al. (1979), the relaxation phase is directly influenced by an electrogenic sarcolemmal Na-Ca exchange mechanism. An increase in Na i is thus expected to decrease the efficiency of the Na-Ca exchange to restore the low diastolic level of the free intracellular Ca concentration

Page 61: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

58 P. Honerj~iger

after repolarization. This interpretation could also explain the prolonga- tion of relaxation time produced by Na channel-gate toxins which, like germitfine (Fig. 3), prolong the action potential only at membrane poten- tial levels far negative to - 3 0 mV (Sect. 4.2.5).

Na channel-gate toxins have never been observed to abbreviate total contraction time by shortening relaxation time. Such a relaxant effect is typically produced by inotropic agents which elevate the cellular concen- tration of cAMP, for instance by/3-adrenoceptor agonists, histamine, or phosphodiesterase inhibitors (Korth 1978; Scholz 1980). While the ino- tropic effect of the toxins clearly differs in this respect from the cAMP- increasing drugs, it is difficult, if not impossible, to distinguish certain other positive inotropic agents from Na channel-gate toxins solely on the basis of the modification of the isometric contraction curve. Thus, like germitrine, the cardioactive steroid dihydro-ouabain produces a positive klinotropic and inotropic effect with little effect on total contraction time (Reiter 1972b).

6.2 Blockade of Sarcolemmal Na Channels by Tetrodotoxin

In the absence of a competitive antagonist for Na channel-gate toxins which lacks intrinsic activity (cf. Sect. 3.10.2), the most specific way to test whether a positive inotropic agent acts by prolonging the open state of Na channels is to use the non-competitive antagonist TTX (or STX). TTX occludes Na channels and thereby prevents the effects of Na chan- nel-gate toxins on membrane potential and Na and Ca influx. In guinea- pig papillary muscle, a TTX concentration which reduces ~max by 50% (10 #mol/litre) has no inhibitory influence on the positive inotropic effect of noradrenaline or theophylline and slightly inhibits that of dihydro-ouabain, but prevents the positive inotropic effect of half-maxi- mally effective concentrations of cevadine, veratridine, and germitrine (Fig. 10). The fact that TTX fails to affect the positive inotropic effect of noradrenaline and theophylline is in agreement with the view that these agents act by increasing the cellular concentration of cAMP and that such an increase mediates the enhancement of slow inward Ca cur- rent and of the amount of Ca releasable from, and sequestered by an intracellular Ca store (for references see Scholz 1980). TTX lacks an effect on slow inward Ca current and is not expected to gain access to the intracellular space during extracellular application (Sect. 4.2.5). Furthermore, even if applied directly to the sarcoplasmic reticulum as in the experiments on skinned cardiac fibres by Fabiato and Fabiato (1973), TTX does not affect the Ca release-sequestration cycle as judged from the unchanged mechanical activity. The finding that TTX less effectively

Page 62: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 59

inhibits the positive inotropic effect of dihydro-ouabain than that of ceveratrum alkaloids, although the action of both cardioactive steroids and Na channel-gate toxins depends on Na influx, has been discussed in Sect. 4.2.5.

The use of TTX for the classification of inotropic mechanisms requires some precautions. It is necessary to rule out that the agent in question acts primarily on neural Na channels to cause the release of noradrenaline from intracardiac nerve endings. Such an effect is also blocked by TTX; in fact by concentrations much lower than those required to block sarco- lemmal Na channels. Among the substances covered in this review only scorpion toxins were found to act mainly by a presynaptic mechanism. In the case of veratridine and cevadine, a neural effect is also demon- strable, but requires concentrations in excess of those affecting sarcolem- mal Na channels (Sect. 4.2.5). It is also important to note that the pat- tern of inhibition by TTX depends on whether the Na channel-gate toxin acts reversibly or irreversibly. In the case of reversibly acting toxins, like veratridine (Honer]alger and Reiter 1975) or ATXII (Ravens 1976), TTX produces a stable inhibition if applied after the effects of the gate toxins have attained steady-state. With irreversibly acting toxins, like batracho- toxin (Honer]alger and Reiter 1977b), the effect of TTX, when applied in a submaximally effective concentration, is to delay the development, but not to prevent the effect of the Na channel-gate toxin. It appears that the change in cardiac membrane potential, such as the delay of the repolarization phase, requires only a small fraction of all Na channels to be modified (Horackova and Vassort 1973; Trautwein 1973). Thus TTX concentrations of 50 umol/litre or less, which reduce Vma x only up to 80% in guinea-pig papillary muscle (Baer et al. 1976), leave a significant fraction of Na channels unblocked, and this unblocked fraction of Na channels may suffice to mediate a prolongation of the action potential or decrease of the resting potential in the presence of a very high concentra- tion of Na channel-gate toxin (Honer/iiger and Reiter 1977b). Ito et al. (1979) observed that 1 ~mol/litre TTX failed to restore the membrane potential in guinea-pig papillary muscle depolarized by the irreversibly acting palytoxin, and they conclude that "the partial antagonism by TTX implies the possibility that PTX [palytoxin] did not act 'specifically' on the Na channel and produced a leaky state". However, their findings that TTX delayed the onset of the palytoxin-induced depolarization and that reduction of [Na]o to 12.3 mmol/litre did restore the membrane potential in the presence of palytoxin are compatible with the view that palytoxin acts entirely by selectively opening Na channels.

Page 63: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

60 P, Honerj/iger

6.3 Contraction Frequency

The frequency dependence of the positive inotropic effect of veratridine (Honerjiiger and Reiter 1975) or germitrine (Honer]ager and Reiter 1977a) differs from that of cAMP-increasing agents and, in certain details, from that of the cardioactive steroid dihydro-ouabain. The ceveratrum alkaloids lack a positive inotropic effect on the rested-state contraction (Sect. 4.2.5) whereas threshold effective concentrations at 1 Hz also increase the peak force of the rested-state contraction in the case of adrenaline and theophylline (cat papillary muscle; Bercsewicz and Reuter 1977) and noradrenaline and N 6 -2'-O-dibutyryl cAMP (guinea-pig papillary muscle; Seibel et al. 1978). Force-frequency relationships obtained with concentrations of dihydro-ouabain that are submaximally effective at 1 Hz (Ebner and Reiter 1977) are virtually identical to those obtained with veratridine or germitrine. Like the ceveratrum alkaloids, these concentrations ofdihydro-ouabain lack an effect on the rested-state contraction and produce a progressively increasing positive inotropic effect as the frequency is raised stepwise from 0.003 Hz to 0.5 Hz. Ceve- ratrum alkaloids lack a positive inotropic effect on the rested-state con- traction even at concentrations exceeding the maximally effective con- centration at a Hz by more than one order of magnitude (Sect. 4.2.5). In the cases of veratridine or cevadine, the demonstration of this lack of positive inotropic effect requires the elimination of their presynaptic effect (Sect. 4.2.5). In contrast, dihydro-ouabain increases the force of the rested-state contraction in concentrations that are maximally or supramaximally effective at 1 Hz (Ebner and Reiter 1977). In the cases of veratridine and germitrine, the phase of increased PNa is linked to the action potential, which explains the absence of a positive inotropic influ- ence under resting conditions. However, it is conceivable that agents which increase resting PNa' like grayanotoxin I in rabbit atrial fibres (Seyama 1978), also increase the rested-state contraction.

6.4 Reduction of Extracellular Na Concentration

Reducing the extracellular Na concentration by one-half greatly dimin- ishes the positive inotropic effect of cardioactive steroids, whereas the inotropic effect of catecholamines is unaffected (Reiter 1972a). Using this test, the ceveratrum alkaloids veratridine and cevadine were shown to be influenced in their effect on guinea-pig papillary muscle like the steroids (Reiter 1963), pointing to the importance of Na influx for the action of the alkaloids.

Page 64: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 61

6.5 Variation ofExtracellular K Concentration

The level of the extracellular K concentration may influence the positive inotropic effect of Na channel-gate toxins by at least two different mechanisms, through its effect on transmembrane potential and on the activity of the Na-K pump. Ravens (1976) showed that ATXII failed to prolong the action potential and to produce a positive inotropic effect in guinea-pig papillary muscle if the K concentration was raised from 2.7 to 14.7 mmol/litre. The elevated K concentration caused a fall of the resting potential to about - 5 0 mV, which is expected to inactivate normal Na channels (Beeler and Reuter 1970a). In contrast to ATXII, agents which increase the cellular cAMP concentration retain their positive inotropic effect and increase amplitude and duration of the action potential through their effect on Isi if Na channels are inactivated by depolarization (for references see Scholz 1980). Like the positive inotropic effect of ATXII, that of goniopora toxin on rabbit atrial preparations is prevented at an elevated (27 mmol/litre) extracellular K concentration (Fufiwara et al. 1979).

Reducing the K concentration below 5.9 mmol/litre enhances the positive inotropic effect of veratridine (Honer]iiger and Reiter 1975). The associated hyperpolarization of the resting potential from about - 8 0 mV at 5.9 mmol/litre [K]o has presumably little effect on the level of steady-state inactivation of the Na channels, since this seems to be already minimal at - 8 0 mV (Chen et al. 1975). It seems more likely that the synergistic action of K withdrawal and veratridine is related to an inhibition of the Na pump by reduction of [K]o, which is expected to increase the extent of the veratridine-induced intracellular Na accumula- tion and therefore the positive inotropic effect. This test does not dis- crimiate between veratridine and dihydro-ouabain, the positive inotropic effect of which is likewise enhanced by a reduction in extracellular K concentration (Reiter et al. 1966). In contrast, the inotropic effect of adrenaline (Reiter et al. 1966) or theophylline (Scholz and de Yazikof 1971) is not increased by a lowering of extracellular K concentration.

6.6 Inhibition of the Na Pump by Dihydro-Ouabain

Dihydro-ouabain potentiates the positive inotropic effect of veratridine (Honer]iiger and Reiter 1975) and germitfine (Honer]iiger and Reiter 1977a), whereas veratridine and noradrenaline act additively. The incre- ment in intracellular Na concentration induced by Na channel-gate toxins is normally counteracted by the Na-K pump, the activity of which is not directly influenced by Na channel-gate toxins. Hence, an inhibition of

Page 65: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

62 P. Honerj~iger

the Na pump will enhance the extent of the increment in intracellular Na concentration caused by agents which increase Na influx. The synergistic action of ceveratrum alkaloids and a specific Na pump inhibitor thus indirectly points to the critical role of intracellular Na concentration for the positive inotropic effect of Na channel-gate toxins.

6.7 Propranolol

(-+) Propranolol (5 /amol/litre) shifts the concentration-effect curve for the positive inotropic effect of veratridine to the right by a factor of 2 (Honerjdger and Reiter 1975). The same concentration of (+) propranolol causes the same degree of inhibition, although this isomer has only about 1/60 the activity of racemic propranolol in blocking the effects of /3-adrenoceptor activation (Howe and Shanks 1966). The antagonism is thus unrelated to the blockade of ~-adrenoceptors by propranolol, but is readily explained by the inhibitory effect of propranolol on myocardial Na channels which is identical for both isomers of propranolol (Pollen et al. 1969). Similarly, the antagonism of the positive inotropic effect of grayanotoxins by propranolol (10 gmol/litre, Sect. 4.5.2) may be entirely due to the blockade of Na channels by propranolol.

7 Summary and Conclusions

In recent years the detailed analysis of the mode of action of various Na channel-gate toxins has revealed that they prolong the open state of Na channels by mechanisms that differ in some detail. The alkaloids veratri- dine, batrachotoxin, and aconitine modify both activation and inactiva- tion characteristics, while certain polypeptide toxins like ATXII pre- dominantly affect Na inactivation and one of the scorpion venoms selec- tively modifies Na activation. These mechanisms were clarified by vol- tage-clamp experiments on single nerve fibres. Less direct experiments were performed on myocardial cells, but they all indicate that the Na channels of cardiac sarcolemma are also modified by various Na channel- gate toxins. The modification of cardiac Na channels results in a prolon- gation of the repolarization phase of the cardiac action potential which, depending on the particular toxin, may become evident at any potential level between the plateau and close to the resting potential. In embry- onic cardiac cells, the application of Na channel-gate toxins revealed the presence of normally silent TTX-sensitive Na channels.

Page 66: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 63

The prolonged phase of repolarization provides the depolarizing stimulus for coupled premature action potentials and thus explains the arrhythmogenic effect of Na channel-gate toxins. This type of arrhyth- mia is not specific for this kind of substances, but it is the consequence of a selective alteration of Na channel kinetics and therefore is completely inhibited by TTX.

With the exception of aconitine, all Na channel-gate toxins with a demonstrable effect on myocardial Na channels were also shown to pro- duce a positive inotropic effect in the prearrhythmic stage of action. Thus, a direct positive inotropic effect is observed in the presence of steroid alkaloids, diterpenoids, and polypeptides. Such a uniform response of the contractile mechanisms in the myocardial cell to substances of widely differing chemical structure suggests that the inotropic effect is somehow related to the known common mechanism of action of these toxins, i.e. the modification of the gating system of sarcolemmal Na channels.

The experimental evidence surveyed indicates that the mechanism of the positive inotropic effect of Na channel-gate toxins involves the following chain of subcellular events: The initial step is the alteration of the sarcolemmal Na channels by the toxin. The essentiality of this step is deduced from the observation that TTX prevents or abolishes the positive inotropic effect at concentrations which also prevent or abolish the electrophysiologic changes resulting from the Na channel modifica- tion. The selectivity of action of TTX in blocking Na channels is well established. In addition, TTX was shown to cause comparatively little or no antagonism to the positive inotropic effect of drugs that do not affect Na channel kinetics (dihydro-ouabain, noradrenaline, theophyl- line).

A cause-effect relationship requires that the causative event precedes the effect. This is clearly shown for Na channel-gate toxins in that the modified repolarization phase precedes the positive inotropic effect.

The slowing of Na channel kinetics prolongs the time during which Na ions flow into the cell. In addition, the prolonged repolarization phase indirectly affects voltage- and time-dependent ionic currents other than Na current. The change in membrane potential, however, is not essential for the positive inotropic effect. As shown in voltage-clamp experiments on frog atrial trabeculae, the positive inotropic effect is still present if the prolongation of the action potential is prevented by submitting the pre- paration to depolarizations of constant amplitude and duration. Hence, the inotropic effect is coupled to the increase in Na current induced by the toxins. The importance of Na influx is also indicated by the fact that the positive inotropic effect of Na channel-gate toxins is potentiated by dihydro-ouabain, an inhibitor of Na efflux.

Page 67: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

64 P. Honerj~ger

How does an increase in Na influx media te a positive ino t rop ic effect?

A wel l -documented mechanism is the Na-Ca exchange, which provides

an increase in t ranssarcolemmal Ca influx in response to an elevation o f

the intracellular Na concent ra t ion . In fact, Na channel-gate toxins were used to demons t ra te the existence, in cardiac cells, o f a Na-Ca exchange

mechanism because they are convenient chemical tools to selectively pro-

duce an increase o f the intracellular Na concen t r a t ion in small cells.

Acknowledgments. The author gratefully acknowledges that his research on cevera- trum alkaloids was encouraged by Professor Dr. M. Reiter and Professor Dr. O. Krayer. I am indebted to Drs. P.F. Baker, O. Krayer, M. Lazdunski, M. Reiter, and W. Ulbricht for reading the manuscript and suggesting improvements.

References

Adam KR, Schmidt H, St~impfli R, Weifi C (1966) The effect of scorpion venom on single myelinated nerve fibres of the frog. Br J Pharmacol 26:666-677

Akera T, Brody TM (1978) The role of Na ÷, K+-ATPase in the inotropic action of digitalis• Pharmacol Rev 29:187-220

Akera T, Ku DD, Frank M, Brody TM, Iwasa J (1976) Effects of grayanotoxin I on • ÷ + . . . . .

cardiac Na , K -adenosine trlphosphatase activity, transmembrane potential and myocardial contractile force. J Pharmacol Exp Ther 199:247-254

Albuquerque EX, Warnick JE (1972) The pharmacology of batrachotoxin. IV. Inter- action with tetrodotoxin on innervated and chronically denervated rat skeletal muscle. J Pharmacol Exp Ther 180:683-697

Allen DG, Blinks JR (1978) Calcium transients in aequorin-injected frog cardiac muscle. Nature (London) 273:509-513

Alsen C, Bdress L, Fischer K, Proppe D, Reinberg T, Sattler RW (1976) The action of a toxin from the sea anemone Anemonia sulcata upon mammalian heart muscles. Naunyn-Schmiedebergs Arch Pharmacol 295:55-62

Arbel ER, Lazzari J, Glick G (1975) Effects of veratrine on repolarization in the canine right bundle branch. Am J Physiol 229:1254-1260

Attwell D, Cohen I, Eisner D, Ohba M, Ojeda C (1979) The steady-state TTX-sensi- tive ("window") sodium current in cardiac Purkinje fibres. Pfltigers Arch 379: 137-142

Baer M, Best PM, Reuter H (1976) Voltage-dependent action of tetrodotoxin in mammalian cardiac muscle. Nature (London) 263:344-345

Baker PF, McNaughton PA (1976) The effect of membrane potential on the calcium transport systems in squid axons. J Physiol (London) 260: 24P-25P

Baker PF, McNaughton PA (1978) The influence of extracellular calcium binding on the calcium efflux from squid axons. J Physiol (London) 276:127-150

Baker PF, Blaustein MP, Hodgkin AL, Steinhardt RA (1969) The influence of cal- cium on sodium efflux in squid axons, J Physiol (London) 200:431-458

Bartels-Bernal E, Rosenberry TL, Daly JW (1977) Effect of batrachotoxin on electro- plax of electric eel: Evidence for voltage-dependent interaction with sodium chan- nels. Proc Natl Acad Sci USA 74:951-955

Basseches P, Bianchi CP (I 976) Mode of action of veratridine on perfused frog ven- tricle. Arch Int Pharmacodyn Ther 221 : 190-196

Page 68: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 65

Bassingthwaighte JB, Fry CH, McGuigan JAS (1976) Relationship between internal calcium and outward current in mammalian ventricular muscle: a mechanism for the control of the action potential duration? J Physiol (London) 262 :15 -37

Beeler GW, Reuter H (1970a) Voltage clamp experiments in ventricular myocardial fibres. J Physiol (London) 207 :165 -190

Beeler GW, Reuter H (1970b) Membrane calcium current in ventricular myocardial fibres. J Physiol (London) 207 :191-209

Beeler GW, Reuter H (1970c) The relation between membrane potential, membrane currents and activation of contraction in ventricular myocardial fibres. J Physiol (London) 207: 211 -229

Beeler GW, Reuter H (1977) Reconstruction of the action potential of ventricular myocardial fibres. J Physiol (London) 268 :177-210

Benforado JM (1957) Studies on veratrum alkaloids. XXVI. Comparison of the car- diac action of various tert iary amine ester alkaloids. J Pharmacol Exp Ther 120: 4 1 2 - 4 2 5

Benforado JM (1967) The veratrum alkaloids. In: Root WS, Hofmann FG (eds) Physiological pharmacology, vol 4. Academic Press, New York, pp 331 -398

Benninger C, Einw~chter HM, Haas HG, Kern R (1976) Calcium-sodium antagonism on the frog's heart: a voltage-clamp study. J Physiol (London) 259 :617-645

Ber~sewicz A, Reuter H (1977) The effects of adrenaline and theophylline on action potential and contraction of mammalian ventricular muscle under "rested-state" and "steady-state" stimulation. Naunyn-Schmiedebergs Arch Pharmacol 301: 99 107

Bdress L, Bdress R, Wunderer G (1975a) Isolation and characterization of three poly- peptides with neurotoxic activity from Anemonia sulcata. FEBS Lett 5 0 : 3 1 1 - 314

Bdress L, Bdress R, Wunderer G (1975b) Purification of three polypeptides with neurotoxic and cardiotoxic activity from the sea anemone Anemonia sulcata. Toxicon 13 :359-367

Bdress L, Wunderer G, Wachter E (1977) Amino acid sequence of toxin III from Ane- monia sulcata. Hoppe-Seylers Z Physiol Chem 358 :986 -988

Bergmann C, Dubois JM, Rojas E, Rathmayer W (1976) Decreased rate of sodium conductance inactivation in the node of Ranvier induced by a polypeptide toxin from sea anemone. Biochim Biophys Acta 455: 173-184

Bernard C, Gargouil YM (1968) Les permdabilitgs de la membrane myocardique embryonnaire du rat ; dtude de leurs dvolutions au cours de l 'embryogdndse fi l 'aide d'inhibiteurs: t~trodoxin, mangan+se, tetraethylammonium. CR Acad Sci (Paris) 267 :1626-1629

Bernard P, Couraud F (1979) Electrophysiological studies on embryonic heart cells in culture. Scorpion toxin as a tool to reveal latent fast sodium channel. Biochim Biophys Acta 553 :154 -168

Blair RW, Peterson DF, Bishop VS (1978) The effects of authopleurin-A on cardiac dynamics in conscious'dogs. J Pharmacol Exp Ther 207:271 276

Blaustein MP (1977) Effects of internal and external cations and of ATP on sodium- calcium and calcium-calcium exchange in squid axons. Biophys J 20 :79-111

Blaustein MP, Hodgkin AL (1969) The effect of cyanide on the efflux of calcium from squid, axons. J Physiol (London) 200 :497-527

B6nisch H, Gra~fe KH, Keller B (1980) Reserpine-like, tetrodotoxin-resistant effect of veratridine in the rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol 31 l :R61

Bohnenkamp H (1922) t)ber die Wirkungsweise der Herznerven. Pfliigers Arch 196: 275 -310

Bozler E (1943) The initiation of impulses in cardiac muscle. Am J Physiol 138: 273 -282

Brooks CMcC, Hoffmann BF, Suckling EE, Orias O (1955) Excitabili ty of the heart. Grune and Strat ton, New York, pp 261-266

Page 69: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

66 P. Honerfiiger

Cahalan MD (1975) Modification of sodium channel gating in frog myelinated nerve fibres by Centruroides sculpturatus scorpion venom. J Physiol (London) 244: 511-534

Carafoli E, Crompton M (1978) The regulation of intracellular calcium by mitochon- dria. Ann NY Acad Sci 307:269-283

Catterall WA (1975) Activation of the action potential Na ionophore of cultured neuro- blastoma cells by veratridine and batrachotoxin. J Biol Chem 250:4053-4059

Catterall WA (1980) Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu Rev Pharmacol Toxicol 20:15-44

Chamberlain SG, Kerkut GA (1969) Voltage clamp analysis of the sodium and cal- cium inward currents in snail neurones. Comp Biochem Physiol 28: 787-801

Chapman RA (1974) A study of the contractures induced in frog atrial trabeculae by a reduction of the bathing sodium concentration. J Physiol (London) 237:295- 313

Chapman RA (1979) Excitation-contraction coupling in cardiac muscle. Prog Biophys Mol Biol 35 :1-52

Chen C, Gettes LS, Katzung BG (1975) Effect of lidocaine and quinidine on steady- state characteristics and recovery kinetics of (dV/dt)ma x in guinea pig ventricular myocardium. Circ Res 37:20-29

Cleeman L, Morad M (1976) Extracellular potassium accumulation and inward-going potassium rectification in voltage-clamped ventricular muscle. Science 191 : 90-92

Coraboeuf E, Deroubaix E, Tazieff-Depierre F (1975) Effect of toxin II isolated from scorpion venom on action potential and contraction of mammalian heart. J Mol Cell Cardiol 7:643-653

Coraboeuf E, Deroubaix E, Coulombe A (1979) Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. Am J Physiol 236:H561- H567

Corrado AP, Antonio A, Diniz CR (1968) Brazilian scorpion venom (Tityus serrula- tus): an unusual sympathetic postganglionic stimulant. J Pharmacol Exp Ther 164:253-258

Couraud F, Rochat H, Lissitzky S (1976) Stimulation of sodium and calcium uptake by scorpion toxin in chick embryo heart cells. Biochim Biophys Acta 433:90-100

Cranefield PF (1977) Action potentials, afterpotentials, and arrhythmias. Circ Res 41:415-423

Daly J, Witkop B (1971) Batrachotoxin, an extremely active cardio-and neurotoxin from the Colombian arrow poison frog. Clin Toxicol 4 :331-342

DeHaan RL, McDonald TF, Sachs HG (1975) Development of tetrodotoxin sensitivity of embryonic chick heart cells in vitro. In: Liebermann M, Sano T (eds) Develop- mental and physiological correlates of cardiac muscle. Raven Press, New York, pp 155-167

Deitmer JW, Ellis D (1978) Changes in the intracellular sodium activity of sheep heart Purkinje fibres produced by calcium and other divalent cations. J Physiol (Lon- don) 277:437-453

DiPolo R (1979) Calcium influx in internally dialyzed squid giant axons. J Gen Physiol 73:91-113

DiPolo R, Beaugd L (1979) Physiological role of ATP-driven calcium pump in squid axon. Nature (London) 278:271 273

Donatsch P, Lowe DA, Richardson BP, Tylor P (1977) The functional significance of sodium channels in pancreatic beta cell membranes. J Physiol (London) 267: 357- 376

Ebner F, Reiter M (1977) The dependence on contraction frequency of the positive inotropic effect of dihydro-ouabain. Naunyn Schmiedebergs Arch Pharmacol 300: 1 9

Fabiato A, Fabiato F (1973) Activation of skinned cardiac cells. Subcellular effects of cardioactive drugs. Eur J Cardiol 1 / 2:143-155

Page 70: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 67

Fayet G, Couraud F, Miranda F, Lissitzky S (1974) Electro-optical system for moni- toring activity of heart cells in culture: application to the study of several drugs and scorpion toxins. Eur J Pharmacol 27:165-174

Feinstein MB, Paimre M (1968) Mechanism of cardiovascular action of tetrodotoxin in the cat. Circ Res 23:553-565

Ferrier GR (1977) Digitalis arrhythmias: role of oscillatory afterpotentials. Prog Cardiovasc Dis 19:459-474

Fieser LF, Fieser M (1959) Steroids. Reihold, New York Fosset M, De Barry J, Lenoir MC, Lazdunski M (1977) Analysis of molecular aspects

of Na + 2+ and Ca uptakes by embryonic cardiac cells in culture. J BiolChem 252: 6112-6117

Frankenhaeuser B, Hodgkin AL (1957) The action of calcium on the electrical prop- erties of squid axons. J Physiol (London) 137:218-244

Fujiwara M, Muramatsu I, Hidaka H, Ikushima S, Ashida K (1979) Effects of gonio- pora toxin, a polypeptide isolated from coral, on electromechanical properties of rabbit myocardium. J Pharmacol Exp Ther 210:153-157

Galper JB, Catterall WA (1979) Inhibition of sodium channels by D 600. Mol Phar- macol 15:174-178

Gettes LS, Reuter H (1974) Slow recovery from inactivation of inward currents in mammalian myocardial fibres. J Physiol (London) 240:703-724

Glitsch HG, Reuter H, Scholz H (1970) The effect of the internal sodium concentra- tion on calcium fluxes in isolated guinea-pig auricles. J Physiol (London) 209: 25-43

Graham HT, Gasser HS (1931) Modification of nerve response by veratrine, proto- veratrine and aconitine. J Pharmacol Exp Ther 43: 163-185

Hashimoto K, Ochi R, Hashimoto K, Inui J, Miura Y (1980) The ionic mechanism of prolongation of action potential duration of cardiac ventricular muscle by antho- pleurin-A and its relationship to the inotropic effect. J Pharmacol Exp Ther 215: 479-485

Hashimoto Y, Ashida K (1973) Screening of toxic corals and isolation of a toxic polypeptide from Goniospora spp. In: Proceedings of the Second International Symposium on Snidaria. Publ Seto Mar Biol Lab 20:703-711

Heistracher P, Pillat B (1962) Elektrophysiologische Untersuchungen fiber die Wir- kung yon Chinidin auf die Aconitinvergiftung yon Herzmuskelfasern. Naunyn- Schmiedebergs Arch Exp Path Pharmak 244:48-62

Hille B (1968) Pharmacological modifications of the sodium channels of frog nerve. J Gen Physiol 51:199-219

Hille B (1970) Ionic channels in nerve membranes. Prog Biophys Mol Biol 21:1-32 Hodgkin AL, Huxley AF (1952) A quantitative description of membrane current and

its application to conduction and excitation in nerve. J Physiol (London) 117: 500 544

Hogan PM, Albuquerque EX (1971) The pharmacology of batrachotoxin. III. Effect on the heart Purkinje fibres. J Pharmacol Exp Ther 176:529-537

Hondeghem LM, Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 472: 373-398

Honerj~iger P (1973) Electrophysiological effects of various ceveratrum alkaloids on single nerve axons. Naunyn Schmiedebergs Arch Pharmacol 280:391-416

Honerj~iger P (1977) Die Kontraktionskraft der Herzmuskulatur bei erh6hter Durch- l~issigkeit des Sarkolemms ffir Natriumionen. Habilitationsschrift, Technische Uni- versit~t Mtinchen

Honerj~iger P (1980) A neurally mediated inotropic effect of veratridine and cevadine on isolated guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol 314:157-160

Honerjgger P, Reiter M (1975) The relation between the effects of veratridine on action potential and contraction in mammalian ventricular myocardium. Naunyn- Schmiedebergs Arch Pharmacol 289:1-28

Page 71: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

68 P. Honerj~iger

Honerjgger P, Reiter M (1977a) Sarcolemmal sodium permeability and contractile force of guinea pig papillary muscle. Effects of germitrine. Circ Res 40:90-98

Honerj~iger P, Reiter M (1977b) The cardiotoxic effect of batrachotoxin. Naunyn- Schmiedebergs Arch Pharmacol 299:239-252

Horackova M, Vassort G (1973) Ionic mechanism of inotropic effect of veratrine on frog heart. Pfltigers Arch 341:281-284

Horackova M, Vassort G (1974) Excitation-contraction coupling in frog heart. Effect o f veratrine. Pfltigers Arch 352: 291-302

Horackova M, Vassort G (1976) Calcium conductance in relation to contractility in frog myocardium. J Physiol (London) 259:597-616

Horackova M, Vassort G (1979a) Sodium-calcium exchange in regulation of cardiac contractility. Evidence for an electrogenic, voltage-dependent mechanism. J Gen Physiol 73:403-424

Horackova M, Vassort G (1979b) Slow inward current and contraction in frog atrial muscle at various extracellular concentrations of Na and Ca ions. J Mol Cell Cardiol 11:733-753

Hotta Y, Takeya K, Kobayashi S, Harada N, Sakakibara J, Shirai N (1980) Relation- ship between structure, positive inotropic potency and lethal dose of grayano- toxins in guinea pig. Arch Toxicol 44:259-267

Howe R, Shanks RG (1966) Optical isomers of propranolol. Nature (London) 210: 1336-1338

Iijima T, Pappano AJ (1979) Ontogenetic increase of the maximal rate of rise of the chick embryo heart action potential: relationship to voltage, time and tetrodo- toxin. Circ Res 44:358-367

Isenberg G (1975) Is potassium conductance of cardiac Purkinje fibres controlled by [Ca 2+] i ? Nature (London) 253 : 273 -274

Ishima Y (1968) The effect of tetrodotoxin and sodium substitution on the action potential in the course of development of the embryonic chick heart. Proc Jpn Acad 44:170-175

Ito K, Karaki H, Urakawa N (1979) Effects of palytoxin on mechanical and electrical activities of guinea pig papillary muscle. Jpn J Pharmacol 29:467-476

Johnson PN, Inesi G (1969) The effect of methylxanthines and local anesthetics on fragmented sarcoplasmic reticulum. J Pharmacol Exp Ther 169:308-314

Kahn JB, Acheson GH (1955) Effects of cardiac glycosides and other lactones, and of certain other compounds, on cation transfer in human erythrocytes. J Pharma- col Exp Ther 115:305-318

Kakisawa H, Kozima T, Yanai M, Nakanishi K (1965) Stereochemistry of grayano- toxins. Tetrahedron 21:3091-3104

Kass RS, Lederer WJ, Tsien RW, Weingart R (1978a) Role of calcium ions in transient inward currents and aftercontractions induced by strophanthidin in cardiac Pur- kinje fibres. J Physiol (London) 281:187-208

Kass RS, Tsien RW, Weingart R (1978b) Ionic basis of transient inward current induced by strophanthidin in cardiac Purkinje fibres. J Physiol (London) 281:209-226

Katz AM, Repke D (1967) Sodium and potassium sensitivity of calcium uptake and calcium binding by dog cardiac microsomes. Circ Res 21:767-775

Kaufmann R, Fleckenstein A, Antoni H, Wolf H (1963) Ursachen und Ausl6sungs- bedingungen yon Myokard-Kontraktionen ohne regulgres Aktionspotential. Pflfi- gers Arch 278:435-446

Kayaalp SO, Albuquerque EX, Warnick JE (1970) Ganglionic and cardiac actions of batrachotoxin. Eur J Pharmacol 12:10-18

Khodorov BI (1979) Some aspects of the pharmacology of sodium channels in nerve membrane. Process of inactivation. Biochem Pharmacol 28:1451 -1459

Khodorov BI, Revenko SV (1979) Further analysis of the mechanisms of action of batrachotoxin on the membrane of myelinated nerve. Neuroscience 4:1315-1330

Koch-Weser J (t 966) Myocardial actions of veratrum alkaloids. 3rd Intern Pharmacol Congr S~o Paolo, No 505 (abstr)

Page 72: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 69

Kopeyan C, Martinez G, Rochat H (1979) Amino acid sequence of neurotoxin III of the scorpion Androctonus australis Hector. Eur J Biochem 94:609-615

Koppenh6fer E, Schmidt H (1968a) Die Wirkung yon Skorpiongift auf die Ionen- str6me des Ranvierschen Schniirrings. I. Die Permeabilit~iten PNa und PK" Pfltigers Arch 303:133-149

Koppenh6fer E, Schmidt H (1968b) Die Wirkung yon Skorpiongift auf die Ionen- str6me des Ranvierschen Schniirrings. II. Unvollst~indige Natrium-Inaktivierung. Pfliigers Arch 303:150-161

Korth M (1978) Effects of several phosphodiesterase-inhibitors on guinea-pig myo- cardium. Naunyn-Schmiedebergs Arch Pharmacol 302:77- 86

Krayer O (1961) The history of the Bezold-Jarisch effect. Naunyn-Schmiedebergs Arch Exp Path Pharmak 240:361-368

Krayer O, Acheson GH (1946) The pharmacology of the veratrum alkaloids. Physiol Rev 26:383 446

Krayer O, George HW (1951) Studies on veratrum alkaloids. XV. The quinine-like effect of veratramine upon the single twitch and upon the "veratrine response" of the sartorius muscle of the frog. J Pharmacol Exp Ther 103:249-258

Krayer O, Meilman E (1977) Veratrum alkaloids with antihypertensive activity. In: Gross F (ed) Antihypertensive agents. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 39, pp 547-570)

Kreitner D (1975) Evidence for the existence of a rapid sodium channel in the mem- brane of rabbit sinoatrial cells. J Mol Cell Cardiol 7:655-662

Ku DD, Akera T, Frank M, Brody TM (1977) The effects of grayanotoxin I and a-dihydrograyanotoxin II on guinea-pig myocardium. J Pharmacol Exp Ther 200: 363 -372

Kumazawa Z, Iriye R (1970) Stereochemistry of grayanotoxin II. Tetrahedron 12: 927 -930

Kupchan SM, By AW (1968) Steroid alkaloids: The Veratrum group. In: Manske RHF (ed) Alkaloids, vol 10. Academic Press, New York, pp 193-285

Kupchan SM, Flacke W (1967) Hypotensive veratrum alkaloids. In: Schlittler E (ed) Antihypertensive agents, vol 7. Academic Press, New York, pp 429-458

Kupchan SM, Zimmerman JH, Afonso A (1961) The alkaloids and taxonomy of Veratrum and related genera. Lloydia 24:1-26

Langer SZ, A.dler-Graschinsky E, Almeida AP, Diniz CR (1975) Prejunctional effects of a purified toxin from the scorpion Tityus serrulatus. Naunyn Schmiedebergs Arch Pharmacol 287:243-259

Lazdunski M, Balerna M, Barhanin J, Chicheportiche R, Fosset M, Frelin C, Jacques Y, Lombet A, Pouyssggur J, Renaud JF, Romey G, Schweitz H, Vincent JP (1980) Molecular aspects of the structure and mechanism of the voltage-dependent Na + channel. Ann NY Acad Sci 358:169-182

Lee CO, Kang DH, Sokol JH, Lee KS (1980) Relation between intracellular Na ion activity and tension of sheep cardiac Purkinje fibres exposed to dihydro-ouabain. Biophys J 29:315-330

Leicht R, Meves H, Wellh6ner HH (1971)The effect of veratridine on Helix pomatia neurones. Pfliigers Arch 323: 50-62

List PH, H6rhammer L (1969) Hagers Handbuch der pharmazeutischen Praxis, vol 2. Springer, Berlin Heidelberg New York

Low PA, Wu CH, Narahashi T (1979) The effect of anthopleurin-A on crayfish giant axon. J Pharmacol Exp Ther 210:417-421

Lowe DA, Bush BMH, Ripley SH (1978) Pharmacological evidence for "fast" sodium channels in nonspiking neurones. Nature (London) 274:289-290

Martinez G, Kopeyan C, Schweitz H, Lazdunski M (1977) Toxin III from Anemonia sulcata: Primary structure. FEBS Lett 84:247-252

Matsuda K, Hoffman BF, Ellner CN, Katz M, Brooks CMcC (1953) Veratrine induced prolongation of repolarization in the mammalian heart. In: Proc 19th Intern Physiol Congr, Montreal, pp 596-597

Page 73: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

70 P. Honerj/iger

Matsuda K, Hoshi T, Kameyama S (1959) Effects of aconitine on the cardiac mem- brane potential of the dog. Jpn J Pharmacol 9:419-429

Matsumura M, Takaori S (1959a) The effect of drugs on the cardiac membrane poten- tials in the rabbit. I. Ventricular muscle fibers. Jpn J Pharmacol 8:134-142

Matsumura M, Takaori S (1959b) The effect of drugs on the cardiac membrane poten- tials in the rabbit. II. Auricular muscle fibers and the sinoatrial node. Jpn J Phar- macol 8:143-154

McAllister RE, Noble D, Tsien RW (1975) Reconstruction of the electrical activity of cardiac Purkinje fibres. J Physiol (London) 251 : 1-59

McDonald TF, Sachs HG (1975) Electrical activity in embryonic heart cell aggregates. Developmental aspects. Pfl~gers Arch 354:151 -164

McDonald TF, Trautwein W (1978) Membrane currents in cat myocardium: separa- tion of inward and outward components. J Physiol (London) 274:193-216

McDonald TF, Sachs HG, DeHaan RL (1972)Development of sensitivity to tetrodo- toxin in beating chick embryo hearts, single ceils, and aggregates. Science 176: 1248-1250

McLean M J, Sperelakis N (1976) Retention of fully differentiated electrophysiologi- cal properties of chick embryonic heart cells in culture. Dev Biol 50:134-141

Miranda F, Kopeyan C, Rochat H, Rochat C, Lissitzky S (1970) Purification of animal neurotoxins. Eur J Biochem 16:514-523

Miyamoto H, Racker E (1980) Solubilization and partial purification of the Ca2+/ Na ÷ antiporter from the plasma membrane of bovine heart. J Biol Chem 255: 2656-2658

Moe GK, Krayer O (1943) Studies on veratrum alkaloids. II. The action of veratri- dine and cevine upon the isolated mammalian heart. J Pharmacol Exp Ther 77: 22O-228

Morad M, Goldman Y (1973) Excitation-contraction coupling in heart muscle: mem- brane control of development of tension. Prog Biophys Mol Biol 27:259-313

Morad M, Trautwein W (1968) The effect of the duration of the action potential on contraction in the mammalian heart muscle. Pfltigers Arch 299:66-82

Morales-Aguilera A, Vaughan Williams EM (1965) The effects on cardiac muscle of /3-receptor antagonists in relation to their activity as local anesthetics. Br J Phar- macol 24:332-338

Moss J, Thoa NB, Kopin IJ (1974) On the mechanism of scorpion toxin-induced release of norepinephrine from peripheral adrenergic neurons. J Pharmacol Exp Ther 190:39-48

Mozhayeva GN, Naumov AP, Negulyaev YA, Nosyreva ED (1977) The permeability of aconitine-modified sodium channels to univalent cations in myelinated nerve. Biochim Biophys Acta 466:461-473

Mullins LJ (1979) The generation of electric currents in cardiac fibers by Na/Ca exchange. Am J Physiol 236:C103-C110

Munson R, Westermark B, Glaser L (1979) Tetrodotoxin-sensitive sodium channels in normal human fibroblasts and normal human glia-like cells. Proc Natl Acad Sci USA 76:6425-6429

Narahashi T (1974) Chemicals as tools in the study of excitable membranes. Physiol Rev 54:813-889

Narahashi T, Seyama I (1974) Mechanism of nerve membrane depolarization caused by giayanotoxin I. J Physiol (London) 242:471-487

Narahashi T, Anderson NC, Moore JW (1966) Tetrodotoxin does not block excita- tion from inside the nerve membrane. Science 153:765-767

Narahashi T, Shapiro BI, Deguchi T, Scuka M, Wang CM (1972) Effects of scorpion venom on squid axon membranes. Am J Physiol 222:850-857

New W, Trautwein W (1972) The ionic nature of slow inward current and its relation to contraction. Pfliigers Arch 334: 24-38

Niedergerke R (1963) Movements of Ca in frog heart ventricles at rest and during contractures. J Physiol (London) 167: 515-550

Page 74: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 71

Noma A, Yanagihara K, Irisawa H (1977) Inward current of the rabbit sinoatrial node cell. Pfltigers Arch 372 :43 -51

Ohta M, Narahashi T, Keeler RF (1973) Effects of veratrum alkaloids on membrane potential and conductance of squid and crayfish giant axons. J Pharmacol Exp Ther 184 :143-154

Pappano AJ (1972) Action potentials in chick atria: increased susceptibility to block- ade by te t rodotoxin during embryonic development. Circ Res 3 1 : 3 7 9 - 3 8 8

Peper K, Trautwein W (1967) The effect of aconitine on the membrane current in cardiac muscle. Pfltigers Arch 296 :328-336

Philipson KD, Nishimoto AY (1980) Na+-Ca 2+ exchange is affected by membrane potential in cardiac sarcolemmal vesicles. J Biol Chem 255 :6880-6882

Pitts B JR (1979) Stoichiometry of sodium-calcium exchange in cardiac sarcolemmal vesicles. Coupling to the sodium pump. J Biol Chem 254 :6232-6235

Pollen DW, Scott AC, Wallace WFM (1969) A comparison of the direct effects and adrenergic blocking activity of D, L- and D-propranolol on the electrical and mechanical behaviours of isolated frog ventricle. Cardiovasc Res 3 : 7 - 1 3

Portius H J, Repke K (1964) Versuch einer Analyse der Beziehungen zwischen chemi- scher Struktur and Digitalis-~ihnlicher Wirksamkeit auf der Rezeptorebene. Arzneim Forsch 14 :1073-1077

Pouyss~gur J, Jacques Y, Lazdunski M (1980) Identif ication of a tetrodotoxin-sensi- t ire Na ÷ channel in a variety of fibroblast lines. Nature (London) 2 8 6 : 1 6 2 - 1 6 4

Rathmayer W, B~ress L (1976) The effect of toxins from Anernonia sulcata (Coelen- terata) on neuromuscular transmission and nerve action potentials in the crayfish (Astacus leptodactylus). J Comp Physiol 109 :373-382

Ravens U (1976) Electromechanical studies of an Anernonia sulcata toxin in mam- malian cardiac muscle. Naunyn Schmiedebergs Arch Pharmacol 2 9 6 : 7 3 - 7 8

Redfern P, Lundh H, Thesleff S (1970) Tetrodotoxin resistant action potentials in denervated rat skeletal muscle. Eur J Pharmacol 11:263 265

Reeves JP, Sutko JL (1979) Sodium-calcium exchange in cardiac membrane vesicles. Proc Natl Acad Sci USA 7 6 : 5 9 0 - 5 9 4

Reeves JP, Sutko JL (1980) Sodium-calcium exchange activity generates a current in cardiac membrane vesicles. Science 208 :1461-1464

Reiter M (1962) Die Entstehung der , ,Nachkontrakt ionen" im Herzmuskel unter Ein- wirkung yon Calcium und yon Digitalisglykosiden in Abh~ingigkeit yon der Reiz- frequenz. Naunyn Schmiedebergs Arch Pharmacol 242:497 507

Reiter M (1963) t2rber die inotrope Wirkung yon Veratridin and Cevadin auf den Herzmuskel. Naunyn Schmiedebergs Arch Pharmacol 246:45

Reiter M (1972a) Drugs and heart muscle. Annu Rev Pharmacol 12:111 - 1 2 4

Reiter M (1972b) Differences in the inotropic cardiac effects of noradrenaline and dihydro-ouabain. Naunyn Schmiedebergs Arch Pharmacol 275 :243 -250

Reiter M (to be published) The positive inotropic action of cardioactive steroids on cardiac ventricular muscle. In: Greeff K (ed) Cardiac glycosides. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 56)

Reiter M, Stickel FJ, Weber S (1966) The influence of the extracellular potassium concentration on the glycoside effects upon contractile force and action potent ial duration of the guinea-pig papillary muscle. Experientia 22:665

Reuter H (1979) Properties of two inward membrane currents in the heart. Annu Rev Physiol 4 1 : 4 1 3 - 4 2 4

Reuter H, Scholz H (1977) A study of the ion selectivity and the kinetic properties of the calcium-dependent, slow inward current in mammalian cardiac muscle. J Physiol (London) 2 6 4 : 1 7 - 4 7

Reuter H, Seitz N (1968) The dependence of calcium efflux from cardiac muscle on temperature and external ion composition. J Physiol (London) 1 9 5 : 4 5 1 - 470

Ritchie JM (1979) A pharmacological approach to the structure of sodium channels in myelinated axons. Annu Rev Neurosci 2 : 3 4 1 - 3 6 2

Page 75: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

72 P. Honerjgger

Rochat H, Rochat C, Kopeyan C, Miranda F, Lissitzky S, Edman P (1970) Scorpion neurotoxins: A family of homologous proteins. FEBS Lett 10:349-351

Rojas E, Rudy B (1976) Destruction of the sodium conductance inactivation by a specific protease in perfused nerve fibres from Loligo. J Physiol (London) 262: 501-531

Romey G, Abita JP, Schweitz H, Wunderer G, Lazdunski M (1976) Sea anemone toxin: A tool to study molecular mechanisms of nerve conduction and excitation- secretion coupling. Proc Natl Acad Sci USA 73 :4055-4059

Romey G, Jacques Y, Schweitz H, Fosset M, Lazdunski M (1979)The sodium chan- nel in non-impulsive cells. Interaction with specific neurotoxins. Biochim Biophys Acta 556 :344-353

Romey G, Renaud JF, Fosset M, Lazdunski M (1980) Pharmacological properties of the interaction of a sea anemone polypeptide toxin with cardiac cells in culture. J Pharmacol Exp Ther 213 :607 -615

Rosen MR, Danilo P (1980) Effects of tetrodotoxin, lidocaine, verapamil, and AHR- 2666 on ouabain-induced delayed afterdepolarizations in canine Purkinje fibres. Circ Res 4 6 : 1 1 7 - 1 2 4

Ross SB, Kelder D (1979) Release of aH-noradrenaline from the rat vas deferens under various in vitro conditions. Acta Physiol Scand 105 :338-349

Roulet M J, Mongo KG, Vassort G, Ventura-Clapier R (1979) The dependence of twitch relaxation on sodium ions and on internal Ca 2÷ stores in voltage-clamped frog atrial fibres. Pfliigers Arch 3 7 9 : 2 5 9 - 2 6 8

Ruiz-Ceretti E, Ponce Zumino A (1976) Action potential changes under varied [Na+]o and [Ca2+]o indicating the existence of two inward currents in cells of the rabbit atrioventricular node. Circ Res 3 9 : 3 2 6 - 3 3 6

Schmidt H, Schmitt O (1974) Effect of aconitine on the sodium permeabili ty of the node o f Ranvier. Pfltigers Arch 349: 1 3 3 - 1 4 8

Schmidt RF (1960) Versuche mit Aconitin zum Problem der spontanen Erregungs- bildung im Herzen. Pfliigers Arch 271 :526-536

Scholz H (1980) Effects of be t a - and alpha-adrenoceptor activators and adrenergic transmitter-releasing agents on the mechanical activity of the heart. In: Szekeres L (ed) Adrenergic activators and inhibitors. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 54/I, pp 6 5 1 - 7 3 3 )

Scholz H, de Yazikof E (1971) I)ber den Mechanismus der positiv inotropen Wirkung yon Theophyllin am Warmbliiterherzen. I. Einflut~ der extracellul~iren Ca-, Na- und K-Konzentration und yon Reserpin. Naunyn Schmiedebergs Arch Pharmacol 271 : 3 7 4 - 3 9 5

Scriabine A, van Arman CG, Morgan G, Morris AA, Bennett CD, Bohidar NR (1979) Cardiotonic effects of anthopleurin-A, a polypeptide from a sea anemone. J Car- diovasc Pharmacol 1 : 571 -583

Seibel K, Karema E, Takeya K, Reiter M (1978) Effect of noradrenaline on an early and a late component of the myocardial contraction. Naunyn Schmiedebergs Arch Pharmacol 3 0 5 : 6 5 - 7 4

Seifen E (1969) The chronotropic effects of ouabain and germine-3-monoacetate as influenced by calcium. Pharmacologist 11:295

Seyama I (1978) Effect of grayanotoxin I on SA node and right atrial myocardia of the rabbit. Am J Physiol 235 :C136-C142

Shanes AM (1952) The ultraviolet spectra and neurophysiological effects of "vera- t r ine" alkaloids. J Pharmacol Exp Ther 105: 216-231

Shanes AM (1958) Electrochemical aspects of physiological and pharmacological action in excitable cells. II. The action potential and excitation. Pharmacol Rev 10 :165-273

Shibata S, Norton TR, Izumi T, Matsuo T, Katsuki S (1976) A polypept ide (AP-A) from sea anemone (Anthopleura xanthog-rarnmica) with potent positive inotropic action. J Pharmacol Exp Ther 199 :298-309

Page 76: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Cardioactive Substances that Prolong the Open State of Sodium Channels 73

Shibata S, Izumi T, Seriguchi DG, Norton TR (1978) Further studies on the positive inotropic effect of the polypeptide anthopleurin-A from a sea anemone. J Pharma- col Exp Ther 205:683-692

Shigenobu K, Sperelakis N (1971) Development of sensitivity to tetrodotoxin of chick embryonic hearts with age. J Mot Cell Cardiol 3:271-286

Shigeto N, Irisawa H (1974) The effect of polarization on the action potential of the rabbit AV nodal cells. Jpn J Physiol 24:605-616

Shimizu T, Iwamura N, Toyama J, Yamada K, Shibata S ,(1979) Effect of cardio- tonic polypeptide anthopleurin-A on canine Purkinje and ventricular muscle fibers. Eur J Pharmacol 56:7-13

Shotzberger GS, Albuquerque EX, Daly JW (1976) The effects of batrachotoxin on cat papillary muscle. J Pharmacol Exp Ther 196:433-444

Sperelakis N, Lehmkuhl D (1968) Ba ++ and Sr ++ reversal of the inhibition produced by ouabain and local anesthetics on membrane potentials of cultured heart cells. Exp Cell Res 49:396-410

Sperelakis N, Pappano AJ (1969) Increase in PNa and PK of cultured heart cells pro- duces by veratridine. J Gen Physiol 53:97-114

Sperelakis N, Shigenobu K (1972) Change in membrane properties of chick embry- onic hearts during development. J Gen Physiol 60:430-453

Starkus JG, Narahashi T (1978) Sensitivity of excitable and inexcitable membranes to a-dihydrograyanotoxin II. Am J Physiol 235 :C204-C211

Sulakhe PV, St Louis PJ (1980) Passive and active calcium fluxes across plasma mem- branes. Prog Biophys Mol Biol 35: 1 3 5 - 1 9 5

Swain HH, McCarthy DA (1957) Veratrine, protoveratrine, and andromedotoxin arrhythmias in the isolated dog heart. J Pharmacol Exp Ther 121:379-388

Tanaka M, Hanin M, Yasunobu KT, Norton TR (1977) Amino acid sequence of the Anthopleura xanthogrammica heart stimulant, anthopleurin-A. Biochemistry 16: 204-208

Tang CM, Strichartz GR, Orkand RK (1979) Sodium channels in axons and glial cells of the optic nerve ofNecturus maculosa. J Gen Physiol 74:629-642

Tanz RD (1974) Pharmacology of aconitine-induced automaticity on in vitro cat myocardial preparations. II. Effects of refractory period prolongation, reduced sodium and tetrodotoxin. J Pharmacol Exp Ther 191:232-240

Tanz RD, Robbins JB, Kemple KL, Allen PA (1973) Pharmacology of aconitine- induced automaticity of cat papillary muscle. I. Effect of dose, tension rate and endogenous catecholamines. J Pharmacol Exp Ther 185:427-437

Tarr M ( 1971) Two inward currents in frog atrial muscle. J Gen Physiol 58: 523-543 Thoa NB, Wooten GF, Axelrod J, Kopin IJ (1975) On the mechanism of release of

norepinephrine from sympathetic nerves induced by depolarizing agents and sym- pathomimetic drugs. Mol Pharmacol 11 : 10-18

Tokuyama T, Daly J, Witkop B (1969) The structure of batrachotoxin, a steroidal alkaloid from the Colombian arrow poison frog, Phyllobates aurotaenia, and par- tial synthesis of batrachotoxin and its analogs and homologs. J Am Chem Soc 91 : 3931-3938

Trautwein W (1963) Generation and conduction of impulses in the heart as affected by drugs. Pharmacol Rev 15:277-332

Trautwein W (1973) Membrane currents in cardiac muscle fibers. Physiol Rev 53: 793-835

Trautwein W, McDonald TF, Tripathi O (1975) Calcium conductance and tension in mammalian ventricular muscle. Pfltigers Arch 354:55-74

Ulbricht W (1969) The effect of veratridine on excitable membranes of nerve and muscle. Erg Physiol 61 : 18 71

Ulbricht W (1972a) Rate of veratridine action on the nodal membrane. I. Fast phase determined during sustained depolarization in the voltage clamp. Pfltigers Arch 336:187-199

Page 77: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

74 P. Honeajgger: Cardioactive Substances

Ulbricht W (1972b) Rate of veratridine action on the nodal membrane. II. Fast and slow phase determined with periodic impulses in the voltage clamp. Pfltigers Arch 336:201-212

Ulbricht W (1974) Drugs to explore the ionic channels in the axon membrane. In: Jaenicke L (ed) Biochemistry of sensory functions. Springer, Berlin Heidelberg New York, pp 351-366

Vassatle M, Bhattacharyya M (1980) Local anesthetics and the role of sodium in the force development by canine ventricular muscle and Purkinje fibers. Circ Res 47: 666-674

Villegas J, Sevcik C, Barnola FV, Villegas R (1976) Grayanotoxin, veratrine, and tertodotoxin-sensitive sodium pathways in the Schwann cell membrane of squid nerve fibers. J Gen Physiol 67:369-380

Walton M, Fozzard HA (1979) The relation of "~max to INa , GNa , and h~ in a model of the cardiac Purkinje fiber. Biophys J 25:407-420

Wiesner K, Kao W, Jay EWK (1969) A rigorous, purely chemical structure proof for aconitine and delphinine. Can J Chem 47:2734-2737

Wood EH, Heppner RL, Weidmann S (1969) Inotropic effects of electric currents. Circ Res 24:409-445

Wunderer G, Eulitz M (1978) Amino acid sequence of toxin I from Anemonia sulcata. Eur J Biochem 89:11-17

Wunderer G, Fritz H, Wachter E, Machleidt W (1976) Amino acid sequence of a coelenterate toxin: Toxin II from Anernonia silcata. Eur J Biochem 68:193-198

Yamagishi S, Sano T (1966) Effect of tetrodotoxin on the pacemaker action poten- tial of the sinus node. Proc Jpn Acad 42:1194-1196

Zlotkin E, Miranda F, Rochat H (1978)Chemistry and pharmacology of Buthinae scorpion venoms. In: Bettini S (ed) Arthropod venoms. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 48, pp 317-369)

Page 78: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Rev. Physiol. Biochem. Pharmacol., Vol. 92 Q b y Springer-Verlag 1982

Factors Influencing Renal Sodium Reabsorption in Volume Expansion

F R A N K L Y N G. K N O X * a n d J O H N A . H A A S *

Contents

1 I n t r o d u c t i o n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Renal 2.1 2.1.1 2.1.2

2.2 2.2.1 2.2.2

2.3 2.3.1 2.3.2 2.3.3 2.3.4 2.3.5 2.3.6

2.4 2.4.1 2.4.2

2.5 2.5.1 2.5.2 2.5.3 2.5.4 2.5.5 2.5.6

2.6

2.7

76

Sod ium Reabso rp t ion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76 H e m o d y n a m i c Fac tors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76 Renal Blood F low and Renal Vascular Resis tance . . . . . . . . . . . . . 76 In t rarenal Dis t r ibut ion of Blood F low . . . . . . . . . . . . . . . . . . . . . 77

Glomerular F i l t ra t ion Rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79 Ef fec t o f Changes in G F R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79 In t rarenal Dis t r ibut ion of G F R . . . . . . . . . . . . . . . . . . . . . . . . . 80

Physical Fac tors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82 Plasma Oncot ic Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82 Per i tubule Capillary Hydros ta t i c Pressure . . . . . . . . . . . . . . . . . . . 85 Inters t i t ia l Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86 Plasma Sod ium Concen t r a t i on . . . . . . . . . . . . . . . . . . . . . . . . . . 88 Preexist ing Extracel lular Fluid Volume . . . . . . . . . . . . . . . . . . . . 89 Tubule G e o m e t r y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

Segmenta l Sod ium Reabsorp t ion . . . . . . . . . . . . . . . . . . . . . . . . 90 Acu te ECVE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90 Chronic ECVE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93

Hormona l Fac tors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94 Renin-Angiot ensin-Aldost c rone Sys tem . . . . . . . . . . . . . . . . . . . . 94 Natr iuret ic H o r m o n e . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95 Prostaglandins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97 Ant id iure t ic H o r m o n e . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97 Para thyro id and Thyroid H o r m o n e . . . . . . . . . . . . . . . . . . . . . . . 97 Neurohumora l . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98

Response of the Perinatal K idney to Volume Expans ion . . . . . . . . . 99

Gast rointes t inal and /o r Hepa topo r t a l Cont ro l o f Renal Sod ium Excre t ion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

101

102

103

* Nephro logy Research Laborator ies , Depa r tmen t s of Phys io logy and Biophysics and Medicine, Mayo Clinic and F o u n d a t i o n , Roches te r , Minnesota , 55905, USA

Page 79: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

76

1 Introduction

F.G. Knox and J.A. Haas

This review discusses factors which influence renal sodium reabsorption in volume expansion. The factors are considered under seven headings: hemodynamic factors; glomerular filtration rate; physical factors; seg- mental sodium reabsorption; hormonal factors; response of the perinatal kidney to volume expansion; and gastrointestinal or hepatoportal control of renal sodium excretion. The results discussed consist primarily of clear- ance, micropuncture, microperfusion, and histologic studies. It seems justified to inject a word of caution in regard to interpretation of the data contained herein. In the majority of the studies, the animals were anesthe- tized, subjected to varying degrees of surgical trauma, and subsequently given an extracellular volume expansion (ECVE). Inasmuch as these maneuvers are not physiologic, extrapolation of the results to normal renal function should be done with caution.

2 Renal Sodium Reabsorption

2.1 Hemodynamic Factors

2.1.1 Renal Blood Flow and Renal Vascular Resistance

Expansion of the extracellular fluid volume (ECFV) by an infusion of isotonic saline has been shown to decrease renal vascular resistance and increase renal blood flow (Barger et al. 1961 ; Earley and Friedler 1965a; Wallin et al. 1971). In initial studies, the extent to which this increased renal blood flow alone results in increased sodium excretion was evalu- ated in clearance experiments in dogs by infusing vasodilators alone, or in the presence of a saline load (Earley and Friedler 1965b). The results of these studies demonstrated that in hydropenic animals, increasing renal blood flow by vasodilators alone was accompanied by an increased sodium excretion in spite of an unchanged filtered load. In animals receiv- ing a saline load, increased renal blood flow of the same magnitude was associated with a threefold greater natriuresis. Further studies demon- strated that infusion of iso-oncotic Ringer's solution, designed not to alter plasma protein concentration, resulted in large increases in arterial pressure, renal blood flow, and urinary sodium excretion. If the kidneys were vasodilated with acetylcholine prior to the iso-oncotic Ringer's loading, the additional natriuresis seen with the vasodilated kidney was significantly reduced (Martino and Earley 1967). These studies were taken as evidence that increases in renal blood flow, per se, can increase

Page 80: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 77

sodium excretion, but can only partially account for the natriuresis accom- panying saline loading. The possibility exists, however, that the natriuretic effect seen with vasodilators is due to a direct action of the drug on the renal tubule and that the increased renal blood flow per se is not neces- sarily natriuretic. For example, secretin is a vasodilator which is not natri- uretic (Marchand et al. 1977a). Further, small infusions of saline which increase urinary sodium excretion may not result in increases in renal blood flow (Martino and Earley 1967).

2.1.2 Intrarenal Distribution of Blood Flow

Volume expansion may be associated with increased medullary renal blood flow, since increased sodium excretion is accompanied by a decrease in urinary osmolality and the extraction ratio ofp-aminohippurate (PAH) (Earley and Friedler 1964, 1965a; Friedler and Earley 1966). This decrease in urinary osmolality, which could not be accounted for by changes in either antidiuretic hormone (ADH) or solute excretion, and the assump- tion that PAH is extracted only from blood perfusing the cortex, led Earley and Friedler to hypothesize that saline loading in the dog results in an increased medullary blood flow, and that there may be a causal relationship between this intrarenal distribution of blood flow and the associated natriuresis of ECVE. The issue of whether a change in the intrarenal distribution of blood flow is associated with the renal vasodila- tion seen with volume expansion has subsequently been studied with a variety of techniques. The different techniques used to measure intrarenal blood flow distribution include the use of extractable substances such as PAH, dye dilution, washout of inert gases like s s Kr and 133 Xe, H~ clear- ance, glomerular basement-membrane antibody technique, and radioac- tive-labeled microspheres. A description of the different methods and a discussion of their validity is given by Barger and Herd (1973). Initial studies which utilized the inert-gas washout or H2 clearance method to evaluate intrarenal distribution of blood flow reported that in volume expanded dogs, blood flow in the renal cortex increases, but there was not a significant change in the distribution of blood flow within the cor- tex (Munck et al. 1970; Loyning 1974). This finding was essentially con- firmed in a subsequent study also carried out in dogs. Bovee and Webster, utilizing the inert-gas washout method and PAH extraction, reported that the increase in renal blood flow during moderate saline loading is limited to the cortex, but during large saline loads, cortical and noncor- tical flows increase proportionately (Bovee and Webster 1971). These findings are in agreement with recent observations of Velasquez, who applied the dye-dilution technique for quantitation of intrarenal blood flow distribution, and reported that during the early phase of saline

Page 81: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

78 F.G. Knox and J.A. Haas

diuresis renal vasodilatation is confined to the cortex, but during later stages of saline loading noncortical blood flow increases also ( Velasquez et al. 1973, 1975).

Interestingly, a study in the rat utilizing the X e washout method found no significant change in either total renal blood flow or outer cortical blood flow after volume expansion with saline (Kinney and DiScala 1974). More recent results evaluating intrarenal distribution of blood flow dur- ing ECVE have been obtained with radioactive microspheres. These studies have shown that, in the dog, an intrarenal distribution of blood flow to inner cortical nephrons occurs (Blantz et al. 1971;Stein et al. 1972; Bruns et al. 1974). Surprisingly, in the rat, an intrarenal distribu- tion of blood flow to the superficial cortex following volume expansion has been reported (Wallin et al. 1971). However, this discrepancy was attributed to an axial streaming of the microspheres caused by the renal vasodilation and reduced hematocrit accompanying volume expansion. The mechanism of cortical blood flow distribution during acute saline loading in the dog has been examined with microspheres (Migdal et al. 1975); their data showed that hemodilution without volume expansion or with intravascular volume expansion alone resulted in a distribution of blood flow to the superficial cortex. This superficial distribution of blood flow was caused by a decreased hematocrit. During saline loading, distri- bution of blood flow to the inner cortex occurred, which was hypothesized to be a consequence of expansion of the intrarenal interstitial volume.

Two mechanisms have been proposed whereby increased blood flow to inner cortical nephrons could affect renal handling of sodium during volume expansion. The first is the medullary washout hypothesis of Earley and Friedler (1965a,b). They proposed that saline loading pro- duces an increase in inner cortical and presumably medullary blood flow. This causes a reduction in medullary interstitial hypertonicity, thus reducing the osmotic movement of water out of the descending limb. A larger volume of tubular fluid with the same amount of sodium, but at a lower concentration, would enter the water impermeable ascending limb. Reabsorption of sodium to the same minimal concentration in the ascending limb would result in the delivery of a larger volume of fluid and an increased total amount of sodium beyond the loop of Henle. This alteration would be most marked in the inner cortical nephrons whose loops descend into the medulla.

Another mechanism whereby intrarenal distribution of blood flow may modulate the natriuresis of ECVE is that it could result in a selec- tive decrease in the filtration fraction in inner cortical nephrons and con- sequent reduction in proximal sodium reabsorption. This hypothesis assumes a direct relationship between peritubular capillary protein oncotic pressure and proximal sodium reabsorption. This hypothesis is based on

Page 82: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 79

experimental observations in several different species. Perhaps the most convincing was a series of experiments in which Nissen made use of the unique blood supply to the kidney of the cat (Nissen 1968). He calcu- lated the filtration fraction from the postglomerular circulation by com- paring the plasma concentrations of inulin and protein in the blood leav- ing the two venous drainage areas with the concentrations in cortical blood. He observed a greater fall of the filtration fraction in the inner cortex than in the outer cortex after volume expansion. Micropuncture studies in the rat by Daugharty et al. (1972), who calculated superficial nephron filtration fraction (SNFF) from systemic and efferent arteriolar protein concentrations, and Barratt et al. (1973), who calculated SNFF by means of the antiglomerular basement membrane antibody technique, showed that the filtration fraction was reduced to a greater extent in the whole kidney compared to the superficial cortex during Ringer loading. Likewise in dogs, using the Hanssen technique and microspheres, esti- mated superficial nephron filtration fraction remained unchanged after volume expansion, but juxtamedullary filtration fraction decreases signi- ficantly (Bruns et al. 1974).

2.2 Glomerular Filtration Rate

2.2.1 Effect o f Changes in GFR

Associated with increases in renal blood flow, several studies have shown that glomerular filtration rate (GFR) is elevated by ECFV expansion (de Wardener et al. 1961; Levinsky and Lalone 1963; Davidrnan et al. 1972). This observation is important as urinary sodium excretion repre- sents the difference between the filtered load of sodium and subsequent reabsorption by the tubules. Therefore, a parallel change in filtered load and sodium excretion seen following volume expansion could, theoreti- cally, explain the rise in sodium excretion seen following volume expan- sion, without necessarily invoking changes in tubular reabsorption. How- ever, de Wardener et al. showed that saline infusion increased urinary sodium excretion independent of changes in GFR. In these studies, GFR was prevented from increasing by simultaneously decreasing the perfu- sion pressure to the kidney (de Wardener et al. 1961). This observation was subsequently confirmed by a number of other investigators who also demonstrated that when ECFV is acutely increased in the presence o f fixed adrenocortical activity, sodium excretion increased independently of changes in GFR (Levinsky and Lalone 1963;Rector et al. 1964).

Page 83: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

80 F.G. Knox and J.A. Haas

2. 2. 2 Intrarenal Distribution of GFR

Whereas increases in GFR may not entirely account for the natriuresis of ECVE, the relationship between changes in ECFV and distribution of single neprhon glomerular filtration rate (SNGFR) may be important as it has been proposed that a redistribution of filtrate may modify urinary sodium excretion.

Intrarenal distribution of filtrate before and after volume expansion has been evaluated with a number of techniques. The first is an indirect evaluation and involved comparing superficial SNGFR to total kidney glomerular filtration rate.

The results are conflicting, with some studies reporting equal changes in whole kidney GFR and superficial SNGFR after volume expansion (Bartoli and Earley 1971; Mandin et al. 1971; Daugharty et al. 1972; Davidman et al. 1972), while others found redistribution of filtrate to outer cortical nephrons (Gertz et al. 1967; Barratt et al. 1973). These data should be critically evaluated for several reasons. First, an increased distribution of filtrate to outer cortical nephrons was found when a pre- viously punctured tubule was repunctured during acute volume expan- sion (Mandin et al. 1971; Stein et al. 1972). In contrast, no change in the intrarenal distribution of filtrate was found when a freshly punctured tubule was utilized. This difference has been atrributed to artifactual alterations in intratubular dynamics in the repunctured tubule due to the high tubular pressure associated with volume expansion, the so-called recollection artifact. However, in sharp contrast, a similar artifact was not noted in other studies in either the dog or rat, in which ECVE caused a proportional increase in both SNGFR and GFR (Brenner et al. 197 la; Schneider et al. 1972). Second, these results involve comparison of only superficial SNGFR and total kidney GFR, without direct measurement of SNGFR in deep nephrons. It has also been proposed that the disagree- ment between the results concerning the changes in SNGFR distribution following volume expansion could be explained on the basis of the degree of volume expansion. Herrera-Acosta concluded that a 10% body weight volume expansion did not change intrarenal filtrate distribution, whereas a progressive volume expansion to 15% of body weight results in a dis- proportionate increase in the filtration rate of superficial nephrons in comparison to total kidney GFR (Herrera-Acosta et al. 1972).

Another method used to study the distribution of GFR is the ferro- cyanide technique. This method involves administering ferrocyanide, which distributes into the extracellular fluid volume and behaves like a glomerular indicator. After injection, the pedicle is ligated, the kidney removed and microdissected. The distance between the glomerulus and the distal front of the precipitated bolus is assumed to be proportional

Page 84: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 81

to the nephron filtration rate. The advantage of this method is that it allows for a more quantitative estimate of the ratio of both superficial and deep SNGFR. Although some studies do not find a change in intra- renal distribution (Bruns et al. 1974; Coelho 1974), others report an increase in the superficial distribution of SNGFR after either chronic or acute salt loading when the labeled ferrocyanide is given as a pulse injec- tion, i.e., Hanssen's technique (de Rouffignac and Bonvalet 1970; Baines 1973). However, when the glomerular marker is infused, SNGFR increases proportionately in both superficial and juxtamedullary nephrons (Carriere et al. 1972; Coelho 1973; Clausen and Tyssebotn 1973; Poujeol et al. 1975). This discrepancy was studied by Charbardes, and it was concluded that the apparent change in intrarenal distribution during ECVE observed with pulse injection is probably the result of an artifactual streaming caused by the method of administration of the label (Chabardes et al. 1974). In addition, a redistribution of SNGFR after acute volume expan- sion using Hanssen's technique was found in young rats, but not in mature adults (Baines 1973). These studies suggest that structural changes with age may modify the response of SNGFR distribution to volume expansion.

Finally, two early micropuncture studies examined directly, by micro- puncture of both superficial and juxtamedullary nephrons, the effect of ECVE on the distribution of single nephron filtration rate in these nephron populations (Horster and Thurau 1968; Jamison and Lacy 1971). Both studies showed a shift of SNGFR distribution toward the superficial nephrons. However, the physiologic significance of a change in the intrarenal distribution of SNGFR is speculative without knowing whether actual sodium transport is altered in these nephron populations during ECVE. In the acute volume expansion study in which sodium concentration in tubule fluid was measured along with inulin, sodium reabsorption was significantly reduced in superficial nephrons, and did not change in deep nephrons (Jamison and Lacy 1971). In contrast, a more recent study revealed that delivery of sodium to the bend of the loop of Henle in the deep nephrons was greater than estimates of delivery in superficial nephrons during Ringer loading (Osgood et al. 1978).

The hypothesis that the intrarenal distribution of single nephron glo- merular filtration rate can affect urinary sodium excretion came from studies by Barger, who proposed that because the juxtamedullary or deep nephrons have long loops of Henle, it is possible that more sodium is removed from them than superficial nephrons with their short loop of Henle (Barger 1966). Thus, intrarenal distribution of glomerular filtra- tion may modify sodium excretion during ECVE by shifting from deep "salt-saving" nephrons to superficial "salt-losing" nephrons. However, a micropuncture study in the Rhesus monkey, a species with short loops of Henle, shows that the fraction of filtered sodium arriving in the early

Page 85: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

82 F.G. Knox and J.A. Haas

distal tubule is similar to values reported for the dog, a species with long loops of Henle (Bennett et al. 1968). This would argue against the con- cept that the length of the loop of Henle is an important factor in the magnitude of sodium transport.

2.3 Physical Factors

2. 3.1 Plasma Oncotic Pressure

On the basis of clearance studies in the dog, it was concluded that net fluid reabsorption is determined, in part, by the rate of removal of reab- sorbate by the capillary circulation (Martino and Early 1967). The rate of removal of this reabsorbate is, in turn, dependent upon the net balance of colloid osmotic and hydrostatic pressures across the peritubular capil- lary wall. Evidence was presented supporting the hypothesis that these "physical forces" play an important role in the decreased proximal tubular reabsorption and increased sodium excretion seen in response to volume expansion.

It was demonstrated that a saline infusion which depressed plasma protein concentration, without increasing arterial pressure or renal blood flow, increased urinary sodium excretion. Subsequent restoration of plas- ma protein concentration by systemic infusion of hyperoncotic albumin decreased sodium excretion in spite of an increase in arterial pressure and renal blood flow (Martino and Earley 1967). This observation was taken as evidence that depressed plasma protein is a major determinant of the natriuresis seen with ECVE. Subsequent micropuncture and microperfu- sion studies, in a variety of experimental conditions designed to assess the importance of plasma oncotic pressure by controlling other physical forces, presented data consistent with the postulate that changes in post- glomerular capillary oncotic pressure play a significant role in the regula- tion of proximal sodium reabsorption (Lewy and Windhager 1968; Wind- hager et al. 1969; Spitzer and Windhager 1970). Brenner, utilizing both free-flow micropuncture and microperfusion techniques, demonstrated a direct relationship between oncotic pressure in efferent arterioles and absolute reabsorption by the proximal tubule of the rat (Brenner et al. 1969b; Brenner and Troy 1971). The relationship between peritubular capillary oncotic pressure and proximal sodium reabsorption has also been studied in the volume expanded animal. During volume expansion, Brenner et al. (1971b) found that capillary microperfusion with hyper- oncotic albumin solution increased reabsorption by the proximal tubule and, similarly, Knox found that infusion of hyperoncotic albumin solu- tion in the renal artery increased proximal sodium reabsorption in saline

Page 86: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 83

loaded dogs (Knox et al. 1973). In micropuncture studies in rats, Daugh- arty compared the effects of iso-oncotic and colloid-free volume expan- sion on proximal reabsorption (Daugharty et al. 1972). In rats in which the filtered load was kept constant by means of aortic constriction, vol- ume expansion with colloid-free (Ringer's) solution resulted in a signifi- cant decrease in proximal reabsorption which was associated with a mar- ked reduction in peritubule protein concentration. In contrast, iso-on- cotic infusions resulted in no significant fall in proximal reabsorption and little change from control in peritubule protein concentration. Son- nenberg and Solomon, using free-flow micropuncture, observed that rela- tive to control hydropenic values, extracellular volume expansion with colloid-free Ringer's solution resulted in a significant decrease in proxi- mal reabsorption, whereas following comparable infusions of iso-oncotic fluid, no significant reduction could be detected (Sonnenberg and Solo- mon 1969).

Several investigators, however, have failed to find a relationship between peritubule capillary oncotic pressure and reabsorption by the proximal tubule. Specifically, in the absence of saline loading, two studies found no difference in proximal sodium reabsorption between iso-oncotic perfusate versus oncotic-free perfusate (Rumrich and Ullrich 1968; Conger et al. 1973). Further, microperfusion studies showed that reduc- tions in absolute reabsorption induced by saline infusion were quantita- tively similar in tubules exposed to the reduced peritubule capillary oncotic pressure and in microperfused tubules with constant peritubular oncotic pressure (Holzgreve and Schrier 1975). Additionally, Kuschinsky et al. compared proximal fractional reabsorption and plasma protein con- centration in rats acutely or chronically infused with isotonic saline (Kuschinsky et al. 1970). During acute ECVE, proximal fractional reab- sorption (FR) was reduced from 61% to 42%, concomitant with a reduced plasma protein from 5.8% to 5.2%. However, during chronic saline infu- sion, fractional reabsorption (FR) was only slightly decreased to 52%, not statistically different from a control group of animals in which FR was 57%. In these two groups plasma protein concentration was reduced to a greater extent (from 5.9% to 3.6% in the control and chronically infused annimals, respectively). Ott et al. investigated the effect of increased peritubule capillary oncotic pressure on sodium reabsorption by the proximal tubule in hydropenic and volume expanded dog (Ott et al. 1975). While efferent oncotic pressure during albumin infusion was increased to the same degree in both groups, proximal sodium reabsorp- tion was increased only in the volume expanded animals. The results sug- gested that ECVE altered the effect of increased peritubule oncotoc pres- sure on sodium reabsorption by the proximal tubule. It was speculated that increased permeability of the proximal tubule following saline loading

Page 87: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

84 F.G. Knox and J.A. Haas

allowed for changes in peritubule capillary oncotic pressure to affect proximal reabsorption. Several studies support a role for altered perme- ability of the proximal tubule following ECVE. In electrophysiological studies, changes in permeability of the proximal tubule following saline loading in the necturus have been demonstrated (Bentzel et al. 1970; Boulpaep 1972; Maunsbach and Boulpaep 1980). Based on these data, it seems likely that increases in membrane permeability are a prerequisite for increased peritubule oncotic pressure to result in increases in isotonic reabsorption by the renal proximal tubule.

Arterial hematrocrit is another physical factor which significantly influences urinary sodium excretion during ECVE. Knox et al. found in micropuncture experiments in dogs that acute reductions in arterial hematocrit were associated with a decrease in fractional reabsorption by the proximal tubule, despite maintenance of a normal extracellular fluid volume and no significant change in urinary sodium excretion (Knox et al. 1968). Clearance experiments have demonstrated a direct relation- ship between sodium excretion and blood viscosity during volume expan- sion (Schrier et al. 1970). Further studies in which hematocrit was either increased or decreased in both hydropenic or volume expanded animals, demonstrated that acute changes in hematrocrit significantly affect sodium excretion and renal hemodynamics in both conditions (Schrier and Earley 1970). Increasing hematocrit during hydropenia or ECVE decreased electrolyte excretion and renal blood flow. Decreasing hemato- crit during hydropenia was associated with an increase in electrolyte excretion. The effect of increasing or decreasing arterial hematocrit on proximal sodium reabsorption has been investigated in dogs (Burke et al. 1971). It was demonstrated that fractional reabsorption by the proximal tubule can be increased or decreased by acutely increasing or decreasing the hematocrit. It seems likely that the effects of arterial hematocrit are mediated through changes in blood viscosity and subsequent effects on peritubule capillary hydrostatic pressures.

It has also been demonstrated that after anesthesia and surgery animals have a markedly impaired ability to excrete a saline load. Keck and co- workers reported that this phenomenon was due to an increased hemato- crit, probably due to an increased permeability of the capillaries which results in a large extravasation of protein and fluid into the extravascular space (Keck et al. 1973). This observation was confirmed in the rat by Maddox, who reported a significant increase in hematocrit accompanied by a large fall in plasma volume following surgery (Maddox et al. 1977).

Extracellular volume expansion has also been shown to depress net absorption of sodium and water by rat (Richet and Hornych 1969; Humphreys and Earley 1971), dog (Higgins and Blair 1971), cat (Gutrnan and Benzakein 1970), and rabbit (DiBona et al. 1974)small intestine.

Page 88: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 85

From studies in the cat, it was postulated that ECVE reduces primarily the lumen to blood sodium flux, analogous to the process of tubular reabsorption in the kidney (Gutman and Benzakein 1970). On the other hand, two studies in the dog (Higgins and Blair 1971; I~Iumphreys and Earley 1971), one in the rat (Chanard et al. 1976), and one in the rabbit (DiBona et al. 1.974) found that ECVE leads to an increase in blood to lumen sodium flux.

The mechanism whereby ECVE depresses intestinal sodium and water transport has been investigated. The results indicate an important role for physical factors in modulating intestinal transport. In vitro studies in dog jejunum showed that when serosal hydrostatic pressure was increased by 2 - 6 cm H~ O, fluid absorption was stopped, and further increases in serosal pressure resulted in fluid secretion (Hakim and Lifson 1969). In vitro studies in rats demonstrated that capillary hydrostatic pressure and colloid osmotic pressure exert opposite effects on transjejunal water transport (Lee 1973). Further, it has been reported that during ECVE in vivo, the decreased net absorption of sodium is accompanied by an increased permeability of the intestinal mucosa (Humphreys and Earley 1971 ). It has also been demonstrated that saline infusion results in a dis- tension of intercellular spaces in the rabbit jejunum (DiBona et al. 1974). In addition, in vivo studies suggest that intestinal absorption increases when plasma oncotic pressure is increased by albumin infusion (Humph- reys and Earley 1971). These observations imply that capillary absorp- tion plays a role in intestinal absorption and that permeability changes modulate the net absorption of sodium and water, as may be the case for fluid reabsorption by the renal proximal tubule during ECVE.

2.3.2 Peritubule Capillary Hydrostatic Pressure

Earley et al., on the basis of clearance studies in dogs, concluded that the natriuretic effect of renal vasodilatation, induced either by infusion of vasodilators, plasma or iso-oncotic saline infusion, may in part result from decreased tubular reabsorption as a consequence of the transmis- sion of the increased pressure to the peritubular capillaries (Earley and Friedler 1966; Earley et al. 1966). It also has been proposed that the exaggerated natriuresis of hypertensive patients and rats when given a saline infusion may be due to a direct effect of the increased arterial pres- sure to decrease fractional reabsorption of sodium (Papper et al. 1960; Buckalew et al. 1969; Stumpe et al. 1970). In addition, a direct relation- ship between the natriuresis of volume expansion and renal perfusion pres- sure has been reported from studies in the isolated dog kidney (McDonaM and de Wardener 1965). Bank and co-workers, using split-drop techniques in saline loaded rats, reported that when renal perfusion pressure was

Page 89: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

86 F.G. Knox and J.A. Haas

lowered to 70-90 mmHg, the reduction in fractional reabsorption which usually occurs in the proximal tubule was greatly minimized (Bank et al. 1969). Associated with this finding was a concomitant decrease in urinary sodium excretion. From these results the authors suggested that the changes in proximal reabsorption during saline loading are related to the increase in peritubular hydrostatic pressure. In an attempt to determine whether transmitted increments in capillary hydrostatic pressure are related to decreases in sodium reabsorption during volume expansion, deep intrarenal venous pressure was used as a qualitative index of renal capillary pressure (Martino and Earley 1968). It was concluded, based on correlations between changes in intrarenal venous pressure and sodium excretion following either saline or plasma infusion, that increases in peri- tubular capillary hydrostatic pressure inhibit reabsorption. Stop-flow microperfusion with or without combined local microperfusion of peri- tubular capillaries has shown that, while hydrostatic pressure from the lumen is not an effective driving force for fluid reabsorption, increases in hydrostatic pressure from the contraluminal side markedly inhibit fluid reabsorption (Sato 1975). Finally, Kunau et al. showed that in rats under- going a saline diuresis an acute increase in renal perfusion pressure resulted in a marked increase in sodium excretion (Kunau and Lameire 1976). This natriuresis occurred in the absence of a change in either total GFR or superficial SNGFR. It was also observed that the natriuresis was not the result of an increased sodium delivery from the superficial late distal tubule. This led to the conclusion that it must be related to an inhibition of sodium reabsorption in either the collecting system or in deep nephrons.

2. 3. 3 Interstitial Pressure

Clearance experiments in dogs demonstrated that administration of dex- tran in isotonic saline leads to a natriuresis, whereas dextran in glucose does not (Schrier et al. 1968). Dextran in saline was associated not only with increased plasma volume, but also with increased interstitial volume, whereas dextran in glucose increased plasma volume alone. From this observation it was postulated that without expansion of the interstitial space, intravascular volume expansion may not be a sufficient stimulus to increase sodium excretion.

Micropuncture techniques have been used to study the respective influ- ence of each of the Starling forces upon proximal tubular reabsorption during hydropenia and volume expansion. The Starling forces, hydro- static and oncotic pressures across the peritubular capillary wall, presum- ably mediate capillary uptake and passive backflux into the proximal tubular lumen through changes in renal interstitial pressure. Peritubular capillary uptake is determined not only by the balance of the Starling

Page 90: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 87

forces, i.e., the net reabsorption pressure, but also by the permeability surface area of the peritubular capillary. Thus, changes in either para- meter lead to changes in capillary uptake. The relationship between net reabsorption pressure and the permeability surface area of the peritubu- lar capillary (reabsorption coefficient) has been studied in the volume expanded rat with differing results. Tucker and Blantz measured proxi- mal reabsorption in rats during hydropenia and saline expansion. They concluded that changes in proximal reabsorption correlate best with changes in filtered load (Tucker and Blantz 1978). Quinn and Marsh con- cluded that it was unlikely the reabsorption coefficient was different between hydropenia, Ringer's expansion, and plasma volume expansion (Quinn and Marsh 1979). They found a strong correlation between abso- lute proximal reabsorption and net interstitial pressure, which was taken as evidence for a role for interstitial pressure in regulating proximal reab- sorption. However, interstitial pressure was directly measured only in saline loaded animals and was calculated for the other conditions. Stron- ger evidence for a positive correlation between renal interstitial pressure and sodium excretion during volume expansion has been presented by Marchand, who observed that reductions in renal perfusion pressure by renal artery constriction prior to volume expansion blocked both the increase in renal interstitial pressure as well as the increase in sodium excretion (Marchand 1978). Kallskog and Wolgast calculated peritubular protein concentration and measured interstitial space pressure (Kallskog and Wolgast 1973). In saline expansion, the interstitial hydrostatic pres- sure almost doubled, whereas interstitial oncotic pressure fell to almost zero. They concluded that the peritubular capillary has a large and a small pore system, and further postulated that the effective capillary area increases during saline loading due to expansion of the capillary pores.

Experiments providing evidence that intrarenal factors are the initial determinants of the natriuresis of saline loading were performed by Fitz- gibbons et al. (1974). As mentioned previously, the natriuretic effect of saline loading has been demonstrated to persist in spite of a reduction of GFR to below preexpansion levels (de Wardener et al. 1961). However, Fitzgibbons reported that in the rat, reduction of renal artery pressure prior to the initiation of ECVE virtually abolished the natriuretic effect of volume expansion. From these findings, they hypothesized that ECVE can induce a natriuresis only if the kidney has been exposed to at least a transient increase in either interstitial hydrostatic pressure and/or renal plasma flow. Further, the results gave strong evidence against an impor- tant role for a reduction in plasma oncotic pressure or a circulating hor- mone as mediators of the natriuresis. This finding was confirmed in a micropuncture study in the rat by Osgood which demonstrated that volume expansion did not decrease proximal reabsorption or cause an

Page 91: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

88 F.G. Knox and J.A. Haas

increase in urinary sodium excretion in immediate-clamp rats (Osgood et al. 1977). In contrast, comparable aortic clamping 40 rain after initia- tion of volume expansion did not prevent a fall in proximal reabsorption or an increase in urinary sodium excretion.Marchand evaluated the effect of reduced peritubule capillary oncotic pressure at reduced renal artery pressure on renal interstitial pressure and sodium excretion in the dog (Marchand 1978). He found that reducing renal artery pressure before volume expansion reduces or prevents increases in interstitial pressure and fractional sodium excretion, depending on the magnitude of reduc- tion of renal artery pressure. Studies, also performed in dogs, demon- strated a saline-induced natriuresis, although blunted, even though perfu- sion pressure was reduced prior to the accompanying volume expansion (Klemmer et al. 1978). This study suggested a possible species difference in the renal natriuretic response to volume expansion at reduced renal perfusion pressure between dogs and rats. In order to test the hypothesis that these conflicting results could be due to differences in preexpansion basal sodium excretion, Lameire manipulated the dietary salt intake to adjust preexpansion fractional excretion of sodium (FENa %) to the same level in both species (Lameire et al. 1979). Hydropenic or salt depleted dogs showed a small but significant increase in FENa % following a 7.5% body wt. volume expansion. In the rat, however, a significant natriuresis did not occur unless the rats were salt loaded. These results were inter- preted to mean that an appropriate intrarenal environment is necessary in the rat, but not the dog, for volume expansion to result in a significant natriuresis. Further, it was concluded that the natriuretic response to ECVE was not dependent on the moment of lowering the renal perfusion pressure. However, it should be emphasized that in both species, regard- less of preexpansion basal sodium excretion, prior reduction of renal per- fusion pressure markedly attenuated the magnitude of the natriuresis in response to volume expansion.

2. 3. 4 Plasma Sodium Concentration

It has been shown that following infusion of hypertonic saline there are increases in plasma sodium concentration, filtered sodium, and urinary sodium excretion (Kamm and Levinsky 1964). The difficulty in assessing the importance of plasma sodium concentration, per se, as a mediator of the natriuresis following hypertonic saline infusion is that, besides hyper- natremia, this experimental maneuver also leads to expansion of the ECFV and a fall in plasma oncotic pressure, all of which could by them- selves result in increased sodium excretion. In order to circumvent this problem, Kamm and Levinsky infused hypertonic saline directly into one renal artery of a dog. Despite a decreased filtered load below that of

Page 92: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 89

preinfusion levels and a comparable volume expansion in the contralateral kidney, the results showed an ipsilateral increase in sodium excretion, which was attributed to an effect of hypernatremia per se to depress net tubular reabsorption of sodium (Kamm and Levinsky 1965). In order to determine whether a low plasma sodium could depress the natriuretic response to ECVE, Davis compared fractional sodium reabsorption in the proximal tubule in normal dogs and in dogs made hyponatremic by chronic administration of vasopressin, water, and ethacrynic acid. Hypo- natremic dogs expanded with hypotonic saline had a smaller decrease in fractional reabsorption than normal dogs expanded with an equal amount of isotonic saline (Davis et al. 1970). Experiments in dogs, which were infused with equal amounts of sodium chloride per kilogram of body weight as either hypotonic, isotonic, or hypertonic solutions, demon- strated that in spite of the fact that hypotonic saline led to a greater expansion of the blood volume and interstitial space, sodium excretion was significantly less in this group (Schrier et al. 1969). Thus, these studies suggest that plasma sodium concentration may influence the natriuretic response to volume expansion.

2.3.5 Preexisting Extracellular Fluid Volume

The effect of the level of the preexisting extracellular fluid volume on the response to acute volume expansion has been studied in the dog and rat. In the dog, animals on a high salt intake and deoxycorticosterone acetate (DOCA) administration have a greater diuretic and natriuretic response to either hyperoncotic albumin solution (Knox et al. 1970) or isotonic saline loading (Higgins 1971). However, in ratsaparadoxical effect of dietary salt intake on the renal response to hypertonic saline loads has been reported (Ben-Ishay 1973). Animals on a low salt regimen demonstrated an enhanced diuretic and natriuretic response to hyper- tonic saline loading compared with rats on a high salt diet. In contrast, studies in dogs maintained on a high sodium intake revealed that they did not have a significantly different natriuresis from those on a low sodium intake, following hypertonic saline infusion (Diaz-Buxo et al. 1976). This was also found to be the case whether or not dogs were in positive or negative sodium balance. However, the natriuretic response to isotonic saline loading was smaller in dogs in negative sodium balance compared with those in positive sodium balance. These findings suggest that hyper- natremia accompanying hypertonic saline infusion can override factors promoting sodium retention in sodium depleted dogs, but does not fur- ther augment sodium excretion in states of positive sodium balance.

Page 93: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

90 F.G. Knox and J.A. Haas

2. 3. 6 Tubule Geometry

A mechanism for glomerular-tubular balance was suggested by Gertz and others (Gertz et al. 1965; Brunner et al. 1966). In this proposal, the rate of proximal tubular reabsorption is thought to be proportional to intra- tubular volume, as a result of a direct relationship between tubular sur- face area and reabsorptive rate. Changes in filtration rate result in propor- tional changes in tubular surface area and subsequently sodium reabsorp- tion. It was proposed that the mechanism by which ECVE suppresses proximal reabsorption was the result of two factors, a decrease in intrin- sic reabsorptive capacity and a diminished tubular volume per given level of GFR (Rector et al. 1967). However, there is experimental evidence which indicates that tubule geometry does not significantly influence sodium reabsorption. Microperfusion studies, which changed either tubu- lar volume or radius, showed no significant correlation between reabsorp- tion and tubular shape or size (Morgan and Berliner 1969b; Burg and Orloff 1968).

2.4 Segmental Sodium Reabsorption

2.4.1 Acute ECVE

There is much evidence from micropuncture studies in the dog and rat to indicate that the natriuresis of acute ECVE is associated with decreased sodium reabsorption by the renal tubule. Numerous studies have demon- strated that ECVE significantly decreases sodium reabsorption by the proximal tubule (Rector et al. 1964; Dirks et al. 1965; Cortney et al. 1965). Because the resulting increase in sodium delivery from the proxi- mal tubule more than accounted for the increased urinary sodium excre- tion, it was first postulated that the proximal tubule was the sole regula- tor of the natriuresis of ECVE. This postulate was questioned, however, by studies which demonstrated that proximal sodium reabsorption can be depressed without/m ensuing natriuresis, suggesting that a saline load may also inhibit sodium reabsorption in a more distal nephron segment (Howards et al. 1968; Brenner and Berliner 1969; Knox et al. 1973; Knight and Weinman 1977). Evaluation of altered reabsorption during acute ECVE by the "distal" tubule can include the loop of Henle, distal convoluted tubule, and the collecting tubule. The discussion will first focus on evidence for and against the loop of Henle as an important mediator of the natriuresis of volume expansion.

On the basis of studies in humans and dogs utilizing free-water clear- ance as an index of loop of Henle reabsorption, most (Eknoyan et al. 1967; Stein et al. 1967; Leeber et al. 1968; Buckalew et al. 1970b;

Page 94: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 91

Bennett 1973), but not all (Barton et al. 1972), report that ECVE sup- presses sodium reabsorption in the loop of Henle. The demonstration that the collecting duct has a marked diluting capacity makes interpretation of free-water clearance data difficult. In contrast, micropuncture studies in which sodium reabsorption along the loop of Henle is estimated by micropuncture of both proximal and distal tubules report increased abso- lute reabsotption after either isotonic or hypertonic saline infusion in the rat (Giebisch et al. 1964; Cortney et al. 1965; Landwehr et al. 1967; Stein et al. 1973; Kunau et al. 1974)or the dog (Dirks and Seely 1970). Similarly, microperfusion studies, indicate that sodium reabsorption in the loop increased linearly as a function of the load delivered to it, and that ECVE, per se, does not affect its intrinsic reabsorptive capacity (Schnermann 1968; Morgan and Berliner 1969a).

In many respects, the transport characteristics of the distal convoluted tubule after volume expansion resemble the loop of Henle. Hayslett, uti- lizing the sprit-drop technique, reported that reabsorption from the distal convoluted tubule is enhanced by saline infusion (Hayslett et al. 1967). Many free-flow micropuncture experiments have found increased abso- lute (Kunau et al. 1974; Knox and Gasser 1974; Khuri et al. 1975), and with one exception (Khuri et al. 1975), decreased fractional reabsorption along the distal tubule after volume expansion. In addition, micropunc- ture experiments in which increased sodium delivery to distal tubules was prevented by reduction of renal perfusion pressure revealed that ECVE had no effect on sodium transport along the superficial distal tubule (Diezi et al. 1980). These results are in agreement with microper- fusion studies which found that the rate of sodium reabsorption paralleled sodium delivery to the distal tubule (Morgan and Berliner 1969a).

Evidence that ECVE affects sodium transport in the collecting duct has been indirectly evaluated by comparison of sodium delivery in super- ficial late distal tubules with final urine. Two studies reported diminished fractional sodium reabsorption in the collecting duct after Ringer's infu- sion when compared with a similar distal delivery of sodium after albu- min infusion (Stein et al. 1973;Knox and Gasser 1974). Diezi compared urinary sodium excretion in nondiuretic and volume-expanded rats in which late distal sodium delivery was adjusted to similar levels by means of aortic constriction (Diezi et al. 1980). Urinary sodium excretion was significantly higher in the volume-expanded animals. The comparison of late distal tubular fluid with final urine to estimate collecting duct reab- sorption assumes that homogeneity of nephron function exists with regard to sodium handling. If nephron heterogeneity exists, changes in excretion could be due to either alterations in collecting duct reabsorp- tion per se, or could be due to the admixture of fluid from superficial and juxtamedullary nephrons. In order to differentiate between these

Page 95: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

92 F.G. Knox and J.A. Haas

possibilities, Diezi performed direct micropuncture of the base and tip of the papillary collecting duct. His results showed that after volume expan- sion, collecting duct fractional sodium reabsorption decreases and abso- lute sodium reabsorption increases (Diezi et al. 1973). Subsequently, in a similar protocol, Stein evaluated papillary collecting duct reabsorption as well as the possibility of nephron heterogeneity, by comparing the delivery of sodium to the end of the distal tubule superficial nephrons with papillary base delivery (Stein et al. 1976). They found that the deliv- ery of sodium to and reabsorption along the papillary collecting duct were markedly greater during Ringer loading than in hydropenia. Further, the amount of sodium delivered to the papillary base was greater than the delivery to the end of the distal tubule of superficial nephrons during Ringer loading, suggesting that deeper nephrons deliver more sodium to the collecting duct. Finally, the difference in sodium excretion between Ringer loading and hyperoncotic albumin infusion was due to events occurring between the late distal tubule of superficial nephrons and the base of the papillary collecting duct. Although these findings do not exclude the possibility that ECVE may alter collecting duct transport, they concluded that the natriuresis of Ringer loading was due, in part, to increased sodium delivery from inner cortical nephrons, and that the terminal part of the collecting duct reduces the magnitude of the natri- uresis. In a subsequent study, direct micropuncture of the deep nephrons during volume expansion confirmed that delivery of sodium to the bend of the loop of Henle in juxtramedullary nephrons was greater than esti- mates of delivery in the superficial nephrons (Osgood et al. 1978). In addition, micropuncture studies by Reineck showed that the net addition of sodium between the late distal tubule and papillary base seen during Ringer loading is abolished if juxtamedullary nephron function is abol- ished by drug-induced necrosis (Reineck et al. 1980). With regard to the finding that in the presence of volume expansion, absolute sodium reab- sorption along the papillary collecting duct is enhanced, this is in sharp contrast to the conclusions drawn in several microcatheterization studies that either no net reabsorption or even net addition of sodium occurs along the papillary collecting duct during Ringer loading (Sonnenberg 1974, 1975; Wilson and Sonnenberg 1979). The difference between the findings have been ascribed to technique (micropuncture vs microcatheterization) and experimental protocol. In the studies by Sonnenberg, the degree of acute extracellular expansion was markedly greater than in the micropunc- ture studies and, in addition, urine was reinfused. Urine reinfusion has been shown to be natriuretic (Harris and Yarger 1976). Accordingly, the differences in results between the micropuncture and microcatheterization studies may be due to the urine reinfusion used in the latter, which in turn may depress sodium transport by the papillary collecting duct.

Page 96: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 93

2.4.2 Chronic ECVE

Chronic ECVE can be produced experimentally by the administration of mineralocorticoids and large amounts of salt in the diet, followed by a return of sodium excretion to control levels. As mentioned previously, this phenomenon is referred to as "DOCA escape". The nephron sites responsible for escape, and the response of the "escaped" animal to volume expansion have been extensively discussed in a previous paper (Knox et al. 1980). In brief, superimposed volume expansion in the DOCA-escaped rat reveals that fractional reabsorption of sodium is diminished in the superficial nephron segment containing the pars recta and loop of Henle. Fractional reabsorption of sodium is also decreased in deep nephrons proximal to the bend in Henle's loop. Finally, escape occurs from the sodium-retaining effects of mineratocorticoids when sodium delivery from both superficial and deep nephrons is increased enough to overcome sodium reabsorption by the cortical collecting tubule which is stimulated by mineralocorticoids.

Chronic ECVE is also a feature of models of heart failure and is charac- terized by the inability to excrete a saline load. Schneider evaluated proximal sodium reabsorption in dogs with aorta-vena cava (AV) fistulas to produce high output heart failure (Schneider et al. 1971). When these animals are given a saline infusion, the normal inhibition of proximal reab- sorption occurs so that delivery from the proximal tubule is markedly increased. However, in these dogs, very little of the increased delivery of sodium appeared in the urine, whereas control dogs had the normal natri- uretic response. This observation indicates that sodium transport in some distal nephron segment is altered in response to changes in ECFV. Sturnpe and associates reported similar findings in rats with AV fistulas (Stumpe et al. 1973). Comparing the rats with AV fistulas with normal rats, they found similar delivery of sodium out of the proximal tubule, but enhanced sodium reabsorption along the loop of Henle. In another model of chronic sodium retention, two studies showed that proximal tubular sodium reab- sorption was not significantly different in normal animals from animals with thoracic vena cava obstruction after saline loading (Auld et al. 1971 ; Levy 1972). Levy also found enhanced sodium reabsorption in the loop of Henle in the AV fistula group, again suggesting that sodium reabsorp- tion at this nephron segment accounts for the inability of animals with experimental heart failure to excrete a saline load.

Page 97: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

94 F.G. Knox and J.A. Haas

2.5 Hormonal Factors

2.5.1 Renin-Ang )tensin-Aldosterone System

It has been prop( ;ed that in the antidiuretic animal, glomerular filtration rate is governed y the orthograde flow of tubule fluid past the macula densa and this in turn may be mediated by the renin-angiotensin system (Schnermann et al. 1970). This hypothesis comes from the observation that in the antidiuretic state, interruption of flow to the macula densa with proximal tubule micropuncture results in a significantly higher single nephron glomerular filtration rate (SNGFR), compared to the SNGFR measured in the distal tubule beyond the macula densa. These experiments imply that distally measured SNGFR represents the true steady-state filtration rate. However, as stated previously, both proximal SNGFR and whole kidney GFR increase in response to extracellular vol- ume expansion (Davidman et al. 1972; Rector et al. 1964), and further, it has been demonstrated that the proximal-distal SNGFR difference is abolished during saline diuresis (Schnermann et al. 1971). If tubuloglo- merular feedback participates in the regulation of filtration rate, one would expect during volume expansion, when distal sodium chloride delivery is elevated, a decrease rather than an increase in filtration rate. Dev and co-workers postulated that this apparent discrepancy might be due to variations of sensitivity of the feedback system as a function of salt intake (Dev et al. 1974). They found that in rats with a sodium intake of greater than 6 mEq/day, the feedback sensitivity (i.e., proximal-distal SNGFR difference) was abolished. In an extension of these studies, Schnermann et al. measured feedback sensitivity by comparing proximal flow rate, filtration rate, and stop-flow pressure in response to loop of Henle perfusion in control rats and DOCA-saline treated rats (Schner- mann et al. 1975). The DOCA-saline treated rats exhibited a blunted feedback responsiveness compared to controls, accompanied by a signifi- cant decrease in juxtaglomerular renin activity. From these observations it was postulated that in animals, either acutely or chronically volume expanded, feedback response is blunted. This impaired feedback accounts for the increase in SNGFR and whole kidney GFR which accompanies ECVE. However, a subsequent study concluded that autoregulation of whole kidney and proximal filtration rate occurred in both sodium depleted and expanded animals in which there was a threefold to four- fold difference in measured renal renin content (Marchand 1978).

Studies by de Wardener et al. demonstrated that acute ECVE increased sodium excretion depsite the administration of large doses of 9 a-fluoro- hydrocortisone and reductions in GFR (De wardener et al. 1961). These experiments were taken as evidence that increases in sodium excretion

Page 98: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 95

following acute volume expansion were independent of changes in adreno- cortical hormone secretion. However, these experiments do not rule out the possibility that acute reductions of aldosterone secretion during vol- ume expansion may be a contributing mechanism for the natriuresis. This possibility was studied by comparing the natriuresis of volume expansion in the intact and adrenalectomized rat. One difficulty of evaluating renal function in the absence of mineralocortocoids is that this maneuver is achieved by adrenalectomy, which usually lowers blood pressure and results in a decreased GFR. Even so, it has been demonstrated that vol- ume natriuresis in response to either isotonic saline or blood volume expansion is similar in intact and adrenalectomized rats (Cortney 1969; Veress and Pearce 1974).

Evaluating the effect of variations in endogenous secretion ofmineralo- corticoids on the natriuresis of ECVE is difficult. In order to achieve a stimulation of aldosterone secretion, animals are given a low sodium diet and/or administered a diuretic. These maneuvers also contract the ECFV, which in itself affects the renal response to ECVE (Higgins 1971). Given the fact that animals administered exogenous mineralocorticoids acutely respond with a diuresis of the same magnitude as untreated ones makes it unlikely that suppression of aldosterone secretion is the primary cause of the saline diuresis. When the ECFV is gradually increased by the chronic administration of mineralocorticoids, an initial retention of sodium is followed by a return of sodium excretion to control levels. This pheno- menon is referred to as escape from the sodium retaining effects of min- eralocorticoids (Knox et al. 1980). The importance of the state of sodium balance in determining the natriuretic response to saline loading has been discussed in Sect. 2.3.5). As mentioned before, an augmented diuretic response to ECVE has been demonstrated in DOCA-escaped dogs. This phenomenon has also been reported in normal humans given 9 ~-fluoro- hydrocortisone (Strauss and Earley 1959) and in patients with primary aldosteronism (Biglieri and Forsharn 1961). In normal subjects, infusion of isotonic saline suppresses aldosterone secretion, whereas patients with primary aldosteronism fail to do so (Espiner et al. 1967). However, both respond with marked natriuresis. This responsiveness of sodium excre- tion to ECVE reinforces the independence from aldosterone secretion.

2.5. 2 Natriuretic Hormone

Several studies have presented evidence suggesting that there is a natri- uretic hormone which contributes to the increase in urinary sodium excretion in response to changes in ECFV expansion. Attempts to prove the existence of a natriuretic hormone have employed several different techniques. The first, cross-circulation, was initially used by de Wardener

Page 99: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

96 F.G. Knox and J.A. Haas

et al. (t 961 ). Cross-circulation involves joining the circulation of two ani- mals via a shunt. One animal serves as a donor and has its ECFV acutely or chronically expanded. In the second animal (recipient) ECFV is kept constant and urinary excretion of sodium is monitored. These cross-cir- culation studies induce an increase in urinary sodium excretion in the assay kidney, which is taken as evidence of a change in the circulating concentration of a natriuretic hormone. Expansion of the donor animal with saline has been performed by several groups (de Wardener et al. 1961 ; Johnston and Davis 1966; Johnston et al. 1967; Blythe et al. 1971 ; McDonald et al. 1967). A number of similar experiments have been per- formed, except, instead of using saline, the donor animals has been expanded with blood or iso-oncotic albumin and the assay kidney is in situ (Bahlrnann et al. 1967; Pearce et al. 1969) or is isolated and per- fused (Lichardus and Pearce 1966; KaIoyanides and Azer 1971;KaIoya- nides et al. 1977). The cross-circulation experiments with saline have been criticized due to the dilution of the blood in the recipient animal (hematocrit, protein concentration), which in itself could result in a natri- uresis in the recipient animal. Two groups have addressed this problem in experiments in which they expanded the donor animal with equilibrated blood from a reservoir (Knox et al. 1968;Bengele et al. 1972). In these animals, as well as those expanded with saline, the sodium excretion in the recipient is usually only a small fraction of that in the donor.

Another approach to detect a natriuretic hormone involves obtaining extracts of plasma, urine or tissue from volume-expanded donors and comparing the natriuresis when injected into bioassay rats with extracts from nonexpanded donors (Sealey et al. 1969; Viskoper et al. 1971; Brown et al. 1972; Gonick and Saldanha 1975). Again, the ensuing natri- uresis is usually modest and sometimes accompanied by an increase in GFR and/or renal blood flow (RBF). These findings raise questions regarding the specificity of the extract, as well as the physiologic signifi- cance.

In vitro assays for natriuretic hormone have involved the measurements of ion transport by the isolated frog skin or toad bladder, the transport of p-aminohippurate by kidney slices, the activity of kidney ATPase and transport of sodium and potassium by renal tubule fragments (Bricker et al. 1968;Buckalew et al. 1970a; Clarkson et al. 1970;Nutbourne et al. 1970; Katz and Genant 1971; Gruber et al. 1980). Many of the findings with in vitro assays have not been confirmed in other laboratories, and the question arises whether the results are relevant to a natriuresis in vivo. The evidence that the natriuresis of ECVE is due, in part, to a natriuretic hormone remains both equivocal and enticing.

Page 100: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 97

2.5.3 Prostaglandins

Saline loading results in an increase in the urinary excretion of PGA and PGE in humans (Papanicolaou et al. 1975), as well as significant changes in intrarenal PGA2 concentration in the rabbit (Attallah and Lee 1973). Following inhibition of PG synthesis by indomethacin administration, sodium excretion in chronically saline loaded rabbits decreased accompa- nied by a significant fall of PGA2 concentration in the outer medulla and papilla. Inhibition of prostaglandin synthesis by either fatty acid depriva- tion (Rosenthal et al. 1974), aspirin (Susic and Sparks 1975), or indo- methacin (Dusing et al. 1977b) has been shown to reduce the natriuresis of saline loading. Dusing and coworkers studied the effect of prostaglan- din synthesis inhibition in ECV-expanded rats on total renal plasma flow and its intrarenal distribution as well as on GFR (Dusing et al. 1977a). In ECV-expanded rats, indomethacin had no effect on GFR, but total renal plasma flow was significantly decreased, which was due to a decrease in outer cortical blood flow. To assess the specific sites of enhanced chlo- ride reabsorption in ECV-expanded rats treated with either indomethacin or meclofenamate, Higashihara performed free flow micropuncture experi- ments in the Munich-Wistar rats (Higashira et al. 1979). The results showed that inhibitors of prostaglandin synthesis increase chloride trans- port in the thick ascending loop of Henle, and/or the cortical and outer medullary collecting tubule. Several studies, however, have reported results which showed that inhibition of prostaglandin synthesis results in a significant natriuresis after saline infusion in rabbit, dog, and man (Oliw et al. 1978; Kirschenbium and Stein 1976; Mountokolakis et al. 1978). In view of this controversy, the physiologic significance of prosta- glandins in mediating the natriuresis of volume expansion is, therefore, not settled.

2.5.4 Antidiuretic Hormone

The possibility that the natriuresis of ECVE is due to a dilution of anti- diuretic hormone, thus leading to a diuresis, has been eliminated. Exo- genous administration of vasopressin to assure a maximal reabsorption of water has little or no effect on the natriuresis of ECVE (de 14/ardener et al. 1961 ; Earley and Friedler 1965a). Further, acute hypophysectomy does not significantly alter the natriuretic response to volume expansion (Kaloyanides et al. 1977).

2.5.5 Parathyroid and Thyroid Hormone

Extracellular volume expansion with calcium-free Ringer's solution results in increases in parathyroid hormone (PTH) secretion as a result of a fall

Page 101: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

98 F.G. Knox and J.A. Haas

in plasma ionized calcium concentration (Schneider et al. 1975). Micro- puncture studies in dogs have shown that infusion of parathyroid hor- mone results in decreased sodium and phosphate reabsorption by the proximal tubule (Agus et al. 1971). From these observations one could hypothesize that PTH may play an important role in the natriuresis accompanying ECVE. However, it has been demonstrated that while para- thyroid hormone significantly affects the phosphaturia of ECVE, the natri- uresis is not dependent on the presence of PTH (Schneider et al. 1975).

Holmes and DiScala have shown that hypertonic saline infusion in hypothyroid rats resulted in fractional excretion of 45% of the filtered load, whereas no control animal excreted more than 12% (Holmes and DiScala 1970). This suggests that a thyroid hormone provides a basal support for sodium transport during ECVE.

2.5.6 Neurohumoral

It has been demonstrated that the natriuresis of blood volume expansion is virtually eliminated by high spinal cord section in the dog (Pearce and Sonnenberg 1965). Gilmore and Daggett observed a blunted natriuresis to volume expansion with 6% dextran in isotonic saline following chronic cardiac denervation (Gilmore and Daggett 1966). This was interpreted as being due to interruption of nonvagal afferent pathways from volume receptors near the heart. Knox et al. confirmed that cardiac denervation attenuates the natriuresis of saline loading, but found that proximal reab- sorption was depressed to a similar degree in response to ECVE as occurs in animals with cardiac innervation (Knox et al. 1967). Subsequently, McDonald and co-workers investigated the influence of afferent and efferent neural pathways on the natriuresis of ECVE (McDonald et al. 1970). High spinal section, which interrupts both afferent and efferent pathways, markedly reduced the natriuretic response to volume expan- sion. However, cord transection at the T6 level, which preserved thoracic but not abdominal innervation, failed to blunt the natriuretic response. Further, interruption of afferent neural pathways by sectioning nerve roots from C8 to T6, did not impair the natriuresis of ECVE. In this same group of animals, vagotomy also failed to affect the natriuretic response. Similar findings in regard to vagotomy have been shown in response to blood volume expansion (Pearce and Lichardus 1967). These results strongly suggest that the adrenergic efferent rather than afferent pathways are important in the natriuresis associated with volume expansion in dogs.

Studies have demonstrated that renal denervation in the volume expanded animals leads to an. additive natriuresis (Bengele et al. 1972; Bello-Reuss et al. 1977), which was due to a further decrease in proximal reabsorption (Bello-Reuss et al. 1977). Further, low frequency electrical

Page 102: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 99

stimulation of the denervated rat kidney reverses the increase in sodium excretion seen in saline expansion (Bello-Reuss et al. 1976). These results are consistent with the notion that a tonic nerve influence on the kidney persists during volume expansion. Studies in the rabbit have, in fact, demonstrated decreased efferent neural traffic during blood volume expansion (Clement et al. 1972).

Previous studies have assessed the interrelationship between the cate- cholaminergic system and ECFV expansion with adrenergic blockade, or measurement of catecholamine blood levels and urinary excretion during acute volume expansion. Gill observed an enhanced natriuresis to saline infusion following guanethidine administration (Gill et al. 1964). Alexan- der observed that sympathetic nerve activity, as shown by measurement of plasma dopamine ~-hydrooxylase and urinary norepinephrine, is sup- pressed during saline infusion (Alexander et al. 1974). Additional studies have confirmed that plasma levels of norepinephrine and epinephrine are reduced during acute saline loading in dogs (Faucheux et al. 1977; Carriere et al. 1978). These reductions were greater than could be accounted for by hemodilution alone. These data indicate that there may be a direct effect of volume expansion to lower circulating plasma catecholamines, and thereby reduce renal sympathetic tone during volume expansion.

2.6 Response of the Perinatal Kidney to Volume Expansion

When a perinatal mammal is given an ECVE, the result is a smaller abso- lute and fractional excretion of sodium compared to an adult receiving an equivalent sodium load. This response has been described in several different species (Aperia et al. 1972;Merlet-Benichou and de Rouffignac 1977; Hurley et al. 1977; Bengele and Solomon 1974; Kleinman and Reuter 1974) and the reasons underlying the phenomenon have been ascribed to several different factors. Among these are rate of glomerular filtration, intrarenal distribution of blood flow, physical and hormonal factors, and inability of the proximal and/or distal tubule to decrease sodium reabsorption in response to a saline load.

The attenuated natriuretic response to volume expansion in the neo- nate was initially attributed to a relatively small increase in glomerular filtration rate in association with volume expansion. Additionally, a change in the intrarenal distribution of blood flow was postulated to influence sodium handling. The results of studies in newborn and adult dogs, however, show that GFR increases similarly in response to volume expansion in dogs of all ages, and that there is no correlation between the blunted natriuresis and the change in intrarenal blood flow distribution in the newborn dog (Kleinman and Reuter 1974, Goldsmith et al. 1979).

Page 103: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

100 F.G. Knox and J.A. Haas

The relationship between changes in physical factors and proximal reabsorption after volume expansion in the neonate is unknown. It has been shown that the oncotic pressure of young rats is lower than that of mature rats (Allison et al. 1972). This observation raises the possibility that in the neonate, volume expansion may not decrease peritubular oncotic pressure to the same extent as the mature animal. However, mor- phological studies demonstrate widening of lateral intercellular spaces during volume expansion in the neonate rat, quantitatively the same as in the mature rat (Misanko et al. 1979).

Another possible explanation for the age-related differences in the natriuretic response to volume expansion is elevated blood levels of aldosterone present in the neonate (Beitens et al. 1972). It is possible that the neonate kidney is exposed to a greater salt-retaining stimulus due to the amount of aldosterone reaching the kidney, although there is a normal response to volume expansion in the mature animal pretreated with exogenous mineralocorticoids. It has been demonstrated that high sodium intake prior to volume expansion enhances the natriuretic response in puppies (Steichen and Kleinman 1975).

Results of experiments in newborn dogs demonstrate that the natri- uretic response to volume expansion can be restored to adult levels by the administration of oxytocin. Furthermore, the effect was localized to a nephron segment beyond the proximal tubule (Kleinrnan and Banks 1980).

Two studies in newborn dogs were carried out to determine whether the attenuated natriuresis to volume expansion is due to enhanced proxi- mal or distal nephron sodium reabsorption. The protocol involved block- ing sodium reabsorption beyond the proximal tubule by administration of diuretics, with the rationale being that a change in sodium reabsorp- tion occurring during volume expansion could be attributed to the proxi- mal tubule (Kleinrnan 1975; Banks and Kleinman 1978). When distal tubular sodium reabsorption was blocked by administration of either amiloride or chlorothiazide and ethacrynic acid, saline expansion increased fractional sodium excretion in the neonate to the same degree as in the untreated volume-expanded adult. These results suggest that the proxi- mal tubule of adult and neonatal dogs respond similarly to volume expan- sion by decreasing proximal reabsorption, but that sodium excretion in more distal segments of the nephron is augmented in the neonate in response to volume expansion.

Page 104: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 101

2.7 Gastrointestinal and/or Hepatoportal Control of Renal Sodium Excretion

The hypothesis that a sodium ion receptor exists in the gut or portal cir- culation came from experiments which showed a greater natriuresis when a hypertonic sodium chloride load was given orally rather than intraven- ously. Lennane and Carey found that in both rabbit and man, oral sodium loading is followed by a greater natriuresis than intravenous sodium load- ing (Lennane et al. 1975a,b; Carey et al. 1976; Carey 1978). Because there were no significant changes in either urinary or plasma aldosterone levels between the oral and intravenous groups, it was suggested that the gastrointestinal tract influences renal sodium excretion by a mechanism independent of aldosterone.

However, other investigators have been unable to confirm the hypo- thesis that a sodium receptor within the GI tract or portal circulation is important in regulating sodium excretion. Hanson found no difference in sodium excretion in dogs receiving hypertonic sodium chloride via the GI tract vs an intravenous infusion (Hanson et al. 1980). Similarly, results of experiments in rabbits could show no difference in urinary sodium excretion following either a gastrointestinal or intravenous administra- tion of hypertonic sodium chloride (Obika et al. 1981). Variations in food intake between the studies may account for the differences seen in dog, rabbit, and man.

It has also been reported that the natriuretic response to a saline load is greater when the infusion is administered into the portal vein rather than into a systemic vein, suggesting that there are osmoreceptors within the portal or hepatic circulation controlling the natriuresis following oral sodium chloride loading. Passo reported that hypertonic infusions of sodium chloride into the hepatic portal vein of the cat results in a greater increase in sodium excretion than do comparable femoral vein infusions (Passo et al. 1972). Similar results were observed in the dog (Daly et al. 1967; Strandhoy and Williamson 1970). However, using similar proto- cols, several studies have been unable to demonstrate an enhanced natri- uresis following hypertonic sodium chloride infusions into the portal vein of the dog (Schneider et al. 1970; Potkay and Gilmore 1970; Kap- teina et al. 1978). It is difficult to reconcile the differences reported in the above studies; therefore, experimental evidence for a GI or portal sodium receptor is not conclusive.

Evidence has been presented that the liver may play an important role in renal tubular sodium reabsorption. Enhanced renal sodium reabsorp- tion and impaired renal concentrating ability may be associated with the heptatorenal syndrome (Shear et al. 1965). Liver damage produced by ligation of the common bile duct has been used as an experimental model

Page 105: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

102 F.G. Knox and J.A. Haas

for the hepatorenal syndrome (Mullane and Gliedman 1970). It has been reported that dogs with ligation of the CBD have a blunted natri- uresis during ECVE, which was attributed to an enhanced proximal and distal tubular sodium reabsorption (Better and Massry 1972). In an ensuing study, it was noted that ECVE does not elicit a renal vasodila- tion in animals with CBD ligation, and it was speculated that this may be partly responsible for the blunted natriuresis (Melman and Massry 1977).

3 Summary

This review summarizes factors influencing renal sodium reabsorption in volume expansion. The influence of renal blood flow and intrarenal blood flow distribution on renal sodium excretion during extracellular volume expansion is unclear. There is no convincing experimental evi- dence that an increase in renal blood flow per se or a change in the intra- renal distribution of renal blood flow is responsible for the natriuresis of ECVE. An increase in whole kidney glomerular filtration rate has been ruled out as the primary cause of the increase in sodium excretion follow- ing volume expansion, and several studies have shown that ECVE is not associated with a change in the intrarenal distribution of GFR. Several investigators propose that the primary variables regulating sodium trans- port during ECVE are physical factors in the peritubule circulation. There is much evidence to indicate that acute ECVE decreases sodium reabsorptibn by the proximal tubule. In animals with chronic ECVE, sodium transport along the loop of Henle is decreased. The role of hor- monal factors in mediating the natriuresis of volume expansion is contro- versial. Although current evidence suggests that neurohumoral factors may be important, a role for other hormones, including "natriuretic hormone", is still not settled. In addition, there is no convincing experi- mental evidence to date to indicate that a sodium ion receptor exists in the gut or portal circulation.

Acknowledgments. Studies from our laboratory were supported by NIH grant HL 14133 and the Mayo Foundation. The authors wish to thank June Hanke for her secretarial assistance.

Page 106: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 103

References

Agus ZS, Puschett JB, Senesky D, Goldberg M (1971) Mode of action of parathyroid • . ! !

hormone and cychc adenosine 3 , 5 -mono-phosphate on renal tubular phosphate reabsorption in the dog. J Clin Invest 50:617-626

Alexander RW, Gill JR, Yamabe H, Lovenberg W, Keiser HR (1974) Effects of dietary sodium and of acute saline infusion on the interrelationship between Dopamine excretion and adrenergic activity in man. J Clin Invest 54:194-200

Allison M, Lipham E, Gottschalk CW (1972) Hydrostatic pressure in the rat kidney. Am J Physiol 223:975-983

Aperia A, Broberger O, Thodenius K, Zetterstrom R (1972) Renal response to an oral sodium load in newborn fullterm infants. Acta Paediatr Scand 61:670-676

Attallah AA, Lee JB (I 973) Radioimmunoassay of prostaglandin A. Intrarenal PGA as a factor mediating saline4nduced natriuresis. Circ Res 28:696-703

Auld R, Alexander E, Levinsky N (1971) Proximal tubular function in dogs with thoracic caval constriction. J Clin Invest 50:2150-2158

Bahlmann JS, McDonald J, Ventom MG, de Wardener HE (1967) The effect on urin- ary sodium excretion of blood volume expansion without changing the composi- tion of the blood. Clin Sci 32:403-413

Baines AD (1973) Redistribution of nephron function in response to chronic and acute saline loads. Am J Physiol 224:237-244

Bank N, Koch KM, Aynedjian HS, Aras M (1969) Effect of changes in renal perfusion pressure on the suppression of proximal tubular sodium reabsorption due to saline loading. J Clin Invest 48:271-283

Banks RO, Kleinman LI (1978) Effects of amiloride on the renal response to saline expansion in newborn dogs. J Physiol 275: 521-534

Barger AC (1966) Renal hemodynamic factors in congestive heart failure. Ann NY Acad Sci 139:276-284

Barger AC, Herd JA (1973) Renal vascular anatomy and distribution of blood flow. In: OrloffJ, Berliner RE, Geiger S R (eds)Handbook of physiology, vol 8, pp 249- 313

Barger AC, Yates FE, Rudolph AM (1961) Renal hemodynamics and sodium excre- tion in dogs with graded valvular damage and in congestive failure. Am J Physiol 200:601-608

Barratt LJ, Wallin JD, Rector FC Jr, Seldin DW (1973) Influence of volume expan- sion on single-nephron filtration rate and plasma flow in the rat. Am J Physiol 224:643-650

Bartoli E, Earley LE (1971) The relative contributions of reabsorptive rate and redis- tributed nephron filtration rate to changes in proximal tubular fractional reab- sorption during acute saline infusion and aortic constriction in the rat. J Clin Invest 50:2191-2202

Barton LJ, Lackner LH, Rector FC Jr, Seldin DW (1972) The effect of volume expan- sion on sodium reabsorption in the diluting segment of the dog kidney. Kidney Int 1 : 19-26

Beitens IZ, Bayard F, Levitsky L, Ances IG, Kowanski A, Migeon CJ (1972) Plasma aldosterone concentration at delivery and during the newborn period. J Clin Invest 51:386-394

Bello-Reuss E, Trevino DL, Gottschalk CW (1976) Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 57:1104- 1107

Bello-Reuss E, Pastoriza-Munoz R, Colindres RE (1977) Acute unilateral renal dener- vation in rats with extracellular volume expansion. Am J Physiol 232:F26-F32

Ben4shay D (1973) Paradoxical effect of salt intake on renal response to hypertonic saline loading in rats. Am J Physiol 225:461-466

Page 107: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

104 F.G. Knox and J.A. Haas

Bengele HH. Solomon S (1974) Development of the renal response to blood volume expansion in the rat. Am J Physiol 227:364-368

Bengele HH. Houttuin E. Pearce JW (1972) Volume natriuresis without renal nerves and renal vascular pressure rise in the dog. Am J Physiol 223:69-73

Bennett CM (1973) Effect of extraceUular volume expansion upon sodium reabsorp- tion in the distal nephron of dogs. J Clin Invest 52:2548-2555

Bennett CM, Brenner BM, Bertiner RW (1968) Micropuncture study of nephron func- tion in the Rhesus monkey. J Clin Invest 47:203-216

Bentzel CJ, Anagnostopoulos T, Pandit H (1970) Necturus kidney: its response to effects of isotonic volume expansion. Am J Physiol 218:205-213

Better OS, Massry SG (1972) Effect of chronic bile duct obstruction on renal handling of salt and water. J Clin Invest 51:402-411

Biglieri EG, Forsham PH (1961) Studies on the expanded extracellular fluid and the responses to various stimuli. Am J Med 30:564-576

Blantz RC, Katz MA, Rector FC Jr, Seldin DW (1971) Measurement of intrarenal blood flow. II. Effect of saline diuresis in the dog. Am J Physiol 220:1914-1920

Blythe WB, D'Avila O, Gitelman H J, Welt LG (1971) Further evidence for a humoral natriuretic factor. Circ Res 28:21-31

Boulpaep EL (1972) Permeability changes of the proximal tubule of necturus during saline loading. Am J Physiol 222:517-531

Bovee KC, Webster GD (1971) Intrarenal distribution of blood flow during saline loading in the dog. Clin Sci 41:519-534

Brenner BM, Berliner RW (1969) Relationship between extracellular volume and fluid reabsorption by the rat nephron. Am J Physiol 217: 6 -12

Brenner BM, Troy JL (1971) Postglomerular vascular protein concentration: Evidence for a causal role in governing fluid reabsorption and glomerulotubular balance by the renal proximal tubule. J Clin Invest 50:336-349

Brenner BM, Troy JL, Daugharty TM (1971a) On the mechanism of inhibition in fluid reabsorption by the renal proximal tubule of the volume-expanded rat. J Clin Invest 50:1596-1602

Brenner BM, Daugharty JM, Ueki IF, Troy JL (1971b) Quantitative assessment of proximal tubule function in single nephrons of the rat kidney. Am J Physiol 220: 2058-2067

Brenner BM, Falchuk KH, Keimowitz RI, Berliner RW (1969) The relationship between peritubular capillary protein concentration and fluid reabsorption by the proximal tubule. J Clin Invest 48:1519-1531

Bricker NS, Klahr S, Purkerson M, Schultze RG, Avioli LV, Birge SJ (1968) In vitro assay for a humoral substance present during volume expansion and uraemia. Nature (London) 219:1058-1059

Brown PR, Koutsaimanis KG, de Wardener HE (1972) Effect of urinary extracts from salt-loaded man on urinary sodium excretion by the rat. Kidney Int 2 :1 -5

Brunner FP, Rector FC Jr, Seldin DW (1966) Mechanism of glomerulotubular balance. II. Regulation of proximal tubular reabsorption by tubular volume as studied by stopped-flow microperfusion. J Clin Invest 45:603-611

Bruns F J, Alexander EA, Riley AL, Levinsky NG (1974) Superficial and juxtamedul- lary nephron function during saline loading in the dog. J Clin Invest 53:971-979

Buckalew VM, Puschett JB, Kintzel JE (1969) Mechanism of exaggerated natriuresis in hypertensive man: Impaired sodium transport in the loop of Henle. J Clin Invest 48:1007-1016

Buckalew VM Jr, Martinez FJ, Green WE (1970a) The effect of dialysates and ultra- filtrates of plasma of saline-loaded dogs on toad bladder sodium transport. J Clin Invest 49:926-935

Buckalew VM Jr, Walker BR, Puschett JB, Goldberg M (1970b) Effect of increased sodium delivery in distal tubular sodium reabsorption with and without volume expansion in man. J Clin Invest 49:2336-2344

Page 108: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 105

Burg MB, Orloff J (1968) Control of fluid absorption in the renal proximal tubule. J Clin Invest 47:2016-2024

Burke TJ, Robinson RR, Clapp Jr (1971) Effect of arterial hematocrit on sodium reabsorption by the proximal tubule. Am J Physiol 220:1536-1541

Carey RM (1978) Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man. Circ Res 43:19-23

Carey RM, Smith JR, Ortt EM (1976) Gastrointestinal control of sodium excretion in sodium-depleted conscious rabbits. Am J Physiol 230:1504-1508

Carriere S, Boulet P, Mathieu A, Brunette MG (1972) Isotonic saline loading and intrarenal distribution of glomerular filtration in dogs. Kidney Int 2:191-196

Carriere S, Lalumiere G, Daigneault A, De Champlain J (1978) Sequential changes in catecholamine plasma levels during isotonic volume expansion in dogs. Am J Physiol 235:F119-F125

Chabardes D, Poujeol P, Deiss S, Bonvalet JP, de Rouffignac C (1974) lntrarenal glo- merular filtration rate distribution in salt loaded rats. Pflfigers Arch 349:191-202

Chanard J, Drueke T, Pujade-Lauraine C, Lacour B, Funck-Brentano JL (1976) Effects of saline loading on jejunal absorption of calcium, sodium and water, and on parathyroid hormone secretion in the rat. Pfliigers Arch 367:169-175

Clarkson EM, Talner LB, de Wardener HE (1970) The effect of plasma from blood volume expanded dogs on sodium, potassium, and PAH transport of renal tubule fragments. Clin Sci 38: 617-627

Clausen G, Tyssebotn I (1973) Intrarenal distribution of glomerular filtration in conscious rats during isotonic saline infusion. Acta Physiol Scand 89:289-295

Clement DL, Pelletier CL, Shepherd JT (1972) Role of vagal afferents in the control of renal sympathetic nerve activity in the rabbit. Circ Res 31 : 824-830

Coelho JB (1973) Effect of dietary sodium intake on the intrarenal distribution of nephron glomerular filtration rates in the rat. Circ Res 33:547-554

Coelho JB (1974) Sodium metabolism and intrarenal distribution of nephron glomer- ular filtration rates in the unanesthetized rat. Proc Soc Exp Biol Med 146: 225-231

Conger JD, Bartoli E, Earley LE (1973) No effect of peritubular plasma protein on proximal tubular volume absorption (JV) during capillary perfusion in situ. Proc Am Soc Nephr 6:25 (abstract)

Cortney MA (1969) Renal tubular transfer of water and electrolytes in adrenalecto- mized rats. Am J Physiol 216:589-598

Cortney MA, Mylle M, Lassiter WF, Gottschalk CW (1965) Renal tubular transport of water, solute and PAH in rats loaded with isotonic saline. Am J Physiol 209: 1199-1205

Daly JJ, Roe J, Horrocks P (1967) A comparison of sodium excretion following the infusion of saline into systemic and portal veins in the dog. Clin Sci 33:481-487

Daugharty TM, Ueki IF, Nicholas DP, Brenner BM (1972) Comparative renal effects of isotonic and colloid-free volume expansion in the rat. Am J Physiol 222:225- 235

Davidman M, Alexander E, Lalone R, Levinsky N (1972) Nephron function during volume expansion in the rat. Am J Physiol 223:188-193

Davis BB, Knox FG, Wright FS, Howards SS (1970) Effect of expansion of extracel- lular fluid volume on proximal sodium reabsorption in hyponatremic dogs. Meta- bolism 19:291-300

Dev B, Drescher C, Schnermann J (1974) Resetting of tubulo-glomerular feedback sensitivity by dietary salt intake. Pfltigers Arch 346:263-277

Diaz-Buxo JA, Haas JA, Ott CE, Cuche J-L, Marchand GR, Knox FG (1976) Sodium balance and the natriuresis of hypertonic saline infusion in dogs. Am J Physiol 230:1183-1186

DiBona DR, Chen LC, Sharp GWG (1974) A study of intercellular spaces in the rabbit jejunum during acute volume expansion and after treatment with cholera toxin. J Clin Invest 53:1300-1307

Page 109: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

106 F.G. Knox and J.A. Haas

Diezi J, Michoud P, Aceves J, Giebisch G (1973) Micropuncture study of electrolyte transport across papillary collecting duct of the rat. Am J Physiol 224:623-634

Diezi J, Nenninger M, Giebisch G (1980) Distal tubular function in superficial rat tubules during volume expansion. Am J Physiol 239:F228-F232

Dirks JH, Seely JF (1970) Effect of saline infusions and furosemide on the dog distal nephron. Am J Physiol 219:114-121

Dirks JH, Cirksena WJ, Berliner RW (1965) The effect of saline infusion on sodium reabsorption by the proximal tubule of the dog. J Clin Invest 44 :1160-I 170

Dusing R, Melder B, Kramer HJ (1977a) Effects of prostaglandin inhibition on intra- renal hemodynamics in acutely saline-loaded rats. Circ Res 41:287-291

Dusing R, Opitz W-D, Kramer HJ (1977b) The role of prostaglandins in the natri- uresis of acutely salt-loaded rats. Nephron 18:212-219

Earley LE, Friedler RM (1964) Observations on the mechanism of decreased tubular reabsorption of sodium and water during saline loading. J Clin Invest 43: 1928- 1937

Earley LE, Friedler RM (1965a) Changes in renal blood flow and possibly the intra- renal distribution of blood during the natriuresis accompanying saline loading. J Clin Invest 44:929-941

Earley LE, Friedler RM (1965b) Studies on the mechanism of natriuresis accompany- ing increased renal blood flow and its role in the renal response to extracellular volume expansion. J Clin Invest 44:1857-1865

Earley LE, Friedler RM (1966) The effects of combined renal vasodilation and pres- sor agents on renal hemodynamics and the tubular reabsorption of sodium. J Clin Invest 45:542-551

Earley LE, Martino JA, Friedler RM (1966) Factors affecting sodium reabsorption by the proximal tubule as determined during blockade of distal sodium reabsorp- tion. J Clin Invest 45:1668-1684

Eknoyan G, Suki WN, Rector FC Jr, Seldin DW (1967) Functional characteristics of the diluting segment of the dog nephron and the effect of extracellular volume expansion on its reabsorptive capacity. J Clin Invest 46:1178-1188

Espiner EA, Tucci JR, Jagger PI, Lauler DP (1967) Effect of saline infusions on aldo- sterone secretion and electrolyte excretion in normal subjects and patients with primary aldosteronism. N Engl J Med 277:1-7

Faucheux B, Buu NT, Kuchel O (1977) Effects of saline and albumin on plasma and urinary catecholamines in dogs. Am J Physiol 232:F123-F127

Fitzgibbons JP, Gennari J, Garfinkel HB, Cortell S (1974) Dependence of saline- induced natriuresis upon exposure of the kidney to the physical effects of extra- cellular fluid volume expansion. J Clin Invest 54:1428-1436

Friedler RM, Eartey LE (I 966) Reduced renal concentrating capacity during isotonic saline loading. Proc S oc Exptl Biol Med 121:352-357

Gertz KH, Mangos JA, Braun G, Pagel HD (1965) On the glomerular tubular balance in the rat kidney. Pfliigers Arch 285:360-372

Gertz KH, Brandis M, Braun-Schubert G, Boylan JW (1967) The effect of saline infu- sion and hemorrhage on glomerular filtration pressure and single nephron filtra- tion rate. Pfltigers Arch 3 I0:193-205

Giebisch G, Klose RM, Windhager EE (1964) Micropuncture study of hypertonic sodium chloride loading in the rat. Am J Physiol 206:687-693

Gill JR Jr, Mason DT, Bartter FC (1964) Adrenergic nervous system in sodium meta- bolism: Effects of guanethidine and sodium-retaining steroids in normal man. J Clin Invest 43:177-184

Gilmore JP, Daggett WM (1966) Response of the chronic cardiac denervated dog to acute volume expansion. Am J Physiol 210: 509-512

Goldsmith DI, Drukker A, Blaufox MD, Edelmann CM Jr, Spitzer A (1979) Hemo- dynamic and excretory response of the neonatal canine kidney to acute volume expansion. Am J Physiol 237:F392-F397

Page 110: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 107

Gonick HC, Saldanha LF (I 975) A natriuretic principle derived from kidney tissue of volume-expanded rats. J Clin Invest 56:247-255

Gruber KA, Whitaker JM, Buckalew VM Jr (1980) Endogenous digitalis4ike sub- . stance in plasma of volume-expanded dogs. Nature (London) 287:743-745

Gutman Y, Benzakein F (1970) Effect of saline loading on absorption from the cat ileum in vivo. Israel J Med Sci 6:195-200

Hakim AA, Lifson N (1969) Effects of pressure on water and solute transport by dog intestinal mucosa in vitro. Am J Physiol 216:276-284

Hanson RC, McLane-Vega LA, Childers JW, Gleason SD, Schneider EG (1980)Lack of evidence for gastrointestinal control of sodium excretion in unanesthetized dogs. Am J Physiol 238:F112-F118

Harris RH, Yarger WE (1976) Urine reinfusion natriuresis: Evidence for potent natri- uretic factors in rat urine. Kidney Int 11:93-105

Hayslett JP, Kashgarian M, Epstein FH (1967) Changes in proximal and distal tubular reabsorption produced by rapid expansion of extracellular fluid. J Clin Invest 46: 1254-1263

Herrera-Acosta J, Andreucci VE, Rector FC Jr, Seldin DW (I 972) Effect of expan- sion of extracellular volume on single-nephron filtration rates in the rat. Am J Physiol 222:938-944

Higashihara E, Stokes JB, Kokko JP, Campbell WB, DuBose TD Jr (1979) Cortical and papillary micropuncture examination of chloride transport in segments of the rat. J Clin Invest 64:1277-1287

Higgins JT Jr (1971) Role of extracellular volume in diuretic response to saline load- ing. Am J Physiol 220:1367-1372

Higgins JT Jr, Blair NP (1971) Intestinal transport of water and electrolytes during extracellular volume expansion in dogs. J Clin Invest 50:2569-2579

Holmes EW, DiScala VA (1970) Exaggerated natriuresis in the hypothyroid rat. Clin Res 18:502

Holzgreve H, Schrier RW (1975)Variation of proximal tubular reabsorptive capacity by volume expansion and aortic constriction during constancy of peritubular capillary protein concentration in rat kidney. Pfliigers Arch 356:73-86

Horster M, Thurau K (1968) Micropuncture studies on the filtration rate of single superficial and juxtamedullary glomeruli in the rat kidney. Pfltigers Arch 301: 162-181

Howards SS, Davis BB, Knox FG (1968) Depression of fractional sodium reabsorp- tion by the proximal tubule of the dog without sodium diuresis. J Clin Invest 47: 1561-1572

Humphreys MH, Earley LE (1971) The mechanism of decreased intestinal sodium and water absorption after acute volume expansion in the.rat. J Clin Invest 50: 2355-2367

Hurley JK, Kirkpatrick SE, Pitlick PT, Friedman WF, Mendoza SA (1977) Renal responses of the fetal lamb to fetal or maternal volume expansion. Circ Res 40: 557-560

Jamison RL, Lacy FB (1971) Effect of saline infusion on superficial and juxtamedul- lary nephrons in the rat. Am J Physiol 221:690-697

Johnston CI, Davis JO (1966) Evidence from cross circulation studies for a humoral mechanism in the natriuresis of saline loading. Proc Soc Exptl Biol Med 121: 1058-1063

Johnston CI, Davis JO, Howards SS, Wright FS (1967) Cross-circulation experiments on the mechanism of the natriuresis during saline loading in the dog Circ Res 20: 1-10

Kaloyanides GJ, Azer M (1971) Evidence for a humoral mechanism in volume expan- sion natriuresis. J Clin Invest 50:1602-1612

Kaloyanides GJ, Cohen L, DiBona GF (1977) Failure of selected endocrine organ ablation to modify the natriuresis of blood volume expansion in the dog. Clin Sci Mol Med 52:351-356

Page 111: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

108 F.G. Knox and J.A. Haas

Kallskog O, Wolgast M (1973) Driving forces over the peritubular capillary membrane in the rat kidney during antidiuresis and saline expansion. Acta Physiol Scand 89: 116-125

Kamm DE, Levinsky NG (1964) Effect of plasma sodium elevation on renal sodium reabsorption. Am J Physiol 206:1131-1136

Kamm DE, Levinsky NG (1965) Inhibition of renal tubular sodium reabsorption by hypernatremia. J Clin Invest 44:1144-1150

Kapteina FW, Motz W, Schwartz-Porsche D, Gauer OH (1978) Comparison of renal responses to 5% saline infusions into vena portal and vena cava in conscious dogs. Pfltigers Arch 374:23-29

Katz AI, Genant HK (1971) Effect of extracellular volume expansion on renal corti- cal and medullary Na+-K + ATPase. Pflfigers Arch 330:136-148

Keck W, Joppich R, v Restoff WD, Finsterer U, Prucksunand P, Brechtelsbauer H, Kramer K (1973) Sodium excretion in conscious and anesthetized dogs after large saline infusion. Pflfigers Arch 341 : 51-62

Khuri RN, Wiederholt M, Strieder N, Giebisch G (1975) Effects of graded solute diu- resis on renal tubular sodium transport in the rat. Am J Physiol 228:1262-1268

Kinney M J, DiScala VA (1974) Volume expansion and intrarenal blood flow of nor- mal and salt-deprived rats. Am J Physiot 227:652-656

Kirschenbaum MA, Stein JH (1976) The effect of inhibition of prostaglandin synthe- sis on urinary sodium excretion in the conscious dog. J Clin Invest 57:517-521

Kleinman LI (1975) Renal sodium reabsorption during saline loading and distal blockade in newborn dogs. Am J Physiol 228:1403-1408

Kleinman LI, Banks RO (1980) Natriuretic effect of oxytocin on saline-expanded neonatal dogs. Am J Physiol 239:F589-F594

Kleinman LI, Reuter JH (1974) Renal response of the newborn dog to a saline load: The role of intrarenal blood flow distribution. J Physiol 239:225-236

Klemmer PJ, De Los Santos C, Blythe WB (1978) Saline-induced natriuresis in the dog without prior exposure of the kidney to the physical effects of expansion of the extracellular fluid compartments. Clin Sci Mol Med 54:525-527

Knight TF, Weinman EJ (1977) Renal sodium reabsorption following induction of and recovery from volume expansion. Am J Physiol 233:F416-F420

Knox FG, Gasser J (1974) Altered distal sodium reabsorption in volume expansion. Mayo Cfin Proc 49:775-781

Knox FG, Davis BB, Berliner RW (1967) Effect of chronic cardiac denervation on renal response to saline infusion. Am J Physiol 213: 174-178

Knox FG, Howards SS, Wright FS, Davis BB, Berliner RW (1968) Effect of dilution and expansion of blood volume on proximal sodium reabsorption. Am J Physiol 215:1041-1048

Knox FG, Schneider EG, Dresser TP, Lynch RE (1970) Natriuretic effect of increased proximal delivery in dogs with salt retention. Am J Physiol 219:904-910

Knox FG, Schneider EG, Willis LR, Strandhoy JW, Ott CE (1973) Effect of volume expansion on sodium excretion in the presence and absence of increased delivery from superficial proximal tubules. J Clin Invest 52:1642-1646

Knox FG, Burnett JC Jr, Kohan DE, Spielman WS, Strand JC (1980) Escape from the sodium-retaining effects of mineralocorticoids. Kidney Int 17:263-276

Kunau RT Jr, Lameire NH (1976) The effect of an acute increase in renal perfusion pressure on sodium transport. Circ Res 39:689-695

Kunau RT Jr, Webb JL, Borman SC (1974) Characteristics of sodium reabsorption in the loop of Henle and distal tubule. Am J Physiot 227:1181-1191

Kuschinsky W, Wahl M, Wunderlich P, Thurau K (1970) Different correlations between plasma protein concentration and proximal fractional reabsorption in the rat dur- ing acute and chronic saline infusion. Pfliigers Arch 321:102-120

Lameire N, Matthys E, Mussche M, Ringoir S, Leusen I (1979)Differences between dog and rat in the natriuretic response to extracellular volume expansion with immediate aortic constriction. J Lab Clin Med 94:215-222

Page 112: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 109

Landwehr DM, Klose RM, Giebisch G (1967) Renal tubular sodium and water reab- sorption in the isotonic sodium chloride-loaded rat. Am J Physiol 212:1327-1333

Lee JS (1973) Effects of pressures on water absorption and secretion in rat jejunum. Am J Physiol 224:1338-1344

Leeber DA, Murdaugh HV, Davis BB (1968) Inhibition of sodium transport by Henle's loop after intravenous saline infusion. J Lab Clin Med 72:220-227

Lennane RJ, Peart WS, Carey RM, Shaw J (1975a)A comparison of natrinresis after oral and intravenous sodium laoding in sodium-depleted rabbits: Evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med 49:433-436

Lennane RJ, Carey RM, Goodwin TJ, Peart WS (1975b) A comparison of natriuresis after oral and intravenous sodium loading in sodium-depleted man: Evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med 49:437- 440

Levinsky NG, Lalone RC (1963) The mechanism of sodium diuresis after saline infu- sion in the dog. J Clin Invest 42:1261-1275

Levy M (1972) Effects of acute volume expansion and altered hemodynamics on renal tubular function in chronic caval dogs. J Clin Invest 51:922-938

Lewy JE, Windhager EE (1968) Peritubular control of proximal tubular fluid reab- sorption in the rat kidney. Am J Physiol 214:943-954

Lichardus B, Pearce JW (1966) Evidence for a humoral natriuretic factor released by blood volume expansion. Nature (London) 209:407-409

Loyning EW (1974) Intracortical distribution of renal blood flow during saline infu- sion in dogs. Acta Physiol Scand 90:409-416

Maddox DA, Price DC, Rector FC Jr (1977) Effects of surgery on plasma volume and salt and water excretion in rats. Am J Physiol 233:F600-F606

Mandin H, Israelit AH, Rector FC Jr, Seldin DW (1971) Effect of saline infusion on intrarenal distribution of glomerular filtrate and proximal reabsorption in the dog. J Clin Invest 50:514-522

Marchand GR (1978) Interstitial pressure during volume expansion at reduced renal artery pressure. Am J Physiol 235 :F209-F212

Marchand GR, Ott CE, Lang FC, Greger RF, Knox FG (1977a) Effect of secretin on renal blood flow, interstitial pressure, and sodium excretion. Am J Physiol 232: F147-F151

Marchand GR, Burke TJ, Haas JA, Romero JC, Knox FG (1977b) Regulation of fil- tration rate in sodium-depleted and -expanded dogs. Am J Physiol 232:F325- F328

Maunsbach AB, Boulpaep EL (1980) Hydrostatic pressure changes related to paracel- lular shunt ultrastructure in proximal tubule. Kidney Int 17:732-748

Martino JA, Earley LE (1967) Demonstration of a role of physical factors as deter- minants of the natriuretic response to volume expansion. J Clin Invest 46:1963- 1978

Martino JA, Earley LE (1968) Relationship between intrarenal hydrostatic pressure and hemodynamically induced changes in sodium excretion. Circ Res 23:371-386

McDonald KM, Rosenthal A, Schrier RW, Galicich J, Lauler DP (1970) Effect of interruption of neural pathways on renal response to volume expansion. Am J Physiol 218:510-517

McDonald M, Schrier RW, Lauler DP (1967) Effect of acute extracellular volume expansion on cross-circulated dogs. Nephron 4 :1 -12

McDonald SJ, de Wardener HE (1965) The relationship between the renal arterial perfusion pressure and the increase in sodium excretion which occurs during an infusion of saline. Nephron 2 :1-14

Melman A, Massry SG (1977) Role of renal vasodilation in the blunted natriuresis of saline infusion in dogs with chronic bile duct obstruction. J Lab Clin Med 89: 1053-1065

Merlet-Benichou C, de Rouffignac C (1977) Renal clearance studies in fetal and young guinea pigs: Effect of salt loading. Am J Pliysiol 232:F 178-F185

Page 113: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

110 F.G. Knox and J.A. Haas

Migdal S, Alexander EA, Bruns F J, Riley AL, Levinsky NG (1975) Effect of hemo- dilution on the distribution of renal blood flow. Circ Res 3 6 : 7 1 - 7 5

Misanko BS, Bengele HH, Solomon S (1979) Renal response to Ringer expansion in developing rats. Biol Neonate 35: 5 2 - 5 9

Morgan T, Berliner RW (1969a) A study by continuous microperfusion of water and electrolyte movements in the loop of Henle and distal tubule of the rat. Nephron 6 :388 -405

Morgan T, Berliner RW (1969b) In vivo perfusion of proximal tubule of the rat: Glo- merular balance. Am J Physiol 217 :992-997

Mountokalakis T, Karambasis T, Mayopoulou-Symvoulidou MG, Merikas G (1978) Effect of inhibition of prostaglandin synthesis on the natriuresis induced by saline infusion in man. Clin Sci Mol Med 5 4 : 4 7 - 5 0

Mullane JF, Gliedman ML (1970) Renal response to saline load in experimental liver disease. J Surg Res 10 :519-523

Munck O, de Bono E, Mills IH (1970) Distribution of blood flow in the renal cortex during saline loading. Clin S ci 3 8 : 6 9 9 - 7 1 2

Nissen OI (1968) Changes in the fil tration fractions in the superficial and deep venous drainage area of the cat kidney due to fluid loading. Acta Physiol Scand 73:320 328

Nutbourne DM, Howse JD, Schrier RW, Talner LB, Ventom MG, Verroust PJ, de War- dener HE (1970) Effect of expanding the blood volume of a dog on the short cir- cuit current across the isolated frog skin incorporated in the dog's circulation. Clin Sci 3 8 : 3 3 - 3 4

Obika LFO, Fitzgerald EM, Gleason SD, Zucker A, Schneider EG (1981) Lack of evidence for gastrointestinal control of sodium excretion in unanesthetized rabbits. Am J Physiol 2 4 0 : F 9 4 - F 1 0 0

Oliw E, Kover G, Larsson C, Anggard E (1978) Indomethacin and diclofenac increase sodium and water excretion after extracellular volume expansion in the rabbit. Eur J Pharmacol 4 9 : 3 8 1 - 3 8 8

Osgood RW, Lameire NH, Sorkin MI, Stein JH (1977) Effect of aortic clamping on proximal reabsorption and sodium excretion in the rat. Am J Physiol 2 3 2 : F 9 2 - F96

Osgood RW, Reineck H J, Stein JH (1978) Further studies on segmental sodium trans- port in th6 rat kidney during expansion of the extracellular fluid volume. J Clin Invest 6 2 : 3 1 1 - 3 2 0

Ott CE, Haas JA, Cuche J-L, Knox FG (1975) Effect of increased peritubule protein concentration on proximal tubule reabsorption in the presence and absence of extracellular volume expansion. J Clin Invest 55: 6 1 2 - 6 2 0

Papanicolaou N, Safar M, Hornych A, Fontaliran F, Weiss Y, Bariety J, Milliez P (1975) The release of renal prostaglandins during saline infusion in normal and hypertensive subjects. Clin Sci Mol Med 4 9 : 4 5 9 - 4 6 3

Papper S, Belsky JL, Bleifer KH (1960) The response to the administration of iso- tonic sodium chloride-lactate solution in patients with essential hypertension. J Clin Invest 3 9 : 8 7 6 - 8 8 4

Passo SS, Thornborough JR, Rothboller AB (1972) Hepatic receptors in control of sodium excretion in anesthetized cats. Am J Physiol 224 :373-375

Pearce JW, Lichardus B (1967) Effects of vagotomy and renal denervation on renal response to blood volume expansion. Can J Physiol Pharmacol 45 :689 -703

Pearce JW, Sonnenberg H (1965) Effects of spinal section and renal denervation on the renal response to blood volume expansion. Can J Physiol Pharmacol 43:211 - 224

Pearce JW, Sonnenberg H, Veress AT, Ackerman U (1969) Evidence for a humoral factor modifying the renal response to blood volume expansion in the rat. Can J Physiol Pharmacol 47: 377 -386

Potkay S, Gilmore JP (1970) Renal response to vena caval and portal venous infu- sions of sodium chloride in unanesthetized dogs. Clin Sci Mol Med 3 9 : 1 3 - 2 0

Page 114: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 111

Poujeol R, Bonvalet JP, de Rouffignac C (1975) Glomerular filtration rate and micro- sphere distributions in single nephron of rat kidney. Pfliigers Arch 357:291-301

Quinn MD, Marsh DJ (1979) Peritubular papillary control of proximal tubule reab- sorption in the rat. Am J Physiol 236:F478-F487

Rector FC Jr, Giesen GV, Kiil F, Seldin DW (1964) Influence of expansion of extra- cellular volume on tubular reabsorption of sodium independent of changes in glo- merular filtration rate and aldosterone activity. J Clin Invest 43:341-348

Rector FC Jr, Sellman JC, Martinez-Maldonado M, Seldin DW (1967) The mechanism of suppression of proximal tubular reabsorption by saline infusions. J Clin Invest 46:47-56

Reineck H J, Parma R, Barnes JL, Osgood RW (I 980) Nephron heterogeneity in renal excretion of sodium and potassium in the rat. Am J Physiol 239:F187-F193

Richet G, Hornych A (1969) The effect of an expansion of extracellular fluids on net Na flux in the jejunum of rats. Nephron 6:365-378

Rosenthal J, Simone PG, Silbergleit A (1974) Effects of prostaglandin deficiency on natriuresis, diuresis and blood pressure. Prostaglandins 5:435-440

Rouffignac C de, Bonvalet JP (1970) Variations in GFR of single superficial and deep nephrons under various conditions of sodium intake in the rat. Pfliigers Arch 317: 141-156

Rumrich G, Ullrich KJ (1968) The minimum requirements for the maintenance of sodium chloride reabsorption in the proximal convolution of the mammalian kid- ney. J Physiol (London) 197:69-70

Sato K (1975) Reevaluation of micropuncture techniques: Some of the factors which affect the rate of fluid absorption by the proximal tubule. In: Angielski S, Dubach UC (eds) Current problems in clinical biochemistry; biochemical aspects of renal function, vol 4, pp 175-187

Schneider EG, Dresser TP, Lynch RE, Knox FG (1971) Sodium reabsorption by proxi- mal tubule of dogs with experimental heart failure. Am J Physiol 220:952-957

Schneider EG, Goldsmith RS, Arnaud CD, Knox FG (1975) Role of parathyroid hor- mone in the phosphaturia of extracellular fluid volume expansion. Kidney Int 7: 317-324

Schneider EG, Lynch RE, Willis LR, Knox FG (1972) Single-nephron filtration rate in the dog. Am J Physiol 222:938-944

Schneider EG, Davis JO, Robb CA, Baumber JS, Johnson JA, Wright FS (1970) Lack of evidence for a hepatic osmoreceptor mechanism in conscious dogs. Am J Physiol 218:42-45

Schnermann J (1968) Microperfusion study of single short loops of Henle in rat kid- ney. Pfliigers Arch 300:255-282

Schnerman J, Hermle M, Schmidmeier E, Dalheim H (1975) Impaired potency for feedback regulation of glomerular filtration rate in DOCA escaped rats. Pfliigers Arch 358:325-338

Schnermann J, Davis JM, Wunderlich P, Levine DZ, Horster M (1971) Technical problems in the micropuncture determination of nephron filtration rate and their functional implications. Pfliigers Arch 329:307-320

Schnermann J, Wright FS, Davis JM, v Stackelberg W, Grill G (1970) Regulation of superficial nephron filtration rate by tubulo-glomerular feedback. Pfliigers Arch 318:147-175

Schrier RW, Earley LE (1970) Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest 49: 1656-1667

Schrier RW, Fein RL, McNeil JS, Cirksena WJ (1969) Influence of interstitial fluid volume expansion and plasma sodium concentration on the natriuretic response to volume expansion. Clin Sci 36:371-385

Schrier RW, McDonald KM, Marshall RA, Lauler DP (1968) Absence of natriuretic response to acute hypotonic intravascular volume expansion in dogs. Clin Sci 34: 57-72

Page 115: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

112 F.G. Knox and J.A. Haas

Schrier RW, McDonald KM, Wells RE, Lauler DP (1970) Influence of hematrocrit and colloid on whole blood viscosity during volume expansion. Am J Physiol 218: 346-352

Sealey JE, Kirshman D, Laragh JH (1969) Natriuretic activity in plasma and urine of salt-loaded man and sheep. J Clin Invest 48:2210-2224

Shear L, Kleinerman J, Gabuzda GJ (1965) Renal failure in patients with cirrhosis of the liver. I. Clinical and pathologic characteristics. Am J Med 39:184-198

Sonnenberg H (1974) Medullary collecting duct function in anti-diuretic and in salt- or water-diuretic rats, Am J Physiol 501-506

Sonnenberg H (1975) Secretion of salt and water into the medullary collecting duct of Ringer-infused rats. Am J Physiol 228:565-568

Sonnenberg H, Solomon S (1969) Mechanism of natriuresis following intravascular and extracellular volume expansion. Can J Physiol Pharmacol 47:153-159

Spitzer A, Windhager EE (1970) Effect of peritubular oncotic pressure changes on proximal tubular fluid reabsorption. Am J Physiol 218:1188-1193

Steichen J J, Kleinmann LI (1975) Influence of dietary sodium intake on renal matura- tion in unanesthetized canine puppies. Proc Soc Exptl Biol Med 148:748-751

Stein JH, Osgood RW, Ferris TF (1972) Effect of volume expansion on distribution of glomerular filtrate and renal cortical blood flow in the dog. Am J Physiol 223: 984-990

Stein JH, Osgood RA, Kunau RT Jr (1976) Direct measurement of papillary collecting duct sodium transport in the rat. J Clin Invest 58:767-773

Stein JH, Osgood RW, Boonjaren S, Ferris T (1973) A comparison of the segmental analysis of sodium reabsorption during Ringers and hyperoncotic albumin infu- sion in the rat. J Clin Invest 52:2312-2323

Stein RM, Abramson RG, Kahn T, Levitt MF (1967) Evidence for a saline-induced limit on distal tubular sodium transport. J Clin Invest 46:1205-1214

Strandhoy JW, Williamson HE (1970) Evidence for an hepatic role in the control of sodium excretion. Proc Soc Exptl Biol Med 133:419-422

Strauss MB, Eartey LE (1959) An inquiry into the role of "sodium-retaining" stero- ids in the homeostasis of body sodium in man. Trans Assoc Am Physicians 72: 200 -206

Stumpe KO, Lowitz HD, Ochwadt B (1970) Fluid reabsorption in Henle's loop and urinary excretion of sodium and water in normal rats and rats with hypertension. J Clin Invest 49:1200-1212

Stumpe KO, Solle H, Klein H, Kruck F (1973) Mechanism of sodium and water retention in rats with experimental heart failure. Kidney Int 4:309-317

Susic D, Sparks JC (1975) Effects of aspirin on renal sodium excretion, blood pres- sure, and plasma and extracellular fluid volume in salt loaded rats. Prostaglandins 10:825-831

Tucker B J, Blantz RC (1978) Determinants of proximal tubular reabsorption as mechanisms of glomerulotubular balance. Am J Physiol 235:F 142-F 150

Velasquez MT, Notargiacomo MV, Cohn JN (1973) Comparative effects of saline and mannitol on renal cortical blood flow and volume in the dog. Am J Physiol 224: 322-327

Velasquez MT, Notargiacomo MV, Cohn JN (1975) Segmental changes in intrarenal hemodynamics during saline infution in the dog. Am J Physiol 228:1663-1668

Veress AT, Pearce JW (1974) The effect of acute adrenalectomy on volume natri- uresis in the rat. Proc Soc Explt Biol 145:533-536

Viskoper JR, Czaczkes JW, Schwartz N, Ullmann TD (1971) Natriuretic activity of a substance isolated from human urine during the excretion of a salt load. Nephron 8:540-548

Wallin JD, Blantz RC, Katz MA, Andreucci VE, Rector FC Jr, Seldin DW (1971) Effect of saline diuresis on intrarenal blood flow in the rat. Am J Physiol 221: 1297-1304

Page 116: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Factors Influencing Renal Sodium Reabsorption in Volume Expansion 113

Wardener HE de, Mills IH, Clapham WF, Hayter CJ (1961) Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 21:249-258

Wilson DR, Sonnenberg H (1979) Medullary collecting duct function in the remnant kidney before and after volume expansion. Kidney Int 15:487 -501

Windhager EE, Lewy JE, Spitzer A (1969) Intrarenal control of proximal tubular reabsorption of sodium and water. Nephron 6:247-259

Page 117: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Rev. Physiol. Biochem. Pharmacol., Vol. 92 © b y Springer-Verlag 1982

Hormonal Coordination of the Immune Response

J E A N C O M S A , H U B E R T L E O N H A R D T , a n d H A R T M U T W E K E R L E *

Contents

1 The T h y m u s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 16 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9

1.9.1 1.9.2 1.9.3

1.9.4 1.10 1.10.1 1 .10.2 1.10.3 1.10.4

I m m u n o l o g i c a l Consequences of T h y m e c t o m y . . . . . . . . . . . . . . . 117 Cell-to-Cell I n t e r a c t i o n in t he I m m u n e Response . . . . . . . . . . . . . . 118 Role of t he T h y m u s in I m m u n o t o l e r a n c e . . . . . . . . . . . . . . . . . . . 119 Role of t he T h y m u s in C y t o t o x i c and Graf t I m m u n e Reac t ions . . . . 120 Suppresso r T Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121 Mechan i sm of the T-Cell-B-Cell I n t e r a c t i o n . . . . . . . . . . . . . . . . . . 122 Di s t i nc t i on o f T and B Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125 S u b p o p u l a t i o n s of T Ceils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126 Role o f t he T h y m u s in Organ iza t ion and G e n e r a t i o n of I m m u n e Response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127 I m m u n o l o g i c a l F u n c t i o n s of T L y m p h o c y t e s . . . . . . . . . . . . . . . . 128 T L y m p h o c y t e D i f f e r en t i a t i on Markers . . . . . . . . . . . . . . . . . . . . 129 Role of T L y m p h o c y t e Subl ines in the Organ iza t ion of the I m m u n e Sys tem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130 G e n e r a t i o n o f An t igen Divers i ty in the T h y m u s . . . . . . . . . . . . . . . 132 Subs t i t u t ive T h e r a p y for the T h y m o p r i v i c C o n d i t i o n . . . . . . . . . . . 133 T h y m i c Graf t s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133 Trans fus ion of T h y m i c or T Cells . . . . . . . . . . . . . . . . . . . . . . . . 134 Cell-Free T h y m i c P repa ra t ions . . . . . . . . . . . . . . . . . . . . . . . . . . 134 T h y m i c Ex t r ac t s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135

2 The A d r e n a l C o r t e x . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145

3 T h e T h y r o i d . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150

4 The G o n a d s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151

5 The A d e n o h y p o p h y N s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153

In f luence o f H y p o p h y s e a l H o r m o n e s on the I m m u n e Response . . . . . . . . . 154 6.1 G r o w t h H o r m o n e . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154 6.2 C o r t i c o t r o p i n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155

Mechan i sms of H o r m o n a l In f luence o n the I m m u n e Response . . . . . . . . . . 156 7.1 Cel lular and Subce l lu la r Aspec t s of H o r m o n a l A c t i o n . . . . . . . . . . 156 7.1.1 The Cor t i cos te ro ids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156 7.1.2 Pept id ic H o r m o n e s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158 7.1.3 Cyclic A d e n o s i n e M o n o p h o s p h a t e (cAMP) . . . . . . . . . . . . . . . . . . 158 7.1.4 S y n t h e t i c Po ly r i bonuc l eo t i de s . . . . . . . . . . . . . . . . . . . . . . . . . . 158

* Univers i t~ t des Saar landes , Mediz in ische Fakul tf i t , D-665 H o m b u r g (Saar)

Page 118: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

116 J. Comsa et al.

7.2 7.2.1 7.2.2 7.2.3 7.2.4

Hormonal Interactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159 Consequences of Thymectomy on the Endocrines . . . . . . . . . . . . . 159 Thymus-Thyroid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161 Thymus-Adrenal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161 Thymus-Adenohypophysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162

8 Possible Alimentary Influences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165

9 General Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166

References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168

For the last 20 years, hormonal influences on the immune system have been subject to an immense amount of research. The documentat ion accumulated thus far obviously differs from one endocrine organ to another and in some cases it has been one-sided. About 10 000 publica- tions have been dedicated to the role of the thymus in immunology, whereas references to the role of the thyroid or the gonads are scarce. Immunological work on the adrenal cortex has been considerable, but (with few exceptions) has dealt only with the immunosuppressive influ- ence of corticoids administered in "unphysiological" amounts to intact animals. The concept of a proper hormonal regulation of the immune response, i.e., the role of interactions of several endocrines, under a pos- sible ultimate neurohormonal control, emerged only recently, and its elucidation is largely a matter for future research. The subject o f the present review is, among other things, an at tempt to indicate possible directions for this research. Thus, the present review has to record immu- nological and endocrinological documentat ion. Since a result o f these considerations is that the proper endocrinological point of view has for some reason been neglected so far by immunologists (except, o f course, for the thymic hormones), this point will be emphasized below. Immu- nological documentat ion will be summarized and limited to information necessary to understand present knowledge in endocrinology.

1 The Thymus

As stated above, more than 10 000 references may be found concerning the role of the thymus in immunity [see reviews 216, 2 1 8 , 2 5 5 , 3 2 9 , and 504]. From this t remendous bibliography some valid conclusions can be drawn. A chronological review presents a good idea of the course of this knowledge.

Page 119: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 117

1.1 Immunological Consequences of Thymectomy

The thymus of immunized rabbits contains no antibodies [62] and the thymus of immunized guinea pigs yields no antibodies in the incubation medium [191. However, thymectomy is followed by a severe decrease in antibody production in weanling guinea pigs injected with Salmonella antigens [115, 2681, rats [e.g. 24, 5251, rabbits [12, 35], and mice [e.g. 15 ,252 ,256 ,261 ,362 , 469,493, 557] suffer from a severe immunodefi- ciency when thymectomized at birth. This is not constant [e.g. 271,252, 35, 484], but thymectomy in prepuberal mice results in immunodefic- ciency within a certain delay. The accelerated development of experimen- tal tumors, whether induced by polyoma virus [133, 315], by synthetic carcinogens [368] or by grafting malignant cells [e.g. 421 ], was explained as an immune deficiency. The rejection of allografts is delayed in mice and rats thymectomized at birth [e.g. 14, 41 ,348, 362, 3711, while in weanling rats, the rejection of skin allografts is only slightly delayed [ 123].

The immune deficiency was considered to be the reason for the charac- teristic wasting of thymectomized mice [e.g. 24] since axenic thymecto- mized mice do not waste [e.g. 543], and this was generally confirmed [410]. This immunodeficiency of thymectomized animals may be paral- leled with the abnormal composition of their immunoglobulins. In these animals, IgM is normal, IgG is deficient, and IgA is absent. Furthermore, sensitized, thymectomized animals fail to perform the switch from IgM production to IgG production during the immune response [see 67 for review].

The immunodeficiency of thymectomized animals (mostly mice) was confirmed by a large and still increasing number of techniques:

1. The plaque-forming cell assay [273]. Plaque-forming cells are severely reduced in number in the spleen of thymectomized mice injected with sheep erythrocytes [e.g. 196, 371].

2. The rosette-forming cell test [e.g. 57]. Rosette-forming cells (with sheep erythrocytes) decreased in number in the spleen of neonatally thymectomized mice [e.g. 29].

3. The graft-vs-host reaction in its in vivo [57, 468] and in vitro form [22]. Spleen cells from thymectomized donors were found to be unable to induce the in vivo [e.g. 134, 347, 505] and the in vitro graft- vs-host reaction [509] (see review of previous documentations on the role in all these reactions [236]).

The (relative) resistance of the immune system in thymectomized puberal mice implies three exceptions:

1. The nude mouse, congenitally deprived of the thymus [549]. This mouse does not reject allografts; its spleen cells are unable to induce

Page 120: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

118 J. Comsa et al.

the graft-vs-host reaction and its hemolysin production after sheep erythrocyte injection is conspicuously low. Normal reactions are reestablished in all these tests by a thymus graft [398]. This topic will be discussed below (see Sect. 1.9.1).

2. The dwarf mouse [157,415]. 3.The thymectomized, lethally irradiated mouse, restored with bone-

marrow cell transfusion [e.g. 367]. These animals survive both thymec- tomy and irradiation, but they do not produce antibodies against a large number of antigens, e.g., sheep erythrocytes [127,367] and skin allograft rejection is delayed [e.g. 361, 515]. This observation devel- oped into a valid and generally accepted experimental design. It may still raise a problem when used to demonstrate the influence of thymic extracts. Indeed, the efficiency of a thymic extract was shown to tend towards zero in irradiated guinea pigs[ 114].This was not demonstrated by immunological testing; nevertheless, it could explain the inefficiency of thymic hormones in irradiated mice [306].

1.2 Cell-to-Cell Interaction in the Immune Response

Irradiated thymectomized mice, injected with lymphocytes from bone marrow or thymus, produced no antibodies when injected with erythro- cytes (as demonstrated with the plaque-forming cell test [367]. Antibody production was normal in similar mice injected with both thymic and bone-marrow cells [e.g. 102]. This could not be observed when the thymic cells were killed by ultrasound [ 102] or by a specific antiserum. Newborn mice (CBA or C 57bl) were thymectomized, X-irradiated, and injected with sheep erythrocytes. Their antibody production was poor, as demon- strated by the plaque-forming cell test. It could be reestablished by injec- tion of thymic and bone-marrow lymphocytes, but not with thymic cells alone [363,365,364] .

Newborn thymectomized CBA mice were injected with syngeneic bone marrow and C 57bl thymocytes together with sheep erythrocytes. Then their spleen was searched for plaque-forming cells. If the test plaques were treated with anti-CBA serum, the number of plaque-form- ing cells decreased to near zero. Anti-C 57b 1 serum did not have a similar effect [363]. Thus, the antibody-producing cells differentiate from the receiver, but the (allogenic) thymus was necessary. In intact X-irradiated mice restoration of the immune response was possible with bone-marrow cell transfusions (plaque-forming cell test); in thymectomized irradiated mice it was not (reviewed in [3651).

CBA mice were thymectomized, X-irradiated, and injected with thymic and bone-marrow cells either from CBA or T6 T6 donors (T6 T6 thymus

Page 121: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 119

+ CBA bone marrow or the opposite). Their spleen cells were injected into second recipients thymectomized, X-irradiated CBA, and previously immunized against T6 T6 mice. In addition, the second recipient was injected with sheep erythrocytes. Three combinations were possible:

1. The second recipient mouse received spleen cells from a donor injected with T6 T6 thymus and CBA bone marrow. There was no net increase in plaque-forming cells in its spleen.

2. The second recipient received spleen cells from a donor bearing CBA thymus and T6 T6 bone-marrow cells. In its spleen there was an explo- sive increase in the mitotic rate, but no increase in plaque-forming cells.

3. The second recipient received CBA thymus and CBA bone-marrow cells. Mitosis and plaque-forming cells increased significantly in num- ber [131]. This interaction between at least two cells for immune response was confirmed by numerous in vitro assays [e.g. 43] (see below).

The two (B and T) cells were incubated in two compartments of a double diffusion chamber with sheep erythrocytes added to one compart- ment only. Antibody production was limited to the B cell compartment, but when B cells were incubated with sheep erythrocytes only, no anti- bodies were produced [3]. Similar observations were made with Shigella antigens [ 1871.

In fact, the cooperation between T and B cells was found to be insuf- ficient [e.g. 13,363]. Macrophages are also necessary [e.g. 185,201,208, 317, 379, 436, see review 282]. Two different T cells seem necessary for this interaction: those killed by antilymphocyte serum (long-lived) and those disappearing shortly after thymectomy [185].

1.3 Role of the Thymus in Immunotolerance

Immunotolerance was first observed in rabbits injected with antigen at birth [246]. This can be induced with repeated small doses or with a single massive dose of antigen. The effect of small doses was enhanced by cortisol injections [ 100].

Thymectomy was followed by a prolongation of immunotolerance beyond the normal time limit [104, 406, 493]. Thus, tolerance seemed to show just the absence of immunocompetent T cells. Still, these cells may be suppressed by thymectomy or by X-irradiation. In tolerant ani- mals, thymectomy prolonged the tolerance period, whereas irradiation shortened it [ 101 ]. Apparently, cells (killed by irradiation) are necessary to maintain the tolerance. Thymectomized, X-irradiated mice bearing

Page 122: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

120 J. Comsa et al.

thymus grafts from tolerant donors [264] or infused with thoracic duct cells [99] or spleen cells [243] from tolerant donors became tolerant. This was confirmed in rats [237]. When the ( tolerant)spleen or thoracic duct cells were treated with anti-Thy 1 serum prior to the transfusion, this passive tolerance was not induced. Tolerance still does not seem to be specific to T cells. Thymectomized, X-irradiated mice injected with bone-marrow and thymic cells became tolerant when either one of the two cells came from tolerant donors [98]. Enhancement of antibody pro- duction or tolerance depends on the ratio of T cells to B cells. Up to a certain limit T cells induce antibody production by B cells; over this limit they suppress it and may induce tolerance [ 184]. Be that as it may, the importance of the thymus in induction of immunotolerance can be demonstrated.

1.4 Role of the Thymus in Cytotoxic and Graft Immune Reactions

The allograft rejection is a reaction of the cellular immunity. Passive transfer of immuni ty against allografts was possible by cell transfer but not by injections of serum from an immunized donor [e.g. 372, reviewed 350]. An allograft is rejected at any rate by a normal animal, but recep- tors of immune cells rejected it as if they had been immunized already by a first graft (i.e., in about half the time required for the rejection of the first graft). Passive transfer of graft immunity by serum was also pos- sible in rabbits [552]. Humoral immuni ty is supposed to play a part in allograft rejection [see review 4781. Allografts included in diffusion cham- bers were not destroyed [e.g. 8]. Divergent observations are scarce: lym- phocytes of an immunized mouse were included in millipore membranes and implanted into an unimmunized animal. Skin grafts of the strain against which the lymphocyte donor was immunized were rejected by the receptor as second grafts [302,385]. Drainage of the thoracic duct in rats (i.e., deprivation principally of small lymphocytes) resulted in an sig- nificant delay in graft rejection [332]. Thymec tomy at birth was followed by a long delay in skin graft rejection in mice [176, 192, 361]. The role of the thymus is essential: X-irradiated, thymectomized CBA mice injected with syngeneic bone marrow and C3H thymic cells normally rejected C 57 B skin grafts but not C3H grafts. Mice injected with anti-Thy 1 serum did not reject skin allografts [428] (see review of previous docu- mentat ion [542]). Allograft rejection demonstrated the function of cyto- toxic cells. Lymph-node cells from rats bearing a skin allograft kill kid- ney cells from the skin donor strain in vitro [ 541 ].

In cytotoxic cells [326], cytostatic activity (demonstrated by the inhibi- tion of thymidine uptake) was distinguished from cytolytic activity

Page 123: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 121

(demonstrated by the release of 51 Cr from the labeled target cells into the medium).

Cytotoxic activity is supported by T cells [514]. It persists in lympho- cytes where B cells have been discarded [e.g. 234]. It can be acquired in vitro by cultivation of T cells (from thymus, lymph nodes or spleen) with target cells [see 327]. This differentiation implies DNA synthesis [388]. Cytotoxic T cells are of a peculiar type, characterized by specific anti- genic markers (see Sect. 1.7). They conserve their cytotoxic potential for months in vitro in the absence of the specific antigen. They have no "hel- per" function [see review 136]. This differentiation implies DNA synthe- sis [e.g. 388].

T cells are sufficient to manifest cytotoxic activity [94]. This observa- tion was not confirmed. Thymocytes (i.e., immature cells) added to the medium, enhanced the cytotoxic activity of (mature) previously sensi- tized spleen cells from CBA mice against BALB lymphocytes [520]. In fact, cytotoxic activity was observed in a multitude of cells: T cells, B cells, null lymphocytes, and macrophages [93]. Macrophages are required for cytotoxic activity [e.g. 521 ], but macrophages alone manifest only cyto- static and no cytolytic potency [e.g. 241,274, 275]. The cytotoxic activ- ity of macrophages may be induced by immunized T cells (immunized T cells conferred a cytotoxic potency to unimmunized bone-marrow cells) [e.g. 240]. Peritoneal macrophages from immunized mice were cytotoxic by themselves (supposed to be influenced by T cells in vivo [324]). It could be shown [84, 323] that the development of cytotoxic activity results from the synergy of two types of T cells, differing only in their antigenic markers (see Sect. 1.8). Cytotoxic activity needs the pres- ence of helper T cells in much the same way as does the differentiation of B cells into antibody producers.

1.5 Suppressor T Cells

Spleen cells stimulated with a mitogen (concanavalin A) added to the medium will reduce the number of plaque-forming cells from spleen cells incubated with sheep erythrocytes [160]. T cells added to the medium induce a decrease in thymus-independent antibodies by B cells [e.g. 205, 206]. Injection of antilymphocyte serum in mice together with a thymus- independent antigen results in an enhanced production of antibodies [e.g. 35]. Mice were rendered tolerant against pneumococcal lipopolysac- charide by a massive injection at birth. Spleen cells of these mice, when added to the medium, will reduce the antibody production of normal spleen cells incubated with the same antigen to zero [ 152]. In nude mice (which produce thymus-independent antibodies in large amounts), the

Page 124: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

122 J. Comsa et al.

injections of thymocytes from their haired littermates together with thymus-independent antigen were followed by a comparatively reduced antibody production [259].

In these experiments the suppression of antibody production appears to demonstrate the activity of a peculiar type of "suppressor" cells. Mouse thymocytes incubated with X-irradiated spleen lymphocytes will develop into suppressor cells and inhibit the 3 H-thymidine uptake in a mixed lymphocyte culture. This characteristic is suppressed by pretreat- ment with anti-Thy 1 serum, suppressor activity is supported by T cells [167] but not by these alone. Immunosuppressor function could be demonstrated in macrophages [565].

The development of thymic cells in either suppressor or helper cells de- pends on the amount of antigen injected. In the spleen cells of mice, injec- tion of 106 sheep erythrocytes induced the development of helper func- tion, whereas injection of 109 erythrocytes induced suppressor function. Does this difference show that the same cells possess both potentialities, or does it demonstrate the selective development of one of those cell types?

T cells were incubated with macrophages sensitized to sheep erythro- cytes. These cells developed a suppressive influence when added to nor- mal spleen cells, and a helper influence when added to spleen cells deprived of T cells [572].

The normal immune response may thus be the algebraic sum of the helper and the suppressor functions [see e.g. 204, 268]. These functions are supported by different cells. They differ in their antigenic markers. Helper cells bear the Ly 1 marker, whereas suppressor cells are labeled Ly 2, Ly 3 [78, 160, 163]. Two cells are necessary for the development of cytotoxic activity.

It is still open to discussion whether suppressor and cytotoxic activity are of different types or two aspects of the same potential. Cytotoxic and suppressor cells bear the same antigenic marker, but suppressor cells are killed by cyclophosphamide [437] and a suppressor activity against cytotoxic cells could be demonstrated in an allograft test [105]. A distinc- tion could be claimed between suppressor and cytotoxic cells [559].

1.6 Mechanism of the T Cell-B-Cell Interaction

Ever since the notion of T and B cells has been defined, speculation has started on the mechanism of their interaction. As a result hypotheses began appearing in great numbers. Just by the wording, these hypotheses seemed to have provided advanced knowledge, or even better, an illusion of knowledge, but in reality were based on absolutely no facts whatso- ever. These hypotheses are obsolete.

Page 125: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 123

Recent investigation has demonstrated that T cells influence the B cells by soluble substances delivered into the medium. Spleen lymphocytes cultivated with sheep erythrocytes develop few plaque-forming cells when previously treated with anti-Thy 1 serum. If T cells previously sen- sibilized to sheep erythrocytes are added, the development of plaque- forming cells was significantly increased. The same effect was obtained by adding the supernatant of T-cell cultures [455]. In the incubation medium IgG and IgM antibodies were found [455]. Spleen cells from neonatally thymectomized mice (which normally do not differentiate into plaque-forming cells when incubated with sheep erythrocytes) develop plaque-forming cells when incubated with thymic lymphocytes or with the supernatant of their culture [e.g. 146, 235, 526]. Spleen cells from irradiated mice do not develop plaque-forming cells in a culture with sheep erythrocytes. This development is restored by addition of thymic lymphocytes from sensitized donors or by the supernatant of their culture medium [517]. Supernatants of activated T cell cultures induced plaque-forming cell differentiation in spleen cells of nude mice [211]. Mice were grafted with nonisologous skin. The regional lymph nodes were included in millipore chambers and implanted into intact mice of the first graft-bearer strain. The recipients rejected similar skin grafts in the time necessary for a secondary rejection [386].

Thymocytes from mice immunized against sheep erythrocytes were incubated with B cells (spleen cells treated with anti-Thy 1 antiserum) in the two compartments of a diffusion chamber separated by a millipore membrane. The B cells developed numerous plaque-forming cells, even when they came from unimmunized mice or from nude mice [ 186] or when a dialyzing membrane separated the two compartments instead of a millipore membrane [ 186]. Supernatants of T-cell culture immunized against Toxoplasma induced the production of anti-Toxoplasrna factor in nonimmunized macrophages [465].

The list of work on this topic is by no means exhaustive. Ten demon- strations were repeated over and over again with reasonably predictable results. Thus, T cellsinfluence B cells by a compound they deliver into the medium. The bulk of T cells can be defined to some degree as a dis- seminated endocrine gland. Apparently this compound is not specific, however, its production is induced by an antigen. Supernatants from mixed lymphocyte cultures could induce the development of the immune response of B cells against sheep erythrocytes [11, 160, 197, 440, 532]. Divergent observations were reported, however. Mice were immunized against synthetic peptidic antigens. T cells from their spleen were incu- bated and the supernatant together with the bone marrow was injected into X-irradiated mice. In the spleen of the recipients plaque-forming cells were found to differentiate from the erythrocytes coated with the

Page 126: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

124 J. Comsa et al.

same antigens, but not from the normal sheep erythrocytes [384]. This mediator secreted by T cells is probably not unique. Some of these fac- tors are peptides with a mol. wt. ranging around 40 000 [ 186]; glycolipidic compounds with a similar action were also isolated [566,569,584] . The intimate mechanism of their action is unknown, but there is a suggestive parallel. Bacterial lipopolysaccharides mitogenic for B cells enhanced the immune response of B cells against sheep erythrocytes, a thymus-depen- dent reaction [276].

In fact, several mediators of different chemical nature were described. Ribonucleic acids from lymph nodes of rabbits bearing skin allografts injected into a normal rabbit induced in this animal the ability to reject similar skin allografts as if it had been immunized itself by a first graft [342]. Ribonucleic acids from spleen cells of immunized donors injected into thymectomized mice induced a normal immune response (plaque- forming cell test) in these animals [283]. Allograft rejection accelerated in rabbits injected with ribonucleic acid from lymph nodes of rabbits bear- ing an allograft [269, 342, 70]. (Still, ribonucleic acids are not supposed to be secreted into the medium.) The "suppressor" incubation medium of mouse spleen cells from donors rendered tolerant by a massive sheep erythrocyte injection contained a ganglioside which showed a suppressor influence in purified form [ 172].

Soluble mediators probably play a role in the interactions between macrophages and lymphocytes. Macrophages were incubated with an antigen. The supernatant of this culture induced a specific helper cell dif- ferentiation when added to the incubation medium of T cells [ 171 ].

Cytotoxic action was found to be mediated by soluble products of lymphocytes (" lymphotoxines" [527]). Development of cytotoxic activ- ity in killer cells was found either to be dependent on a soluble product from helper cells [474] or enhanced by the supernatant of a mixed lym- phocyte culture ("killing assisting factor" [393]). Supernatant of a lym- phocyte culture from mice tolerant to human globulin was found to render mice injected with it tolerant [95]. This (unidentified) compound is secreted by T cells, since pretreatment of the lymphocytes with anti- Thy 1 serum sppressed the reaction. In conclusion, the intricate cell-to- cell interactions, ultimately resulting from the immune response, appear to be mediated by compounds delivered by the different cells into the medium. The intimate mechanisms of these reactions are unknown. Further information on the role of cAMP will be commented on in Sect. 6.1.3. The relation of the cell-to-cell activations mentioned above with the different hormones influencing the immune response awaits further research.

Page 127: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 125

1.7 Distinction of T and B Cells

For many years it was believed that lymp,hocytes leave the thymus, which led to the conclusion that some of the lymphocytes circulating in the blood or fixed in lymphatic tissues may be of thymic origin. This was demonstrated first by two methods:

1. The consequences of thymectomy on the lymphocyte pool. Thymec- tomy was followed by lymphopenia and by atrophy of lymph nodes and spleen follicles [reviewed in 116]. In lymph nodes and spleen, the zones affected by this atrophy could be delimited (thymus-dependent zones [see e.g. 399, 400]). These zones include about 70% of the lymph nodes and 20% of the spleen. Lymphocytes in the thoracic duct are, for the most part, of thymic origin. After labeling the thymus in situ with 3 H-thymidine, about 0.02%-0.12% of the lymphocytes in the lymph nodes showed the label [533]. Thus, from one test to another the results were very different.

2. The description of thymic lymphocytes of intracellular enzymes dif- fered from those of the lymph nodes' lymphocytes such as alkaline phosphatase [50]. By this test, 10% of the circulating lymphocytes were identified to be of thymic origin, but no such lymphocytes were found in the lymph nodes. This research was placed on solid ground when the antigenic markers specific for the thymic lymphocytes [e.g. 424, 426, 429, 456] were identified, detectable by specific purified antibodies [e.g. 422, 427]. They were different from those directed against the antigenic marker of B cells [424].

These observations made it possible to describe with validity other dif- ferences between T and B cells:

The surface of T cells is smooth, that of B cells villous [456]. Drugs such as phytohemagglutinin [e.g. 169] or concanavalin A induce an increased proliferative activity in lymphocytes of thymic origin only. It is possible to conclude from the phytohemagglutinin test that all cir- culating lymphocytes are of thymic origin [e.g. 145].

T cells and B cells have shown a different mobility in free-flow electro- phoresis [e.g. 442, 545,556]. In fact, this could be expected. In free-flow electrophoresis of normal mouse lymphocytes two populations could be separated, whereas those of thymectomized, irradiated mice, restored with bone-marrow cells, migrated in a unique bulk [441 ].

In irradiated mice, injected bone-marrow cells migrate in the thymus, the bone marrow, and the lymph nodes. Thymocytes will not migrate into the thymus [ 193]. More elaborate techniques permitted the identifi- cation of several subpopulations in T cells:

Page 128: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

126 J. Comsa et al.

1. By the antigenic markers. Within the thymus the Thy 1 antigen is highly concentrated on the surface of cortical lymphocytes, whereas in the medulla and on the circulating lymphocytes the markers Ly 1, Ly 2, and Ly 3 are highly concentrated, and Thy 1 is low [e.g. 84, 481]. The former are killed by an injection of cortisol in milligram dose, whereas the latter survive [65, 297].

2. The cortisol-resistant cells correspond to the mature, immunocompe- tent T cells, Cortisol was injected in milligram amounts into a first mouse. Its thymus cells were transfused into an X-irradiated mouse together with sheep erythrocytes. Plaque-forming cells in the spleen of the irradiated receptor were about 20 times more numerous than after the transfer of the same number of thymocytes from a normal mouse [106]. Cortisol is known to kill about 95% of the thymocytes [see 147]. The cortisol-resistant cells in the medulla are derivatives of the cortisol-sensitive cortical thymocytes. When applied on the surface of the thymus, 3 H-thymidine labeled first the cortical cells, characterized by high density of Th 1 marker on the surface, then later the lympho- cytes in the mid-cortex, and lastly those in the medulla, which are known to be cortisol resistant [533].

1.8 Subpopulations of T Cells

Antigenic differences seem to determine the function of the thymic cells. When leaving the thymus, different cells will sttle in the spleen and in the lymph nodes [456].

Research into antigenic markers may identify various subpopulations but of different significance:

1. Different stages in the maturation of T cells 2. Different types of mature T cells 3. Four successive stages can be distinguished.

1. Different stages in the maturation of T cells: a) The primitive (prethymic) lymphocyte located in the bone marrow.

Its surface is smooth (not villous [499]. (Both smooth and villous lym- phocytes were found in the spleen of nude mice as well.) It bears a weak Thy 1 [499] antigenic marker which is not dependent on the thymus (it was found in the spleen of nude mice [328, 435]) and in the bone marrow of thymectomized rats [262]. It is assumed that these cells are predetermined to migrate into the thymus when leaving the bone marrow. This seems to result from the observation of Nakao and co-workers [387]. Bone-marrow lymphocytes were separated by sedimentation. Those bearing a weak Thy 1 antigenic marker were

Page 129: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 127

thus separated from the so-called stem cells. Injected into irradiated mice these cells, and these only, repopulated the thymus. The stem cells did not. Yet fetal liver cells, i.e., B cells (refractory to anti-Thy 1 antiserum), injected into splenectomized irradiated mice, repopulated in the thymus, lost their antigenic B-cell markers and became sensitive to anti-Thy 1 serum [214].

b) The proper thymocyte, located within the thymus, bearing a high con- centration of Thy 1 antigen [e.g. 85,482].

c) The postthymic immature lymphocyte, still bearing a high density of Thy 1 antigen [482] and a low density of Ly 1, Ly 2, and Ly 3 anti- gens. They lose the TL antigenic marker when leaving the thymus [297]. All these cells are immunoincompetent . They acquire full immunocompetence at the periphery [482] or in contact with thymic epithelial cells [524].

d) The immunocompetent mature T cells. According to Stutrnan [482], mostly immature immunoincompetent lymphocytes leave the thymus. The few mature T cells within the thymus were said to remain (in grafted thymuses they were still of the donor type one year after the operation [4821 ). (For a review see [580, 5811 ).

2. Differences between mature T cells, related to their function: a) Helper T cells bear the Ly 1 antigenic marker, cytotoxic and suppres-

sor cells the Ly 2 and Ly 3 marker [84, 86]. b) Helper and cytotoxic cells can be separated by sedimentation on a

velocity gradient [513]. Suppressor and cytotoxic cells sedimented together and, since they are both Ly a- Ly 2÷, it is open to discussion whether they are different from each other. The fractionation by free- flow electrophoresis seemed to separate rather the immature port thymic precursors (small, sensitive to cortisol) from the mature T cells (larger, resistant to cortisol [ 1541 ). (For review see [205] ).

In short, the differentiation of the different lymphocytes involved in the immune response appear to be in some way predetermined and not haphazard (those that do happen to reach the thymus on their migration from the bone marrow and those that do not). Still, all these cells circu- late in the same blood, and the hormonal influences they are subjected to may have different consequences from one cell to another.

1.9 Role of the Thymus in Organization and Generation of Immune Response (H. Wekerle)

The thymic cortex is a reticular sponge of epithelium-derived cells, which form sparse intercellular contacts via desmosomes. The wide gaps between

Page 130: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

128 J. Comsa et al.

the reticular meshwork are densely filled with small to medium-sized lymphocytes, those, particularly close to the reticulum cells, which dis- play frequent mitotic activity. A possibly specialized epithelial cell of the thymic cortex, which might have a central part in T-cell maturation by engulfing certain lymphoid components, will be described below. Principally, the thymic cortex appears to be the location where most of the lymphoid proliferation occurs. Nevertheless, it is not fully clear why this proliferation occurs and what becomes of the cellular progeny which will not leave the thymus.

The thymic medulla is composed of more solid epithelium, which ultrastructurally is distinct from the cortical reticuloepithelial cells. It is still unclear which maturation processes occur in this region. These pro- cesses appear, however, to be relatively late in the T-cell developmental pathway, since here most of the T lymphocytes, already immunocompe- tent, appear to be concentrated. Treatment of mice with high doses of corticoids results in a fast involution of the thymuses, principally of the cortex. Whereas in the cortex practically all lymphoid cells are lost within hours, the fewer medullary thymocytes are mostly preserved. Immunological function tests reveal that the cortisone-resistant thymo- cytes are immunocompetent , being responsive in lectin-induced mito- genesis, in transplantation, and graft-vs-host reactions.

Generally, a pathway of lymphocyte migration can be observed in postnatal thymuses. Bone-marrow-derived, still incompetent pre-T cells invade the organs across the capsules. Having undergone the developmen- tal steps leading to clonal diversity and propagation, the immunocompe- tent T cells appear to selectively leave the thymus via the high endothelial postcapillary venules to peripheralize into the lymph nodes and the spleen.

1.9.1 Immunological Functions of T Lymphocytes

Removal of the thymus during embryonic or perinatal stages has grave effects on the morphology and the function of the immune system. Inde- pendently Miller and Good found that thymoprivic animals do not reject foreign tissue transplants. Moreover, removal of the thymus impairs the capacity of the immune system to mount humoral antibody responses of the IgG type and to establish immunological memory. Delayed-type hypersensitivity reactivity and cellular immune responses against viral or related diseases are equally impaired. The depriving effects of thymec- tomy may be strong enough to prevent orderly growth of developing infant animals. Generalized wasting disease may be the cause of chronic infections by various agents.

The impaired immune function corresponds to similarly grave changes in the lymphoid organ architecture. DeSousa et al. investigated the

Page 131: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 129

histology of lymphoid organs from thymectomized mice. They found that the reduction of the organ sizes results mainly from the loss of lym- phoid population of distinct fixed areas. The paracortical regions of the lymph nodes and the pericapillary cuffs of the spleeen were depleted. They are truly thymus-dependent areas, since restoration of the thymo- privic animals with transferred thymocytes also restores these areas. In contrast, other areas of the lymphoid organs, such as the primary follicles and the rims of germinal centers, are not affected by thymectomy, and are thus thymus-independent.

1.9.2 T Lyrnphocyte Differentia tion Markers

Thymus-dependent T lymphocytes are morphologically identical with the thymus-independent, bone-marrow-derived B lymphocytes. Both subgroups can, however, be distinguished by several typical markers on their surface membranes. B lymphocytes bear classic immunoglobulin on their membranes. In contrast, T cells lack surface immunoglobulins. In addition, Ig B cells, in most cases bear on their membranes not only Ig, but also receptors for Fc parts of extraneous immunoglobulins, and for C components. Most, but not all, of the T lymphocytes lack these receptors.

Positive T cell markers have been identified following allogeneic immuni- zation. The most prominent among them is the Thy-1 antigen, the ori- ginal 0 specificity. This antigen occurs in two allelic variants, Thy-1.1 characteristic for the AKR/J murine strain, and Thy-1.2 for most of the other strains. Thy-1 antigens are present during T-cell differentiation within the thymus as well as later on peripheral immunocompetent T cells. Moreover, it appears that low concentrations of Thy-1 are present on the membranes of pre-T cells, which have not been processed by the thymus. Except on T lineages, Thy-1 is found in brain tissue, and on certain myo- genic cell stages. In contrast to Thy-1 antigen, which is present on most sublines and differentiation stages of T cells, other T-cell markers are typical for limited stages or isolated functional sublines. Thus, they are true differentiation markers. Prime examples for intrathymic developing cells is the TL antigen system, which is not found on normal peripheral T cells, but on some thymus-dependent leukemias. Differentiation mar- kers of peripheral as well as thymic, functionally definable subsets include antigens of the Ly series. Characteristic combinations of Ly-1 and Ly-2.3 antigens, which are genetically unrelated, are found on various T-cell subsets, such as T helpers, T suppressors, T killer cells, and T cells involved in delayed-type hypersensitivity (vide infra). Finally, certain T-cell sub- lines carry on their surfaces components of the major histocompatibility gene complex (MHC) or of associated genes. These include the I4 sub- region products of the H-2 (the murine MHC system), which are found

Page 132: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

130 J. Comsa et al.

only on suppressor T cells; antigens of the Qa series, which have been recognized only recently, seem to appear only at various mature stages, indluding certain helper populations.

These alloantigenic markers concern only the murine immune system. Analogous antigens are being recognized, however, also in other mam- malian species, including man. This holds particularly true for the MHC- associated antigens and Thy-1 analogs. It should be mentioned, however, that human T cells exhibit an unique marker, namely receptors for un- treated sheep red blood cells (SRBC receptors), a property which has been highly instrumental in isolating peripheral human blood T and B lymphocytes.

1.9.3 Role of T Lymphocyte Sublines in the Organization of the Immune System

As already mentioned, B lymphocytes are the precursors of the effector cells in the humoral immune response, the plasma cells. The role of the T cells is by far more complex. They include not only precursors for thymus-dependent immune functions, such as killer cells in the graft- rejection response, or in the delayed-type hypersensitivity, but possibly more intriguing is that the T-cell sublines effect the regulation and dosage of immune responses, both on the cellular and on the humoral level. There are T-cell populations which help, or increase, the effector func- tion of either B cells or effector T cell precursors. On the other hand, other T-cell subsets, the suppressor T cells, counteract immune activation either by suppressing the activity of the effector cells directly, or more indirectly, by decreasing the activity of the helper cells required. Obvi- ously, helper and antagonistic suppressor cells are vital components of regulatory systems necessary for fine dosage and self-limitation of a given immune response, as will be discussed later.

Thus, the original concept of clonal selection theories, which imply that a given antigen selects a passively waiting, preexisting lymphocyte clone with complementary receptors, is not totally tenable. Rather, the immune system appears to be a most complicated cybernetic network with many cellular components necessary to elicit one given response and to cause its termination. Obviously, these cells have to communicate with each other. Cellular communications within the immune system can principally occur either via soluble mediators, or via direct cell contacts, supposedly involving complementary receptor/ligand interactions. Both types of interactions have been described in the case of T cells and their reaction partners. Perhaps the best characterized mediator factor is the one emitted by suppressor T cells. It has been shown by Tada and his col- leagues that suppressor T cells can be activated by antigen in a particular

Page 133: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 131

context to release factor(s) which can suppressively act upon effector lymphocytes. These factors are remarkable insofar as they possess regions complementary to the eliciting antigen. Thus they include genuine anti- gen receptors. Moreover, the structure of these antigen-binding regions in many respects resembles that of comparable antibodies. The suppressive factors do not express, however, constant protein regions of immuno- globulins. They rather express determinants of the MHC and, specifically, of the I-J subregion, which has already been mentioned as being typical of suppressor T cells. There are claims that helper cells release analogous factors also characterized by antigen-binding regions and determinants of (non I-J subregion) loci of the MHC. These helper factors, quite obvi- ously, would not suppress immune activation but would rather help its initiation and continuation.

In addition to the antigen-specific, T-cell products involved in the regulation of the immune response, numerous antigen-unspecific factors have been identified, which can modulate effector activity. Among them, there are the T-cell replacing factor described by Schimpl and Wecker, which is thought to act in relatively late differentiation phases of B cell activation. Other factors modulate in vitro mixed lymphocyte reactions and the in vitro generation of T killer cells, and others appear to promote growth of single T lymphocytes to clones.

Direct intercellular interactions are not as accessible as humoral inter- actions in terms of experimental investigations. There are, however, some stages of the ongoing immune response which undoubtedly depend on intercellular contact and recognition. The first stage of any immune reac- tion is recognition of the immunogen by the responding, complementary lymphocyte. A plethora of experimental data indicate that in the case of T cells mere binding of antigen to the complementary receptor regions is necessary (and this is true for many, if not all, T-cell sublines), however, it is by no means sufficient for recognition leading to T-cell activation and differentiation. The studies of Zinkernagel [587, 588] and Doherty, of Shearer, and of Rosenthal and associates showed that T cells have to recognize "their" antigen in the context of determinants of the self MHC. Thus, a virus-specific effector T cell would only recognize "its" virus when it is presented on a somatic cell of the same organism, thus posess- ing the same MHC antigens as the T cell. The same is basically true for the recognition of soluble or particulate antigen. Any antigen must be presented by an autologous cell, and this is done exclusively by the macro- phage or by its functional sublines. It is still unclear how the associative recognition of antigen plus self recognition is effected by the T cells. The following principles seem to be valid. T-cell recognition aimed at eliminat- ing a membrane-expressed (foreign) antigen, such as virus-infected cells, is associated with corecognition of the classical transplantation antigens

Page 134: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

132 J. Comsa et al.

(H-2K/D determinants in the mouse, HLA-A/B/C in humans). T-cell recognition, which leads to regulation and dosage of immune responses, in contrast, involves recognition of Ia determinants, which are equally coded for in the MHC, but which are predominantly expressed on lym- phoid cells and macrophages in the body.

The requirement of Ia antigen identity is also marked in reaction stages subsequent to antigen recognition. They may be the most impor- tant examples of contact interactions in the immune system. Ia antigen compatibility is apparently required for various stages of interactions between helper T cells and B cells as well as between suppressor cells and their respective targets, i.e., helper T cells and B cells.

1.9.4 Generation of Antigen Diversity in the Thymus

One of the most intriguing problems in cellular and molecular immunology is how the structural diversity of the antigen-complementary lymphocyte surface receptors is generated. For decennia, the core question was whether receptor diversity is precoded firmly in the genetic information ("germ-line hypothesis") or whether it is rather the result of somatic mutation. Recent experimental evidence, stemming from the work of Tonegawa et al., appears to favor a compromise. It appears now that most of the structural information of receptor amino acid sequences is, indeed, contained within the transmittable genetic information. It is, however, probably arranged in relatively small sequence fragments, which are somatically recombined to give rise to the structural diversity underlying the clonal complementarity.

It is not known how and where exactly the cellular events, basic to molecular diversification, are happening. In the case of T cells, it is very probable that generation of diversity occurs within the thymus. This may be particularly evident in generating MHC determinant corecognition by developing T cells. Jerne has postulated that incompetent lymphoid pre- cursors, which express receptors for self antigens, enter the thymus and start to interact there with their complementary "self" MHC determi- nants present in thymic stromal components. As a consequence, the primitive cells start to divide. In the course of proliferation, selective mutations were thought to alter the self-recognition, T-cell receptors to receptor structures complementary to some foreign structure. Indeed, Zinkernagel et al. reported of experiments which support part of this hypothesis. Their experiments suggest that the capacity of T cells to co- recognize self MHC determinants along with the foreign antigen struc- tures is acquired while in the thymus, probably following a selective inter- action with the thymic stroma. Wekerle and his colleagues very recently have found a new thymic reticular cell type, which could be involved in

Page 135: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 133

that particular stage. These cells, thymic nurse cells (TNCs), are of epi- thelial origin as indicated by their ultrastructure and have the capacity to be invaded by viable T lymphocytes [585, 586]. Invasion appears to be the consequence of (self) recognition. Subsequently, the incorporated cells start to divide within their nurse cell. When the engulfed lympho- cytes are completely surrounded by internal epithelial membranes, which have several specializations indicative of secretory activity, it is possible that the particular microenvironment may lead to guided differentiation. This could result either in receptor diversification or in ramifications of the specialized, functional T-cell subsets. Thymical hormonal factors could act particularly stringently in this environment. (In addition to receptor diversification, specialization into various functionally specialized T-lym- phocyte subsets is assumed to occur within the thymus. It should be noted that incompetent precursor cells enter the organ and that their immunocompetent progeny leave it finally as specialized subsets, as indi- cated by functional tests as well as by suface marker analyses.)

1.10 Substitutive Therapy for the Thymoprivic Condition

Restoration of normal reactions in thymectomized animals (and in nude mice) was attempted by several methods and demonstrated by several tests. These tests are not equally significant. The most convincing is the survival test in animals known to waste and die following thymectomy, such as mice, hamsters, and guinea pigs. Certainly, this is only a basic test, and its results must be rechecked with specific immunological tests. However, thymic preparations previously tested on the survival of thym- ectomized animals acquire thus an outstanding validity when compared to those not tested in this way. This distinction is always made below.

1.10.1 Thyrnic Grafts

Wasting was prevented in thymectomized mice by thymic grafts [ 134] and their immune functions were restored [134, 486]. These mice rejected skin allografts normally [314, 318, 361 ], and their reactivity towards sheep erythrocytes (plaque-forming cell test)was restored [7, 130, 314]. This experiment was repeated over and over again with similar results. Conversely, immunocompetence of spleen cells in thymectomized rats (0 previously) was restored following their perfusion through a thymus [80]. The accelerated development of benzopyrene-induced skin tumor in thymectomized mice was abolished by thymic grafts [358]. Thymic grafts were able to restore the immunocompetence of thymectomized animals when enclosed in diffusion chambers [7, 212, 448, 487, 549].

Page 136: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

134 J. Comsa et al.

Incubation of mouse thymocytes with thymic epithelium resutted in an enhancement of their activity in a mixed lymphocyte culture [379]. This was tested by numerous methods [7,320, 346].

Grafts of thymuses deprived of thymocytes (by previous X-irradiation or by previous incubation in vitro [e.g. 252, 521, 524] were similarly active. In nude mice, thymic grafts, enclosed in diffusion chambers, induced a decrease in the lymphocytes bearing a (weak) Thy-1 marker [435].

These experiments support the supposition of a hormonal influence of the thymus.

1.10.2 Transfusion of Thymic or T Cells

Wasting of thymectomized mice was prevented by transfer of thymocytes [e.g. 165,553]. These animals recovered normal immune potency. Similar results were obtained with transfer of spleen cells [e.g. 363,486]. In pre- puberal thymectomized and X-irradiated mice this technique was exten- sively used to restore immune functions [e.g. 363, 127]. The increased sensitivity to polyoma virus in thymectomized mice was suppressed by transfer of spleen cells [3131. Every study has reported that the results of this therapy are transitory, although the influence of thymic epithelial grafts lasts as long as the graft itself. If the effect of thymocytic transfer results from the influence of thymic hormones, this could indicate that thymocytes carry the hormone but do not produce it themselves.

1.10. 3 Cell-Free Thymic Preparations

The ideal way to at tempt substitutive therapy in thymectomized animals was to use the supernatant of thymic epithelial cell cultures. However, to obtain this compound in amounts sufficient to prevent wasting in dozens of thymectomized mice is wishful thinking. This technique was limited to miniaturized tests under cell-culture conditions.

A single injection of thymic culture supernatant accelerated the devel- opment of lymphatic organs in newborn mice [351 ].

The (weakly) Thy-1 spleen cells of nude mice acquired an increased reactivity in a mixed lymphocyte culture, when previously incubated on a monolayer culture of thymic epithelium [445]. The supernatant of thymic epithelial cultures, added to the incubation medium of spleen cells from nude mice gave them the capacity to differentiate into plaque- forming cells [307]. Mice were immunized against rat fibroblasts, thym- ectomized, and X-irradiated. Spleen cells from these mice, when injected into the hind paw of rats, induced only a very weak swelling of the popli- teal lymph nodes of the recipient. The swelling of the lymph nodes was significantly enhanced when the spleen cells were previously incubated

Page 137: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 135

with the supernatant of a monolayer culture of thymic epithelium. After incubation with the supernatant of thymus culture, spleen cells from nude or thymectomized mice induced a graft-vs-host reaction and a sen- sitivity to concanavaline A. This was not the case with spleen cells from intact normal mice [3 24, 356]. Thus, the supernatant of a thymus epithe- lial culture proved to exert a specific influence on lymphocytes. It acted inasmuch as it substituted for the thymus.

1.10.4 Thyrnic Extracts

The simplest cell-free preparation is the supernatant of homogenized thymic tissue washed by an appropriate solvent (water, saline etc.) and separated by centrifugation. The first preparations were tested for their stimulatory influence on lymphatic cell proliferation in newborn animals [242, 351] and in rats made leucopenic by irradiation [83]. Injected into intact mice, the supernatant of a thymus homogenate induced an increase in labeled thymidine and glycocoll uptake of the lymphocytes in the thymus, the lymph nodes, and the spleen. Immunological tests with simi- lar compounds are few. Supernatants of homogenized Sprague-Dawley rat thymus, injected into neonatally thymectomized Sprague-Dawleys bearing Wistar rat skin grafts, accelerated the rejection from 60 days (in untrated rats) to 12 days [81 ]. A crude aqueous extract from acetone- defatted calf thymus enhanced the antibody productions of irradiated rabbits [357]. A crude extract of rabbit thymus prolonged the survival and delayed the tumor development in thymectomized mice grafted with Lewis sarcoma [4631.

Experimental testing of crude organ preparations is rarely satisfactory. The action of these preparations is always the expression of a sum of the actions of several compounds. This sum may be algebraic: protein frac- tions isolated from the thymus were shown to inhibit lymphocytic pro- liferation [289] and various aspects of the immune response [87,381, 405]. A dialyzable, nonpeptidic (pronase-resistant) immunosuppressive fraction could be isolated from calf thymus by precipitations with mer- cury nitrate [560]. The description of several extraction and fractiona- tion methods made the use of crude thymic extracts very soon obsolete.

1.10.4.1 Purified Extracts Commonsense tells us that several truths must be emphasized from a biological point of view before discussing this topic.

1. An organ extract expected to contain a hormone is worth as much as the bioassay tests proposed for its activity. This truism is valid as long as the hormone is not obtained in a pure state and its composition is not known exactly.

Page 138: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

136 J. Comsa et al.

2. One test is no test. Several tests may be valid and yet in contradiction to each other. They may have different meanings.

3. There is only one way to distinguish a hormone from a specific cellular constituent. By definition a hormone is secreted. This can be demon- strated by two experiments:

a) The hormone (or its characteristic activity) is present in normal ani- mals in the corresponding gland and elsewhere.

b) Following extirpation of the gland, the hormone (or its activity) dis- appears entirely.

There are two sorts of biological tests: a) Global tests. The typical example is the survival test, if available (as

for the thymus in mice, hamsters, and guinea pigs). This, however, is only a first step, just demonstrating indubitably the existence of the hormone.

b) More elaborate tests which elucidate the mechanism of the hormone action considered. These tests attempt to define which functions are lost following, e.g., thymectomy, and which thymic extracts are able to restore these functions. These tests make much use of isolated organs or cells. It is obvious that these tests performed in vitro are more convincing if the cells used come from thymectomized animals.

1.10.4.2 Peptidic Extracts

Extracts Known to Ensure Survival of Thymectomized Animals: Thymosin (A.L. GoMstein and co-workers) Thymosin was obtained from a saline thymic extract by heating it to 80°C (precipitate discarded) and by successive precipitation with acetone and ammonium sulfate. Further purification was attained by successive chromatography on Sephadex, carboxymethyl cellulose, and diethyl- aminoethyl cellulose [222, 224, 258, 217,218]. A homogeneous peptide was thus obtained and its amino acid sequence determined [571]. Several consecutive reviews of this work were published [217, 218]. Of the thym- extomized mice injected neonatally with thymosin, 70% survived with no obvious disorders, whereas only 34% of the untreated mice survived. The dose injected was thus just below the optimal dose (which perhaps would restore the mice 100%). In these mice the blood lymphocyte count (decreased following thymectomy) was restored to (about) normal. Thymosin seems to exert a stimulatory growth influence on lymphocytes. It hastens the regeneration of lymphatic tissue following X-irradiation [220] or cortisol injections (in enormous amounts [450]).

Thymosin was injected into neonatally thymectomized C57 B 1 mice at 1 mg daily (a partially purified compound). Spleen cells from these mice were injected into newborn BALB mice in which they induced graft-vs-host

Page 139: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 137

reaction, whereas spleen cells from untreated thymectomized mice did not. Similar doses of spleen extracts injected were found to be inactive [315]. Since the spleen contains ten times less hormone than the thymus [ 121,329] , this dose was probably insufficient. Injected into thymecto- mized mice thymosin enhanced the proliferation of their spleen cells in mixed lymphocyte culture [423].

Thymectomized mice injected neonatally with thymosin normally rejected skin allografts [219,243]. They rejected normally, after a transi- tory growth, sarcomas induced by Moloney virus [ 558 ], whereas there was no rejection of those tumors in neonatally thymectomized untreated mice. Conversely, injections of an antithymosin antiserum induced a sig- nificant delay in allograft rejection [248] .In thymectomized mice injected with anti thymocyte serum thymosin had no effect on tumor aUograft rejection [4231.

The influence of thymosin on humoral immune response in thymecto- mized mice was less significant [219, 248, 483]. (Nevertheless, thymosin injections could not restore the ability of neonatally thymectomized mice to reject allografts or their spleen cells to induce a graft-vs-host reaction in newborn mice [4831.) In thymectomized, X-irradiated rats (900 rad) reconstituted with isologous bone-marrow thymosin injections had no influence on lymphatic tissue regeneration and antibody produc- tion [306]. We should recall that in irradiated guinea pigs the influence of thymic hormone tended toward zero [ 111 ].

In nude mice, thymosin injections induced an increase in the number of plaque-forming cells after an injection of sheep erythrocytes [63]. When incubated with thymosin, spleen cells of nude mice developed plaque-forming cells [ 11 ]. Incubation of bone-marrow lymphocytes with thymosin resulted in the appearance of antigenic markers specific for T cells on the spontaneous rosette-forming cells [30]. The enzyme termi- nal deoxynucleotidyl-transferase, characteristic for thymocytes, was induced in bown-marrow cells of thymectomized or nude mice [401].

In humans suffering from immune deficiency thymosin was largely used. The first case report (as far as we know) was that of a girl suffering from almost constant recurrence of infections constained for years with antibiotics. She was unable to develop positive cutaneous reactions after an infection (Candida sepsis) or vaccination (mumps) or to produce anti- bodies when challenged with various antigens. Spontaneous rosette-form- ing cells in her blood were significantly rare. All these abnormalities were suppressed by repeated thymosin injections [529]. Thymosin therapy for immunodeficient patients resulted in an improved general condition, an increased blood lymphocyte count, and in an increased number of rosette- forming cells [225,529] . In cancer patients similar results were obtained on lymphocyte count and the number of rosette-forming cells.

Page 140: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

138 J. Comsa et al.

"The clinical response must be considered anecdotical" [217, 447]. Incubation with thymosin induced the development of antigenic markers in human lymphocytes (from healthy subjects and one cancer patient [503]). Incubation with thymosin of circulating human lymphocytes resulted in an increase in the number of rosette-forming cells [528]. The same influence was found with fetal calf serum [82]. The authors con- sider this observation as (primary) evidence for the delivery of thymosin into the circulation. Still, serum of nude mice has shown the same influ- ence (T.D. Luckey, unpublished communication).

Thymosin Activity Tested In Vitro. Thymosin was added to the incuba- tion medium of lymphocytes. The cells, thus treated, were tested for their degree of differentiation and maturation. Incubation with thymosin induced the appearance of antigenic markers of thymocytes in mouse bone-marrow lymphocytes, in lymphocytes from nude mice or from 14-day-old fetuses [295]. The maturation of spleen cells from mouse fetuses and newborn mice was hastened (as demonstrated by their ability to induce graft-vs-host reaction and their behavior in mixed lymphocyte culture) by previous incubation with thymosin [ 108, 221 ]. Bone-marrow cells from newborn mice were incubated with thymosin and injected into thymectomized, X-irradiated mice together with normal bone-marrow cells. In the spleen of the recipients, normal numbers of plaque-forming cells were found, just as if they had received bone marrow and thymo- cytes [359]. In bone marrow incubated with thymosin, the number of cells killed by an (brain!) anti-Thy 1 antiserum increased [358, 503]. Lymphocytes from nude mice, from fetal mouse fiver or from bone mar- row differentiated into T cells as evidenced by specific antigenic markers, by their ability to ensure helper function and to form T-cell rosettes with sheep erythrocytes [451]. Thus, thymosine was proved to be active in thymectomized and in congenitally thymoprivic mice. This is demon- strated by the survival test and by a large range of immunological tests.

Extracts from a culture of thymic epithelial cell, prepared with the thymosin method, showed immunostimulant properties similar t-o those of thymosin [563]. But it must be said that the survival test was per- formed only once with a very crude preparation. The last steps of purifi- cation were only tested by the rosette test, and the reliability of these results may be questionable (Luckey and co-workers).

Thymic Hurnoral Factor ( Trainin and co-worker) Preparation [301,508, 506]. A centrifuged, thymic homogenate in 0.1 M phosphate buffer at pH 7.4 was fractionated by successive dialyses (dis- carding by the first molecules of 120 000 and by the second molecules of 6000). The second dialysate contained the hormone in purified form. Precipitation by ammonium sulfate was not carried out.

Page 141: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 139

Injections of the thymic humoral factor reduced the incidence of wasting in neonatally thymectomized mice to 20% (from 60% in untreated mice [ 510] ). This treatment prevented thymoprivic atrophy of lymphatic tissue and the decrease in the number of circulating lymphocytes. Thym- ectomized mice thus treated rejected skin allografts normally [507, 505].

The authors made much use of the in vitro graft-vs-host reaction test [22]. Spleen cells from neonatally thymectomized mice were found unable to induce the growth of an allogenic spleen fragment when added to the medium. This capacity was restored by repeated injections of thymic humoral factor [505]. Spleen cells from thymectomized mice acquired the graft-vs-host ability when incubated with thymic humoral factor [509]; such treatment also increased the survival rate of thymo- cytes when cortisol was added to the medium. Thymocytes incubated with thymic humoral factor induced the in vitro graft-vs-host reaction. In other words, they behaved like the few mature T cells present in the thymus, which are also resistant against cortisol [511]. This indicates that thymic humoral factor is involved in some way in the maturation process of thymocytes.

This supposition was substantiated by further experiments. Prepuberal mice were thymectomized, X-irradiated, restored with bone marrow, and injected with sheep erythrocytes. Spleen cells from these mice did not differentiate into plaque-forming cells, even when the mice received thymic humoral factor injections. The normal reaction was restored when the mice received injections of thymocytes together with the hor- mone, or thymocytes preincubated with the hormone [439]. Mice were injected with anti-lymphocyte serum. Spleen cells from these mice did not induce the in vitro graft-vs-host reaction, even when thymocytes were added. The reaction was restored when thymocytes and thymic humoral factor were added together [327]. Lymphocytes from thymec- tomized mice reacted poorly in mixed lymphocyte cultures. Normal reaction was restored when thymic humoral factor was added. The addi- tion of thymic humoral factor had no effect on lymphocytes from thym- ectomized, X-irradiated mice, unless thymocytes (inactive by themselves) were added together with the hormone. Thymic cells from a mouse, pre- viously injected with 5 mg of cortisol, enhanced the mixed lymphocyte reaction by themselves, but in this system thymic humoral factor had no additional influence [516]. This indicated:

1. That the target of thymic humoral factor as the immature thymocytes, in which it induces the maturation to T cells.

2. That the cells able to respond to thymic humoral factor are in some way predisposed to do so. (Could this explain the inactivity of the thymic hormone in irradiated animals mentioned above?)

Page 142: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

140 J. Comsa et al.

Mouse fetal liver lymphocytes, i.e., B cell precursors (only?), incubated with thymic humoral factor, induced the in vitro graft-vs-host reaction [2"13]. Yet, spleen cells from thymectomized mice preincubated with thymic humoral factor did not induce the in vitro graft-vs-host reaction [486], and thymic humoral factor did not induce transplantation immun- ity in nude mice [408; see also 579].

The mechanism for the action of thymic humoral factor is not known.

Homeostatic Thymic Hormone (Comsa and co-workers) Preparation [see 113], from a crude acidic extract (H~ SO4 M) fraction- ated successively by ammonium sulfate precipitation and isoelectric pre- cipitation in 60% alcohol solution (pH 7 for impurities, pH 6.2 for the active fraction) a homogeneous compound was obtained by successive chromatography on Sephadex and hydroxyapatite (elution with potas- sium phosphate buffer at pH 6.75 in a molarity gradient).

Wasting in thymectomized guinea pigs was prevented by using partially purified thymic extract and a purified fraction of this same extract [see 113]. It was a complete success, since all thymectomized guinea pigs thus treated survived in good condition, whereas only 60%-70% of neonatally thymectomized mice were preserved from wasting by administering thymosin or thymic humoral factor injections. Wasting after thymectomy is less frequent in guinea pigs (50%-60%) than in mice (70%, according to A. Goldstein and co-workers). In rats thymectomized at 30 days, injec- tions of homeostatic thymic hormone prevented the consequences of thymectomy on the endocrine glands and on lymphatic tissue [see 1131.

Circumstantial evidence was obtained to support the supposition that this hormone is secreted. It was found in the thymus, in the lymph nodes, and in the spleen or normal prepuberal rats, in the ratio 10:3:1 [124].

Three days after thymectomy, it disappeared from the lymph nodes and the spleen [121]. Its secretion is influenced by the adenohypophysis, the adrenal cortex, the thyroid, and the gonads (see Sect. 6.2).

Immunological tests performed with this compound are scarce. In infantile thymectomized guinea pigs, it restored the antibody production against HO Salmonella antigen [ 115]. In thymectomized and hypophys- ectomized rats it restored the influence of hypophyseal growth hormone on antibody production [125] and on allograft rejection [123]. The acceleration of allograft rejection, induced by corticotropin, was sup- pressed by a simultaneous injection of thymic hormone ("The thymic hormone is immunostimulant and immunosuppressive. It all depends on the hypophyseal hormone it has to face") [ 123].

Thymosin or homeostatic thymic hormone delayed the death of mice injected with a supernatant of Yersinia pestis culture [141]. This may indicate an immunostimulant influence, among others.

Page 143: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 141

With the allograft rejection test it could be seen that the thymic hor- mone is only needed for the primary reaction: Skin allografts were rejected by normal rats within 7.1 -+ 1.0 days and by thymectomized rats in 9.8 -+ 1.3 days. Second grafts implanted in those rats were rejected in 4.6 --- 0.5 and 4.4 --- 0.4 days, respectively.

The hormone of Bernardi and Comsa exerted a chemotactic influence on lymphocytes. However, it cannot be said on which one it was [ 125]. This has been presumed [349, 245, see review] with no direct evidence.

Considering the intricate interactions between the homeostatic thymic hormone and other hormones, this topic will be resumed below (see Sects. 2 -6) .

Thymic Polypeptidic Hormones Not Tested with the Survival Tests Thymopoietin ( G. GoMstein and co-workers) Preparation. An extract with 0.1 M ammonium carbonate was fraction- ated by heating to 70°C, dialyzed, and successive chromatographies on Sephadex and hydroxyapatite and polyacrylamide electrophoresis were carried out [228]. By this method two different homogeneous fractions were obtained, both active in GoMstein's test. Both peptides were ob- tained in a pure state and their amino acid sequence was determined [461].

The starting point of this work was the observation of an accelerated neuromuscular transmission in thymectomized animals, which can be prevented by thymic grafts [230]. Conversely, the neuromuscular chron- axy was found to be decreased in thymectomized rats [420]. From calf thymus, an extract could be prepared which, by repeated injections, induced a neuromuscular block in guinea pigs [226]. The neuromuscular disorder induced by this compound (named thymin, now called thymo- poietin) is described in detail in [231]. The guinea pigs served as a basis for bioassay using thymopoietin.

Culture of bone-marrow lymphocytes or of the B-cell fraction from mouse spleen lymphocytes with thymopoiet in added resulted in the appearance of TL and Thy 1 antigenic markers [42,296]. Spleen lympho- cytes from nude mice treated with thymopoiet in acquired the antigenic markers TL and Thy 1 and developed a helper influence toward B cells, as shown by the plaque-forming test [450]. In the B-cell fraction of mouse spleen lymphocytes, the addition of thymopoiet in to the medium induced the appearance of TL antigenic marker [43]. The cells contain- ing terminal deoxynucleotidyl-transferase from mouse bone marrow are lysed by anti-Thy 1 antiserum after pretreatment with thymopoiet in (in other words, they differentiated into prothymocytes [232]). In a one- way mixed mouse lymphocyte culture, thymopoiet in induced an increase in the cyclic AMP content [488]. In thymocyte precursors thymopoietin,

Page 144: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

142 J. Comsa et al.

added to the medium, induced the appearance of antigenic markers specific for T cells (TL, Ly 1, Ly 2, Ly 3, Ly 5).

But thymopoietin was unable to restore the normal reaction to PHA 0.2 concanavalin A of lymphocytes from thymectomized mice [574].

Serum Thymic Factor (Bach and co-workers) The compound was isolated from blood serum by two dialyses (active fraction is dialyzed in the first step and retained in the second) the suc- cessive chromatographies on Sephadex and carboxymethyl cellulose, thin-layer chromatography, and high-voltage electrophoresis were carried out [32]. The composition of the serum thymic factor was determined [ 129, 417]. (For an extensive review see [27] ).

Bioassay of this compound is performed by the azathioprine test. Aza- thioprine, added to the medium, killed few of the spontaneous rosette- forming cells from mouse bone marrow but killed significantly more rosette-forming cells from bone-marrow cells preincubated with thymo- sin [30]. This test was further developed [33].

According to the following descriptions, azathioprine was added to the medium:

At 1 ug/ml it totally suppresses rosette-forming cells from the thymus and up to 20% from the spleen.

At 50/~g/ml it suppresses 70% from the lymph nodes. At 100 ug/ml it suppresses up to 20% only from the spleen of thymecto-

mized mice.

Mice were thymectomized or injected with anti-Thy 1 antiserum. The rosette-forming cells did not decrease in number. However, the azathio- prine-sensitive cells decreased and the azathioprine-resistant cells increased. Incubation of these cells with thymosin or normal mouse serum resulted in an increase in the number of azathioprine-sensitive cells. Serum from thymectomized or from nude mice did not have this effect [26].

Thus, the highly azathioprine-sensitive, rosette-forming cells were pre- sumed to be of thymic origin. Spontaneous rosette-forming cells from bone marrow are insensitive to anti-Thy 1 antiserum. Preincubation with normal mouse serum resulted in the appearance of spontaneous rosette- forming cells sensitive to anti-Thy 1 antiserum in bone-marrow cells from normal, thymeectomized, or nude mice. Nude mouse serum did not have this influence. This potency of normal mouse serum decreased by half within 150 min following thymectomy, remained constant at this de- creased level for 1 week, and began slowly decreasing again later on [28]. The serum thymic factor was found in human serum. Its level is high in children and decreases with age. It decreased to zero in a patient thym- ectomized for myasthenia gravis [33].

Page 145: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 143

The serum thymic factor is prepared from pig serum (the serum thymic factor content decreased in the serum following thymectomy in pigs [309]. Serum thymic factor, added to the medium, increased the resis- tance of thymocytes against cortisol (circumstantial evidence of their maturation). It induced the appearance of specific T-cell antigenic mar- kers and an increase in cyclic AMP content in these cells [21 ]. In normal mice, one single injection of serum thymic factor increased about 5 - 8 times the number of rosette-forming spleen cells [561].

The validity of induction of antigenic markers, characteristic o fT cells, as a test for thymic hormone action cells was questioned. Thus differen- tiated, they did not necessarily show T-cell properties in other tests, such as helper function or graft-vs-host reaction. Only thymopoietin, thymo- sine, and thymic humoral factor were found to be able to induce in vitro a total T-cell maturation [479]. Furthermore, serum thymic factor injec- tions in thymectomized mice did not restore the normal reaction of their lymphocytes to phytohemagglutinin and to concanavalin A [574].

A demonstration of thymic origin of the serum thymic factor was at tempted [33]. Grafts of thymic epithelium (thymomas or thymic grafts borne 8 days previously by a first recipient, in which thymocytes are known to be dead), enclosed in millipore chambers, were implanted into neonatally thymectomized mice. In the spleen of these mice the azathio- prine-sensitive, rosette-forming cells increased in number. This proves that thymic epithelium exerts its influence through a millipore membrane. Nevertheless, some doubts arose as to whether serum thymic factors are secreted by the thymus. A thymic extract was prepared from calf thy- mus using Bach's method. This extract did not induce the development ofT-cell rosettes when injected into nude mice. On the other hand, serum thymic factor activity was found in similar calf thymus extracts when this factor was added to the thymus homogenate before the extraction. Thus, the extraction did not destroy the serum thymic factor presumably contained in the thymus [2841. This observation rejects by no means the idea that the thymus is involved in the production of serum thymic fac- tor. Its site of production remains, however, to be found.

Lymphocyte Stimulating Hormone (Luckey and co-workers) A saline thymic extract was precipitated with 20% ammonium sulfate. The precipitate was dissolved in water and precipitated with methanol. The redissolved precipitate was fractionated by successive chromato- graphy on diethylaminoethyl cellulose and Sephadex. It was proved homogeneous by polyacrylamide electrophoresis [329,434].

The original bioassay test for monitoring the extraction and purifica- tion is based essentially on the acceleration of the development of the lympho nodes in newborn mice [351]. The influence of this compound

Page 146: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

144 J. Comsa et al.

on the immune response was demonstrated. Injected into new-born mice, the fraction known to induce the accelerated lymph node maturation induced also the increase in the number of plaque-forming cells against sheep erythrocytes in the spleen of unimmunized newborn mice (back- ground plaque-forming cells) and of newborn mice injected with sheep erythrocytes [91, 247, 434]. From the impurities discarded by electro- phoresis, a fraction was identified which antagonized the lymphocyte- stimulating factor.

Lymphocyte-stimulating activity was found in calf spleen extracts pre- pared and fractionated by Luckey's method (about six times less than that from calf thymus). This may be correlated with the observations of Comsa and co-workers [ 124, 121] who found a roughly similar relation in the rat thymus and spleen content of homoeostatic thymic hormone.

Thymus Polypeptide Fraction (Milcu and Potop) The preparation is described in [334]. It is a crude extract, and although not tested with the survival test, it was proved active in thymectomized rats with an impressive number of metabolic tests [356]. Its influence on the immune response was demonstrated by the observation of an increased antibody production in hamsters injected with influenza virus and in X-irradiated rabbits injected with HO Salmonella antigen. As far as we know, the influence on immune response has not been tested in thymec- tomized animals.

This extract was shown to delay the development of malignant tumors induced by carcinogens (such as methylcholanthrene or dimethylamino- azobenzene) or grafts (Guerin's tumor) in rats. This was also observed in cultures from a cancer derived from buccal epitheliums (KB tumor) [356]. It was also alluded to above that there is a delayed influence of the thymus on cancer development and an acceleration of cancer devel- opment in thymectomized animals. This has generally been interpreted as a thymic influence on cancer immunity. The observations made on cancer cultures hardly fit into this hypothesis.

1.10.4.3 Lipidic Extracts The first attempt to prevent the consequences of thymectomy in guinea pigs with a lipidic thymic extract was mede by Bomskov and co-workers [see 113]. It was a total failure.

Isakovic and co-workers [270] extracted calf thymus with chloroform and methanol. The extract, suspended in saline, was injected into neo- natally thymectomized rats. This treatment prevented the delay in growth and the decrease in lymphocyte count following thymectomy. Rats, thus treated, were immunized against bovine serum albumin at 60 days, and the delayed hypersensitivity test was performed 18 days later. The reaction

Page 147: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 145

decreased in untreated thymectomized rats and was normal in those injected with the extract.

The Thymosterines (Potop and Milcu) Calf thymus was extracted with acetone and the residue was extracted with ether. Phospholipids were discarded by cold acetone from the dried etheric extract. The residue was fractionated by successive chromatogra- phies [see 421 for details].

First fractionation separated two fractions: III B stimulating and IIB inhibiting tumor development. By several chromatographies of I I B a steroidic fraction was obtained (fraction S) strongly inhibiting tumor development. This fraction was named Thymosterin. Fraction S inhibited in vitro the development of KB tumor and human thyroid cancer cul- tures. In vivo, it delayed the growth of carcinogen-induced and grafted tumors, such as Jensen's, Walker's, and Ehrlich's sarcoma and Gu+rin's adenocarcinoma. Tumor grafts in thymosterin-injected rats showed signs of regression, such as necrosis and fibrosis. Walker sarcoma grafts decreased in size in thymosterin-injected rats, and these rats survived without exception when all untreated tumor-graft rats were dead.

The influence of this extract on immune response was tested on mice injected with sheep erythrocytes. Hemolysin titers and plaque-forming cell development were significantly increased in mice injected with the partially purified fraction I IB . Thus, the influence of thymosterin on tumor development in vivo can be understood as expressing the stimula- tion of immune functions. The influence of thymosterin on tumor devel- opment in vitro cannot. The immunostimulant action and the retardant action on tumor cultures are certainly two different phenomena. Since the immunostimulant effect was demonstrated with the partially purified fraction B (and, as far as we know, not with the presumably pure thymo- sterin), it is open to discussion whehter these two actions express the activity of the same chemical entity.

2 The Adrenal Cortex

Adrenalectomized and normal rabbits were injected with typhoid vaccine. The adrenalectomized animals produced three times more antibodies [267]. Normal and adrenalectomized rats were injected with sheep eryth- rocytes. Lymphocytes from their lymph nodes and spleen were incubated and the hemolysin released into the medium was determined. It was lower in adrenalectomized rats [433]. Thus from the very start the obser- vation appeared controversial.

Page 148: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

146 J. Comsa et al.

Adrenalectomy was said either to result in an accelerated rejection of skin allografts in mice [e.g. 90, 319, 353] or to show no influence [48, 351]. Still, these observations raise some doubt. The adrenalectomized mice were "protected" from the consequences of adrenalectomy on elec- trolyte metabolism by repeated injections of desoxycorticosterone in large amounts (1-2 .5 mg once a week, as microcrystalline suspensions). This is a very important source of error. Strictly speaking, the authors never saw a truly adrenoprivic mouse. Allograft rejection was slightly accelerated in adrenalectomized mice protected just by NaC1 added to the drinking water [89, 90, 238].

In Sprague-Dawley rats grafted with DA rat skin (a H 1 incompatibil- ity) adrenalectomy resulted in a slight delay in skin allograft rejection from 7.1 -+ 1.3 days in normal rats to 12.2- 1.5 days in adrenalectomized animals. Additional thymectomy was followed by an additional delay (to 15.9 -+ 1.6 days). In Sprague-Dawley rats grafted with DB rat skin, adrenalectomy had no influence on the graft rejection [48].

Most of the experiments on the influence of the adrenal cortex on the immune response were performed on normal animals injected with large doses of corticosteroids (see [576] for a recent review).

The earliest experiments, performed with adrenocortical extracts of an unknown composition, showed that repeated injections of these extracts, together with, before or immediately after the injection of an antigen into normal rabbits [96, 195, 18] enhanced antibody production. This was explained as a result of the well-known deleterious influence of adrenocortical hormones on lymphocytes [147]. The increased amounts of antibodies in the serum were supposed to be a result of their release from the lysed lymphocytes. This explanation is not exhaustive. The lysis of lymphocytes takes place within hours after corticoid injection, whereas the increase in the antibody level in the serum is gradual, occur- ring over several weeks [96]. In addition, the mature, differentiated lym- phocytes, participating in the immune response, are not lysed by corti- coids [e.g. 106, 107]. Cortisone or cortisol injections in milligram amounts, before or together with the antigen but not afterward [166], were shown to result in a decreased production of antibodies [e.g. 52, 53, 61, 143, 153, 179, 190 ,200 ,203 ,250 , 2 5 3 , 3 3 5 , 3 4 1 , 3 5 2 , 373].

In mice, injection of 2.5 mg cortisol resulted in a decrease of in vitro spontaneous killer activity of their spleen cells [257]. In mice, IgM and IgG hemolysin production is totally suppressed when cortisone is given 4 days previous to the antigen (sheep erythrocytes). Administered after the antigen, cortisone injection results in suppression of IgG antibodies only [ 168]. In previously immunized rabbits, a single cortisone injection suppressed the secondary response [ 191 ]. Sheep erythrocytes are lysed with a significant delay by macrophages of rabbits injected with cortisone

Page 149: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 147

[280]. In frogs, cortisone injections were followed by an increased anti- body production [60].

In all these experiments cortisone or cortisol was administred in large, arbitratily chosen, doses. A quantitative relation between the injected corticoid and the injected antigen dose could be roughly demonstrated: in rats, cortisone injections (4 mg) suppressed the anti-sheep-erythrocyte antibody production. This could be restored if the antigen dose was increased a 1000-fold [54]. In mice, the production of hemolytic anti- bodies against sheep erythrocytes was totally suppressed by an injection of 5 mg corticosterone, whereas 1.0 mg or 2.5 mg were followed by a partial suppresion only. Desoxycorticosterone was found to be inactive [389]. In rats, single injections of 5 mg desoxycorticosterone were fol- lowed by an enhanced antibody production [97].

Allograft rejection was delayed by cortisone injections in rabbits [58], guinea pigs [476], and rhesus monkeys [305]. Desoxycorticosterone was inactive [305]. Aldosterone injections also delayed the allograft rejection in rats but so did spironolactone [48]. Metopyrone inhibited the in vivo graft-vs-host reaction [1]. Thus, corticoids and corticoid antagonists showed similar effects. The development of grafted [5, 374] or virus- induced [3451 tumors was accelerated by cortisone injections.

In all these experiments, steroids were administered in milligram amounts to intact animals. These observations were not entirely con- firmed in doses closer to normal conditions. Adrenalectomized or adrenal- ectomized and thymectomized Sprague-Dawley rats were grafted with DA rat skin. They were implanted with pellets of aldosterone, cortico- sterone, desoxycorticosterone or cortisol, alone or in combination. They resorbed daily 1 /ag of aldosterone or 130/~g of the other steroids. Those are mounts just sufficient to ensure survival. In these animals:

Adrenalectomy was followed by a slight delay in the allograft rejection (from 7.1 -+ 1.3 to 12.2 -+ 1.6 days).

Additional thymectomy was followed by an additional delay (15.8-+ 1.3 days).

Implants of aldosterone, corticosterone or desoxycorticosterone partially suppressed this delay (8 .5-10.0 days) in both adfenalectomized and adreno-thymectomized animals.

Implants of two steroids reestablished at least the normal rejection period (6 .7-7 .0 days). A third implant had no additional influence.

Cortisol implants were by themselves inactive, but additional cortisol implants delayed the rejections in animals implanted with one or several of the other steroids [ 120].

There was no difference between the corticoid effect in adrenalec- tomized and adreno-thymectomized rats. Furthermore, in adreno-thym-

Page 150: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

148 J. Comsa et al.

ectomized rats injected daily with the Bernardi-Cornsa thymic hormone preparations, this additional t reatment had no influence on the allograft rejection [ 117]. As soon as corticoids were administered, the influence of the thymus disappeared.

From this experiment we can identify under physiological conditions: (a) three immunostimulant corticosteroids (aldosterone, corticosterone, and desoxy.corticosterone) and (b) a minor immunosuppressive steroid, cortisol (this is not exactly under physiological conditions, since rats do not produce cortisol).

This conclusion is oversimplified. Under adequate conditions all corti- costeroids known thus far have shown an immunostimulant effect.

Rabbits were immunized against bovine serum albumin or diphtheria toxoid, and 4 0 - 1 0 0 days later their lymphocytes were incubated with sheep erythrocytes coated with the same antigens. These erythrocytes were lyzed if the medium contained at least 1 ng/ml and less than 0.1 gg/ ml cortisol [ 10]. Without added cortisol, the hemolysis occurred only if the incubation medium contained 25% fetal calf serum.In higher concen- trations cortisol added to the medium suppressed antibody production in vitro [109], [e.g. 380], cortisone (70 #g/ml was ineffective on the in vitro antibody production of immunized lymphocytes [ 179]. It should be noted that metopyrone injections inhibited the graft-vs-host reaction in rats [ 1]. In conclusion, the dose-response curves of corticoids on the immune response appear to be bell shaped.

Cortisol acts as an immunostimulant at 1 ng/ml of medium and as an immunosuppressive at 0.1 #g/lnl [ 10].

Aldosterone acts as an immunostimulant at 1/~g/day [ 117], as a partially immunosuppressive at 1 rag/day, and as a totally immunosuppressive at 5 mg/day [389].

Desoxycorticosterone still acts as an immunostimulant at 5 mg/day [97].

The immunosuppressive dose range is unknown. Perhaps it exists since desoxycorticosterone was prophlogistic at milligram doses and antiphlogis- tic at 25 mg/day [432]. This is, of course, a rough estimate. The results may differ within enormous limits according to the test used. For instance, cortisol was found to be immunostimulant on incubated human B cells when added in such enormous concentrations as 10 s [567].

Stress was generally followed by a depression of the immune response. This was obtained by overcrowding [473, 518], by training to avoid elec- troshock announced by a light-signal [473, 547], by adaptation to high altitues [77], by ether anesthesia [207] or by short exposure to a temper- ature of 37°C [416]. In fact, the observations are not easy to interpret. During the general adaptation syndrome, distinguishable stages should be considered: (a) the alarm stage, lasting several hours, and characterized

Page 151: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 149

by a relative adrenocortical insufficiency; (b) the resistance stage, lasting for weeks, characterized by an enhanced corticoid production and by symptoms of hyperadrenocorticism and (c) the terminal exhaustion stage, characterized by adrenal deficiency. Thus, the effects of stress are certainly different in terms of duration. Examination of the adrenals is a necessary complement to those experiments. It was performed by Gisler [207] who found an approximately twofold increase in the plasma corti- costerone level in mice following ether anesthesia. A detailed dose- response curve of corticosterone on immune response would be useful. The experiments quoted above simply indicate the possibility of plotting this curve. It is generally believed that corticosteroids inhibit the immune response inasmuch as they kill cells [e.g. 147, 150]. Which cells are killed? Adrenalectomy is followed by thymic hypertrophy, but the hormone content of this big thymus decreases [ 124, 137].

Administered in large amounts, cortisol induces a wave of pyknoses in the thymus and to a lesser extent in the lymph nodes [see 147]. Small lymphocytes were primarily killed by this method [ 182, 151 ]. Added to the medium, cortisol (0.01 /~g/ml) or corticosterone (0.1 ~g/ml) shor- tened the survival time of lymphocytes [291,462, 519]. At 2.0/~g/ml cortisol killed the small lymphocytes from embryonic mouse thymus. At 50 ug/ml it killed all cells [430]. The surviving cells show an increased helper potency [106] and an increased potency to induce the graft-vs- host reaction [65, 107]. Following a single injection of 2 mg of cortisol the spontaneous Thy 1 positive, rosette-forming cells did not decrease in number, while total lymphocyte count decreased by 90% [33]. In con- clusion, cortisol killed the immature cells only. This observation was con- firmed over and over again.

Cortisol appeared to kill other cells, besides the small (immature) thy- mic lymphocytes. In mice injected with 15 mg of cortisol, the mono- nuclear cells disappeared from the blood [497]. Three hundred micro- grams of cortisone/g body wt. were injected into mice. Spleen cells from these mice did not differentiate into cytotoxic cells when incubated with allogenic spleen cells, however, they developed helper cell function. It was concluded that another member of the cell-to-cell interaction was killed [316]. Speculatively this cell was identified as the macrophage. Spleen cells from mice, stressed by ether anesthesia, produced few plaque-forming cells with sheep erythrocytes. Addition of syngeneic T cells did not result in any increase in their number, whereas a significant increase in plaque-forming cells was observed following the addition of syngeneic B cells and macrophages. In conclusion, stress results in damaging B cells and macrophages, but not T cells [207]. It remains open to discussion as to how stress resulted in this effect. It should be noted that at weak con- centrations (10- 8) cortisol induced an increased proliferative activity

Page 152: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

150 J. Comsa et al.

in incubated lymphocytes [430, 539]. Dose response curves of these cor- ticoid influences are much needed. From these observations, it is not possible to understand the immunostimulant influences of corticoids administered in small amounts. Concerning this peculiar aspect of this phenomenon, we only know that the rejection of a second skin allograft is not influenced by adrenalectomy in rats which had already rejected a similar first graft:

Rejection time (days) First Graft Second Graft

Normal rats 7.1 -+ 1.3 4.3 + 0.5 Adrenalectomized 12.2 +- 1.5 4.4 -+ 0.5 Adrenalectomized and thymectomized 15.9 -+ 1.6 4.6 +- 0.5

Thus, the immunostimulant effect of the adrenal cortex appears to express an influence of corticosteroids on the differentiation of immuno- competent cells. As soon as this occurs, corticoids are no longer neces- sary. The influence of corticoids and of thymic hormones seems to be exerted on the same stage of the immune response.

3 The Thyroid

To our knowledge, the first observation concerning the role of the thyroid in immune response was made by Houssay and Sordelli [260]. Thyroid- ectomized rabbits and horses were injected with sheep erythrocytes, typhoid vaccine or tetanus or diphteria toxoid. They produced less anti- toxins than intact ones, whereas the agglutinin and hemolysin titers of their serum were equal to those of intact animals.

Rats were thyroidectomized at birth. They were injected with sheep erythrocytes at the age of 2 months. Plaque-forming cells in their spleen decreased in comparison with intact rats. Daily thyroxine injection (10 micrograms/animal, the reason for this dose is not explained) restored the normal reaction [ 173].

Humans were injected with sheep erythrocytes or antigens of Shigella flexneri, Salmonella typhi or Escherichia coli. The antibody production was higher in Graves' disease patients and lower in hypothyroid patients than in healthy subject [501].

Guinea pigs were inoculated with tuberculosis bacilli and injected with a lethal dose of tuberculin. In intact animals this induced a rise in body temperature, but in thyroidectomized animals it did not. Serum from tuberculosis-injected guinea pigs was injected into normal animals to- gether with tuberculin. The temperature of recipients rose if the serum donor were intact, but not if the donor were thyroidectomized [288].

Page 153: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 151

One-month-old male Sprague-Dawley rats received DA skin grafts. The recipients were thyroidectomized, thyroidectomized and thymectomized, thyroidectomized and adrenalectomized or subjected to all three opera- tions. Thyroidectomy by itself delayed graft rejection (7.1 -+ 1.1 days - 9.7 -+ 1.3 days). In thymectomized, adrenalectomized and thymo-adrenal- ectomized rats the rejection (delayed already by these operations) was not further delayed by thyroidectomy. Daily thyroxine injections (5 ~g/ 100 g, the dosage known to be sufficient to prevent thiouracil goiter) restored the normal rejection in thyroidectomized rats, but had no influ- ence on thymectomized, adrenalectomized or thymo-adrenalectomized [ 118]. Thus, at least in the peculiar case of graft immunity:

1. The immune response is depressed by thyroidectomy and restored to normal by thyroxine in thyroidectomized animals.

2. Neither thyroidectomy nor thyroxine influences the immune re- sponse in the absence of the thymus or the adrenals.

The influence of the thyroid on the immune response appears to be mediated by the thymus and the adrenal. (Both thymus and adrenal are atrophic following thyroidectomy, see Sect. 6.2.2-6.2.4.)

4 The Gonads

Female mice are better humoral immune responders than males [e.g. 46, 215, 477]. F (C 57bl × BALB) mice were injected with erythrocytes from BPS mice. Their serum was fractionated in order to separate 7S and 19S antibodies. In males hemagglutinins were present in the 19S fraction only, whereas in females both fractions contained hemagglutinin [45].

Skin allograft rejection was faster in females than in males [90, 238, 472]. Castration was followed by an accelerated allograft rejection in males, less so in females [90, 238, 472]. Syngeneic grafts of ovaries in males and of testes in females had no significant influence on allograft rejection [90, 238, 4721. Testosterone injections (650 ~g three times weekly) delayed the rejection in castrates [89]. In rats similar results were observed [ 119], the production of hemagglutinins against allogeneic mouse erythrocytes increased in castrates but hemagglutinin production against sheep erythrocytes decreased. Estradiol injections in male mice were followed by an increased antibody production (e.g. 2.5 ug daily [ 287], 10/~g [477] ). Allograft rejection was delayed following estradiol injection (50/~g three times weekly) in X-irradiated mice reconstituted with syngeneic bone marrow [496]. The development of adjuvant arthri- tis (by injection of Freund's adjuvant) or autoimmune thyroiditis (by injection of thyreoglobulin) was delayed in female rats by daily injections

Page 154: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

152 J. Comsa et al.

of 0.5 mg estradiol and in males by daily injections of 0.5 mg testosterone [279]. In F (C 57bl × BALB) mice injected with BP8 erythrocytes, hem- agglutinin production was increased in castrates and was depressed in castrates bearing estradiol implants (the daily resorption rate was not determined [45]). Skin allograft rejection was delayed by estradiol injec- tion (500 ~g daily) in rabbits bearing a corneal graft from the skin donor strain [583]. Thus, the enhancement of immune response by estradiol was not generally confirmend.

Thymectomized male rats were injected with estradiol (200 #g daily for 16 days). Their serum was added to the incubation medium of human lymphocytes. These ceils produced less rosettes with sheep erythrocytes than those incubated with normal rat serum [578].

Castrated Sprague-Dawley rats (males and females) rejected DA skin allografts in 5 -6 days (intact animals in 7.1 -+ 1.0 days). Implants of estradiol in females (daily resorption rate 0.4 ~g) and of testosterone in males (daily resorption rate 40 /~g) restored the normal rejection. In thymectomized castrates of both sexes, the grafts were rejected as in thymectomized rats (9.8 - 1.6 days) and sex hormone implants were of no influence. In thymectomized castrates daily injections of the Bernardi- Cornsa thymic hormone preparation (100/~g) was followed by rejection within normal time limits, whereas the same injections were of no influ- ence on those castrated alone. Thus, in this experiment the influence of the gonads on allograft rejection appeared to express the influence of the gonads on the thymus [ 119]. Receptors for estradiol were demonstrated on the surface [577] and in the cytosol [568] of thymocytes.

Female thymectomized CBA mice were mated with T6 T6 males. They rejected T6 T6 skin grafts in normal time limits. This is not due to sex hormones. Pseudopregnancy had no similar effect. The extirpation of the fetuses on the 10th day of pregnancy (placenta left in place) resulted in a significant delay in the graft rejection which can only be explained by the passage of hormones from the fetus to the mother [and not by pas- sage of cells from the F (CBA X T6 T6) fetus] [394]. In female nude mice mated with CBA males the pregnancy did not enhance the immune response against sheep erythro cytes [ 570].

Progesterone injections had no effect on skin allograft rejection in nor- mal mice and rabbits [e.g. 351]. In spayed female rats bearing implants of progesterone (they resorbed 400 ug daily of the steroid), skin allo- grafts were rejected in 9.3 +- 0.9 days, whereas spayed controls did so in 5.8 -+ 1.0 days. In spayed females bearing similar progesterone implants associated with estradiol implants (they resorbed daily 0.4 #g of the latter), skin allografts were rejected within 7.6 -+ 1.1 days. In other words, these rats reacted like normal females (rejection within 7.1 -+ 0.8 days) and not like castrates. Estradiol + progesterone -- 1:1000 is the well-known

Page 155: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 153

ratio of these hormones which induces a pseudopregnancy in spayed females. Administration of estradiol and progesterone under these condi- tions was thus observed to suppress the consequences of ovariectomy on the immune response as well [119]. Spleen cells of pregnant mice showed a decreased activity in mixed lymphocyte culture but an increased plaque- forming cell activity. These modifications could be reproduced with injections of human chorionic gonadotropin but not of progesterone.

Osoba observed that [3941 (see above):

1. Pregnant thymectomized mice reject skin grafts like normal animals. 2. Extirpation of the fetuses but not of the placentas results in a signifi-

cant delay in rejection. 3. Pseudopregnancy has no similar consequences.

These observations seem to exclude the influence of the corpus lute- urn and to emphasize the influence of the placenta on the immune response. An immunostimulant influence seems to emanate from the fetus (perhaps from its thymus). These observations allude to the contro- versial problem of the mother-fetus tolerance. Mating between animals histoincompatible to each other results in a normal pregnancy and the offspring are reared normally. Immunosuppressive influences seem, there- fore, to be active during pregnancy. Experimental analysis of this phe- nomenon is scarce. The attempts to reproduce the influence of pregnancy with hormone injections were not always performed under valid condi- tions, that is:

In castrated animals Parallel experiments with injections of progesterone alone and with pro-

gesterone associated with estradiol in the well-known ratio of 1000: 1, which induces the pseudopregnancy reaction in the gonaducts of ovar- ectomized animals.

According to Osoba an immunostimulant influence seems to emanate from the fetus itself and the placenta seems to exert an inhibitory influ- ence. In fact, the role of the placenta is a matter for future research. The placenta is a plurivalent endocrine gland. The list of the hormones pro- duced by the placenta is not yet complete, but an immunosuppressive influence may emanate from estriol, which the placenta produces in large amounts.

5 The Adenohypophysis

The description of the consequences of hypophysectomy on the immune response are divergent from one author to another. Hypophysectomized mice were injected with sheep erythrocytes but few plaque-forming cells

Page 156: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

154 J. Comsa et al.

developed in their spleen. The normal reaction was restored by injections of growth hormone or corticotropin [209, 210]. Plaque-forming cells and serum agglutinin titers were significantly low in hypophysectomized rats injected with sheep erythrocytes [397]. Hypophysectomized Sprague- Dawley rats grafted with DA rat skin rejected those grafts with a signifi- cant delay [123]. Hypophysectomized Wistar-Furth rats produced fewer antibodies against sheep erythrocytes and rejected skin allografts later than normal rats [575]. Divergent observations were registered too. Hypophysectomized rats reacted normally to sheep erythrocyte injec- tions [ 159,277]. We cannot explain these divergencies.

The consequences of hypophysectomy on immune response were revealed only after a subsequent X-irradiation [502]. In these animals, both skin allograft rejection and hemagglutinin production after sheep erythrocyte injection were significantly depressed [277].

The observations on immune response in Snell-Bagg dwarf mice were explained. These mice are dwarves inasmuch as they suffer from a severe adenohypophyseal deficiency (see Sect. 6.2.2). Dwarf mice are severely immunodeficient. Following sheep erythrocyte injection they develop significantly few plaque-forming cells in the spleen [36, 37, 277]. Serum agglutinin titers were low after sheep erythrocyte or Brucella injections [157]. Dwarf mice did not reject allografts [175]. The secondary immune response of dwarf mice to sheep erythrocytes was normal [38]. Neverthe- less, thymocytes or spleen cells from dwarf mice induced the in vivo graft-vs-host reaction if injected into F (SB × AKR) mice [ 158].

6 Influence of Hypophyseal Hormones on the Immune Response

6.1 Growth Hormone

Growth hormone injections in hypophysectomized mice were followed by restoration of the immune response [209, 210]. Growth hormone injection in dwarf mice was followed by activation of the immune response [e.g. 175, 397]. Thyreotropin and thyroxine had a similar effect [37]. The enhancement of the immune response (number of plaque-forming cells in the spleen after injection of sheep erythrocytes) was particularly significant when growth hormone and thyroxine were injected together [413]. The thymus is involved in this effect of growth hormone. In thym- ectomized dwarf mice, growth hormone injections had no effect on the immune response, but they induced normal growth [174]. This involve- ment of the thymus in the influence of the growth hormone on the immune response was observed in hypophysectomized rats. In hypophys-

Page 157: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 155

ectomized and thymectomized rats the dose-response ratio of growth hormone to growth was low although some effect was observed [see 329 for review]. However, the growth hormone injections had no effect on the immune response of these rats. Hypophysectomized and thymecto- mized rats produced no antibodies against human serum albumin. The normal response was restored by injections of growth hormone and the Bernardi-Comsa thymic preparation, not by growth hormone or thymic hormone alone [125]. Skin allograft rejection was delayed to the same extent in hypophysectomized and in hypophysectomized thymectomized rats. In those only hypophysectomized, the normal reaction was restored by growth hormone injections; in those thymectomized and hypophys- ectomized, growth hormone and thymic hormone injections had the same effect (but not growth hormone or thymic hormone alone [ 123]). These observations may explain the influence of thyreotropin or thyro- xine on the immune response of dwarf mice. Thyroxine is a permissive factor for the secretion of thymic hormone [ 124] and indeed thyroxine injections enhanced the immune response in dwarf mice, but not in neo- natally thymectomized mice [ 16] of normal strains.

6.2 Corticotropin

The humoral immune response was depressed by corticotropin injections. Antibody production against ovalbumin [190], pneumococcal antigen [203, 621, horse serum [250], typhoid vaccine [373], and bovine serum albumin [341,389] was severely inhibited following corticotropin injec- tion in large doses. There were remarkably few plaque-forming cells in the spleen of intact mice when these were injected with corticotropin and sheep erythrocytes.

On the allograft immune response corticotropin influence was less obvious. A slight delay was observed in mice [3511 and no influence was observed on rhesus monkeys [305], rabbits [9], guinea pigs, pigs or humans [ 170]. These experiments were carried out on intact animals. The corticotropin dosage is difficult to understand, since corticotropin doses were expressed in units of weight from the start, regardless of the successive purifications.

In hypophysectomized and thymectomized rats, daily injections of 300 milliunits of corticotropin were followed by a remarkably accelerated skin allograft rejection (17.8 -+ 1.2 days - 6.7 -+ 0.8 days). Additional injections of the Bernardi-Comsa thymic hormone preparation resulted in a nearly complete suppression of the corticotropin effect (rejection in 15.2 -+ 1.2 days) [ 123]. From previous experiments it was known that thymic hormone is a synergist to growth hormone and that it antagonizes

Page 158: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

156 J. Comsa et al.

corticotropin. The immunological tests mentioned above gave results consistent with this notion.

There is little to be said about the influence of other adenohypophyseal hormones on the immune response. The restoration of a normal response to sheep erythrocytes with thyreotropin injections [175] has been men- tioned already. In hypophysectomized and thymectomized rats thyreo- tropin injections had no influence on skin allograft rejection (J. Comsa and H. Leonhardt, unpublished observations). Thus, the influence of thyreotropin may be mediated by the thymus via the thyroid, see Sect. 3.

Pancreatectomy was followed in rats by a delayed rejection of skin allografts and no change in the immune response to sheep erythrocytes, Brucella antigen or bovine serum albumin. As far as we know, this is the first attempt to investigate the influence of the pancreas on immune functions.

7 Mechanisms of Hormonal Influence on the Immune Response

This problem can be considered from two aspects:

1. Events on the cellular of subcellular level which may enable us to understand the hormonal influences.

2. All the hormones mentioned above are present in normal animals. Intricate interactions between them were demonstrated by several tests. To what extent could these interactions influence the immune response? Can we imagine a hormonal coordinating mechanism for immune functions?

7.1 Cellular and Subcellular Aspects of Hormonal Action

The following summary is by far inexhaustive. This would unreasonably exceed the limits of this review.

7,1.1 The Corticosteroids

Corticoids enter the cells, are fixed to a transcortin analog in the cytosol [e.g. 322,383,497; see 187], traverse the cell thus bound, and are finally fixed to specific receptors in the nucleus [e.g. 449, 466, 546]. This is completed within minutes [466]. The nuclear receptor was thought to be a histone [467] or an acidic protein [e.g. 2]. The binding protein is per- haps essential for corticoid action within the nucleus. Purified "chroma- tin" is able to induce RNA synthesis in vitro. This synthesis is depressed by protein-bound cortisol, but not by free steroids [446]. The presence

Page 159: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 157

of specific corticoid receptors on lymphocytes is essential for the cyto- toxic corticoid effect. Incubated with cortisol, the corticoid receptors of lymphocytes decrease with time in the surviving cells [49]. (The cells bearing a dense receptor net are killed.)

Corticoids increase the stability of cellular and subcellular membranes. Hemolysis by antibodies or by physiochemical agents is inhibited by cor- ticosteroids [e.g. 4, 272]. Hamster kidney cells infected with rubella virus are not lysed by antirubella serum if cortisol is added to the medium [498]. Intracellularmembranes were also found to be stabilized by adding cortisol [ 162]. Cortisol inhibited the release of lysosomal enzymes into the cytosol [532, 534]. Corticoids interfere with glucose metabolism. Glucose transport and phosphorylation [69, 3831, glucose uptake [281, 375], and ATP synthesis [391] are inhibited by adding cortisol (at 10 - 7 - 10 -6 M concentration). Metabolism by the pentose cycle was found to be enhanced [69], this action is blocked, however, by puromycin [376,339]. It was concluded that cortisol induces the synthesis of a proteidic inhibi- tor of glucose metabolism.

Corticoids inhibit DNA and RNA synthesis [see 495 for review]. Thy- midine uptake [339, 340, 376], DNA polymerase [290], and thymidine- kinase activity [241] are depressed, also uridine uptake [199, 551], ade- nine uptake [77], RNA polymerase activity [2, 68, 194, 340], and DNAse activitiy is enhanced [443].

Corticoids inhibit protein synthesis in most tissues (except in the liver). Amino acid uptake [e.g. 64, 181,227, 375,537] is depressed in presence of cortisol and so is the activity of various transaminases [e.g. 64]. The inhibition of lymphokine synthesis [ 523] is particularly relevant to our topic. Amino acid release by incubated lymphocytes is enhanced in pres- ence of cortisol [489]. Thus, cortisol appears to inhibit the anabolism and to promote the catabolism of nucleic acids and proteins. These effects were obtained with cortisol at high concentrations ( 10 -7 - 10 -6 M). They are supposed to be direct with no second messenger needed [495]. Yet cortisol injections depressed the adenylate-cyclase activity in X-irra- diated rats [285].

It is interesting to note that the stimulating effect of cortisol at low concentrations on lymphocyte proliferation in vitro (10-a M [ 539] ) was supposed to be mediated by cyclic AMP. It should also be noted that the stabilizing effect on lysosome membranes in vitro was observed at low, but still immunostimulant concentrations [ 144]. These two observations are the only ones possibly related to the immunostimulant influence of corticoids within the physiological range.

Page 160: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

158 J. Comsa et al.

7.1.2 Peptidic Hormones

It is generally accepted that peptidic hormones do not enter the cell. Thus a "second messenger", transporting the hormonal message from the cell membrane (to the nucleus?), becomes relevant.

7.1.3 Cyclic Adenosine Monophosphate (cAMP)

Added to the medium, cyclic AMP stimulates lymphocyte proliferation [333]. Injection of sheep erythrocytes into immunized mice resulted in an increase in the cyclic AMP level in their spleen lymphocytes within 2 - 1 0 min [418]. When (butyryl)- cyclic AMP was added to the medium [e.g. 70, 266, 530], plaque-forming cells increased in number in spleen cells from mice immunized against sheep erythrocytes. Adenylcyclase stimulating catecholamines (e.g., epinephrine) enhanced the immune response [70] and so did those drugs which inhibit phosphodiesterase [72]. This is, however, only valid up to a certain point. When added in excessive amounts, cyclic AMP inhibited plaque-forming cell differentia- tion [73]. The cytolytic activity of immunized C57 b 1 mouse spleen cells against DBA mastocytoma was inhibited by cyclid AMP [254]. Plaque- forming cell formation was inhibited in mouse spleen cells by cyclic AMP added to the medium. (Was it added in excess in these two experiments?) Rosette-forming cells increased in number in human lymphocytes by administration of drugs which increase the cyclic MP content of lym- phocytes and then decreased when dibutyryl-cyclic AMP was added to the medium [99] (perhaps in excess, see above).

7.1.4 Synthetic Polyribonucleotides

The enhancing effect of poly (A:U) on the immune response [ 56, 72, 74, 73, 266, 343] at low concentrations (high concentrations show an oppo- site effect [72]) was interpreted as an enhancing influence on cyclic AMP synthesis [70]. Poly (A:U) injected into neonatally thymectomized mice induces a normal rosette-forming cell differentiation and a normal allo- graft rejection [126]. Still poly (A:U) added to the medium enhanced cytotoxic activity of spleen cells cultivated with allogenic cells in normal mice but not in the nude ones (the thymus was necessary [56]). Prosta- glandins were also said to enhance the immune response [265] and the prostaglandin synthesis inhibitors did as well [531 ]. In this new field the observations are still confusing.

Poly (A:U), prostaglandin E2 or cyclic AMP, added to the medium, induced the potency of graft-vs-host reaction in spleen cells from thym- ectomized mice; incubation of mouse lymphocytes with thymic humoral factor resulted in an increased cyclic AMP content [299]. Incubation of

Page 161: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 159

spleen cells from nude mice with thymopoietin, cyclic AMP or poly (A:U) induced the appearance of antigenic markers and helper function [451]. Neither thymosin [20] nor serum thymic factor [20] induced an increased cyclic AMP content in thymocytes when added to the medium. Also, incubation of thymocytes with serum from normal or thymecto- mized pigs induced an increased cyclic AMP content in these cells, whereas the serum thymic factor produced by synthesis did not [34].

Perhaps, this partly confusing picture could be somewhat clarified if we knew the consequences of thymectomy on the cyclic AMP level of lymphocytes. Remarkable as it may sound, we do not.

7.2 Hormonal Interactions

The hormones mentioned thus far are simultaneously present in the organism. The hormonal influence on immune response (i.e., its action directly on the immune system or mediated by another endocrine) is expressed by an algebraic sum. This assertion is self-evident. Thus far, the documentation concerning this topic is poor. Elements of the hormonal interactions in general must be noted. (Observations mentioned without references are described in extenso [ 114]). Hormonal interactions must be seen from two different aspects:

1. The reciprocal influence between gland A and gland B 2. The interaction between the hormones of gland A and gland B in their

circulating form

These two aspects probably are linked to each other in some way. However, we can only assume this up to now.

7.2.1 Consequences of Thymectorny on the Endocrines

Following thymectomy, a transitory stimulation of the thyroid, and the gonads, and the adrenal cortex was observed in guinea pigs and rats [ 114]. These endocrines returned to normal in rats and in those guinea pigs which recovered from thymectomy. In those which waste (examined sub finem) degenerative changes were observed. This was the case in thymec- tomized mice. As far as we know, the endocrines were examined in wasted mice only [ 155]. This is insufficient. Degenerative changes in the endocrines occur in wasted animals, whatever the reason for wasting may be (e.g., in the terminal stage of deficiency diseases). The consequences of thymectomy on the adrenal cortex seem ambiguous at first sight. Evi- dence of stimulation was noted [see 114, 140]. However, the corticoste- roid content of the systemic blood was found to be decreased [ 137, 177] whereas aldosterone content was increased [ 177]. Still, the corticosterone

Page 162: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

160 J. Comsa et al.

level increased in the efferent blood of the adrenal [79,470]. This discre- pancy is believed to result from an accelerated denaturation of cortico- sterone in thymectomized animals, perhaps mediated by the stimulated thyroid. Indeed, thyroxine injections were followed by an accelerated reduction of ring A in steroid molecules [550]. A methodical investiga- tion of the steroid turnover rate in thymectomized animals would be of interest.

In the adenohypophysis, thymectomy was followed by signs of stimu- lation of, more or less, all cells. The sequence of the events is different from one species to another. In rats [114, 1371 and in mice [55], the stimulation of ~ cells occurs early. In guinea pigs [ 114], 6 cells precede the ~ cells, which show signs of stimulation only in recovering animals. In wasted guinea pigs the adenohypophysis is completely dedifferentiated (consisting only of small chromophobes). In mice, the stimulation of

cells appears before the onset of wasting [415]. In thymectomized axenic mice, which do not waste following thymectomy, similar changes in the adenohypophyseal cells occurred [415, 475].

Further research concentrated on the ~ cells. Electron microscopy indicated an enhanced endoplasmic reticulum and an almost total disap- pearance of secretion grains [562, 475] in thymectomized mice. This evidence of an increased activity is consistent with the increase in the growth hormone level in the serum [ 137]. We noted that following thym- ectomy the efficiency of the growth hormone is decreased (by the loss of its synergist). This results in an increased growth hormone secretion by a negative feedback effect.

All these changes were prevented by thymic grafts in mice [54] or by daily injections of the Bernardi-Comsa thymic hormone preparation [see 113]. The increase in the serum growth hormone level following thymec- tomy was prevented by injections of the same compound [562].

The nude mouse is supposed to suffer from a severe thymic deficiency. But thymosin could be prepared from the rudimentary thymus of nude mice [573]. The histological picture of the endocrines shows to a certain extent that of thymectomized mice at the terminal wasting stage. The thyroid shows degenerative changes. In the adrenal at the age of 50 days, the reticular zone of the adrenal cortex is peculiarly large. At 90 days the cortex is shrunken. The growth hormone cells of the adenohypophysis show the same picture as in thymectomized mice. Blood thyroxine levels are low. Corticosterone levels temporarily increased (at 14 days) and later decreased. Sex steroids decreased. In vitro, adrenals of nude mice produce less corticosterone, more desoxycorticosterone, and as much aldosterone as those of normal mice. Addition of corticotropin to the medium results in normalization of the steroids produced [408, 409]. Thymic grafts in nude mice suppressed all degenerative changes in the

Page 163: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 161

endocrines. The consequences of thymic extract injection on the endo- crines of nude mice have not been investigated as far as we know.

7.2.2 Thymus-Thyroid

Following thyroidectomy, the thymus undergoes atrophy of the senile type in infant guinea pigs [see 114]. The hormone content of the thy- mus, the lymph nodes, and the spleen decreased in thyroidectomized rats. This could be prevented by daily injections of 5/~g of thyroxine, the minimal dose for preventing thiouracil goiter [ 124]. In guinea pigs, the minimum dose necessary was 2 /~g daily. Increased thyroxine amounts induced thymic hypertrophy (up to 16 ~g). Larger amounts, however, resulted in a relative atrophy with histological signs of intense stimula- tion, which points to the picture of human thymus in Graves' disease. The lymphocytosis induced by thyroxine injections is mediated by the thymus. In doses inducing lymphocytosis in normal guinea pigs, thyro- xine injections are followed by lymphopenia in thymectomized animals [114].

The thyroid seems to regulate in some way the thymus functions. Thymic hypertrophy induced by castration is inhibited by simultaneous thyroidectomy [344] as well as an increase in the hormone content of the thymus in castrates [ 124].

The influence of the thyroid on the thymus is probably direct. Thymic hormones and thyroxine are mutual antagonists (demonstrated with the Bernardi-Comsa compound [see 1141 and with thymosin [see 127]. The influence of the thymus on the thyroid (the thyroid stimulation follow- ing thymectomy) is more intricate. The thymus antagonizes thyreotropin and it decreases the thyreotropin secretion [see 114].

7.2.3 Thymus-Adrenal

The influence of the adrenal on the thymocytes was described above. In addition, an adrenal influence on the thymic glandular epithelium seems probable. Adrenalectomy is followed by thymic hypertrophy [see 114 for review], but the hormone content of this enlarged thymus is low [ 124, 137] and increased above the normal level in adrenalectomized rats with corticosterone or desoxycorticosterone [ 124].

The influence of the thymus on the adrenal cortex is intricate. The stimulated condition of the adrenal cortex following thymectomy (pre- vented by thymic hormone injections) was mentioned above. The adrenal of thymectomized rats was incubated in vitro. Addition of thymosin to the medium was followed by an increased oxygen consumption. The oxygen consumption of adrenals from thymectomized mice previously injected with thymosin or with homeostatic thymic hormone was low

Page 164: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

162 J. Cornsa et al.

(equal to that of normal mice if homeostatic thymic hormone was injected, but still 30% higher after thymosin injections [140] ). Obviously, two mechanisms interplay: (a) the antagonistic action of the thymus toward corticotropin (see above) and (b) a possible direct action of the thymus on the adrenal cortex.

The thyroid seems to play a permitting role on the adrenal's influence on the thymus. The "big empty thymus" of adrenalectomized rats is not seen in tyhroidectomized and adrenalectomized rats. In these rats, the thymus shrinks just as in those thyroidectomized alone.

7.2.4 Thymus-Adenohypophysis

Following hypophysectomy the thymus shrinks, and the picture is that of senile involution. The lobules shrink, the cortex is narrow but particu- larly well delimited from the medulla, there are no lymphocytes in the medulla, and the lymph nodes shrink [452]. Thymidine uptake is de- creased in the thymus and in the spleen [293]. The validity of this test could be questioned because hypophysectomy had no effect on thymi- dine uptake in the testes [293].

Antigrowth hormone antiserum induced a similar thymic atrophy [411]. The hormone content of the thymus decreased as well as the stores of thymic hormone [124, 128, 137] in the lymph nodes and the spleen. Daily injections of growth hormone, corticotropin or thyreotro- pin prevented these changes [ 124]. The shrunken lymph nodes of hypo- physectomized rats are restored to normal by growth hormone injections.

These observations may demonstrate: 1. An influence of growth hormone on thymic lymphocytes, this is an

acquired characteristic. There are specific receptors for growth hormone on the surface of lymphocytes [e.g. 397]. Im lymphocyte cultures growth hormone addition is followed by an increased mitosis rate [333], an increased thymidine and uridine uptake [397,490]. This action is sup- posed to be mediated by cyclic AMP since addition of coffeine to the medium decreased the minimal efficient growth hormone concentration by two-thirds [333]. Growth hormone seemed to favor the maturation of thymocytes. Thymectomized mice, injected with sheep erythrocytes, develop few plaque-forming cells. Injection of growth hormone and thy- mocytes was followed by an increase in the plaque-forming cell number, whereas neither growth hormone alone, nor thymocytes alone had any effect [ 16]. Injection of newborn Long-Evans rat spleen cells in newborn Ch River rats (of Sprague-Dawley origin) induced runting syndrome only when injected together with growth hormone. The influence of growth hormone thus appears to be exerted on Stutman's postthymic immature cells.

Page 165: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 163

2. An influence of growth hormone on the secretory thymic reticulo- epithelium. This ir purely hypothetical.

It has also been documented that growth hormone is a synergistic to thymic hormone (see above).

A clear-cut difference appears between the stimulatory influence of growth hormone on the thymus and the synergism between growth hor- mone on the thymus and the synergism between growth hormone and thymic hormone.

It has been mentioned already that corticotropin injections restored the hormone content of the thymus, the lymph noces, and the spleen in hypophysectomized rats. The mechanism of this phenomenon is open to discussion. It can be understood as being mediated by the adrenal cortex (see above) but a direct influence of corticotropin on the isolated rat thymus has also been observed [137]. The restoration of the hormone content in the thymus of hypophysectomized rats by thyreotropin can certainly be understood as being mediated by the thyroid.

Injections of an antigrowth hormone antiserum in 27-day-old mice resulted in a wasting syndrome similar to that induced by neonatal thym- ectomy. The thymus of these animals shrunk and their immune response became deficient. In their hypophyses the growth-hormone cells were modified as in thymectomized mice. Their thymuses shrunk [475]. Injec- tions of an antithymus antiserum had no similar effect, perhaps because it was principally an anti thymocyte serum. For this test, antithymic anti- sera should be prepared with cells from the secretory thymic reticuloepi- thelial cells.

The dwarf mouse suffers from a severe adenohypophyseal deficiency [e.g. 40, 321, 471]. This deficiency is conditioned by the adenohypo- physis itself and not by the hypothalamus. The graft of a syngeneic nor- mal hypophysis in the sella turcica of dwarf mice was followed by normal growth [88]. Substitutive therapy with adenohypophyseal and other hor- mones to some extent produced confusing results. Dwarf mice resumed growth when injected with growth hormone, thyreotropin [47] or thy- roxine [236, 390, 472]. Bioassay and polyacrylamide electrophoresis of a crude hypophyseal extract of dwarf mice demonstrated a severe growth hromone deficiency [321 ]. Thus, dwarf mice are dwarves inasmuch as they are deficient in growth hormone (in fact, the other hypophyseal hormones have not been researched as far as we know).

The thymus, the lymph nodes, and the splenic white pulp are atrophic in dwarf mice. At 20 days the thymus shows senile atrophy, and at 60 days the terminal stage of deficiency diseases [36]. Yet this thymus was proven functional (see Sect. 5). Thyroid and adrenals are atrophic.

The restoration of dwarf mice by thyreotropin or thyroxine injections raises some problems. The restoration of the immune response by thyroxine

Page 166: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

164 J. Comsa et al.

may result from the influence of thyroxine on the thymus. We know, indeed, that thyreotropin restored the thymus function in hypophysec- tomized rats. Unfortunately, we do not know which changes in the thy- mus of dwarf mice are induced by thyroxine. In any case, this explana- tion is unsatisfactory since thymic hormone was shown to be of no influ- ence on the immune response in hypophysectomized animals, unless growth horrhone had also been injected (see above). Thus, we could sus- spect that thyroxine injections in dwarf mice induced an increased growth hormone secretion also. It is, indeed, open tO discussion whether the adenohypophysis of dwarf mice is asleep or dead. In the first case, thyroxine may induce a chain of events in the adenohypophysis of thy- roidectomized rats, the growth hormone content tending toward zero. It is restored with thyroxine injections [321]. There is circumstantial evidence that the well-known hypertrophy of the adrenal cortex follow- ing thyroxine injections is mediated by the adenohypophysis [e.g. 164]. Corticotropin injections resulted in an increased growth hormone secre- tion [e.g. 480, 555]. In dwarf mice growth hormone injections showed a gonadotropic effect. Puberty was induced and fertilization, pregnancy, and breeding were possible [39]. An intricate interaction within the cells of the adenohypophysis could be possible in the particular case of the dwarf mouse which is injected with one or another hypophyseal hor- mone. This presumption indicates that the adenohypophysis of the dwarf mouse is only in a deep resting state (asleep) and is still able to respond to stimulation.

In comparing this hypophysis-to-hypophysis interaction, could a thy- mus-to-thymus interaction be acquired? The thymus also secretes several hormones. The answer is short and simple: We just do not know.

Thus, an intricate network of hormonal interaction appears to influ- ence the immune functions. The notion of a coherent coordinative mech- anism for these functions can be imagined. This suspicion could be sup- ported further from the observations made on the nervous system's involvement in these interactions. Destruction of hypothalamic areas was followed by a depression of the immune response; their stimulation by faradization enhanced it [294]. Serum corticosterone level, action poten- tial of the hypothalamic ventromedian area, and the number of plaque- forming cells in the spleen increased in demonstratively parallel curves following sheep erythrocyte injections in rats [54]. The stimulatory influence of antigens on these mechanisms seems to be exerted at differ- ent levels and not on the hypothalamus alone. Corticosterone produc- tion by incubated adrenals was increased, following addition of an anti- gen (enterotoxin) to the medium [224], and the corticotropin release of incubated hypophyses was also increased by the addition of E. coli endotoxin [491,358].

Page 167: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 165

The thymus may exert an influence on this mechanism. RNA synthesis increased in the hypothalamus of thymectomized rats incubated in vitro. This was prevented by thymosin or homeostatic thymic hormone injec- tions. Added to the medium, both hormones caused a decrease in RNA synthesis in the incubated hypothalamus of intact rats [ 142]. This seems to indicate a negative feedback effect of thymectomy on the hypothala- mus. This entirely new field awaits further research.

8 Possible Alimentary Influences

The picture of coordinatory mechanisms of immune functions is not complete if alimentary factors are not taken into account. The experi- mental documentation on this is poor. However, a superabundant num- ber of clinical documentations are available concerning immune distur- bances in underfed human subjects. Avitaminosis A, pantothenic acid, and pyridoxal deficiency in rats and avitaminosis C in guinea pigs resulted in a decreased antibody production. Thiamine, riboflavine, and folic acid deficiency were of no influence [see review 23]. Pair-fed controls showed a normal immune response, however, their thymus was also atrophic. Thus, this influence of specific deficiencies on the immune response did not result from the underfeeding which is by definition a consequence of avitaminoses. Rat fed a pyridoxine-deficient diet had no immunocom- petent mature T cells in the thymus. Thymocytes from these rats acquired immunocompetence when incubated on a monolayer of thymic reticulo- epithelium from normal rats, but not if the reticuloepithelial cells were taken from pyridoxine-deficient rats [540]. This suggests that pyridoxine deficiency may interfere with the immune response inasmuch as it inhibits thymic hormone production. This is perhaps not the only way. Lympho- cytes from BALB mice incubated with irradiated C3H lymphocytes developed cytotoxic functions, which decreased in time after the anti- genic lmyphocytes were added after more than 20 days of culture. After 35 days of culture, the ability to develop cytotoxic functions was lost. It was restored by addition of pyridoxal to the medium [464].

Here again a new field of interest opens. As long as our documentation on this subject remains as poor as it is, the coordinatory mechanisms of immune functions will not be completely understood.

Page 168: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

166

9 General Conclusions

J. Comsa et al.

This review contains evidence for the influence of nearly all hitherto known hormones on the immune response. As stated above, the docu- mentat ion for this evidence differs quantitatively from one hormone to another: abundant for the thymus, in general it is scarce for the other endocrines, because the attention of immunologists has thus far focused more or less exclusively on the thymus. This is unjustifiable. There is valid evidence for pluriglandular influences on the immune response. Korneva's observations indicate an influence of the hypothalamus [294].

It was postulated for the thymus, that its influence is needed for the differentiation of the immune system ( thymec tomy is o f no consequences in animals whose immune system is already mature). This is not entirely valid. Endocrine mutilation resulted in immune disturbances in pre- puberal animals, as wag shown above.

A difference mfist be made between mature lymphocytes and senti- tized lymphocytes. In the lymphocytes , the first contact with an antigen results in changes which are under hormonal influences. Once these changes have occurred, hormones are apparently no longer needed (the secondary immune response is not influenced by endocrine mutilation.

The mechanism for these hormonal influences differs from one endo- crine to another. Some act directly on the immune system. The synergic growth hormone, the thymus, and the cort icosteroids are examples of this condition. Some endocrines influence the immune system inasmuch as they stimulate or inhibit other glands. This may occur in two different ways:

1. An interaction between two hormones in their circulating form (such as the interaction thymus-corticotropin)

2. An influence of a hormone on a gland itself; the influence of the thy- roid and the gonads is mediated by the thymus.

A scheme (Fig. 1) summarizes those interactions. Do these observations themselves just ify the postulate of a hormonal

coordination of the immune response? At first glance, no. It requires the demonstration of an induction of the hormonal reaction by a specific stimulant. The stimulant may act directly (the isolated perfused pancreas secretes increased amounts of insulin if the glucose content of the perfu- sion liquid is increased). The reaction may result from an intricate mech- anism involving several organs (energetic metabolism increases in the cold, under the influence of the thyroid and the adrenal cortex, but not in hypophysectomized animals). In order to accept the postulate of a hor- monal coordination of the immune response, we must observe, that the presence of an antigen within the organism results in an increased activity

Page 169: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response

Fig. 1. Summary of the hormonal coordi- nation of the immune response. Stimulating influences, - . . . . //inhibiting influences. 1, adenohypophysis; 2, thy- roid; 3, thymus; 4, gonads; 5, adrenal; 6, lymphocytes. Abbreviations: BC, thy- mic hormone (Bernardi-Comsa); TS, tes- tosterone; OF., estradiol; X, unknown; STH, growth hormone; TSH, thyreotro- pin; ACTH, corticotropin; T4 Ta, thyroid hormone

STH

Hypothalamus

, T~T3

3

TS

167

Antigen

ACT'H

of the endocrines mentioned above. This evidence is given partially by the observations of Besedowsky and Sorkin [54]: in presence of sheep erythrocytes there is a parallel increase of the action potentials in the hypothalamus, the corticosterone content of the blood, and the number of plaque-forming cells in the spleen. It would be of supreme interest to extend this fundamental observation to the other endocrines known to influence the immune system.

Be that as it may, our knowledge of these mechanisms will remain incomplete as long as alimentary factors are not taken into account. The observations of Willis-Carr and St. Pierre are of great interest in this con- text [540]. Earlier documents are not entirely satisfactory, concluding (in our opinion somwhat quickly) that most alimentary factors are of little or no influence on the immune system [see 23]. This conclusion is in striking contradiction to the everyday clinical routine. It is universally known that patients suffering from malnutrition are highly sensitive to infection that can develop with a peculiarly poor reaction and a catas- trophal prognosis. This suggests the hypothesis of a state of immunodefi- ciency in these patients. To our knowledge, no attempt has yet been made to verify this hypothesis.

On the other hand, it is known that malnutrition results in an intricate hormonal deficiency. A characteristic pattern of thymic atrophy is an early consequence of every deficiency disease. Later, the adenohypophy- sis is severely affected (malnutrition was called the nonsurgical hypo-

Page 170: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

168 J. Comsa et al.

physectomy). This, in turn, affects the thyroid, the adrenal, and the gonads. The documenta t ion reviewed allows us to postulate a link between hormonal deficiency and immune deficiency (to some extent underfed subjects suffer f rom immune deficiency inasmuch as they suffer f rom hormonal deficiencies).

One may conceive that the thymus is of primary importance in this syndrome. Its a t rophy is peculiarly early and pecularly severe. In dys- peptic infants underfed for therapeutic reasons the thymus may lose 90% of its normal weight and its hormone content tends toward zero [see 329]. In the late 1940s an at tempt at substitutive therapy with thymic extract was made in these patients with encouraging results [see 329].

In our opinion, interesting new aspects of the physiopathology of the immune response may appear if:

1. The pluriglandular coordinat ion of the immune response were to be considered (instead of the exclusive concentrat ion on the thymus).

2. The accidental, acquired forms of immunodefic iency were also inves- tigated (research has so far focused on congenital forms).

References

1. Abe T, Nomura M (1970) Amelioration of runt disease in rats by metopirone. J Nat Cancer Inst 45:597

2. Abraham AD, Sekeris CE (1971) Inhibitory action of steroid hormones on RNA synthesis of isolated thymus nuclei. Biochim Biophys Acta 247:562

3. Adams PB (1975) Mechanism of interaction between and ceils in the in vitro response to SRBC. Immunology 28:253

4. Agarwal K, Garby L (1964) Inhibition by corticosteroids or red cell lysis in vitro. Acta Endocrinol [Suppl] (Copenh) 93

5. Agosier M, Christen R, Badiner O, Gasic G (1952) Cortisone-induced metastases of adenocarcinom in mice. Proc Soc Exp Biol Med 80:128

6. Aisenberg AC, Davis C (1968) Thymus and recovery of the sheep erythrocyte response in irradiated mice. J Exp Med 128:1327

7. Aisenberg AC, Wilkes B (1965) Partial immunological restoration of neonatally thymectomized rats with thymus-containing diffusion chambers. Nature 25:716

8. Algire GH, Weaver JM, Prahn RT (1957) Studies on tissue homotransplantation using diffusion chambers. Ann NY Acad Sci 64:1009

9. Allen H L, Williams RD, Lovingood CG, Ellison EH (1952) Effect of donorskin desensitization and ACTH on survival of skin homograft. Ann Surg 135:239

10. Ambrose CT (1964) Requirement of hydrocortisone in antibody forming tissue cultivated in serum-free medium. J Exp Med 119:1027

11. Amerding D, Katz DM (1975) Activation of T and B cells in vitro. J Immunol 116:1248

12. Archer OK, Pierce JC (1961) Role of the thymus in developing of the immune response. Fed Proc 20:26

13. Argyris B (1969) Thymus-bone marrow interaction in transplantation immunity. Transplantation 8: 538

14. Arnason BG, Jankovic BD, Waksman BH, Wennersten C (1962) Role of the thy- mus in inmmune reaction in rats. J Exp Med 116:177

Page 171: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 169

15. Arnason BG, Vaux de St Cyr C, Shafner JB (1964) Comparison of immunoglobu- lin and antibody production in normal and thymectomized mice. J Immunol 93 : 915

16. Arrenbrecht S, Sorkin E (1973) Growth-hormone-induced cell differentiation. Eur J Immunol 3:601

17. Asanuma Y, Goldstein AL, White A (1970) Reduction of the incidence of wast- ing disease in neonatally tymectomized mice by thymosin. Endocrinology 86: 600

18. Aschkenasy A, Bussand A, Corvazier P, Grabar P (1950) Role de la corticosur- renale dans la leucopoiese et l'immunitd. Rev Hematol 5:107

19. Askonas BA, White RG (1956) Site of the antibody production in the guinea pig. J Exp Pathol 37:61

20. Astaldi A, Wijemans P (1977) Thymosin-induced human serum thymic factor increasing cyclic AMP. J Immunol 119:1106

21. Astaldi G, Astaldi A, Groenewoud M, Wijemans PS, Schellekens PG, Eijsvogel VO (1977) Effect of a human serum thymic factor on cortisol treated thymo- cytes. Eur J Immunol 7:836

22. Auerbach R, Globerson A (1966) In vitro induction of the graft-versus-host reac- tion. Exp Cell Res 42:31

23. Axelrod AE, Prezansky J (1955) Role of the vitamins in antibody production. Vitam Horm 13:1

24. Azar NA, Williams K, Takatsuki K (1964) Development of plasma cells and immunoglobulin in neonatally thymectomized rats. In: Defendi V, Metcalf D (eds) The thymus. Wistar Institute Press, Philadelphia

25. Bach JF (1973) Demonstration of a circulating thymic hormone. Immunology 25:353

26. Bach JF (1973) Thymic dependency of rosette-forming cells. Contemp Top Immunol 2:86

27. Bach JF, Carnaud C (1976) Thymic factors. Prog Allergy 21:342 28. Bach JF, Dardenne M (1973) Antigen recognition by T lymphocytes. Cell

Immunol 6:394 29. Bach JF, Dardenne M, Davies AJS (1971) Early effects of adult thymectomy.

Nature (London) 231 : 231 30. Bach JF, Dardenne M, Goldstein AL, Guha A, White A (1971) Appearance of T

cell markers in bone-marrow rosette-forming cells after incubation with thymo- sin. Proc Natl Acad Sci USA 68:2774

31. Bach JF, Papiernik M, Levasseur P (1972) Evidence for a serum factor secreted by the human thymus. Lancet II: 1056

32. Bach JF, Dardenne M, Pleau JM, Bach MA (1975) Isolation, biochemical charac- teristics and biological activity of a circulating thymic hormone. Ann NY Acad Sci 249:186

33. Bach JF, Dural D, Dardenne M, Salomon JC, Tursz T (1975)Effect of steroids on T cells. Transplant Proc 7:23

34. Bach MA (1977) Sera from normal and thymectomized animals produce eleva- tion of cyclic AMP in thymocytes. Cell Immunol 33:226

35 Baker PM (1975) Homeostatic control of antibody response. Transplant Rev 26:3

36. Baroni C (1967) Thymus, peripheral lymphnodes and immunological responsive- ness of pituitary dwarf mice. Experientia 23:282

37. Baroni C, Fabris N, Bertoli G (1969) Synergistic action of thyroid and growth hormone in pituitary dwarf mice. Immunology 17:303

38. Baroni C, Pesardo PC, Bertoli G (1971) Delayed development of immunological capacity in pituitary dwarf mice. Immunology 21:455

39. Bartke A (1964) Histology of antehypophyse, thyroid and gonads of two types of dwarf mice. Anat Rec 149:225

Page 172: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

170 J. Comsa et al.

40. Bartke A (1965) Response of two types of dwarf mice to growth hormone. Thyrotropine and thyroxine. Gen Comp Endocrinol 5:418

41. Basch RS (1966) Immunological competence after thymectomy. Int Arch Allergy Appl Immunol 30:165

42. Basch RS, Goldstein G (1974) Induction of T cell differentiation in vitro by thyrriin. Proc Natl Acad Sci USA 71 : 1474

43. Basch RS, Goldstein G (1975) Antigenic and functional evidence for the in vitro inductive activity of thymoporetine on thymocyte precursory. Ann NY Acad Sci 249:290

44. Basten A, Mtiller JFAP, Sprent J, Cheers C (1974) Cell to cell interaction in the immune response. J Exp Med 140:199

45. Batchelor JR (1971) Hormonal control of antibody formation. In: Cinader B (ed) Regulation of antibody response. Thomas, Springfield

46. Batchelor JR, Chapman BA (1961) Influence of sex on antibody response to an incompatible tumour. Immunology 9: 553

47. Bates RW, Laanes T, Riddle O (1935) Evidence from dwarf mice against the individuality of growth hormone. Proc Soc Exp Biol Med 33:446

48. Bathmann A, Land W, Koczorek K, Stass P (1971) Immuno suppressive proper- ties of corticosteroids. Eur Surg Res 3:40

49. Baxter JD, Harris AW (1975) Mechanisms of glucocorticoid action. Transplant Proc 7:55

50. Beauvieux Y (1963) Donnds experimentales sur l'un des aspects de la physiologie du thymus. CR Acad Sci [D] (Paris) 256:2914

51. Bekkum DW van (ed) (1975) Biological activities of thymic hormones. Koojker, Rotterdam

52. Berglund K (1956) Studies on factors which condition the effect of cortisone on antibody production. Acta Pathol Microbiol Scand 38:311

53. Berglund K, Fagreus A (1961) Effect of homologous spleen cells on antibody formation in cortisone treated rats. Acta Pathol Microbiol Scand 52:321

54. Besedowsky H, Sorkin E (1977) Network of immunoneuroendocrine interac- tion. Clin Exp Immunol 27:176

55. Bianchi E, Pierpaoli W, Sorkin E (1971) Cytological changes in the mouse ante- rior pituitary after neonatal thymectomy. J Endocrinol 51 : 1

56. Brick HC (1977) Cytotoxic T cell activation by polyribonucleotids. J Exp Med 146: 844

57. Billingham RE, Brent L (1958) Quantitative studies on transplantation immun- ity. Philos Trans R Soc (London) [Biol] 242:439

58. Billingham RE, Krohn PL, Medawar PB (1951) Effect of cortisone on survival of skin homografts in rabbits. Br Med J I : l 157

59. Biozzi G, Stiffel C, Mouton D, Liacopoulos-Briot M (1966) Etude de l'immuno- adherence au cours d l'immunisation. Ann Inst Pasteur (Paris) [Suppl 3] 110

60. Bisset KA (1949) Influence of adrenal cortical hormone on immunity on cold- blooded vertebrates. J Endocrinol 6:94

61. Bjornboe M, Fischel EL, Stoerk HC (1951) Effect of ACTH and cortisone on concentration of circulating antibody. J Exp Med 93:37

62. Bjornboe M, Gormsen H, Lundquist LF (1967) Further studies on the role of plasma ceils as antibody producers, l I mmunol 55:121

63. Blankwater MJ, Levert LA, Swart AC, Bekkum DW van (1978) Effect of various thymic and non-thymic factors on in vitro antibody formation by spleen cells of nude mice. Cell Immunol 35: 242

64. Blecher M, White A (1958) In vitro effect of adrenocortical steroids on transami- nation by cell suspensions of rat thymus. Endocrinology 63:65

65. Blomgren H, Anderson B (1969) Evidence for a small pool of immunocompetent ceils in the thymus. Exp Cell Res 57:185

66. Blomgren H, Anderson B (1971) Characteristics of the inmmunocompetent cells in the mouse thymus. Cell Immunol 1:545

Page 173: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 171

67. Bloom BR (1974)Cellular bases of immune response: cAMP, growth and immune response. Springer, Berlin Heidelberg New York

68. Bottoner GD, Stitch RD, Roesel OF (1973) Effects of cortisol-protein complex on RMA-polymerase activity in isolated pig liver and thymus nuclei. Proc Soc Exp Biol Med 140:946

69. Boyett JD, Hoffert JF (1972) Inhibition of glucose metabolism in thymus lym- phocytes by cortisol. Endocrinology 91:233

70. Braun W (1974) Regulatory factors in the immune response. Springer, Berlin Heidelberg New York

71. Braun W, Cohen EP (1971) Role of the nucleic acids in antibody formation. In: Cinader B (ed) Regulation of the immune response. Thomas, Springfield

72. Braun W, Ishizuka M (1971) Antibody formation. Reduced responses after administration of excessive amounts of nonspecific stimulators. Proc Natl Acad SciUSA 68:1114

73. Braun W, Rega MJ (1971) Adenyl-cyclase-stimulating catecholamines as modi- fiers of antibody formation. Immunol Commun 1:523

74. Braun W, Ishizuka M, Matsumoto T (1971) Cyclic AMP and immune response. J Immunol 107:1027

75. Braun W, Ishizuka M, Winchurch R, Webb D (1971) Role of cyclic AMP immune response. Ann NY Acad Sci 185:41B

76. Brinck-Johnson T, Dougherty TF (1965) Effect of cortisol and corticotropin on incorporation of adenine-8 C in lymphatic tissue nucleic acids. Acta Endocrinol (Copenh) 49:471

77. Brown GL, Rothlauf MW, Heimzeiling RH, Myers TS (1971) Antibody forma- tion in rabbits adapted to high altitude. Infect Immun 3:358

78. Brunner KT, Manuel J, Rudolf M, Chapin B (1970) Studies on allograft immun- ity. Immunology 18:501

79. Buntner B, Szymik M (1974) Effect of thymectomy on steroid secretion and adrenal venous blood in male rats. Endocrinol Exp (Bratisl) 8:31

80. Burleson R, Levey RH (1971) Demonstration of thymic function in vitro. Trans- plant Proc 3: 918

81. Buscarini L, Bedarda G, Marandola P (1964) Thymectomized rats treated with thymus homogenates reject skin homografts. Experientia 20:696

82. Byrom NA, Campbell MA, Staughton RCD (1977) Thymosine-like activity in fetal calf serum. Lancet II:1132

83. Camblin JG, Bridges JB (1964) Effect of cell-free thymus extracts in leucopenic rats. Transplantation 2:785

84. Cantor H, Boyse EA (1975) Functional subclasses of T lymphocytes bearing different Ly antigens. J Exp Med 141:1376

85. Cantor H, Boyse EA (1977) Lymphocytes as models for study of mammalian cell differentiation. Immunol Rev 33:105

86. Cantor H, Shen FW,.Boyse EA (1976) Separation of helper and suppressor cells. J Exp Med 143:1391

87. Carpenter CB, Boylston AW, Merrile JP (1971) Immunosuppressive globulin from bovine thymus. Cell Immunol 2:423

88. Carsner RL, Rennels EG (1960) Primary site of gene action in dwarf mice. Science 131:829

89. Castro JE (I 974) Orchidectomy and the immune response. Proc R Soc (London) [Biol] 185:425

90. Castro JE, Hamilton DNH (1972) Adrenalectomy and orchidectomy as immuno- potentiating procedures. Transplantation 13:614

91. Ceglowski WS, Labadie GW (1975) Influence of thymic extracts on maturation of the immune system. Ann NY Acad Sci 249:343

92. Ceglowski WS, Hand TL, Friedman H (1973) Biologic activities of thymic pro- tein in the maturation of immune response. In: Luckey TD (ed) Thymic hor- mones. University Park Press, Baltimore

Page 174: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

172 J. Comsa et al.

93. Cerrottini JC, Brunner KT (1974) Cell mediated cytotoxicity. Adv Immunol 18:67

94. Cerrottini JC, Nordin AA, Brunner KT (1970) Specific in vitro cytotoxicity of thymic lymphocytes sensitized to alloantigens. Nature (London) 228:1308

95. Chaourat G (1978) Suppressor T cells in tolerance to human globulin. Cell Immunol 36 : 1

96. Chase J, White A, Dougherty TF (1946) Enhancement of circulating antibody concentration by adrenal cortical hormones. J Immunol 52:101

97. Chebotarev F (1968) Comparative study of the effect of desoxycorticosterone acetate on the level of antibodies in serum and lymphnode extracts. Vopr Immunol 3:35

98. Chiller JM, Habicht GS, Weigl WO (1970) Cellular sites of immune responsive- ness. Proc Natl Acad Sci USA 65:551

99. Chisari FV, Edington TS (1974) Human T lymphocytes "E", rosette function. J Exp Med 140:1123

100. Claman H, Bronsky EA (1960) Tolerance produced in immunized adult mice and its potentiation by immunosuppressive therapy. J Allergy 37:117

101. Claman I-I, McDonald W (1964) Thymus and irradiation in the termination of acquired immune tolerance. Nature (London) 202:712

102. Claman H, Chaperon EA, Triplett RF (1966) Thymus-marrow cell combina- tion. Synergism in antibody production. Proc Soc Exp Biol Med 122:1167

103. Claman H, Moorhead JW, Brunner WH (1971) Corticosteroids and lymphoid cells in vitro. J Lab Clin Med 78:499

104. Claman I-IM, Talmadge DW (1963) Thymectomy; prolongation of tolerance in the adult mouse. Sci Am 141:1193

105. Clark DA (1977) Characterization of the cell that suppresses the cytotoxic activity of T cells. Cell Immunol 34:25

106. Cohen JJ, Claman HM (1971) Hydrocortisone-resistant cells and processes in the hemolytic antibody response. J Exp Med 133:1061

107. Cohen JJ, Fischbach M, Claman HM (1970) I-Iydrocortisone resistance of graft versus host activity in mouse thymus, spleen and bone marrow. J Immunol 105: 1146

108. Cohen J J, Hooper JA, Goldstein AL (1975) Thymosine-induced differentiation of murine thymocytes. Ann NY Acad Sci 249:144

109. Cohen JT, Stavy L, Feldman M (1970) Glucocorticoids and cellular immunity in vitro. J Exp Med 132:1055

110. Colley DG, Malakian A, Waksman B (1970) Cell differentiation in the thymus. J Immunol 104:505

111. Comsa J (1952) Modification de Faction antithyroidienne du thymus chez le cobaye irradie aux rayons. Experientia 8:267

112. Comsa J (1959) Physiologie et physiopathologie du thymus. Doin, Paris 113. Comsa J (1973) Thymus substitution. In: Luckey TD (ed)Thymic hormones.

University Park Press, Baltimore 114. Comsa J (1973) Hormonal interactions of the thymus. In: Luckey TD (ed)

Thymic hormones. University Park Press, Baltimore 115. Comsa J, Filip G (1966) Influence de l'hormone thymique sur la production

d'anticorps chez le cobaye thymiprive. Ann Inst Pasteur (Paris) 110:365 116. Comsa J, Hook R (1973) Thymectomy. In: Luckey TD (ed) Thymic hormones.

University Park Press, Baltimore 117. Comsa J, Leonhardt H (1976) Influence de l'interaction thymus-corticosur-

renale sur le reject d'allogreffes chez le rat. Ann Endocinol (Paris) 37:51 118. Comsa J, Leonhardt H (1977) Mdcanisme de l'influence de la thyroide sur le

rejet d'allogreffe chez le rat. J Physiol (Paris) 73:36A 119. Comsa J, Leonhardt H (1977) Influence of the thymus-gonad interaction on

allograft rejection. Acta Endocrinol [Suppl] (Copenh) 212:258

Page 175: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 173

120. Comsa J, Leonhardt H (to be published) Influence of the thymus-adrenocorti- cal interaction in transplantation immunity. Res Exp Med

121. Comsa J, Philipp EM (1971) Essai de demonstration de la sdcrdtion de l'hor- mone thymique. J Physiol 63:193A

122. Comsa J, Schweissfurth R (1972) L'action chimiotactique de l'hormone thy- mique sur les lymphocytes. Pathol Biol (Paris) 20:639

123, Comsa J, Leonhardt H, Schwarz JA (1975) Influence of the thymus-corticotro- pine-growth hormone interaction on the rejection of skin allografts in rats. Ann NY Acad Sci 249:387

124. Comsal J, Schwarz JA, Neu H (1974) Influence of the thymus-growth hormone interaction on the production of precipitating antibodies in rats. Immunol Commun 3:11

125. Comsa J, Leonhardt H, Ozminski K (to be published) Hormonal influence on the function of the thymus. Thymus

126. Cone RE, Johnson AG (1971) Regulation of the immune response system by synthetic polynucleotides. J Exp Med 133:665

127. Cross AM, Leuchars E, Miller JFA (1974) Recovery of the immune response in irradiated mice thymectomized in adult life. J Exp Med 119:837

128. Dardenne M, Papiernik M, Bach JF, Stutman O (1974) Epithelial origin of the serum thymic factor. Immunology 27:299

129. Dardenne M, Pleau JM, Man MK, Bach JF (1977) Structural study of circulat- ing thymic factor. J Biol Chem 252:8040

130. Davies JS (1969) The thymus and cellular basis of immunity. Transplant Rev I: 43

131. Davies JS, Leuchars E, Wallis V, Koller PC (1966) Mitotic response of thymus- derived ceils to antigenic stimulation. Transplantation 4:438

132. Davies JS, Leuchars E, Wallis V, Marchant R, Elliot VE (1967) Failure of thy- mus-derived cells to produce antibody. Transplantation 5:222

133. Defendi V, Roosa RA (1964) Role of the thymus in carcinogenesis. In: Defendi, Metcalf (eds) The thymus. Wistar Institute Monographs, Philadelphia

134. Delmasso AP, Martinez C, Good RA (1962) Failure of spleen cells from thym- ectomized mice to induce graft-versus-host reaction. Proc Soc Exp Biol Med 110:205

135. Delmasso AP, Martinez C, Sjodin K, Good RA (1963) Role of the thymus in immunobiology. J Exp Med 118:1089

136. Dennert G (1976) Thymus-derived killer cells. Transplant Rev 29:59 137. Deschaux P (1977) Etudes in vivo et in vitro des interrdlation du thymus avec

certaines glandes endocrines. Thesis, Lyon 138. Deschaux P, Fontange R (1971) Effect de la thymectomie ndonatale ou adulte

sur la synthdse de la corticosterone chez le rat. J Physiol (Paris) 71:336A 139. Deschaux P, Portier A, Fontange R (1971) Influence de la corticotropine sur la

consommation d'oxyg~ne chez le rat. C R Acad Sci (Paris) 265:2123 140. Deschaux P, Flores JL, Fontange R (1974) Influence de la thymectomie sur la

surrdnale. Arch Int Physiol Biochim 82:115 141. Deschaux P, Dodin A, Laval F, Fontange R (1975) RSle de deux extraits thy-

miques darts le mdcanisme de protection contre une infection d'dpreuve. CR Acad Sci (Paris) 281 : 1443

142. Deschaux P, Morel G, Binimbo-Massengo A, Fontange R (1975) Contribution l'dtude de l'axe hypothalamohypophyseo-thymique. Arch Int Physiol Biochim

83:423 143. Dews PB, Code CF (1953) Anaphylactic reaction and antibody concentration

in rats and rabbits, effect of adrenalectomy and cortisone. J Immunol 70:199 144. Diamantstein T (1970) Mechanismus der immunosuppressiven Corticoidwir-

kung. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 196:76 145. Doenhoff MJ, Davies AJS, Leuchars E, Wallis T (1970) The thymus and cir-

calating antibodies. Proc R Soc Lond [Biol] 176:69

Page 176: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

174 J. Comsa et al.

146. Doria G, Agarossi G, Pietro S Di (1972) Enhancement of activity of a cell-free thymocyte culture medium on the in vitro response of spleen ceils from thym- ectomized mice to SRBC. J Immunol 108:268

147. Dougherty TF (1952) Effect of hormones on lymphatic tissues. Physiol Rev 32:379

148. Dougherty TF, White A (1945) Relationship of the effects~of adrenocortical secretion on lymphoid tissue and antibody titres. Am J Anat 77:81

149. Dougherty TF, Chase JH, White A (1945) Pituitary-adrenocortical control of antibody release from lymphocytes. Proc Soc Exp Biol Med 58:135

150. Dougherty TF, Berliner DC, Berliner ML (1961) Corticosteroid-tissue interac- tion. Metabolism 10:966

151. Dougherty TF, Berliner MZ, Schneebeli G, Berliner DL (1963) Hormonal con- trol of lymphatic structure and function. Ann NY Acad Sci 113:825

152. Duclos TW, Kim BS (1977) Suppressor T cells, presence in mice rendered tole- rant by neonatal treatment with antireceptor antibody or autrem. J Immunol 119:1769

153. Dukor P, Dietrich FM (1968) Characteristic features of immunosuppression by steroids and cytotoxic drugs. Int Arch Allergy Appl Immunol 34-32

154. Dumont F (1978) Physical subpopulations of mouse thymocytes. Immunology 34:841

155. Dunn TD, Trainin N, Levey RH (1966) Studies on thymic function. In: Met- calf, Defendi (eds) The thymus. Wistar Institute, Philadelphia

156. Duquesnoy RJ (1969) Effect of hypophysectomy on immunologic recovery from sublethal irradiation. Proc Soc Exp Biol Med 131 : 1076

157. Duquesnoy RJ (1975) Pituitary dwarf mouse, a model for study of endocrine immunodeficiency. Birth Defects 11:530

158. Duquesnoy RJ, Ahrens RC (1973) Increased responsiveness to PBA and graft versus host reaction of thymus cell from dwarf mice. J Immunol 110:578

159. Duquesnoy RJ, Mariani T, Good RA (1969) Thymus dependent lymphoid system in dwarf mice. Fed Proc 28:276

160. Dutton RW (1973) Inhibitory and stimulatory effect of con A on the response of mouse spleen cell suspension to antigens. J Exp Med 138:1496

161. Dutton RW, Falcoff R, Hirst JA, Hoffmann M (1971) Is there an evidence for non-antigen-specific diffusable chemical mediator from thymus-cells in the ini- tiation of the immune response. Prog Clin Immunol 355

162. Duve C De (1964) In: Thomas L, Ulu JW, Grant L (eds) Injure, inflammation, immunity. Williams & Wilkins, Baltimore

163. Eardley DD, Gershon RK (1976) Induction of suppressor cells in vitro. J Im- munol 117:313

164. Eartly H, Leblond PC (1954) Identification of the thyroxine effects mediated by the hypophyse. Endocrinology 54:949

165. East J, Parott DMV (1964) Prevention of wasting in mice thymectomized at birth and subsequent rejections of allogenic leukemic cells. J Nat Cancer Inst 33:673

166. Eisen I-IN, Mayer MM, Moore DH, Tarr RR, Stoerk HC (1947) Failure of adre- nocortical activity to influence circulating antibodies and globulin. Proc Soc Exp Biol Med 65:301

167. Eisental A, Nachtigal D, Feldman M (1977) Induction of allospecific T cells in vitro. Cell Immunol 34:112

168. Elliott EV, Sinclair MR (1968) Effect of cortisone on 19S and 7S hemolysin antibody. Immunology 15:643

169. Elliott EV, Weil V, Davies AJS (1971) Origin of the PHA responsive cells in the mouse thymus after treatment with cortisone. Nature (New Biol) 234:77

170. Ellison EH, Martin PC, Williams RD, Chatworthy HW, Hamwi G, Zollinger RM (1951) Adrenal cortical hormones and homografting. Ann Surg 134:495

Page 177: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 175

171.

172.

173.

174.

175.

175a.

176.

177.

178.

179.

180.

181.

182.

183.

184. 185.

186.

186a.

187.

188.

189.

190.

191.

192.

193.

194.

195.

Erb P, Feldmann M (1978) Role of macrophages in generation of T helper cells. Eur J lmmunol 5:759 Esselman WJ (1977) Modulation of cell response by a glycolipid released from antigen stimulated T cells. J lmmunol 119:1994 Fabris N (1973) Immune depression in thyroidectomized animals. Clin Exp Immunol 15:601 Fabris N, Piantanelli L, Muzzoli M (1977) Differential effects of pancreatec- tomy on humoral and cellular immune response. Clin Exp Immunol 28:306 Fabris N, Pierpaoli W, Sorkin E (9171) Hormones and immunological capacity. Clin Exp Immunol 9:209 Fabris N, Pierpaoll W, Sorkin E (1971) Hormones and immunological capacity. Clin Exp Immunol 9:227 Fache B, Charlemagne J (1975) Influence on allograft rejection of thymectomy at different larval states of Plemodeles. Eur J Immunol 5:133 Fachet J, Stark E, Vanant K, Palkovits M (1962)Some observations on func- tional interrelationship between thymus and adrenal cortex. Acta Med Acad Sci Hung 18:461 Fachet J, Palkovits M, Vallant K (1965) Effect of neonatal thymectomy on lymphatic organs, reticular elements and blood count. Acta Med Acad Sci Hung 221:303 Fagreus A (1952) Role of ACTH and cortisone in resistance and immunity. Acta Pathol Microbiol Scand [Suppl] 93:20 Fagreus A, Berglund K (1962) Inhibition of cortisone effect on antobody for- mation by heterologous spleen cells. Acta Pathol Microbiol Scand [A] 55:187 Feigelson P, Feigelson M (1968) Mechanism of cortisone action. In: Litwac (ed) Action of hormones on molecular processes. Wiley, New York, pp 57-128 Feldmann M (1972) Cell to cell interactions in the immune response in vitro. J Exp Meal 135:1049 Feldman M (1974) Cell to cell interaction in immune response. Ser Haematol 7:593 Feldman M (1974) T cell suppression in vitro. Eur J Immunol 4:667 Feldman M (1977) Requirement for interaction between two subpopulations of T ceils for helper cell induction in vitro. Immunitaetsforsch Immunobiol 153:217 Feldman M, Basten A (1972) Cell interactions in the immune response in vitro. J Exp Med 136:49 Feldman M, Basten A (1972) Cell interactions in the immune response in vitro. J Exp Med 136:722 Feldman M, Globerson A (1972) The inductive phase of antibody production. In: Borek F (ed) Immunogenetics. North-Holland, Amsterdam Feldman M, Funder JW, Edelman IS (1972) Subcellular mechanisms of steroid action. Am J Med 53:545 Feldman M, Kilburn JG, Levy J (1975) T-T cell interaction in the generation of helper cells. Nature (London) 256:741 Fischel EE (1950) Relationship of adrenocortical activity to immune response. Bull NY Acad Meal 26:255 Fischel EE, Vaughan JH, Photopoulos K (1952) Inhibition of rapid production of antibodies by cortisone. Proc Soc Exp Biol Med 81:346 Fisher ER, Fisher B (1965) Role of the thymus in skin and tumor cell trans- plantation in the rat. Lab Invest 16:546 Ford LF, Michclen HS (1963) Thymus and lymphnodes in radiation chimaeres. Lancet I:359 Fox KE, Gabourel JD (1972) Effect of cortisol on activity and distribution of two DNA-dependent RNA-polymerases of rat thymus. Endocrinology 90:1388 Fox CA, Whitehead RH (1936) Relation of the adrenal glands to immunologi- cal processes. J Immunol 30:51

Page 178: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

176 J. Comsa et al.

196. Friedman H (1965) Absence of antibody plaqueforming cells in spleens of thymectomized mice immunized with sheep erythrocytes. Proc Soc Exp Biol Med 118:1176

197. Friedman H (1975) Stimulation of B-immunocytes by a T cell factor produced in mixed lymphocyte cultures. Ann NY Acad Sci 249:266

198. Friedman H (1977) Differential effects of T cell-derived soluble factors on vir- gin and primed B cells. Transplant Proc 9:811

199. Gabourel GD, Comstock JP (1969) Effect of cortisol on aminoacid incorpora- tion by microsomes from mouse lymphoma. Biochem Pharmacol 13:1369

200. Gabrielson A, Good RA (1967) Chemical suppression of adaptive immunity. Adv Immunol 6:90

201. Galili R, Feldman M (1967) Role of macrophages in induction of antibody in X-irradiated animals. Immunology 12:197

202. Germuth FG (1956) Role of adrenocortical steroids in infection. Pharmacol Rev 8:1

203. Germuth FG, Oyama J, Ottenger B (1951) Mechanism of action of II dehydro- corticosterone and of adrenocorticotropic hormone in experimental hypersen- sitivity in rabbits. J Exp Med 96:139

204. Gershon RK (1974) T cell control of antibody production. Contemp Top Immunobiol 3:1

205. Gershon RK (1976) Role of T cells in immunosuppression. Adv Exp Med Biol 73:3

206. Gershon RK, Cohen P, Hencin R, Liebhaber SA (1972) Suppressor T cells. J Immunol 108:586

207. Gisler R (1971) Stress and the hormonal regulation of immune response. Psychother Psychosom 23:197

208. Gisler R, Dukor P (1972) Three cell mosaic cultures;in vitro immune response by combination of T and B cells with added macrophages. Cell Immunol 4:341

209. Gisler R, Schenkel-Hulliger L (1971) Influence of pituitary and adrenal activity on immune response. Cell Immunol 2:646

210. Gisler R, Schenkel-Hulliger L (1971) Hormonal regulation of the immune response. Cell Immunol 2:534

211. Gisler R, Staber F, Rude E, Dukor P (1973) Soluble mediators of T-B interac- tion. Eur J Immunol 3:650

212. Globerson A, Auerbach R (1967) Reactivation in vitro of immunocompetence in irradiated mouse spleen. J Exp Med 126:223

213. Globerson A, Umiel T, Friedman H (1975) Activation of immune competence by thymus factors. Ann NY Acad Sci 249:268

214. Globerson A, Kirov SM, Parish CR (1976) Involvement of ceils with B proper- ties in development of T helpers. Adv Exp Med Biol 66:69

215. Goble FC, Konopka EA (1973) Sex as a factor in infectious disease. Trans NY Acad Sci 35:325

216. Gotdstein AL (1970) The thymus as an endocrine gland. Recent Prog Horm Res 26:505

217. Goldstein AL (1978) Thymosin, basic properties and clinical potential in the treatment of patients with immunodeficiencies and cancer. Antibiot Chemo- ther 24:47

218. Goldstein AL, White A (1970) Thymus as an endocrine gland. In: Litwac G (ed) Biochemical action of hormones. Academic Press, London New York

219. Goldstein AL, Asanuma Y, Batisto JR, Hardy MA, Quint J, White A (1970) Influence of thymosin on cell-mediated and humoral immune response in nor- mal and immunodeficient mice. J Immunol 104:359

220. Goldstein AL, Bannerjee S, Schneebeli GL, Dougherty TF, White A (1970) Acceleration of lymphoid tissue regeneration in X-irradiated mice by thymosin. Radiat Res 41 : 579

Page 179: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 177

221. Goldstein AL, GuhaA, Howe ML, White A (1971) Ontogenesis of cell-mediated immunity in murine thymocytes and spleen cells. J Immunol 106:773

222. Goldstein AL, Guha A, Zatz MM, Hardy MA, White A (1972) Purification and biological activity of thymosis, a thymic hormone. Proc Natl Acad Sci USA 69:1800

223. Goldstein AL, Guha A, Hardy MA et al (1977) Thymosin, isolation and sequen- tial analyse. Proc Natl Acad Sci USA 74:725

224. Goldstein AL, Slater FD, White A (1966) Preparation, assay and partia ! purifi- cation of thymosin, a thymic lymphopoietic factor. Proc Natl Acad Sci USA 56:1010

225. Goldstein AL, Thureau GB, Rossio JL, Constantio JS (1977) Immunological reconstitution of patients with primary immunodeficiency and cancer. Trans- plant Proc 9:1141

226. Goldstein G (1968) The thymus and neuromuscular transmission. Lancet 119

227. Goldstein G (1974) Isolation of bovine thymin, a polypeptidic hormone of the thymus. Nature (London) 247:II

228. Goldstein G (1975) Isolation of thymopoietine (thymus). Ann NY Acad Sci 249:177

229. Goldstein G, Boyse EA (1975) Differentiation of T cells in nude mice. Science 190:1211

230. Goldstein G, Hoffman WW (1969) Endocrine function of the thymus affecting neuromuscular transmission. Clin Exp Immunol 6:181

231. Goldstein G, Manganaro A (1975) Thymin, a thymic polypeptide causing neuromuscular block of myasthenia gravis. Ann NY Acad Sci 183:230

232. Goldstein G, Silvestroni AE, Cantor H, Baltimore D (1974) Terminal-deoxy- nucleotidyl transferase is formed in prothymocytes. J Exp Med 144:543

233. Goldstein P, Wigzell H, Blomgren H, Svedmyr EAJ (1972) Cells mediating specific in vitro cytotoxicity. J Exp Med 135:890

234. Good RA, Delmasso C, Martinez C, Archer P, Pierce JC, Papermaster BW (1962) Role of the thymus in development of immunologic capacity. J Exp Med 116:773

235. Gorczynski RM, Miller RG, Phillips RA (1973) Reconstitution of T cell repleted spleen population by a factor derived from T cells. J Immunol 111 : 900

236. Gowans JL, McGregor DD (1965) Immunological activities of lymphocytes. Prog Allergy 9:1

237. Gowans JL, McGregor DD, Cowen DM (1964) Role of small lymphocytes in the rejection of skin homografts. In: Wolstenholme GEW, Knight J (eds) The immunologically competent cell. Little, Boston

238. Graff RJ, Lappe M, Snell GD (1969) Influence of gonads and adrenals on tissue response to skin grafts. Transplantation 7:105

239. Grant CK, Currie GA, Alexander P (1972) Thymocytes from mice immunized against an allograft render bone-marrow cells specifically cytotoxic. J Exp Med 135:150

240. Grant CK, Evans R, Alexander P (1973) Multiple effector roles of lymphocytes in allograft immunity. Cell Immunol 8:136

241. Greengard R, Cline O (1972) Hydrocortisone regulation of thymidine-kinase in thymus involution:. Biochim Biophys Acta 286:382

242. Gregoire C, Duchateau GH (1956) Reactions on the lymphatic tissue to ex- tracts and implants of the epithelial component of the thymus. Arch Biol (Liege) 67:269

243. Ha Ty, Wathsman BH (1973) Role of the thymus intolerance. J Immunol 110: 129

244. Haksar A (1975) Stimulation of cAMP and corticoid production in the isolated rat adrenal by cholera enterotoxin. Biochim Biophys Acta 381 : 301

245. Hammar JA (1936) Die normalmorphologische Thymusforschung. Barth, Leipzig

Page 180: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

178 J. Comsa et al.

246. Hanan R, Oyama J (1954) Inhibition of antibody formation in the rabbit by contact with antigen at an early age. J Immunol 73:49

247. Hand TL, Ceglowski WS, Damongsak D, Friedman H (1970) Development of antibody forming cells in neonatal mice. Stimulation and inhibition by calf thymus fraction. J Immunol 105:442

248. Hardy MA, Qunit AL, Slate D, White A (1968) Effect of thymosin and an anti- thymosin serum on allograft survival in mice. Proc Natl Acad Sci USA 61:875

249. Hartmann KW (1971) Induction of a hemolysin response in vitro. J Exp Med 133:1325

250. Hayes SP, Dougherty TF (1952) Effect of ACTH and cortisone on antibody synthesis and disappearance rate of antigen. Fed Proc 11:67

251. Hays EF (1969)Effect of epithelial remnants and whole organ grafts of thymus on the recovery of thymectomized X-irradiated mice. J Exp Med 129:1235

252. Hays EF, Albert PF (1969) Effect of short-termed epithelial reticular and whole organ thymus grafts in neonatally thymectomized mice. J Exp Med 130: 847

253. Hellig H, Waldek JF (1974) Effect of cortisol on the primary immune response, to sheep erythrocytes in vivo by mouse spleen cells. J Vet Res 41:29

254. Henney CS (1974) Relationship between cytolytic activity of thymus derived lymphocytes and cyclic nucleotide concentration. In: Bloom BR (ed) cAMP growth and immune response. Springer, Berlin Heidelberg New York

255. Hess MW (1966) Experimental thymectomy. Springer, Berlin Heidelberg New York

256. Hess MW, Stoner RD (1966) Further studies on tetanus antitoxin response in neonatally thymectomized mice. Arch Allergy Appl Immunol 30:37

257. Hochman PS, Kovacz G (1977) Different sensitivities to cortisol of natural killer cell activity and hybrid resistance to parental marrow grafts. J Immunol 119:2013

258. Hooper JS, McCaniel MC, Thurman GB, Cohen GH, Sculof RS, Goldstein AL (1975) Purification and properties of bovine thymosin. Ann NY Acad Sci 249: 125

259. Hopkin WJ (1978) Restoration of suppressor function in athymic mice. Im- munology 34:309

260. Houssay BA, Sordelli A (1921) Formation d'anticorps chez les animaux ethy- roidds. CR Soc Biol (Paris) 85:679

261. Humphrey JH (1964) Studies on globulin and antibody production in mice thymectomized at birth. Immunology 7:419

262. Hunt SW, Mason DW, Williams AF (1977) In rat bone marrow Thy antigen is present on ceils with membrane immunoglobulin and precursors of B cells. Eur J Immunol 7:817

263. Inzerillo R, Chiti E (1933) Ghiandole endocrine ed immunita. Arch Maragliano Patol Clin 8:595

264. Isakovic K, Smith SB, Waksman BH (1965) Role of the thymus in tolerance. J Exp Med 122:1103

265. Ishizuka K (1974) Promotion of antibody formation by prostaglandins. Experi- entia 30:1207

266. Ishizuka K, Gafni M, Braun W (1970) Cyclic AMP effects on antibody forma- tion and their similarities to hormone-mediated events. Proc Soc Exp Biol Med 134:963

267. Jaff~ HL, Marine D (1924) Effect of suprarenalectomy on agglutinine forma- tion in rats. J Infect Dis 35:334

268. Janeway CA (1978) Suppressor T cells and immunoregulation. Transplant Proc 10:355

269. Jankovic BD, Dvorak HF (1962) Enzymatic inactivation of immunologically competent lymph node ceils in the transfer reaction. J Immunol 89:571

Page 181: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 179

270.

271.

272.

273.

274.

275.

276.

277.

278.

279.

280.

281.

282.

283.

284.

285.

286.

287.

288.

289.

290.

291.

292.

293.

294.

295.

296.

Jankovic BD, Isakovic K, Horvat J (1965) Effect of a lipid fraction from rat thymus on the delayed hypersensitivity reaction. Nature (London) 208:356 Jeejeebhoy HF (1965) Immunological studies in rats thymectomized in adult life. Immunology 9:417 Jennings J, Taylor G (1964) Effect of cortisone hemisuccinate on immune lysis of sheep erythrocytes. Nature (London) 203:661 Jerne NK, Nordin AA (1965) Plaque formation by single antibody-producing cells. Science 140:405 Jones B, Jones TC (1978) Allograft cytotoxicity cooperation between alloim- mune T cells and macrophages. Immunology 34:247 Jones B, Jones TC, Roiff IM (1977) Allograft cytotoxicity. Immunology 32: 591 Jones JM, Kind PD (1972) Enhancing effect of bacterial endotoxin on bone marrow cell in the immune response. J lmmunol 108:1453 Kalden JR, Evans MM, Irvine WJ (1970) Effect of hypophysectomy on immune response. Immunology 18:671 Kaplan HS, Nagareda CS (1961) Effect of hydrocortisone and andrenalectomy on uptake of amino isobutyric acid. Am J Physiol 200:1035 Kappas A, Jones HEH, Roitt JM 91963) Effects of steroid sex hormones on immunological phenomena. Nature (London) 198:902 Kass EH, Kendrick ML, Finland M (1955) Effects of corticosterone, hydrocor- tisone and corticotropin on production of antibodies. J Exp Med 102:767 Kattwinkel J, Munck A (1966) Activities in vitro of glucocorticoids and related steroids to glucose uptake by rat thymus cells. Endocrinology 79:387 Katz DH, Bennacerraf B (1972) Regulatory influence of activated T cells. Adv Immunol 15: 2 Kayibanda B, Rosenfeld C (1975) Echanges d'information entre cellules T et pour la synthdse d'anticorps. CR Acad Sci [D] (Paris) 279:1645 Kelemen H, Lasmoler F, Milland G (1978) Is serum thymic factor of thymic origin? Natuere (London) 272:65 Kemp R, Duquesnoy RJ (1975) Lymphoic cell adenylatecyclase activity after X-irradiation and cortisone treatment. J Immunol 114:660 Kemp T, Marx L (1937) Beeinflussung yon erblichem hypophys/iren Zwerg- wuchs dutch Hypophysenhormone. Acta Pathol Microbiol Scand [A] 14:197 Kenny JF, Pangburn PC, Fraig G (1976) Effect of oestradiol on immune com- petence. Infect Immun 13:448 Kepinov L, Metalnikov S (1922) Glande thyroide et sensibilitd fi la tuberculine. CR Soc Biol (Paris) 87:10 Kiger M, Florentin I, Mathd G (1975) Further purification of the lymphocyte inhibiting factor from the thymus. Boll Ist Sieroter Milan 54:3 Kimberg DV, Loeb JH (1971) Differential sensitivity of nuclear and mitochon- drial DNA synthesis to cortisone. Biochim Biophys Acta 245:412 Kinoshita Y (1974) Cytolytic effects of glucocorticoids on thymic medullary lymphocytes in vitro. Exp Cell Res 87:387 Klein JJ, Goldstein AL, White A (1966) Effect of the thymus lymphopoietic factor. Ann NY Acad Sci 135:485 Knutson F, Lundin PM (I 966) Effect of hypophysectomy, adrenalectomy and cortisone on thymidicine incorporation in the ~:at organs. Acta Endocrinol (Copenh) 53:519 Komeva FA (1963) Effect of destruction of the hypothalamic areas on im- munoglucosis. Firziol Zh SSSR 49:42 Komuro K, Boyse EA (1973) Induction of T lymphocytes from precursor cells in vitro by a production of the thymus. J Exp Med 138:476 Komuro K, Goldstein G, Boyse A (1975) Thymus-rel0ol0ulating capacity of ceils that can be induced to differentiate to T cells in vitro. J Immunol 115: 195

Page 182: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

180 J. Comsa et al.

297. Konda S, Stockert E, Smith RT (1973) Immunologic properties of mouse thy- mus cells. Cell Immunol 17:275

298. Kontiainen S, Feldman M (1976) Suppressor cell induction in vitro. Eur J Immunol 6: 296

299. Kook AI, Trainin N (1974) Hormone-like activity of thymic humoral factors on induction of immune competence. J Exp Med 139:193

300. Kook AI, Trainin N (1975) Control excited by thymic hormone on cellular cAMP level and immune reactivity. J Immunol 115: 8

301. Kook AI, Yakir Y, Trainin N (1975) Isolation and partial chemical characterisa- tion of THF, a thymic hormone involved in immune maturation. Cell Immunol 19:151

302. Kretchmer RR, Perez-Tamayo R (1962) Role of humoral antibodies in skin allograft rejection in rabbits. J Exp Med 116:879

303. Kreth HW, Williamson A (1971) Cellular surveillance modes for lymphocyte cooperation. Nature (London) 255: 552

304. Krinsbeek AM (1978) Effect of aging and tumour-bearing on thymic hormonal function. Thesis, Utrecht

305. Krohn PL (1954) Effects of steroid hormones on the survival of skin allografts. J Endocrinol 12:78

306. Kfiiger J, Goldstein AL, Waksman BH (1970) Immunologic and anatomic con- sequences of calf thymosin injection in rats. Cell Immunol 1:51

307. Krisbeek AM, Astaldi GCB, Blankwater MJ, Zijlstra JJ, Levent LA, Astaldi A (1978) In vitro effect of a thymic epithelial culture supernatant on mixed lym- phocyte reactivity. Cell Immunol 35:134

308. Labat M, Moroz C (1975). Surface immunoglobulins in mousethymuscells. Cell Immunol 18:110

309. Lacombe M, Pleau F, Dardenne MA, Bach JF (1974) Thymectomy in young pigs effect on level of circulating thymic hormone. Surgery 76:558

310. Lance EM, Medawar PB (1969) Induction of tolerance with antilymphocyte serum. Transplant Proc 1:429

311. Laskov R (1968) Rosette-forming cells in nonimmunized mice. Nature (Lon- don) 219:975

312. Law LW (1965) Neoplasms in thymectomized mice following room infection with polyoma virus. Nature (London) 205:672

313. Law LW (1966) Immunologic responsiveness and induction of experimental neoplasms. Cancer Res 26:112

314. Law LW, Trainin N, Levey RH (1966) Studies on thymic function. In: Defendi, Metcalf (eds) The thymus. Wistar Institute

315. Law LW, Goldstein AL, White A (1968) Influence of thymosin on immuno- logic competence of lymphoid cells from thymeectomized mice. Nature (Lon- don) 219:1391

316. Lee KC (1977) Cortisone as a probe for cell interaction in the generation of cytotoxic T cells. J Immunol 119:1836

317. Lee KC, Langman RE, Paltken VH, Diener E (1975) Cellular basis of cortisone- induced immunosuppression of the antibody response studied by its reversal in vitro. Cell Immunol 17:403

318. Leuchars E, Gross AM, Dukor P (1967) Restoration of immunologic function by thymus grafting in thymectomized X-irradiated mice. Transplantation 3:28

319. Levey RH, Medawar PB (1966) Nature and mode of anti-lymphocytic anti- serum. Proc Natl Acad Sci USA 56:1130

320. Levey RH, Trainin N, Law LW (1963) Evidence for function of thymus tissue in diffusion chambers. J Nat Cancer Inst 31:199

321. Lewis W J, Cheerer EV, Vanderlaan WD (1965) Growth hormone in normal and dwarf mice. Endocrinology 76:210

322. Lipman MF, Halteman RH, Levinthal BG, Percy S, Thomson E (1973) Gluco- corticoid-binding proteins in human acute lymphoblastic leukemia. J Clin Invest 52:1715

Page 183: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 181

323. Litvac G (1970) Biochemical action of hormones. Academic Press, New York 324. Lohmann-Mathes ML, Fischer H (1973) T cell cytotoxicity and amplicication

of cytotoxic action by macrophages. Transplant Rev 17:150 325. Lonai P, Feldman M (1970) Coordination of lymphoid cells in an in vitro graft

reaction sytem. Transplantation 10:372 326. Lonai P, Clark WR, Feldman M (1972) Participation of theta bearing cells in an

in vitro assay of transplantation immunity. Nature (London) 229:566 327. Lonai P, Rotter V, Mogilnes B, Trainin N (1972) Effect of THF on differentia-

tion ofT cells. Isr J Med Sci 8:648 328. Loot F, Amstutz H, Hggg LB, Mayor KS, Roelants GE (1976) T cell lineage in

nude mice born from Nu/nu homozygous parents. Eur J Immunol 6:663 329. Luckey TD (1973) Thymic hormones. University Park Press, Baltimore 330. Luckey TD, Venugopal B (1975) Isolation of LSH and the evaluation of related

serum basic proteins in normal adults and cancer patients. Ann NY Acad Sci 249:166

331. McGillivray MW, Jones VE, Leskovits S (1974) Restoration of immunocompe- tence in thymectomized rats by a non-cellular thymic factor. Fed Proc 23:189

332. McGregor DD, Gowans JL (t964) Survival of homografts in rats depleted of lymphocyles by continuous drainage of the thoracic duct. Lancet 1:629

333. McManus JP, Whitfield JF (1969) Mediation of the mitogenic action of growth hormone by cyclic AMP. Proc Soc Exp Biol Med 132:409

334. McManus JP, Whitfield JF (1969) Stimulation of DNA synthesis and mitotic activity of thymic lymphocytes by cyclic AMP. Exp Cell Res 58:188

335. McMaster PD, Franzl RB (1961) Effect of adrenal corticosteroids on antibody formation. Metabolism 11:990

336. Maisin HF (1964) Essai d'immunoprophylaxie du cancer experimental. Bull Acad R Med Belg 4:197

337. Makman MH, Dvoskin B, White A (1961) Induction by cortisol of a protein inhibitor for transport and phosphorylation in rat thymocytes. Proc Natl Acad Sci USA 68:1269

338. Makman MH, Dvoskin B, White A (1966) Alteration in protein and nucleic acid metabolism of thymocytes by adrenal steroids. J Biol Chem 241 : 1646

339. Makman MH, Nakagawa S, White A (1967) Mode of action of adrenal steroids on lymphocytes. Recent Prog Horm Res 23:195

340. Makman MH, Nakagawa S, Dvoskin B, White A (1970) Inhibitory effect of cor- tisol and antibiotics on substrate entry and RNA synthesis in rat thymocytes in vitro. J Biol Chem 245:2556

341. Malkiel S, Hargis BJ (1952) Effect of ACTH and cortisone on the quantitative precipitin reaction. J Immunol 69:217

342. Mannick JA, Egdahl RH (1964) Transfer of heightened immunity to skin homo- grafts by RMA. J Clin Invest 43:2166

343. Marchalonis JJ, Cone RE, Rolley RT (1973) Amplification of thymus influ- enced lymphocytes by poly (A:W). J Immunol 110:561

344. Marine D, Manley OT, Bauman EJ (1924) Influence of thyroidectomy, gonad- ectomy, suprarenalectomy and splenectomy on the thymus. J Exp Med 40:429

345. Markham RB, White A, Goldstein AL (1975) Selective immunosuppressive activity in mice inoculated with Moloney sarcoma virus. Proc Soc Exp Biol Med 148:190

346. Martin W J, Miller JFAP (1968) Cell-to-cell interaction in the immune response. J Exp Med 128:855

347. Martinez C, Delmasso AP, Blaese M, Good RA (1962) Runt disease produced in thymectomized hybrid mice injected with parental strain lymphocytes. Proc Soc Exp Biol Med 111:404

348. Martinez C, Kersey B, Papermaster W, Good RA (1962) Skin homograft sur- vival in thymectomized mice. Proc Soc Exp Biol Med 109:193

349. Maximov A ( 1901) tYber Histogenese der Thymus bei S~iugetieren. Arch Mikrosk Anat Entwicklungsmech 74:525

Page 184: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

182 J. Comsa et al.

350. Medawar PB (1958) The homograft reaction. Proc R Soc Lond [Biol] 149:145 351. Medawar PB, Sparrow EM (1956) Effect of adrenocortical hormones, adreno-

corticotropic hormone and pregnancy on skin transplantation immunity. J Endocrinol 14:240

352. Meshalova AM, Frazinova IB (1960) Effect of cortisone on immunogenesis. Zh Mikrobiol Epidemiol Immunobiol 31 : 23

353. Metcalf D (1956) Thymic origin of plasma lymphocytosis stimulating factor. Br J Cancer 10:442

354. Metcalf D (1964) Functional interaction between thymus and other organs. In: Defendi V, Metcalf D (eds) The thymus. Wistar Institute Press, Philadelphia

355. Metcalf D (1965) Delayed effect of adult thymectomy on immunocompetence. Nature (London) 208:1336

356. Milcu S, Potop J (1973) Biologic action of thymic protein extracts. In: Luckey TD (ed) Thymic hormones. University Park Press, Baltimore

357. Milcu S, Potop J, Boer V, Olinici N (1975) Stimulation of antibody formation through polypeptide thymic factors in X-irradiated rabbits. Ann NY Acad Sci 249:380

358. Miller HC, Esselmann WJ (1975) Identification of theta bearing T cells derived from bone marrow cells treated with thymic factors. Ann NY Acad Sci 249:54

359. Miller HC, Schniege SK, Rule A (1973) Production of functional T cells after treatment of bone marrow with thymic factor. J Immunol Ill : 1005

360. Miller JFAP (1961) Immunological function of the thymus. Lancet II:748 361. Miller JFAP (1962) Role of the thymus in transplantation immunity. Ann NY

Acad Sci 99:340 362. Miller JFAP (1973) Immunological memory. In: Davies AJS, Carter RL (eds)

Contemp-topics in immunobiology. Plenum Press, New York 363. Miller JFAP, Mitchell GF (1968) Cell-to-cell interaction in the immune response.

J Exp Med 128:801,821,836 364. Miller JFAP, Mitchell GF (1968) Immunologic activity of thymus and thoracic

duct cells. Proc Natl Acad Sci USA 59:296 365. Miller JFAP, Mitchell GF (1969) Thymus and antigen reactive ceils. Transplant

Rev 1:3 366. Miller JFAP, Osoba D (1967) Current concepts of the immunologic function of

the thymus. Physiol Rev 47:437 367. Miller JFAP, Doak SMA, Cross MA (1963) Role of the thymus in the recovery

of immune mechanisms in the X-irradiated adult mouse. Proc Soc Exp Biol Med 192:785

368. Miller JFAP, Grant GA, Roe FJC (1963) Effect of thymectomy on induction of skin tumours by benzopyrene. Nature (London) 199:920

369. Miller JFAP, Leuchars E. Cross AM, Dukor P (1964) Immunologic role of the thymus in radiation chimaeras. Ann NY Acad Sci 120:205

370. Miller JFAP, Osoba D, Dukor P (1965) Humoral mechanisms responsible for immune maturation. Ann NY Acad Sci 124:95

371. Miller JFAP, Brugh PM de, Graflt GA (1969) Thymus and the antibody P.F.C. Nature (London) 208:1332

372. Mitchison MA (1953) Passive transfer of transplantation immunity. Nature (London) 171:267

373. Moeschlin S, Baguerra R, Baguerra J (1953) Influence of ACTH and cortisone on antibody production in rabbits. Bull Schweiz Akad Med Wiss 8:153

374. Moore PF, Kondo T, Oliver RJ (1960) Effect of cortisone on tumour trans- plantation. J Nat Cancer Inst 25 : 1097

375. Morita Y, Munck A (1964) Effects of glucocorticoids in vivo and in vitro on net glucose uptake and aminoacid incorporation. Biochim Biophys Acta 93:150

376. Mosher KM, Young DA, Munck A (1973) Time course of early events in the action of glucocorticoids on rat thymus ceils. J Biol Chem 248:2922"

Page 185: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 183

377. Mosher KM, Young DA, Munck A (1971) Irreversible actinomycine and tem- perature-sensitive steps following binding of cortisol to glucocorticoid recep- tors. J Biol Chem 246:654

378. Mosier DE, Coppleson LW (1968) A three-cell interaction required for induc- tion of primary response. Proc Natl Acad Sci USA 61 : 542

379. Mosier DE, Pierce W (1972) Functional maturation of thymic, lymphocyte populations in vitro. J Exp Med 136:1984

380. Mountain JM (1955) Antibody production in vitro. J Immunol 74:270 381. Mowbray JF (1963) Ability of large doses of plasma protein fraction to inhibit

antibody production. Immunology 6:217 382. Munck A (1965) Steroid concentration and tissue integrity as factors determin-

ing the physiological significance of effects of adrenal steroids in vitro. Endo- crinology 77: 356

383. Munck A, Brink-Johnson T (1968) Specific and nonspecific physicochemical interaction of glucocorticoids with rat thymus. J Biol Chem 243:5556

384. Munro AJ. Taussig MJ, Campbell R, Williams H, Lawson Y (1974) Antigen- specific T-cell-factor in cell cooperation. J Exp Med 140:1579

385. Najarian JS, Feldman M (1962) Function of the sensitized lymphocytes in homograft rejection. Ann NY Acad Sci 99:470

386. Najarian JS, Feldman M (1962) Passive transfer of transplantation immunity. J Exp Med 115:1083

387. Nakao S, Namba Y, Hanaoka M (1978) Differentiation of mouse T lympho- cytes. Acta Pathol Jpn 28:357

388. Nedred J, Touton M, Clark WR (1975) Requirement for DNA synthesis and generation of cytotoxicity in vitro. J Exp Med 142:960

389. Newson S, Darrach M (1954) Effect of corticotropin and corticosterone on hemolytic antibody production in the mouse. Can J Biochem 32:372; 33:374

390. Nielsen EL (1953) Effect of thyroxine and growth hormone on growth. Acta Pathol Microbiol Scand [A] 32:316

391. Norden SK, Young DA (1976) Glucocorticoid action on rat thymocytes. J Biol Chem 251:7295

392. North JR, Kremshead JT, Askonas BA (1977) Non-specific factor replace T cells in an JGG response to soluble antigen. J Immunol 33:321

393. Orosz CG (1978) Influence of killing assisting factor on generation of cytotoxic T cells. Cell Immunol 37:86

394. Osoba D (1965)Effect of pregnancy on restoration of immunSlogical responses in thymectomized mice. Science 147:298

395. Osoba D (1966) Effects of thymus and other organs enclosed in diffusion chambers on neonatally thymectomized mice. J Exp Med 122:191

396. Owen JT, Raff MC (1970) Differentiation of thymus-derived lymphocytes. J Exp Med 132:1216

397. Pandian MR, Talwar GP (1971) Effect of growth hormone on metabolism of thymus and immune response. J Exp Med 134:1095

398. Pantelouris S (1971) Immunobiology of nude mice. Immunology 20:247 399. Parrott D, Sousa M de (1971) Thymus-dependent and independent cell popula-

tions. Clin Exp Immunol 8:663 400. Parrott D, Sousa M de, East J (I 966) Thymus-dependent areas in lymphatic

organs of neonatally thymectomized mice. J Exp Med 123:191 401. Paznino MM, Ihle JM, Goldstein AL (1978) Induction in vivo and in vitro of

• terminal deoxymecleotidyltransferase in bone narrow cells of nude mice. J Exp Med 147:708

402. Pena A, Dwoskin B, White A (1966) Effect of a single cortisol injection on amino- acid incorporation of rat livers and thymus in vitro. J Biol Chem 241:2166

403. Perri WL, Faulk M, Shapiro E, Mellors T, Money WL (1963) Function of the thymus and growth of the mouse homograft. Nature (London) 200:1294

Page 186: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

184 J. Comsa et al.

404. Perlman P, Holm C (1969) Cytotoxic effects on lymphoid cells in vitro. Adv Immunol 11 : 117

405. Phflipps SM, Carpenter CB, Lane P (1975) Immunosuppressive globulin from bovine thymus and serum. Ann NY Acad Sci 249:236

406. PierpaoliW (1967) Thymectomy and prolongation of tolerance to bovine serum albumin. Nature (London) 214:802

407. Pierpaoli W, Besedowsky HO (1975) Failure of thymic factor to restore trans- plantation immunity in athymic mice. Br J Exp Pathol 56:180

408. Pierpaoli W, Besedowsky HO (1975) Role of the thymus in programming of neuroendocrine function. Clin Exp Immunol 20:323

409. Pierpaoli W, Sorkin E (1967) Relationship between thymus and hypophyse. Nature (London) 215:834

410. Pierpaoli W, Sorkin E (1967) Cellular modifications in the hypophyse of neo- natally thymectomized mice. Br J Exp Pathol 48:627

411. Pierpaoli W, Sorkin E (1968) Effect of heterologous antigrowth hormone serum on thymus and peripheral lymph nodes in mice. J Immunol 101:1036

412. Pierpaoli W, Sorkin E (1972) Alterations of adrenal and thyroid in mice with congenital absence of the thymus. Nature (New Biol) 238:282

413. Pierpaoli W, Baroni C, Fabin M, Sorkin E (1969) Reconstitution of antibody production in hormonally deficient mice by growth hormone, thyrotropine and thyroxin. Immunology 16: 217

414. Pierpaoli W, Fabris H, Sorkin E (1970) Developmental hormones and immuno- logical maturation. Ciba Found CoUoq

415. Pierpaoli W, Bianchi E, Sorkin E ( 1971) Hormones and immunological capacity. Clin Exp Immunol 9:889

416. Pitkins DH (1966) Effect of physiological stress on the delayed hypersensitivity reaction. Proc Soc Exp Biol Med 120:350

417. Pleau JM, Dardenne M, Bioquet Y, Bach JF (1977) Structural study of circulat- ing thymic factors. J Biol Chem 252:8045

418. Plescia O, Yamamoto I, Shimawara T, Fert C (1975) Early cellular events in the response of mice to SRBC reflected in the spleen level of cAMP. Ann NY Acad Sci 249:362

419. Pollak A, H~immerling W, Lampen M, Harveirs E de (1975) Surface morphology of murine and T lymphocytes. Eur J Immunol 5:32

420. Pora E. Toma V, Wittenberger C, Rusdea D (1961) Effects of thymectomy on cholinester~se activity, tissue respiration and muscle chronaxy in rats. Stud Univ Babes-Bolyai [Biol] (ser II) 2:202

421. Potop J, Milcu S (1973) Thymosterine. In: Luckey TD (ed) Thymic hormones. University Park Press, Baltimore

422. Potvorski EF, Maires RC (1967) Specific antigenicity of thymocytes. Nature (London) 213:135

423. Primus FJ, Martino L de, McDonald R, Hansen HJ (1978) Immunological reconstitution of T cell deprived mice. Cell Immunol 35: 25

424. Raff MC (1970) Two distinct populations of peripheral lymphocytes in mice distinguishable by immunofluorescence. Immunology 19: 637

425. Raff MC, Cantor H (1972) Subpopulations of thymus cells and thymus derived cells. In: Amos W (ed) Ist Internat Congress of Immunology. Academic Press, New York

426. Raft MC, Wortis HH (1970) Thymus-dependence of theta bearing cells in peri- pheral lymphatic tissue. Immunology 18:929

427. Raff MC, Nase S, Mitchison MA (1971) Mouse specific bone-marrow-derived lymphocyte antigen as a marker for thymus independent lymphocytes. Nature (London) 230:50

428. Reckard CR (1973) Tolerance in rats by treatment with antilymphocyte serum and adult skin homografts. J Surg Res 14:207

Page 187: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 185

429. Reif AE, Allen JMV van (1964) The AKR thymic antigen and its distribution in leukemia and nervous tissue. J Exp Med 120:413

430. Ritter MA (1977) Embryonic mouse thymocyte development enhancement by corticosteron. Immunology 33:241

431. Rixon RH, Whitfield JF, McManus JP (1971) Stimulation of growth hormone of DNA synthesis of rat thymocytes. Horm Metab Res 3:28

432. Robert A, Nazanine J (1961) Antiphlogistic property of certain II desoxystero- ids after systemic administration. Endocrinology 68:932

433. Roberts S, White A (1951) Influence of adrenal cortex on antibody production in vitro. Endocrinology 48:741

434. Robey G (1975) Further characterisation of an antibody stimulating factor isolated from bovine thymus. Ann NY Acad Sci 249:210

435. Roelants GE, Mayor-Withery KS (1977) Regulation of the T cell precursor pool by a humoral factor released by the thymus. Cell Immunol 34:420

436. Roitt IM, Torrigiani G, Greaves MF, Brostoff J, Playfair JHL (1969) Cellular basis of immune response. Lancet II:367

437. Rollinghoff MA, Pfitzenmaier K, Wagner H (1977) Cyclophosphamide-sensitive T cells suppress the in vivo generation of antigen-specific cytotoxic T lympho- cytes. J Exp Med 145:455

438. Rotter V, Nakamura J, Globerson A, Trainin M (1972) Thymus extracts induce differentiation of thymus-derived cells participating in the immune response. Isr J Med Sci 8:647

439. Rotter V, Globerson A, Nakamura J, Trainin M (1973) Studies on characterisa- tion of the thymus lymphatic target cell for activity of a thymic humoral fac- tor. J Exp Med P 38:130

440. Rubin AS, Carpenter CR (1977) Dual biological function of a T cell derived immunoenhancing factor. Cell Immunol 34:104

441. Ruthenstroth-Baur W, Liicke-Huhle C (1968) Two populations of small lym- phocytes. J Cell Biol 37:196

442. Sabolevic EB, Dumont F (1973) Separation and characteristics of cell sub- populations in the thymus. Cell Immunol 24:601

443. Sand H, Haynes RC (1970) Effects of glucocorticoids on the acid DNAse of the thymus. Endocrinology 86:144

444. Sanders GC, King DW (1966) Antibody synthesis in vitro by paired explants of thymus and spleen. Science 151 : 1390

445. Sato VL, Waksal SI), Herzenberg LA (1976) Identification and separation of pre T cells from nu/nu mice by preculture with thymic reticuloepitelial cells. Cell Immunol 24:173

446. Savart M, Daniel-Lamaziere JM (1975) Effets sur la transcription du cortisol et du complexe transcortine cortisol du thymus. CR Acad Sci [D] (Paris) 281 : 1517

447. Schafer LA, Goldstein AL, Luttermann JW, Heisler EM (1976) In vitro and in vivo studies with thymosin in cancer patients. Ann NY Acad Sci 277:609

448. Schaller RT, Stevenson JK (1967) Reversal of post-thymectomy wasting syn- drome by multiple thymus grafts in diffusion chambers. Proc Soc Exp Biol Med 124:199

449. Schaumburg BP (1972) Glucocorticoid-binding protein from thymocytes. Biochim Biophys Acta 263:416

450. Scheid MP, Goldstein G, Hammerling W, Boyse EA (1975) Lymphocyte differ- entiation from precursor ceils in vitro. Ann NY Acad S ci 249:531

451. Scheid MP, Hoffman MK, Komuo K et al (1973) Differentiation of T ceils induced by preparations of thymus and nonthymic agents. J Exp Med 138:1027

452. Schellein Y, Hesselj6 R, Paulsen F, Malgren J (1954) Plasma cell production promoted by pituitary somatotropic hormone in the adaptation syndrome. Acta Pathol Microbiol Scand [A] 35:503

Page 188: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

186 J. Comsa et al.

453. Schimpl A, Wecker E (1970) Inhibition of in vitro response by treatment of spleen cells with antitheta serum. Nature (London) 226:1258

454. Schimpl A, Wecker E (1972) Replacement of T cell function by a T cell pro- duct. Nature (London) 237:15

455. Schimpl A, Wecker E (1973) Stimulation of JgG antibody response in vitro by T cell replacing factor. J Exp Med 137:547

456. Schlesinger M (1970) Antitheta antibodies for detecting thymus-dependent lymphocytes in the immune response. Nature (London) 226:1254

457. Schlesinger M (1974) The lymphocyte membrane. Ser Haematol 7:427 458. Schlesinger M, Goldstein G (1975) The aminoacid sequence of thymopoietine.

Cell 5:361 459. Schlesinger M, Yaron T (1969) Antigenic changes in lymph node cells follow-

ing thymectomy. Isr J Med Sci 5:445 460. Schlesinger M, Shlonai-Korzash Z, Israel E (1973) Antigenic difference between

spleen-seeking and lymph-node seeking thymus cells. Eur J Immunol 3:339 461. Schlesinger M, Goldstein G, Scheid M, Boyse EA (1975) Chemical synthesis of

a peptide of thymopoietine inducing T cell differentiation. Cell 5:367 462. Schrek B (1966) Cytotoxicity of adrenal cortex hormones on normal and

malignant lymphocytes. Proc Soc Exp Biol Med 108:1120 463. Senon B, Renne T, Sermlar R, Delor B, Dubois JB, Thierry C (1975) T-lympho-

cyte maturation and antitumoral effect of a thymic extract obtained from a stimulated model. Ann NY Acad Sci 249:328

464. Sergeev AV, Bykovskaya SM, Lucharskaya LM (1978) Pyridoxine deficiency and cytotoxicity of T cells. Cell Immunol 38:193

465. Sethi KK, Brandis H (1978) Characteristics of soluble T cell derived factors. Z Immunitaetsforsch Immunobiol 154:226

466. Shaskar JR, Bottoner GD (1974) Intranuclear binding of cortisol in liver and thymus. Proc Soc Exp Biol Med 147:232

467. Shuyser M (1969) Interaction of steroid-hormones with histones in vitro. Bio- chim Biophys Acta 182:235

468. Simonsen M (1962) Graft versus host reaction. Prog Allergy 6:349 469. Sinclair MR, Elliott EV (1968) Neonatal thymectomy and hemolysin response

in mice. J Immunol 101:251 470. Sininski A (1967) Influence of thymectomy on plasma corticosterone in the

rat. Gen Comp Endocrinol 8:378 471. Smith PE, McDowell EC (1931) Differential effect of hereditary mouse dwarf-

ism on the anterior pituitary hormones. Anat Rec 50:85 472. Snell GD (1930) Effect of anterior pituitary extracts on the thyroid of dwarf

mice. Anat Rec 47:316 473. Solomon GE (1969) Stress and antibody response in rats. Arch Allergy 35:97 474. Sopori ML, Alter B J, Bach FH, Bach ML (1977) Cell-free factor substitute for

signal in generation of cytotoxic reactions. Eur J Immunol 7:823 475. Sorkin E, Pierpaoli W, Fabris N, Bianchi F (1971) Relation of growth hormone

to thymus and immune response. In: Pecile A (ed) Growth and growth hor- mone (2nd Intern Sympos Excerpta Med, Amsterdam)

476. Sparrow E (1953) Behaviour of skin auto- and homografts in the guinea pig with special reference to the effect of cortisone and ascorbic acid. J Endocrinol 9:101

477. Stern K, Davidsohn J (1955) Effect of estrogen and cortisone on immune hemoantibodies. J Immunol 74:474

478. Stetson CA (1963) Role of humoral antibody in the homograft reaction. Adv Immunol 3:97

479. Stobo JD, Pane WE (1972) Functional heterogeneity of murine lymphatic cells. Cell Immunol 34:367

480. Strauch G~ Pardos P, Luton JP, Bricairne H (1971) Stimulation de la secretion d'hormone de croissance par la corticotropine. Ann Endocrinol 32:526

Page 189: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 187

481. Stutman O (1978) Intrathymic and extrathymic cell maturation. Transplant Rev 42:138

482. Stutman O (1975) Humoral thymic factors influencing post thymic cells. Ann NY Acad Sci 249:89

483. Stutman O, Good RA (1973) Thymus hormones. Comtemp Top Immunobiol 2:299

484. Stutman O, Good RA (1974) Duration of thymic function. Ser Haematol 7: 505

485. Stutman O, Yunis EJ, Martinez C, Good RA (1967) Reversal of postthymec- tomy wasting in mice by multiple thymus grafts. J Immunol 98:79

486. Stutman O, Yunis EJ, Good RA (1969) Carcinogen induced tumours of the thymus. J Nat Cancer Inst 43:499

487. Stutman O, Yunis EJ, Good RA (1970)Cooperative effect of thymic function and lymphohematopoietic cells in restoration of neonatally thymectomized mice. J Exp Med 132:583

488. Sunshine GH, Basch RS, Coffey RG, Cohen KW, Goldstein G (1978)Thymo- poietin enhances the allogenic response and cyclic AMP levels of mouse peri- pheral thymus derived lymphocytes. J Immunol 120:1594

489. Sutherland EW, Hayes RC (1967) Increased aminoacid release from rat thymus after corticoid administration. Endocrinology 80:288

490. Talwar GP, Hanjan SHS, Kidvaz Z, Gupta PD, Mahrota ND, Sayana R, Bhattarai R (1976) Growth hormone action on thymus and lymphatic ceils. In: Pecile A, Muller E (Hrsg) Growth hormone and related peptides. Elsevier, Amsterdam

491. Tasuda M, Greer MA (1978) Evidence that the hypothalamus mediates endo- toxine stimulation of adrenocorticotropic hormone secretion. Endocrinology 102:947

492. Taylor RB (1964) Effect of thymectomy on recovery from immunologic para- lysis. Immunology 7: 595

493. Taylor RB (1965) Decay of immunologic responsiveness after thymectomy in adult life. Nature (London) 208:1334

494. Taylor RB, Allison AC (1967) Observations on thymectomy and carcinogene- sis. Cancer Res 27:763

495. Thompson EB, Lippman MF (1974) Mechanism of glucocorticoid action. Meta- bolism 23:159

496. Thompson JS, Furth R van (1973) Effect of glucocorticoids on proliferation and kinetics of promonocytes and monocytes of the bone marrow. J Exp Med 137:10

497. Thompson JS, Crawford MK, Reilly R, Sevensen C (1967) Estrogenic hor- mones in immune response in normal and X-irradiated mice. J Immunol 98: 331

498. Thong YA, Hensen SA, Vincent MM, Rola-Pleszczinski M, Walsh JB, Bellanti JA (1975) Effect of cortisol on in vitro cellular immunity to viruses in man. Clin Immunol Immunopathol 3:363

499. Thurman GB, Brosio JL, Goldstein AL (1972) Thymosin induced recovery of T-cell function following cortisol treatment. Transplant Proc 9:1201

500. Thurman GB, Barr PS, Goldstein AL (1975) Examination of lymphocyte mem- brane of nude mice with scanning electrone microscope. Ann NY Acad Sci 249:154

501. Torgyan S (1972) Thyroid connection of humoral immunorectivity. Ann Immu- nol Hung 16:459

502. Touraine JL, Incefy GS, Touraine F, Rho YM, Good RA (1974) Differentia- tion of human bone marrow cells into T-cells when incubated with a thymic factor. Clin Exp Immunol 17:151

503. Touraine JL, Incefy GS, Goldstein AL, Good RA (1975) Thymic factor and human T-cell differentiation. In: Bekkum DW van (ed) Biologic activity of thymic hormones. Kooykes, Rotterdam

Page 190: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

188 J. Comsa et al.

504. Trainin N (1974) Thymic hormones and the immune response. Physiol Rev 51:272

505. Trainin N, Linker-Israeli M (1967) Restoration of immunologic activity of thymectomized mice by calf thymus extract. Cancer Res 27:309

506. Trainin N, Small M (1970) Some physicochemical properties of a thymic humoral factor confering immunocompetence on lymphoid cells. J Exp Med 132:885

507. Trainin. N, Burger M, Linker-Israeli M ( 1967) Restoration of homograft response in neonatally thymectomized mice by a thymic humoral factor. Williams & Wil- kins, Baltimore

508. Trainin N, Burger M, Kaye AM (1967) Characteristics of a thymic humoral factor determined by in vivo assay in lymph nodes from thymectomized mice. Biochem Pharmacol 16:711

509. Trainin N, Small M, Globerson A (1969) Immunocompetence of spleen cells from neonatally thymectomized mice conferred in vitro by a syngenic thymus extract. J Exp Med 130:765

510. Trainin N, Small M, Kimhi Y (1973) Characteristics of a thymic humoral fac- tor involved in development of cell-mediated immune competence. In: Luckey TD (ed) Thymic hormones. University Park Press, Baltimore

511. Trainin N, Levo Y, Rotter V (1974) Resistance to cortisol conferred upon thymocytes by a thymie humoral factor. Eur J Immunol 4:634

512. Trainin N, Kook AJ, Albuia M, Umiel T (1975) Nature and mechanism of stimulation of immune response by thymus extracts. Ann NY Acad Sci 249: 349

513. Tse Hy (1978) Separations of helper and suppressive T cells. J Immunol 120: 1149

514. Tucker DF, Dennert G, Lennox ES (1974) Thymus-derived lymphocytes as mediators of cell-mediated immunity. J Immunol 113: 1288

515. Tyan HL, Cole LJ, Davies WE (1963) Thymus; its limited role in the recovery of homograft response in X-irradiated mice. Science 142:584

516. Umiel T, Trainin N (1975) Increased reactivity of responding cells in the mixed lymphocyte reaction by a thymic humoral factor. Eur J Immunol 5:85

517. Vann DC (1974) Restoration of the in vitro antibody response of cortisone- treated spleen cells by T-cells or a soluble factor. Cell Immunol 11 : 11

518. Vessey SH (1964) Effect of grouping on levels of circulating antibodies in mice. Proc Soc Exp Biol Med 115:252

519. Visscher TL (1972) Effect of cortisol in the reactivity of thymus and spleen cells to in vitro stimulation. Immunology 23:777

520. Wagner H (1973) Synergy during in vitro cytotoxic allograft response. J Exp Med 138:1379

521. Wagner H, Feldman M, Boyle W, Scinader JW (1972) Requirement for macro- phages in cytotoxic reaction against cell-bound and subcellular antigens. J Exp Med 136:331

522. Wagner H, Harris AW, Feldman M (1972) Cell-mediated immune response in vitro. Cell Immunol 4:30

523. Wahl S J, Altmann LC, Rosenstreich DL (1975) In vitro inhibition of lympho- kinine synthesis by glucocorticoids. J Immunol 115:476

524. Waksal D, Cohen JR, Waksal HW, Wekerle H, St Pierre R, Feldman M (1975) Induction of T-cell differentiation in vitro by thymus epithelial cells. Ann NY Acad Sci 249:492

525. Waksman BH, Arnason BG, Jankovic BD (1962) Role of the thymus in immune reaction in rats. J Exp Med 116:187

526. Waldmann H, Munro A (1974) T cell-dependent mediator in immune response. Immunology 27:53

527. Walker SM, Lucas ZJ (1972) Cytotoxic activity of lymphocytes. J Immunol 109:1233

Page 191: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 189

528. Wara W, Ammann AJ (1975) Activation of T cell rosettes in immuno deficient patients by thymosine. Ann NY Acad Sci 249:308

529. Wara W, Goldstein AL, Doyle H, Ammann AJ (1975) Thymosine activity in immunodeficient patients. N Engl J Med 292:70

530. Watts HG (1971) Role of cyclic AMP in the immunocompetent cell. Transplan- tation 12:229

531. Webb DR (1977) Role of prostaglandin in the control of immune response. Cell Immunol 33:1

532. Wecker E, Schimpl A, Htinig T, Kophn L (1975) T-cell produced mediator active in the humoral immune response. Ann NY Acad Sci 249:258

533. Weismann JL (1973) Thymus cell maturation. J Exp Med 137:504 534. Weismann G, Thomas L (1962) Effect of endotoxine tolerance and cortisone

on the release of acid hydrolases from lysosomes. J Exp Med 116:433 535. Weismann G, Thomas L (1964) Effect of corticosteroids on connective tissue

and lysosomes. Recent Prog Horm Res 20:115 536. Wekerle H (1973) Thymus reticulum confers T cell properties on spleen cells

from thymectomized animals. Eur J Immunol 3: 745 537. Werthamer S, Hicks C, Amarat L (1969) Protein synthesis in human leukocytes

and lymphocytes. Blood 34:348 538. Wexler BC, Dolgin AE, Trygzynski EW (1957) Effect of bacterial polysaccha-

ride on pituitary-adrenal axis. Endocrinology 61 : 300 539. Whitfield JF, McManus JP, Rixon RH (1970) Cyclic AMP mediated stimulation

of thymocyte proliferation by low concentrations of cortisol. Proc Soc Exp Biol Med 134:1170

540. Willis-Cart J J, St Pierre RL (1978) Effects of vitamin B6 deficiency on thymic epithelial cells and T lymphocyte differentiation. J Immunol 120:1153

541. Wilson DB (1963) Reaction of immunologically activated lymphocytes against homologous target cells. J Cell Physiol 62:273

542. Wilson DB, Billingham RE (1967) Lymphocytes and transplantation immunity. Ad~/Immunol 7:189

543. Wilson R, SjSdin K, Beahnar M (1964) Thymus studies in germfree mice. In: Defendi V, Metcalf D (eds) The thymus. Wistar Institute Press, Philadelphia

544. Winchurch R, Ishizuka M, Webb D, Braun W (1971) Activity of spleen cells exposed to immunoenhancing synthetic oligo- and polynucleotides. J Immunol 106:1399

545. Wioland M, Sabolovic D, Burg C (1972) Electrophoretic mobilities of T and B cells. Nature (London) 237:274

546. Wira C, Munck A (1970) Specific glucocorticoid receptors on thymus cells. J Biol Chem 245:3436

547. Wistar R, Hildeman WH (1960) Effect of stress on skin transplantation immun- ity. Science 131 : 159

548. Wong FM, Taub RH, Sherman JD, Dameshek W (1966) Effect of thymus en- closed in millipore envelopes on thymectomized hamsters. Blood 28:40

549. Wortis HH, Nielsen S, Owen JJ (1971) Abnormal development of the thymus in nude mice. J Exp Med 134:681

550. Yates FE, Urquhard J, Herbst AL (1958) Effect of thyroid hormones on ring A reduction of cortisone by liver. Am J Physiol 195:373

551. Young DA (1970) Ghicocorticoid action on rat thymus cells. J Biol Chem 245: 2749

552. Young RH, Hopkins P, Esparza A (1963) Humoral aspects of homograft in the rabbit. Am J Pathol 43:227

553. Yunis L, Hillgard HR, Martinez C, Good RA (1965) Immunologic reconstitu- tion of thymectomized mice. J Exp Med 121:607

554. Zaalberg OBVD, Maul VA, Twisk MJ (1964) Antibody production of isolated spleen cells. J Immunol 100:451

Page 192: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

5. Comsa et al. 190

555. Zahnd GR, Nadeau A, Muhlendahl KE (1969) Effect of corticotrophine on plasma growth hormone. Lancet II: 1287

556. Ziller K (1972) Thymus specific antigens on electrophoretically separated rat. Eur J Immunol 2:439

557. Zinzar SM, Svetmoldavski GY (1967) Features of antibody formation in neo- natally thymectomized mice. Nature (London) 244:295

558. Zissblatt M, Goldstein AL, Lily F, White A (1970) Acceleration by thymosin of development of resistance to murine virus-induced sarcoma in mice. Proc Natl Acad Sci USA 66:1170

References added in proof

559. A1-Adra AR, Pilanke LM (1978) Antigen specific suppression of cytotoxic T cell response. Eur J Immunol 8:360

560. Bezvershenko I, Giulling E, Dyugovskaya L (1979) Suppression of IgE anti- body production by non-polypeptide dialysable thymic factor. Immunology 36:229

561. Dardenne M (1978) Alteration in thymocyte surface marker after in vivo treat- ment with serum thymic factor. Cell Immunol 34:47

562. Deschaux P, Claustrat B, Fontanges R (1978) Modifications quantitatives des ceUules somatotropes hypophysaires de rat aprds thymectomie. Experientia 34: 1525

563. Deschaux P, Fontanges R, Goldstein AL (1979) Effets de la thymosine et d'un extrait de cultures de cellules dpithdliales thymiques sur la production d'anti- corps. Experientia 35: 678

564. Eldinger D, Garrett TJ (1971) Regulatory effects of sex hormones on antibody production. J Exp Med 136:1098

565. Elliott LH (1978) Suppressor cell regulation of the spontaneously induced anti- body response. Cell Immuno140:46

566. Esselman WJ, Miller HC (1977) Modulation of B cell response by glycolipid released from antigen stimulated T cells. J Immunol 119:1996

567. Fauci AS, Pratt KR, Whalen G (1977) Activation of human B lymphocytes. J Immunol 119:598

568. Gillette S, Gillette R (1979)Changes in thymic estradiol receptor expression following castration in males. Cell Immuno142:194

569. Hoffmann MK, Watson J (1979) Helper T cell replacing factors secreted thy- mus-derived cells and macrophages. J Immunol 122:1371

570. Humber DP, Pinder M, Hetherington CM (1975) Effects of pregnancy on the immunocompetence of congenitally athymic (nude) mice. Transplantation 19:9

571. Law LW, Trainin N, Levey RH (1964) Humoral thymic factor in mice. Science 143:1049

572. McDougal JL, Shen FW, Elster P (1979) Generation of cytolytic lymphocytes in vitro. J Immunol 122:437

573. Mandi B (1979) Detection of thymosin in calf and mouse thymus and in nude mouse dysgenetic thymus. Folia Biol (Praha) 25:49

574. Martinez D, Field A, Schwann H, TyreU AA, Hilleman MR (1978) Failure of thymopoietine, ubiquitine and serum thymic factor to restore immune response in T cell deficient mice. Proc Soc Exp Biol Med 159:195

575. Nagy E (1978) Immunodeficiency in hypophysectomized rats. Acta Endocrinol (Copenh) 89:530

576. Parfillo E (1979) Mechanism of glucocorticoid action on immune response. Ann Rev Pharmacol Toxicol 19:179

577. Reichman ME (1978) Oestradiol binding by rat thymus cytosol. J Steroid Bio- chem 9:637

Page 193: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Hormonal Coordination of the Immune Response 191

578. Stimson WH, Hunter IC (1976) Immunosuppressive properties of oestrogens. J Endocrinol 69:42

579. Stutman O (1974) Inability to restore immune functions in nude mice with humoral thymic factor. Fed Proc 33:136

580. Stutman O (1978) Intrathymic and extrathymic T cell maturation. Transplant Rev 42:138

581. Stutman O (1979) Postthymic precursor ceils give rise to Ly+l Ly+23 subsets of T cells. Transplant Proc 11:907

582. Tenet GSL, Morrison SL, Habicht GS (1968) Quantitative differences in the immune response between male and female mice. Proc Soc Exp Biol Med 127: 664

583. Waltman SR, Brude RM, Benios J (t 971) Prevention of corneal graft rejection by oestrogens. Transplantation 11 : 194

584. Watson J, Aarden LA, Lefkowitz I (1979) Purification and quantitation of helper T-cell replacing factors secreted by murine cells. J Immunol 122:209

585. Wekerle H, Ketelsen UP (to be published) Nature (London) 586. Wekerle H, Ketelsen UP, Ernst M (to be published) J Exp Med 587. Zinkernagl RM (1978) Thymus and lymphohemopoietic cells, their role in

T cell maturation, in selection of T cells, H 2 restriction, specificity and H 2 linked Ir gene control. Transplant Rev 42:224

588. Zinkernagl RM, Althage A (1979) Search for suppression of T cells specific F 1 leads to prediation chimaeras. J Immunot 122:1742

Page 194: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index Page numbers in italics refer to the bibliography. Numbers shown in parentheses are the numbers of the references in the bibliography.

Aarden LA, see Watson J (584) 124,191

Abe T, Nomura M (1) 147, 148, 168

Abita JP, see Romey G 11, 72 Abraham AD, Sekerin CE (2)

156,157,168 Abramson RG, see Stein RM

90,112 Aceves J, see Diezi J 92, 106 Acheson GH, see Kahn JB

36, 68 Acheson GH, see Krayer O

3, 4, 23, 69 Ackerman U, see Pearce JW

96,110 Adam KR, Schmidt H,

St~mpfli R, Weig C 10, 64 Adams PB (3) 119,168 Adler-Graschinsky E, see

Langer SZ 44, 69 Agarossi G, see Doria G (146)

123,174 Agarwal K, Garby L (4) 157,

168 Agosier M, Christen R, Badi-

ner O, Gasic G (5) 147,168 Agus ZS, Puschett JB, Senesky

D, Goldberg M 98,103 Ahrens RC, see Duquesnoy RJ

(158) 154,174 Aisenberg AC, Davis C (6) 168 Aisenberg AC, Wilkes B (7)

133, 134,168 Akera T, Brody TM 56, 64 Akera T, Ku DD, Frank M,

Brody TM, Iwasa J 42, 43, 64

Albuquerque EX, see Shotz- berger GS 39, 73

Alexander E, see Auld R 93,103

Alexander EA, see Bruns FJ 78 ,79 ,81 ,104

Alexander E, see Davidman M 79, 80, 94,105

Alexander EA, see Migdal S 78,110

Alexander P, see Grant CK (239,240) 121,177

Alexander RW, Gill JR, Yamabe H, Lovenberg W, Keiser HR 99, 103

Alfonso A, see Kupchan SM 4, 69

Algire GH, Weaver JM, Prahn RT (8) 120, 168

Allen DG, Blinks JR 56, 64 Allen HL, Williams RD, Lovin-

good CG, Ellison EH (9) 155,168

Allen JMV van, see Reif AE (429) 125,185

Allen PA, see Tanz RD 41, 73 Allison AC, see Taylor RB

(494) 187 Allison M, Lipham E, Gott-

schalk CW 100, 103 Almeida AP, see Langer SZ

44, 69 Alsen C, B6ress L, Fischer K,

Proppe D, Reinberg T, Sattler RW 46, 64

Alter B J, see Sopori ML (474) 124,186

Akera T, see Ku DD 42, 43, 69 Althage A, see Zinkernagl RM A1-Adra AR, Pilanke LM (559)

122, 190 Albert PF, see Hays EF (252)

117, 134,178 Albuia M, see Trainin M (512)

188 Albuquerque EX, Warnick JE

13, 64 Albuquerque EX, see Hogan

PM 17, 37, 38, 49, 67 Albuquerque EX, see Kayaalp

SO 37, 68

(588) 131,132,191 Altmann LC, see Wahl SJ

(523) 157,188 Amarat L, see Werthamer S

(537) 157,189 Ambrose CT (10) 148, 168 Amerding D, Katz DM (11)

123 ,137 ,168 Aramann A J, see Wara W

(528,529) 137,138,189 Amstutz H, see Loor F (328)

126,181

Anagnostopoulos T, see Bentzel CJ 84,104

Ances IG, see Beitens IZ 100, 103

Anderson B, see Blomgren H (65, 66) 126,149, 170

Anderson NC, see Narahashi T 31,70

Andreucci VE, see Herrera- Acosta J 80, 107

Andreucci VE, see Wallin JD 76, 78,112

Anggard E, see Oliw E 97, 110

Antoni H, see Kaufmann R 18, 68

Antonio A, see Corrado AP 44, 66

Aperia A, Broberger O, Thode- nius K, Zetterstrom R 99,103

Aras M, see Bank N 85, 86, 103

Arbel ER, Lazzari J, Glick G 17, 21, 22, 49, 64

Archer OK, Pierce JC (12) 117,168

Archer P, see Good RA (234) 121,177

Argyris B (13) 119,168 Arman CG van, see Scriabine

A 49,72 Axnason BG, Jankovic BD,

Waksman BH, Wennersten C (14) 117,168

Arnason BG, Vaux de St Cyr C, ShafnerJB (15) 117,169

Arnason BG, see Waksman BH (525) 117,188

Arnaud CD, see Schneider EG 98,111

Arrenbrecht S, Sorkin E (16) 155, 162, 169

Asanuma Y, Goldstein AL, White A (17) 169

Asanuma Y, see Goldstein AL (219) 137,176

Aschkenasy A, Bussand A, Corvazier P, Grabar P (18) 146,169

Page 195: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

194 Author Index

Ashida K, see Fujiwara M 12, 50, 61, 67

Ashida K, see Hashimoto Y 6 ,67

Askonas BA, White RG (19) 117,169

Askonas BA, see North JR (392) 183

Astaldi A, Wijemans P (20) 159,169

Astaldi A, see Astaldi G (21) 143, 169

Astaldi A, see Krisbeek AM (307) 134,180

Astaldi G, Astaldi A, Groene-. woud M, Wijemans PS, Schellekens PG, Eijsvogel VO (21) 143,169

Astaldi GCB, see Krisbeek AM (307) 134,180

Attallah AA, Lee JB 97,103 Attwell D, Cohen I, Eisner D,

Ohba M, Ojeda C 15, 22, 64 Auerbach R, Globerson A

(22) 117, 139,169 Auerbach R, see Globerson A

(212) 133,176 Auld R, Alexander E, Levinsky

N 93,103 Avioli LV, see Bricker NS

96, 104 Axe[rod AE, Prezansky J (23)

165, 167,169 Axe[rod J, see Thoa NB 26, 73 Aynedjian HS, see Bank N

85, 86, 103 Azar NA, Williams K, Takat-

suki K (24) 117,169 Azer M, see Kaloyanides GJ

96,107

Bach FH, see Sopori ML (474) 124, 186

Bach JF (25, 26) 142, 143, 169

Bach JF, Carnaud C (27) 142, 169

Bach JF, Dardenne M (28) 142, 169

Bach JF, Dardenne M, Davies AJS (29) 117,169

Bach JF, Dardenne M, Gold- stein AL, Guha A, White A (30) 137, 142, 169

Bach JF, Dardenne M, Pleau JM, Bach MA (32) 142, I69

Bach JF, Dural D, Dardenne M, Salomon JC, Tursz T (33) 142, 143,149,169

Bach JF, Papiernik M, Levas- seurP (31) 169

Bach JF, see Dardenne M (128, 129) 142, 162, 173

Bach JF, see Lacombe M (309) 143,180

Bach JF, see Pleau JM (417) 142, 184

Bach MA (34) 159,169 Bach MA, see Bach JF (32)

142, 169 Bach ML, see Sopori ML (474)

124,186 Badiner O, see Agosier M (5)

147,168 Baer M, Best PM, Reuter H

31, 37, 59, 64 Baguerra J, see Moeschlin S

(373) 146,155,182 Baguerra R, see Moeschlin S

(373) 146,155,182 Bahlmanns JS, McDonald J,

Ventom MG, Wardener HE de 96,103

Baines AD 81,103 Baker PF 64 Baker PF, Blaustein MP, Hodg-

kin AL, Steinhardt RA 51, 52, 55, 64

Baker PF, McNaughton PA 52, 53, 64

BakerPM (35) 117,121,169 Balerna M, see Lazdunski M

3, 69 Baltimore D, see Goldstein G

(232) 141,177 Bank N, Koch KM, Aynedjian

HS, Aras M 85, 86,103 Banks RO, Kleinman LI

100, 103 Banks RO, see Kleinman LI

100,108 Bannerjee S, see Goldstein AL

(220) 136,176 Barger AC 81,103 Barger AC, Herd JA 77,103 Barger AC, Yates FE, Rudolph

AM 76,103 Barhanin J, see Lazdunski M

3, 69 Bariety J, see Papanicolao u N

97,110 Barnes JL, see Reineck HJ

92, 111 Barnola FV, see Villegas J

12,74 BaxoniC (36) 154, 163,169 Baroni C, Fabris N, Bertoli G

(37) 154,169 Baxoni C, Pesardo PC, Bertoli

G (38) 154,169 Baroni C, see Pierpaoli W

(413) 154, 184

Barr PS, see Thurman GB (5O0) 187

Barratt L J, Wallin JD, Rector FC Jr, Seldin DW 79, 80, 103

Barry J de, see Fosset M 14, 37, 53, 54, 55, 67

Bartels-Bernal E, Rosenberry TL, Daly JW 38, 64

Bartke A (39, 40) 163, 164, 169, 170

Bartoli E, Early LE 80, 103 Bartoli E, see Conger JD

83,105 Barton LJ, Lackner LH, Rector

FC Jr, Seldin DW 91,103 Bartter FC, see Fill JR Jr

99,106 Basch RS (41) 117, 1 70 Basch RS, Goldstein G

(42, 43) 119, 141,170 Basch RS, see Sunshine GH

(488) 141,187 Basseches P, Bianchi CP 26, 64 Bassingthwaighte JB, Fry CH,

McGuigan JAS 27, 65 Basten A, Miiller JFAP, Sprent

J, Cheers C (44) 170 Basten A, see Feldman M

(186) 123,124,175 BatchelorJR (45) 151,152,

170 Batchelor JR, Chapman BA

(46) 151,170 Bates RW, Laanes T, Riddle O

(47) 163,170 Bathmann A, Land W, Koczo-

rek K, Strass P (48) 146, 147,170

Batisto JR, see Goldstein AL (219) 137,176

Bauman EJ, see Marine D (344) 161,181

Baumber JS, see Schneider EG 101,111

Baxter JD, Harris AW (49) 157, 170

Bayard F, see Beitens IZ 100, 103

Bealmar M, see Wilson R (543) 117,189

Beaug6 L, see Di Polo R 52, 53, 66

Beauvieux Y (50) 125,170 Bedarda G, see Buscarini L

(81) 135,171 Beeler GW, Reuter H 15, 31,

51, 61, 65 Beitens IZ, Bayard F. Levitsky

L, Ances IG, Kowanski A, Migeon CJ 100,103

Page 196: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 195

Bekkum DW van (51) 1 70 Bekkum DW van, see Blank-

water MJ (63) 137,170 Bellanti JA, see Thong YA

(498) 157,187 Bello-Reuss E, Pastoriza-Munoz

R, Colindres RE 98, 103 Bello-Reuss E, Trevino DL,

Gottschalk CW 99,103 Belsky JL, see Papper S

85,110 Benforado JM 3, 4, 19, 65 Bengele HH, Houttuin E,

Pearce JW 96, 98, 104 Bengele HH, Solomon S

99, 104 Bengele HH, see Misanko BS

100, 110 Ben-Ishay D 89, 103 Benios J, see Waltman SR

(583) 152, 191 Bennacerraf B, see Katz DH

(282) 112, 179 Bennett CM 91,104 Bennett CM, Brenner BM,

Berliner RW 82, 104 Bennett CD, see Scriabine A

49, 72 Benninger C, Einw~ichter HM,

Haas HG, Kern R 55, 65 Bentzel C J, Anagnostopoulos

T, Pandit H 84, 104 Benzakein F, see Gutman Y

84, 85,107 Beresewicz A, Reuter H 60, 65 B~ress L, B6ress R, Wunderer

G 6 ,65 B6ress L, Wunderer G, Wach-

t e rE 6,65 B~ress L, see Alsen C 46, 64 B~ress L, see Rathmayer W

11, 71 B~ress R, see B~ress L 6, 65 Berglund K (52) 146,170 Berglund K, Fagreus A (53)

146, 170 Berglund K, see Fagreus A

(180) 175 Bergmann C, Dubois JM,

Rojas E, Rathmayer W 11, 65

Berliner DC, see Dougherty TF (150) 149, 174

Berliner DL, see Dougherty TF (151) 149, 174

Berliner ML, see Dougherty TF (150) 149,174

Berliner MZ, see Dougherty TF (151) 149,174

Berliner RW, see Bennett CM 82, 104

Berliner RW, see Brenner BM 82, 90,104

Berliner RW, see Dirks JH 90, 106

Berliner RW, see Knox FG 84, 96, 98,108

Berliner RW, see Morgan T 90, 91,110

Bernard C, Gargouil YM 36, 65

Bernard P, Couraud F 12, 45, 46, 65

Bertoli G, see Baxoni C (37, 38) 157, 169

Besedowsky H, Sorkin E (54) 147, 160, 164, 167, 170

Besedowsky HO, see Pierpaoli W (407, 408) 140, 160, 184

Best PM, see Baer M 31, 37, 59, 64

Better OS, Massry SG 102, 104

Bezvershenko I, Giulling E, Dyugovskaya L (560) 135,190

Bhattacharyya M, see Vassalle M 22,74

Bhattarai R, see Talwar GP (490) 162,187

Bianchi CP, see Basseches P 26, 64

Bianchi E, Pierpaoli W, Sorkin E (55) 160,170

Bianchi E, see Pierpaoli W (415) 118, 160,184

Bianchi E, see Sorkin E (475) 160, 163,186

Biglieri EG, Forsham PH 95,104

Billingham RE, Brent L (57) 117, 170

Billingham RE, Krohn PL, Medawar PB (58) 147, 1 70

Billingham RE, see Wilson DB (542) 120,189

Binimbo-Massengo A, see Deschaux P (142) 165,173

Bioquet Y, see Pleau JM (417) 142, 184

Biozzi G, Stiffel C, Mouton D, Liacopoulos-Briot M (59) 170

Birge S J, see Bricker NS 96,104

Bishop VS, see Blair RW 4, 65 Bisset KA (60) 147,170 Bjornboe M, Fischel EL,

Stoerk HC (61) 146,170 Bjornboe M, Gormsen H, Lund-

quist LF (62) 117, 155, 170

Blaese M, see Martinez C (347) 117, 181

Blair NP, see Higgins JT Jr 84, 85,107

Blair RW, Peterson DF, Bishop VS 4, 65

Blankwater M J, Levert LA, Swart AC, Bekkum DW van (63) 137,170

Blankwater MJ, see Krisbeek AM (307) 134, 180

Blantz RC, Katz MA, Rector FC Jr, Seldin DW 78, 104

Blantz RC, see Tucker BJ 87, 112

Blantz RC, see Wallin JD 76, 78,112

Blaufox MD, see Goldsmith DI 99, 106

Blaustein MP 52, 65 Blaustein MP, Hodgkin AL

52, 65 Blaustein MP, see Baker PF

51, 52, 55, 64 Blecher M, White A (64)

157, 170 Bleifer KH, see Papper S

85,110 Blinks JR, see Allen DG

56,64 Blomgren H, Anderson B

(65, 66) 126,149,170 Blomgren H, see Goldstein P

(233) 177 Bloom BR (67) 117,171 Blythe WB, D'Avila O, Gitel-

man HJ, Welt LG 96,104 Blythe WB, see Klemmer PJ

88,108 B6nisch H, Graefe KH, Keller

B 26, 65 Boer V, see Milcu S (357)

135,182 Bohidar NR, see Scriabine A

49, 72 Bohnenkamp H 23, 65 Bomskov 144 Bona DR Di, Chen LC, Sharp

GWG 84, 85,105 Bona GF Di, see Kaloyanides

GJ 96, 97, 107 Bono E de, see Munck O

77,110 Bonvalet JP, see Chabardes D

81,105 Bonvalet JP, see Poujeol R

81,111 Bonvalet JP, see Rouffignac

C de 81,111 Boonjaxen S, see Stein JH

91,112

Page 197: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

196 Au tho r Index

Borman SC, see Kunau RT Jr 86, 91,108

Bose TD Du Jr, see Higashi- hara E 97, 107

Bottoner GD, Stitsch RD, Roesel OF (68) 157,171

Bottoner GD, see Shaskar JR (466) 156,186

Boulet P, see Carriere S 81,105

Boulpaep EL 84,104 Boulpaep EL, see Maunsbach

AB 84,109 Bovee KC, Webster GD

77,104 Boyett JD, Hoffert JF (69)

157, 171 Boylan JW, see Gertz KH

80, 106 Boyle W, see Wagner H (521)

121,134,188 Boylston AW, see Carpenter

CB (87) 135,171 Boyse EA, see Cantor H (84,

85, 86) 121,126,127,171 Boyse EA, see Goldstein G

(229) 177 Boyse EA, see Komuro K

(295, 296) 138, 141,172 Boyse EA, see Scheid MP

(450) 136,141,185 Boyse EA, see Schlesinger M

(461) 141,186 Bozler E 18, 65 Brandis H, see Sethi KK (465)

123,186 Brandis M, see Gertz KH

80, 106 Braun G, see Gertz KH

90, 106 BraunW (70) 124, 158,171 BraunW, Cohen EP (71)

171 Braun W, Ishizuka M (72)

158,171 Braun W, Ishizuka M, Matsu-

moto T (74) 158,171 Braun W, Ishizuka M, Win-

church R, Webb D (75) 171 Braun W, Rega MJ (73) 158,

171 Braun W, see Ishizuka K (266)

158,178 Braun W, see Winchurch R

(544) 189 Braun-Schubert G, see Gertz

KH 80, 106 Brechtelsbauer H, see Keck W

84,108 Brenner BM, Berliner RW

82, 90, 104

Brenner BM, Daugharty JM, Ueki IF, Troy JL 82,104

Brenner BM, Falchuk KH, Keimowitz RI, Berliner RW 82, 104

Brenner BM, Troy JL 82, 104 Brenner BM, Troy JL, Daug-

harty TM 80, 104 Brenner BM, see Bennett CM

82,104 Brenner BM, see Daugharty

TM 79, 80, 83,105 Brent L, see Billingham RE

(57) 117,170 Bricaine H, see Strauch G

(480) 164,186 Brick HC (56) 158,170 Bricker NS, Klahr S, Purker-

son M, Schultze RG, Avioli LV, Birge SJ 96,104

Bridges JB, see Camblin JG (83) 135,171

Brinck-Kohnson T, Dougherty TF (76) 171

Brinck-Johnson T, see Munk A (383) 156,157,183

Broberger O, see Aperia A 99,103

Brody TM, see Akera T 42, 43, 56, 64

Brody TM, see Ku DD 42, 43, 69

Bronsky EA, see Claman H (100) 119, 172

Brooks CMcC, Hoffmann BF, Suckling EE, Orias O 19, 65

Brooks CMcC, see Matsuda K 19, 69

Brosio JL, see Thurman GB (499) 126,187

Brostoff J, see Roitt IM (436) 119,185

Brown GL, Rothlauf MW, Heimzelling RH, Myers TS (77) 148,157,171

Brown PR, Koutsaimanis KG, Wardener HE de 96,104

Brude RM, see Waltman SR (583) 152, 191

Brugh PM de, see Miller JFAP (3711 117,182

Brunette MG, see Carrier S 81,105

Brunner FP, Rector FC Jr, Seldin DW 90,104

Brunner KT, Manuel J, Rudolf M, ChapinB (78) 122,171

Brunner KT, see Cerrottini JC (93, 94) 121,172

Brunner WH, see Claman H (103) 172

Bruns F J, Alexander EA, Riley AL, Levinsky NG 78, 79, 81,104

Bruns FJ, see Migdal S 78,110 Buckalew VM, Puschett JB,

Kintzel JE 85,104 Buckalew VM Jr, Martinez F J,

GreenWE 96,104 Buckalew VM Jr, Walker BR,

Puschett JB, Goldberg M 90,104

Buckalew VM Jr, see Gruber KA 96,107

Buntner B, Szymik M (79) 160,171

Burg C, see Wioland M (545) 125,189

Burg MB, Orloff J 90,105 Burger M, see Trainin M

(507,508) 138,139,188 Burke TJ, Robinson RR,

Clapp Jr 84,105 Burke TJ, see Marchand GR

77, 109 Burleson R, Levey RH (80)

133,171 Burnett JC Jr, see Knox FG

93, 95,108 Buscarini L, Bedarda G,

Marandola P (81) 135,171 Bush BMH, see Lowe DA

12, 69 Bussand A, see Aschkenasy A

(18) 146,169 Buu NT, see Faucheux B

99, 106 By AW, see Kupchan SM

4, 5, 69 Bykovskaya SM, see Sergeev

AV (464) 165,186 Byrom NA, Campbell MA,

Staughton RCD (82) 138, 171

Calahan MD 11, 66 Camblin JG, Bridges JB (83)

135,171 Campbeel R, see Munro AJ

(384) 124, 183 Campbell MA, see Byrom NA

(82) 138,171 Campbell WB, see Higashihara

E 97,107 Cantor H, Boyse EA (84, 85)

121,126,127,171 Cantor H, Shen FW, Boyse EA

(86) 127, 1 71 Cantor H, see Goldstein G

(232) 141,177 Cantor H, see Raff MC (425)

184

Page 198: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 197

Carafoli E, Crompton M 51, 66

Carey RM 101,105 Carey RM, Smith JR, Ortt EM

101,105 Carey RM, see Lennane RJ

101,109 Carnaud C, see Bach JF (27)

142, 169 Carpenter CB, Boylston AW,

MerrileJP (87) 135,171 Carpenter CB, see Philipps SM

(405) 135,184 Carpenter CR, see Rubin AS

(440) 123,185 Carriere S, Boulet P, Mathieu

A, Brunette MG 81,105 Carriere S, Lamumiere G,

Daigneault A, Champlain J de 99,105

Carsner RL, Rennels EG (88) 163, 171

Castro JE (89) 146,151,171 Castro JE, Hamilton DNH

(90) 146,151,171 CatterallWA 3, 7, 11, 13, 14,

25, 66 Catterall WA, see Galper JB

14 ,67 Ceglowski WS, Hand TL,

Friedman H (92) 171 Ceglowski WS, Labadie GW

(91) 144,171 Ceglowski WS, see Hand TL

(247) 144, 178 Cerrottini JC, Brunner KT

(93) 121,172 Cerrottini JC, Nordin AA,

Brunner KT (94) 121,172 Chabardes D, Poujeol P, Deiss

S, Bonvalet JP, Rouffignac C de 81,105

Chamberlain SG, Kerkut GA 13, 66

Champlain J de, see Carriere S 99,105

Charad J, Drueke T, Pujade- Lauraine C, Lacoar B, Funck, Brentano JL 85, 105

Chaourat G (95) 124, 172 Chaperton EA, see Claman H

(102) 118, 172 Chapin B, see Brunner KT

(78) 122,171 Chapman BA, see Batchelor

JR (46) 151,170 Chapman RA 55, 66 Charlemagne J, see Fache B

(176) 120, 175 Chase J, White A, Dougherty

TF (96) 146,172

Chase JH, see Dougherty TF (149) 174

Chatworthy HW, see Ellison EH (170) 155,174

ChebotarevF (97) 147, 148, 172

Cheers C, see Basten A (44) 170

Cheever EV, see Lewis WJ (321) 163, 164,180

Chen C, Gettes LS, Katzung BG 61, 66

Chen LC, see Di Bona DR 84, 85,105

Chicheportiche R, see Laz- dunski M 3, 69

Childers JW, see Hanson RC 101,107

Chiller JM, Habicht GS, Weigl WO (98) 120,172

Chisari FV, Edington TS (99) 120,158,172

Chiti E, see Inzerillo R (263) 178

Christen R, see Agosier M (5) 147,168

Cirksena WJ, see Dirks JH 90,106

Cirksena W J, see Schrier RW 89,111

Claman H, Bronsky EA (100) 119,172

Claman H, Chaperton EA, Triplett RF (102) 118,172

Claman H, McDonald W (101) 119,172

Claman H, Moorhead JW, BrurmerWH (103) 172

Claman HM, Talmadge DW (104) 119,172

Claman HM, see Cohen JJ (106,107) 126,146,149, 172

Clampham WF, see Wardener HE de 79, 87, 94, 95, 96, 97,113

Clapp Jr, see Burke TJ 84,105 Clark DA (105) 122, 172 Clark WR, see Lonai P (326)

120,181 Clark WR, see Ned_red J (388)

121,183 Clarkson EM, Talner LB,

Wardener HE de 96,105 Clausen G, Tyssebotn I

81,105 Clanstrat B, see Deschaux P

(562) 160, 190 Cleeman L, Morad M 28, 66 Clement DL, Pelletier CL,

Shepherd JT 99,105

Cline O, see Greengard R (241) 121. 157, 177

Code CF, see Dews PB (143) 146,173

Coelho JB 81,105 Coffey RG, see Sunshine GH

(488) 141,187 Cohen EP, see Braun W (71)

171 Cohen GH, see Hooper JS

(258) 136,178 Cohen I, see Attwell D

15, 22, 64 Cohen J J, Claman HM (106)

126, 146,149, 172 Cohen J J, Fischbach M, Claman

HM (107) 146,149,172 Cohen JJ, Hoope~ JA, Gold-

steinAL (108) 138, 172 Cohen JR, see Waksal D (524)

127, 134, 188 Cohen JT, Stavy L, Feldman

M (109) 148,172 Cohen KW, see Sunshine GH

(488) 141,187 Cohen L, see Kaloyanides GJ

96, 97, 107 Cohen P, see Gershon RK

(206) 121,176 Cohn JN, see Velasquez MT

77, 78,112 Cole LJ, see Tyan HL (515)

118,188 Colindres RE, see Bello-Reuss

E 98,103 Colley DG, Malakian A, Waks-

manB (110) 172 Comsa J (111,112, 113, 114)

118, 137, 140, 144,159, 160, 161, 167,172

ComsaJ, Filip G (115) 117, 140, 172

ComsaJ, Hook R (116) 125, 172

Comsa J, Leonhardt H (117, 118, 119,120) 147,148, 151,152, 153,155,156, 172,173

Comsa J, Leonhardt H, OzminskiK (125) 140, 141, 155, 173

Comsa J, Leonhardt H, Schwarz JA (123) 117, 140, 154,155,173

Comsa J, Philipp EM (121) 137, 140, 144, 173

Comsa J, Schwarz JA, Neu H (124) 140,144,149, 155, 161,162, 173

Comsa J, Schweissfurth R (122) 173

Page 199: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

198 Author Index

Comstock JP, see Gabrourel GD (199) 157,176

Cone RE, Johnson AG (126) 158,173

Cone RE, see Marchalomis JJ (343) 158,181

Conger JD, Bartoli E, Earley LE 83,105

Constantio JS, see Goldstein AL (225) 137,177

Coppleson LW, see Mosier DE (378) 183

Coraboeuf E, Deroubaix E, Coulombe A 16, 22, 38, 66

Corahoeuf E, Deroubaix E, Tazieff-Depierre F 44, 45, 66

Corrado AP, Antonio A, Diniz CR 44, 66

Cortell S, see Fitzgibbons JP 87,106

Cortney MA 95,105 Cortney MA, Mylle M, Lassiter

WF, Gottschalk CW 90, 91, 105

Corvazier P, see Asehkenasy A (18) 146,169

Coulornbe A, see Coraboeuf E 16, 22, 38, 66

Couraud F, Rochat H, Lissitzky S 37, 46, 54, 55, 66

Couraud F, see Bernard P 12, 45, 46, 65

Couraud F, see Fayet G 45, 67 Cowen DM, see Gowans JL

(237) 120,177 Cranefield PF 17, 18, 66 Crawford MK, see Thompson

JS (497) 149, 156,187 Crompton M, see Carafoli E

51, 66 Cross AM, Leuchars E, Miller

JFA (127) 118,134,161, 173

Cross AM, see Miller JFAP (367,369) 118,182

Cuche J-L, see Diaz-Buxo JA 89,105

Cuche J-L, see Ott CE 83,110 Currie GA, see Grant CK (239)

177 Czaczkes JW, see Viscoper JR

96, 112

Daggett WM, see Gilmore JP 98,106

Daigneault A, see Carriere S 99, 105

Dalheim H, see Schnermann J 94, 111

Daly J, Witkop B 37, 66

Daly J J, Roe J, Harrocks P 101,105

Daly JW, see Baxtels-Bernal E 38, 64

Daly JW, see Shotzherger GS 39,73

Daly J, see Tokuyama T 5, 73 Dameshek W, see Wong FM

(548) 189 Damongsak D, see Hand TL

(247) 144,178 Daniel-Lamaziere JM, see

Savart M (446) 156,185 Danilo P, see Rosen MR

18,72 Dardenne M (561) 143,190 Dardenne M, Papiernik M,

Bach JF, Stutman O (128) 162,173

Dardenne M, Pleau JM, Man MK, BachJF (129) 142, 173

Dardenne M, see Bach JF (28, 29, 30, 32, 33) 117, 137, 142,143,149,169

Dardenne M, see Pleau JM (417) 142, 184

Dardenne MA, see Lacombe M (309) 143,180

Darrach M, see Newson S (389) 147,148,155,183

Daugharty JM, see Brenner BM 82,104

Daugharty TM, Ueki IF, Nicho- las DP, Brenner BM 79, 80, 83,105

Daugharty TM, see Brenner BM 80, 82, 104

Davidman M, Alexander E, Lalone R, Levinsky N 79, 80, 94,105

Davidsohn J, see Stern K (477) 151,186

Davies AJS, see Bach JF (29) 117,169

Davies AJS, see Doenhoff MJ (145) 125,173

Davies AJS, see Elliott EV (169) 125,174

DaviesJS (130) 133,173 Davies JS, Leuchaxs E, Wallis

V, KollerPC (131) 119,173 Davies JS, Leuchars E, Wallis

V, Marchant R, Elliot VE (132) 173

Davies WE, see Tyan HL (515) 118,188

D'Avila O, see Blythe WB 96,104

Davis BB, Knox FG, Wright FS, Howards SS 89,105

Davis BB, see Howards SS 90, 107

Davis BB, see Knox FG 84, 96, 98, 108

Davis BB, see Leeber DA 90,109

Davis C, see Aisenberg AC (6) 168

Davis JM, see Schnermann J 94,111

Davis JO, see Johnston CI 96,107

Davis JO, see Schneider EG 101,111

Defendi V, Roosa RA (133) 117,173

Deguchi T, see Narahashi T 11, 70

DeHaan RL, McDonald TF, Sachs HG 36, 66

Deiss S, see Chabardes D 81,105

Deitmer JW, Ellis D 55, 66 Delmasso AP, Martinez C,

Good RA (134) 117,133, 173

Delmasso AP, Martinez C, Sjodink, Good RA (135) 173

Delmasso AP, see Martinez C (347) 117, 181

Delmasso C, see Good RA (234) 121,177

Delor B, see Senon B (463) 135,186

De Los Santos C, see Klemmer PJ 88, 108

Dennert G (136) 121,173 Dennert G, see Tucker DF

(514) 121,188 Deroubaix E, see Coraboeuf E

16, 22, 38, 44, 45, 66 Deschaux P (137) 149,159,

160,161, 162,163,173 Deschaux P, Claustrat B, Fon-

tanges R (562) 160, 190 Deschaux P, Dodin A, Laval F,

Fontange R (141) 140,173 Deschaux P, Flores JL, Fon-

tange R (140) 159,162,173 Deschaux P, Fontange R (138)

173 Deschaux P, Fontange R, Gold-

stein AL (563) 138,190 Deschaux P, Morel G. Binimbo-

Massengo A, Fontange R (142) 165,173

Deschaux P, Portier A, Fon- tangeR (139) 173

Dev B, Drescher C, Schner- mann J 94, 105

Page 200: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 199

Dews PB, Code CF (143) 146, 173

Diamantstein T (144) 157, 173

Diaz-Buxo JA, Haas JA, Ott CE, Cuche J-L, Marchand GR, Knox FG 89,105

Diener E, see Lee KC (317) 119, 180

Dietrich FM, see Dukor P (153) 146, 174

Diezi J, Michoud P, Aceves J, Giebisch G 92, 106

Diezi J, Nenninger M, Gie- bisch G 91,106

Diniz CR, see Corrado AP 44, 66

Diniz CR, see Langer SZ 44, 69

Dirks JH, Cirksena WJ, Berli- net RW 90, 106

Dirks JH, Seely JF 91,106 Doak SMA, see Miller JFAP

(367) 118, 182 Dodin A, see Deschaux P

(141) 140,173 Doenhoff MJ, Davies AJS,

Leuchars E, Wallis T (145) 125, 173

Doherty, Shearer, Rosenthal 131

Dolgin AE, see Wexter BC (538) 1.89

Donatsch P, Lowe DA, Richardson BP, Tylor P 12,66

Doria G, Agarassi G, Pietro SDi (146) 123,174

Dougherty TF (147) 126, 146, 149,174

Dougherty TF, Berliner DC, Berliner ML (150) 149,174

Dougherty TF, Berliner MZ, Schneebeli G, Berliner DL (151) 149, 174

Dougherty TF, Chase JH, WhiteA (149) 174

Dougherty TF, White A (148) 174

Dougherty TF, see Brinck- Johnson T (76) 171

Dougherty TF, see Chase J (96) 146,172

Dougherty TF, see Goldstein AL (220) 136, 176

Dougherty TF, see Hayes SP (250) 146,155,178

Doyle H, see Wara W (529) 137, 188

Drescher C, see Dev B 94,105

Dresser TP, see Knox FG 89,108

Dresser TP, see Schneider EG 93,111

Drueke T, see Chanard J 85,105

Drukker A, see Goldsmith DI 99,106

Dubois JB, see Senon B (463) 135,186

Dubois JM, see Bergmann C 11, 65

Duchateau GH, see Gregoire C (242) 135,177

Duclos TW, Kim BS (152) 121,174

Dukor P, Dietrich FM (153) 146,174

Dukor P, see Gisler R (208, 211) 119,123,176

Dukor P, see Leuchars E (318) 133,180

Dukor P, see Miller JFAP (369,370) 182

Dumont F (154) 127,174 Dumont F, see Sabolevic EB

(442) 125,185 Dunn TD, Trainin N, Levey

RH (155) 159,174 Duquesnoy RJ (156,157)

118, 154,174 Duquesnoy RJ, Ahrens RC

(158) 154,174 Duquesnoy RJ, Mariani T,

Good RA (159) 154,174 Duquesnoy RJ, see Kemp R

(285) 157,179 Dusing R, Melder B, Kramer

HJ 97, 106 Dusing R, Opitz W-D, Kramer

HJ 97, 106 DuttonRW (160) 121,122,

123,174 Dutton RW, Falcoff R, Hirst

JA, Hoffmann M (161) 174 Dural D, see Bach JF (33)

142, 143,149, 169 Duve C De (162) 157, 174 Dvorak HF, see Jankovic BD

(269) 124,178 Dvoskfn B, see Makman MH

(337,338,340) 157,181 Dwoskin B, see Pena A (402)

183 Dyugovskaya L, see Bezver-

shenko I (560) 135,190

Eardley DD, Gershon RK (163) 122,174

Earley LE, Friedler RM 76, 77, 78, 85, 97,106

Earley LE, Martino JA, Friedler RM 85,106

Earley LE, see Bartoli E 80, 103

Earley LE, see Conger JD 83,105

Earley LE, see Friedler RM 77,106

Earley LE, see Humphreys MH 84, 85,107

Earley LE, see Martino JA 76, 77, 82, 86,109

Earley LE, see Schrier RW 84,111

Earley LE, see Strauss MB 95, 112

Eartley H, Leblond PC (164) 164, 174

East J, Parott DMV (165) 134, 174

East J, see Parrott D (400) 125,183

Ebner F, Reiter M 60, 66 Edelman IS, see Feldman M

(188) 175 Edelmann CM Jr, see Gold-

smith DI 99,106 Edington TS, see Chisari FV

(99) 120, 158, 172 Edman P, see Rochat H 6, 72 Egdahl RH, see Mannick JA

(342) 124,181 Eijsvogel VO, see Astaldi G

(21) 143, 169 Einw~chter HM, see Benninger

C 55, 65 Eisen HN, Mayer MM, Moore

DH, Tart RR, Stoerk HC (166) 146,174

Eisental A, Nachtigal D, Feld- manM (167) 122,174

Eisner D, see Attwell D 15, 22, 64

Eknoyan G, Suki WN, Rector FC Jr, Seldin DW 90, 106

Eldinger D, Garrett TJ (564) 190

Elliott EV, Sinclair MR (168) 146,174

Elliott EV, Weft V, Davies AJS (169) 125, 174

Elliott EV, see Davies JS (132) 173

EUiott EV, see Sinclair MR (469) 117,186

Elliott LH (565) 122, 190 Elhs D, see Deitmer JW 55, 66 Ellison EH, Martin PC, Williams

RD, Chatworthy HW, Hamwi G, Zollinger RM (170) 155, 174

Page 201: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

200 A u t h o r I n d e x

Ellison EH, see Allen HL (9) 155,168

EUner CN, see Matsuda K 19, 69

Elster P, see McDougal JL (572) 122, 190

Epstein FH, see Hayslett JP 91 ,107

Erb P, Feldmann M (171) 124, 175

Ernst M, see Wekerle H (586) 133,191

Esparza A, see Young RH (552) 120,189

Espiner EA, Tucci JR, Jagger PI, Lauler DP 95,106

Esselman WJ (172) 124,175 Esselman WJ, Miller HC (566)

124,190 Esselman W J, see Miller HC

(358) 133; 138,164,182 Eulitz M, see Wunderer G

6,74 Evans MM, see Kalden JR

(277) 154,179 Evans R, see Grant CK (240)

121,177

Fabiato A, Fabiato F 58, 66 Fabiato F, see Fabiato A

58, 66 Fabin M, see Pierpaoli W (413)

154, 184 Fabris H, see Pierpaoli W (414)

184 Fabris N (173) 150, 175 Fabris N, Piantanelli L,

Muzzoli M (174) 154,175 Fabris N, Pierpaoli W, Sorkin

E (175) 154, 156, 175 Fabris N, see Baroni C (37)

154,169 Fabris N, see Sorkin E (475)

160, 163,186 Facile B, Charlemagne J (176)

120, 175 Fachet J, Pakovits M, Vallant

K (178) 175 Fachet J, Stark E, Valiant K,

Pakovits M (177) 159,175 Fagreus A (179) 146,148,175 Fagreus A, Berglund K (180)

175 Fagreus A, see Berglund K

(53) 146,170 Falchuk KH, see Brenner BM

82, 104 Falcoff R, see Dutton RW

(161) 174 Faucheux B, Buu NT, Kuchel

O 99,106

Fauci AS, Pratt KR, Whalen G (567) 148,190

Faulk M, see Perri WL (403) 183

Fayet G, Couraud F, Miranda F, Lissitzky S 45, 67

Feigelson M, see Feigelson P (181) 157,175

Feigelson P, Feigelson M (181) 157, 175

Fein RL, see Schrier RW 89,111

Feinstein MB, Paimre M 31,67

Feldman M (182,183,184, 185) 119 ,120 ,149 ,175

Feldman M, Basten A (186) 123,124,175

Feldman M, Funder JW, Edel- manIS (188) 175

Feldman M, Globerson A (187) 119,156,175

Feldman M, Kliburn JG, Levy J (189) 175

Feldman M, see Cohen JR (109) 148,172

Feldman M, see Eisental A (167) 122,174

Feldman M, see Erb P (171) 124,175

Feldman M, see Galili R (201) 119,176

Feldman M, see Kontiainen S (298) 180

Feldman M, see Lonai P (325, 326) 120,181

Feldman M, see Najarian JS (385,386) 120,123,183

Feldman M, see Wagner H (521,522) 121 ,134 ,188

Feldman M, see Waksal D (524) 127,134,188

Ferrier GR 18, 6 7 Ferris T, see Stein JH 91,112 Ferris TF, see Stein JH

78, 80,112 Fert C, see Plescia O (418)

158,184 Field A, see Martinez D (574)

142 ,143 ,190 Fieser LF, Fieser M 4, 67 Fieser M, see Fieser LF 4, 67 Filip G, see Comsa J (115)

117,140,172 Fill JR Jr, Mason DT, Bartter

FC 99,106 Finland M, see Kass EH (280)

147, 179 Finsterer U, see Keck W 84,108 Fischbach M, see Cohen JJ

(107) 146,149,172

Fischel EE (190) 146, 155, 175

Fischel EE, Vaughan JH, Pho- topoulos K (191) 146, 175

Fischel EL, see Bjornboe M (61) 146, 170

Fischer H, see Lohmann- Mathes ML (324) 121,135, 181

Fischer K, see Alsen C 46, 64 Fisher B, see Fisher ER (192)

120, 175 Fisher ER, Fisher B (192)

120, 175 Fitzgerald EM, see Obika LFO

101,110 Fitzgibbons JP, Gennari J,

Garfinkel HB, Cortell S 87,106

Flacke W, see Kupchan SM 4, 69

Fleckenstein A, see Kaufmann R 18,68

Florentin I, see Kiger M (289) 135,179

Flores JL, see Deschaux P (140) 159, 162, 173

Fontaliran F, see Papanicolaou N 97,110

Fontanges R, see Deschaux P (138-142, 562, 563) 138, 140, 159, 160,162, 165, 173, 190

Ford LF, Michclen HS (193) 125,175

Forsharn PH, see Biglieri EG 95,104

Fosset M, Barry J de, Lenoir MC, LazdunskiM 14, 37, 53, 54, 55, 67

Fosset M, see Lazdunski M 3, 69

Fosset M, see Romey G 12, 13, 37, 47, 48, 55, 72

Fox CA, Whitehead RH (195) 146, 175

Fox KE, Gahourel JD (194) 157,175

Fozzard HA, see Walton M 15,74

Fraig G, see Kenny JF (287) 151,179

Frank M, see Akera T 42, 43, 64

Frank M, see Ku DD 42, 43, 69 Frankenhaeuser B, Hodgkin

AL 14, 67 Franzl RB, see McMaster PD

(335) 146, 181 Frazinova JB, see Meshalova

AM (352) 146, 182

Page 202: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 201

Frelin C, see Lazdunski M 3, 69

Friedler RM, Earley LE 77, 106

Friedler RM, see Earley LE 76, 77, 78, 85, 97, 106

Friedman H (196, 197, 198) 117, 123,176

Friedman H, see Ceglowski WS (29) 171

Friedman H, see Globerson A (213) 140, 176

Friedman H, see Hand TL (247) 144, 178

Friedman WF, see Hurley JK 99, 107

Fritz H, see Wunderer G 6, 74 Fry CH, see Bassingthwaighte

JB 27, 65 Fujiwara M, Muramatsu I,

Hidaka H, Ikushima S, Ashida K 12, 50, 61, 67

Funck-Brentano JL, see Chanard J 85,105

Funder JW, see Feldman M (188) 175

Furth R van, see Thompson JS (496) 151,187

Gabourel GD, Comstock JP (199) 157, 176

Gabourel JD, see Fox KE (194) 157, 175

Gabrielson A, Good RA (200) 146, 176

Gabuzda G J, see Shear L 101,112

Gafni M, see Ishizuka K (266) 158,178

Galicich J, see McDonald KM 98, 109

Galili R, Feldman M (201) 119,176

Galper JB, CatterallWA 14, 67 Garby L, see Agarwal K (4)

157,168 Garfinkel HB, see Fitzgibbons

JP 87,106 Gargouil YM, see Bernard C

36, 65 Garrett T J, see Eldinger D

(564) 190 Gasic G, see Agosier M (5)

147, 168 Gasser J, see Knox FG 91,108 Gauer OH, see Kapteina FW

101,108 Genant HK, see Katz AI

96, 108 Gennari J, see Fitzgibbons JP

87, 106

George HW, see Krayer O 4, 69

Germuth FG (202) 176 Germuth FG, Oyama J, Otten-

get B (203) 146, 155,176 Gershon RK (204, 205)

121,122, 127, 176 Gershon RK, Cohen P, Hencin

R, Liebhaber SA (206) 121, 176

Gershon RK, see Eardley DD (163) 122,174

Gertz KH, Brandis M, Braun- Schubert G, Boylan JW 80,106

Gertz KH, Mangos JA, Braun G, Pagel HD 90,106

Gettes LS, Reuter H 18, 67 Gettes LS, see Chert C 61, 66 Giebisch G, Klose RM, Wind-

hager EE 91,106 Giebisch G, see Diezi J

91, 92,106 Giebisch G, see Khuri RN

91,108 Giebisch G, see Landwehr DM

91,109 Giesen GV, see Rector FC Jr

79, 90, 94,111 Gill JR, see Alexander RW

99,103 Gillette R, see Gillette S

(568) 152,190 Gillette S, Gillette R (568)

152, 190 Gilmore JP, Daggett WM

98,106 Gilmore JP, see Potkay S

101,110 Gisler R (207) 148,149,176 Gisler R, Dukor P (208)

119,176 Gisler R, Schenkel-Hulliger L

(209, 210) 154, 176 Gisler R, Staber F, Rude E,

DukorP (211) 123,176 Gitelman H J, see Blythe WB

96,104 Giulling E, see Bezvershenko I

(560) 135,190 Glaser L, see Munson R 12, 70 Gleason SD, see Hanson RC

101,107 Gleason SD, see Obika LFO

101,110 Glick G, see Arbel ER

17, 21, 22, 49, 64 Gliedman ML, see Mullane JF

102,110 Glitsch HG, Reuter H, Scholz

H 53, 55, 67

Globerson A, Auerbach R (212) 133, 176

Globerson A, Kirov SM, Parish CR (214) 127, 176

Globerson A, Umiel T, Fried- manH (213) 140,176

Globerson A, see Auerbaeh R (22) 117,139, 169

Globerson A, see Feldman M (187) 119, 156, 175

Globerson A, see Rotter V (438, 439) 139, 185

Globerson A, see Trainin M (509) 117, 139, 188

Goble FC, Konopka EA (215) 151,176

Goldberg M, see Agus ZS 98, 103

Goldberg M, see Buckalew VM Jr 90, 104

Goldman Y, see Morad M 57, 70

Goldsmith DI, Drukker A, Blaufox MD, Edelmann CM Jr, Spitzer A 99, 106

Goldsmith RS, see Schneider EG 98,111

Goldstein AL (216, 217) 116, 136, 138, 140, 176

Goldstein AL, Asanuma Y, Batisto JR, Hardy MA, Quint J, White A (219) 137, 176

Goldsteitl AL, Bannerjee S, Schneebeli GL, Dougherty TF, White A (220) 136,176

Goldstein AL, Guha A, Hardy MA (223) 177

Goldstein AL, Guha A, Howe ML, White A (221) 138, 177

Goldstein AL, Guha A, Zatz MM, Hardy MA, White A (222) 136, 177

Goldstein AL, Slater FD, White A (224) 136,164,177

Goldstein AL, Thureau GB, Rossio JL, Constantio JS (225) 137,177

Goldstein AL, White A (218) 116, 136, 176

Goldstein AL, see Asanuma Y (17) 169

Goldstein AL, see Bach JF (30) 137, 142, 169

Goldstein AL, see Cohen JJ (108) 138,172

Goldstein AL, see Deschaux P (563) 138, 190

Goldstein AL, see Hooper JS (258) 136, 178

Page 203: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

202 A u t h o r I n d e x

Goldstein AL, see Klein JJ (292) 179

Goldstein AL, see Kriiger J (306) 118, 137,180

Goldstein AL, see Law LW (315) 117, 137,180

Goldstein AL, see Markham RB (345) 147,181

Goldstein AL, see Paznino MM (401) 137,183

Goldstein AL, see Schafer LA (447) 138,185

Goldstein AL, see Thurman GB (499,500) 126,187

Goldstein AL, see Touraine JL (503) 138,187

Goldstein AL, see Wara W (529) 137,188

Goldstein AL, see Zissblatt M (558) 137,190

Goldstein G (226,227,228) 141 ,157 ,177

Goldstein G, Boyse EA (229) 177

Goldstein G, Hoffman WW (230) 141,177

Goldstein G, Manganaro A (231) 141,177

Goldstein G, Silvestroni AE, Cantor H, Baltimore D (232) 141, 177

Goldstein G, see Basch RS (42, 43) 119, 141,170

Goldstein G, see Komuro K (296) 141,179

Goldstein G, see Scheid MP (450) 136,141,185

Goldstein G, see Schlesinger M (45,461) 141,186

Goldstein G, see Sunshine GH (488) 141,187

Goldstein P, Wigzell H, Blom- gren H, Svedmyr EAJ (233) 177

Gonick HC, Saldanha LF 96, 107

Good RA, Delmasso C, Marti- nez C, Archer P, Pierce JC,

Papermaster BW (234) 121,177

Good RA, see Delmasso AP (134, 135) 117,133,173

Good RA, see Duquesnoy RJ (159) 154, 174

Good RA, see Gabrielson A (200) 146,176

Good RA, see Martinez C (347,348) 117,181

Good RA, see Stutman O (483, 484, 485,486,487) 117,133,134, 137,140,187

Good RA, see Touraine JL (502, 503) 138 ,154 ,187

Good RA, see Yunis L (553) 134,189

Goodwin T J, see Lennane RJ 101,109

Gorczynski RM, Miller RG, Phillips RA (235) 123,177

Gormsen H, see Bjornboe M (62) 117,155,170

Gottschalk CW, see Allison M 100, 103

Gottschalk CW, see Bello- Reuss E 99,103

Gottschalk CW, see Cortney MA 90, 91,105

Gowans JL, McGregor DD (236) 117 ,163 ,177

Gowans JL, McGregor DD, Cowen DM (237) 120, 177

Gowans JL, see McGregor DD (332) 120,181

Grabar P, see Aschkenasy A (18) 146,169

Graefe KH, see B6nisch H 26, 65

Graft RJ, Lappe M, Snell GD (238) 146 ,151 ,177

Graham HT, Grasser HS 8, 67 Grant CK, Currie GA, Alexan-

derP (239) 177 Grant CK, Evans R, Alexander

P (240) 121,177 Grant GA, see Miller JFAP

(368,371) 117,182 Grasser HS, see Graham HT

8 ,67 Greaves MF, see Roitt IM

(436) 119,185 Green WE, see Buckalew VM

Jr 96,104 Greengard R, Cline O (241)

121 ,157 ,177 Greet MA, see Tasuda M (491)

164,187 Greger RF, see Marchand GR

77, I O9 Gregoire C, Duchateau GH

(242) 135,177 Grill G, see Schnermann J

94,111 Groenewoud M, see Astaldi G

(21) 143,169 Gross AM, see Leuchars E

(318) 133,180 Gruber KA, Whitaker JM,

Buckalew VM Jr 96 ,107 Guha A, see Bach JF (30)

137,142, 169 • Guha A, see Goldstein AL (221)

222, 223) 136 ,138 ,177

Gupta PD, see Talwar GP (490) 162, 187

Gutman Y, Benzakein F 84, 85 ,107

Haan RL De, see McDonald TF 36, 37, 70

Haas HG, see Benninger C 55, 65 Haas JA, see Diaz-Buxo JA

89,105 Haas JA, see Marchand GR

77,109 Haas JA, see Ott CE 83,110 Habicht GS, see Chiller JM

(98) 120, 172 Habicht GS, see Tener GSL

(582) 191 Hiigg LB, see Loor F (328)

126, 181 H~immerling W, see Pollak A

(419) 184 Hakim AA, Lifson N 85 ,107 Haksar A (244) 177 Halteman RH, see Lipman MF

(322) 156, 180 Hamilton DNH, see Castro JE

(90) 146,151,171 Hammar JA (245) 141,177 Hammerling W, see Scheid MP

(450) 136, 141,185 Hamwi G, see Ellison EH

(170) 155,174 Hanan R, Oyama J (246)

119,178 Hanaoka M, see Nakao S

(387) 126, 183 Hand TL, Ceglowski WS,

Damongsak D, Friedman H (247) 144, 178

Hand TL, see Ceglowski WS (92) 171

Hanin M, see Tanaka M 6, 73 Hanjan SHS, see Talwar GP

(490) 162, 187 Hansen HJ, see Primus FJ

(423) 137, 184 Hanson RC, McLane-Vega LA,

Childers JW, Gleason SD, Schneider EG 10t, 107

Harada N, see Hotta Y 43, 68 Hardy MA, Quint AL, Slate D,

White A (248) 137, 178 Hardy MA, see Goldstein AL

(219, 222, 223) 136, 137, 176, 177

Hargis BJ, see Malkiel S (341) 146,155,181

Harris AW, see Baxter JD (49) 157, 170

Harris AW, see Wagner H (522) 188

Page 204: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 203

Harris RH, Yarger WE 92, 107 Harrocks P, see Daly JJ

101,105 Hartmann KW (249) 178 HalveRs E de, see Pollak A

(419) 184 Hashimoto K, Ochi R, Hashi-

moto K, Inui J, Miura Y 6, 49 ,67

Hashimoto K, see Hashimoto K 6,49,67

Hashimoto Y, Ashida K 6, 67 Ha Ty, Wathsman BH (243)

120, 137,177 Haynes RC, see Sand H (443)

157, 185 Hayes RC, see Sutherland EW

(489) 157, 187 Hayes SP, Dougherty TF

(250) 146,155,178 Hays EF (251) 178 Hays EF, Albert PF (252)

117, 134, 178 Haystett JP, Kashgarian M,

Epstein FH 91,107 Hayter CJ, see Wardener HE de

79, 87, 94, 95, 96, 97,113 Heimzeiling RH, see Brown

GL (77) 148, 157,171 Heisler EM, see Schafer LA

(447) 138, 185 Heistracher P, Pillat B

17, 18, 40, 41, 42, 67 Hellig H, Waldek JF (253)

146,178 Hencin R, see Gershon RK

(206) 121,176 Henney CS (254) 158,178 Hensen SA, see Thong YA

(498) 157, 187 Heppner RL, see Wood EH

34, 74 Herbst AL, see Yates FE (550)

160, 189 Herd JA, see Barger AC

77,103 Hermle M, see Schnermann J

94,111 Herrera-Acosta J, AndreuCci

VE, Rector FC Jr, Seldin DW 80,107

Herzenberg LA, see Sato VL (445) 134, 185

Hess MW (255) 116,178 Hess MW, Stoner RD (256)

117,178 Hesselj6 R, see Sehellein Y

(452) 162, 185 Hetherington CM, see Humber

DP (570) 152, 190 Hicks C, see Werthamer S

(537) 157, 189

Hidaka H, see Fujiwara M 12, 50, 61, 67

Higashihara E, Stokes JB, Kokko JP, Campbell WB, Du Bose TD Jr 97,107

Higgins JT Jr 89, 95,107 Higgins JT Jr, Blair NP

84, 85,107 Hildeman WH, see Wistar R

(547) 148,189 Hille B 3, 14, 15, 67 Hilleman MR, see Martinez D

(574) 142, 143,190 Hillgard HR, see Yunis L

(553) 134,189 Hirst JA, see Dutton RW

(161) 174 Hochman PS, Kovacz G (257)

146,178 Hodgkin AL, Huxley AF

3, 7, 20, 67 Hodgkin AL, see Baker PF

51, 52, 55, 64 Hodgkin AL, see Blaustein MP

52, 65 Hodgkin AL, see Franken-

haeuser B 14, 67 H6rhammer L, see List PH

5, 69 Hoffert JF, see Boyett JD (69)

157,171 Hoffmann BF, see Brooks

CMcC 19, 65 Hoffman BF, see Matsuda K

19, 69 Hoffmann MK, Watson J

(569) 124,190 Hoffmann M, see Dutton RW

(161) 174 Hoffmann MK, see Scheid MP

(451) 138,159,185 Hoffman WW, see Goldstein G

(230) 141,177 Hogan PM, Albuquerque EX

17, 37, 38, 49, 67 Holm C, see Perlman P (404)

184 Holmes EW, DiScala VA

98,107 Holzgreve H, Schrier RW

83,107 Hondeghem LM, Katzung BG

15, 67 Honerjiiger P 8, 9, 23, 24, 25,

26, 27, 30, 33, 67 Honerjiiger P, Meissner A 42 Honerj/igerP, ReiterM 18, 23,

24, 25, 26, 28, 29, 30, 31, 32, 34, 35, 38, 39, 59, 60, 61, 62, 67, 68

Hook R, see Comsa J (116) 125, 172

Hooper JA, see Cohen JJ (108) 138, 172

Hooper JS, McCaniel MC, Thurman GB, Cohen GH, Sculof RS, Goldstein AL (258) 136,178

HopkinWJ (259) 122, 178 Hopkins P, see Young RH

(552) 120,189 Horackova M, Vassort G

19, 20, 23, 24, 55, 59, 68 Hornych A, see Papanicolaou

N 97,110 Hornych A, see Richet G

84,111 Horster M, Thurau K 81,107 Horster M, see Schnermann J

94, 111 Horvat J, see Jankovic BD

(270) 144,179 Hoshi T, see Matsuda K

40, 41, 70 Hotta Y, Takeya K, Kobayashi

S, Harada N, Sakakibara J, Shirai N 43, 68

Houssay BA, Sordelli A (260) 150,178

Houttuin E, see Bengele HH 96, 98, 104

Howards SS, Davis BB, Knox FG 90, 107

Howards SS, see Davis BB 89, 105

Howards SS, see Johnston CI 96,107

Howards SS, see Knox FG 84, 96,108

Howe ML, see Goldstein AL (221) 138, 177

Howe R, Shanks RG 62, 68 Howse JD, see Nutbourne DM

96,110 Hiinig T, see Wecker E (532)

123,157,188 Humber DP, Pinder M, Hethe-

rington CM (570) 152, 190 Humphrey JH (261) 117,178 Humphreys MH, Earley LE

84, 85,107 Hunt SW, Mason DW, Williams

AF (262) 126,178 Hunter IC, see Stimson WH

(578) 152, 191 Hurley JK, Kirkpatrick SE,

Pitlick PT, Friedman WF, Mendoza SA 99,107

Huxley AF, see Hodgkin AL 3, 7, 20, 67

Iijima T, Pappano AJ 36, 68 Ikushima S, see Fujiwara M

12, 50, 61, 67

Page 205: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

204 A u t h o r Index

Ihle JM, see Paznino MM (401) 137,183

Incefy GS, see Touraine JL (502, 503) 138 ,154 ,187

Inesi G, see Johnson PN 24, 68

Inui J, see Hashimoto K 6, 49, 67

Inzerillo R, Chiti E (263) 178 Irisawa H, see Noma A

16, 42, 71 Irisawa H, see Shigeto N

16,73 Iriye R, see Kumazawa Z

6, 69 Irvine W J, see Kalden JR

(277) 154, 179 Isakovic K, Shmith SB, Waks-

man BH (264) 120, 178 Isakovic K, see Jankovic BD

(270) 144, 179 Ischizuka M, see Winchurch R

(544) 189 Isenberg G 27, 68 Ishima Y 36, 68 IshizukaK (265) 158,178 Ishizuka K, Gafni M, Braun W

(266) 158,178 Ishizuka M, see Braun W

(72, 74, 75) 158, 171 Israel E, see Schlesinger M

(460) 186 Israelit AH, see Mandin H

80, 109 Ito K, Karaki H, Urakawa N

59, 68 Iwamura N, see Shimizu T

17, 48, 49, 73 Iwasa J, see Akera T 42, 43,

64 Izumi T, see Shibata S

48, 49, 72, 73

Jacques Y, see Lazdunski M 3, 69

Jacques Y, see Pouyss6gur J 12, 71

Jacques Y, see Romey G 12, 13, 72

Jaff6 HL, Marine D (267) 145, 178

Jagger PI, see Espiner EA 95,106

Jamison RL, Lacy FB 81,107

Janeway CA (268) 117,122, 178

Jankovic BD, Dvorak HF (269) 124, 178

Jankovic BD, Isakovic K, Horvat J (270) 144,179

Jankovic BD, see Arnason BG (14) 117,168

Jankovic BD, see Waksman BH (525) 117, 188

Jay EWK, see Wiesner K 6, 74 Jeejeebhoy HF (271) 117,179 Jennings J, Taylor G (272)

157,179 Jerne NK, Mordin AA (273)

117,132,179 Johnson AG, see Cone RE

(126) 158, 173 Johnson JA, see Schneider EG

101,111 Johnson PN, Inesi G 24, 68 Johnston CI, Davis JO

96 ,107 Johnston CI, Davis JO,

Howards SS, Wright FS 96 ,107

Jones B, Jones TC (274) 121,179

Jones B, Jones TC, Rofff IM (275) 121,179

Jones HEH, see Kappas A (279) 152,179

Jones JM, Kind PD (276) 124,179

Jones TC, see Jones B (274,275) 121,179

Jones VE, see McGillivray MW (331) 181

Joppich R, see Keck W 84,108

Kahn JB, Acheson GH 36, 68 Kahn T, see Stein RM 90, 112 Kakisawa H, Kozima T, Yanai

M, Nakanishi K 6, 68 Kalden JR, Evans MM, Irvine

WJ (277) 154,179 Kallskog O, Wolgast M

87,108 Kaloyanides G J, Azer M

96,107 Kaloyanides GJ, Cohen L,

Di Bona GF 96, 97 ,107 Kamyama S, see Matsuda K

40, 41, 70 Kamm DE, Levinsky NG

88, 89 ,108 Kang DH, see Lee CO 56, 69 Kao W, see Wiesner K 6, 74 Kaplan HS, Nagareda CS (278)

179 Kappas A, Jones HEH, Roitt

JM (279) 152,179 Kapteina FW, Moth W,

Schwartz-Porsche D, Gauer OH 101,108

Karaki H, see Ito K 59, 68

Karambasis T, see Mountoka- lakis T 97,110

Karema E, see Seibel K 60, 72 Kashgarian M, see Haystett

JP 91 ,107 Kass EH, Kendrick ML, Fin-

land M (280) 147,179 Kass RS, Lederer W J, Tsien

RW, Weingart R 18, 68 Kass RS, Tsien RW, Weingart

R 18,68 Katsuki S, see Shibata S

48, 49, 72 Kattwinkel J, Munck A (281)

157, 179 Katz AI, Genant HK 96,108 Katz AM, Repke D 51, 68 Katz DH, Bennacerraf B (282)

112,179 Katz DM, see Amerding D

(11) 123,137,168 Katz M, see Matsuda K 19, 69 Katz MA, see Blantz RC

78, 104 Katz MA, see Wallin JD

76, 78, 112 Katzung BG, see Chen C

61, 66 Katzung BG, see Hondeghem

LM 15, 67 Kaufmann R, Fleckenstein A,

Antoni H, WolfH 18, 68 Kayaalp SO, Albuquerque EX,

Warnick JE 37, 68 Kaye AM, see Trainin M (508)

138,188 Kayibanda B, Rosenfeld C

(283) 124, 179 Keck W, Joppich R, Restoff

WD v, Finsterer U, Pruck- sunand P, Brechtelsbauer H, Kramer K 84,108

Keeler RF, see Ohta M 4, 71 Keimowitz RI, see Brenner

BM 82, 104 Keiser HR, see Alexander RW

99, 103 Kelder D, see Ross SB 26, 72 Kelemen H, Lasmoler F,

Milland G (284) 143,179 Keller B, see B6nisch H

26, 65 Kemp R, Duquesnoy RJ (285)

157,179 Kemp T, Marx L (286) 179 Kemple KL, see Tanz RD

41 ,73 Kendrick ML, see Kass EH

(280) 147,179 Kenny JF, Pangburn PC, Fraig

G (287) 151,179

Page 206: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

A u t h o r l n d e x 205

Kepinov L, Metalrtikov S (288) 150,179

Kerkut GA, see Chamberlain SG 13, 66

Kern R, see Benninger C 55, 65 Kersey B, see Martinez C

(348) 117,181 Ketelsen UP, see Wekerle H

(585,586) 133,191 Khodorov BI 3, 11, 68 Khodorov BI, Revenko SV

9, 68 Khuri RN, Wiederholt M,

Strieder N, Giebisch G 91,108

Kidvaz Z, see Talwar GP (490) 162, 187

Kiger M, Flotentin I, Math6 G (289) 135, 179

Kill F, see Rector FC Jr 79, 90, 94, 111

Kilburn JG, see Feldman M (189) 175

Kim BS, see Duclos TW (152) 121,174

Kimberg DV, Loeb JH (290) 157, 179

Kimhi Y, see Trainin M (510) 139,188

Kind PD, see Jones JM (276) 124, 179

King DW, see Sanders GC (444) 185

Kinney MJ, Di Scala VA 78,108

Kinoshita Y (291) 149,179 Kintzel JE, see Buchalew VM

85,104 Kirov SM, see Globerson A

(214) 127,176 Kirkpatrick SE, see Hurley JK

99, 107 Kirschenbaum MA, Stein JH

97, 108 Kirshman D, see Sealey JE

96,112 Klahr S, see Bricker NS

96,104 Klein H, see Stumpe KO

93, 112 Klein J J, Goldstein AL, White

A (292) 179 Kleinerman J, see Shear L

101,112 Kleinman LI 100, 108 Kleinman LI, Banks RO

100, 108 Kleinman LI, Reuter JH

99, 108 Kleinman LI, see Banks RO

100, 103

Kleinman LJ, see Steichen JJ 100,112

Klemmer PJ, De Los Santos C, Blythe WB 88, 108

Klose RM, see Giebiseh G 91,106

Klose RM, see Landwehr DM 91,109

Knight TF, Weinman EJ 90,108

Knox FG, Burnett JC Jr, Kohan DE, Spielman WS, Strand JC 93, 95,108

Knox FG, Davis BB, Berliner RW 98,108

Knox FG, Gasser J 91,108 Knox FG, Howards SS, Wright

FS, Davis BB, Berliner RW 84, 96,108

Knox FG, Schneider EG, Dres- ser TP, Lynch RE 89,108

Knox FG, Schneider EG, Willis LR, Strandhoy JW, Ott CE 83, 90 ,108

Knox FG, see Davis BB 89,105

Knox FG see Diaz-Bixo JA 89,105

Knox FG, see Howards SS 90 ,107

Knox FG, see Marchand GR 77, 109

Knox FG, see Ott CE 83,110

Knox FG, see Schneider EG 80, 93, 98,111

Knutson F, Lundin PM (293) 162,179

Kohayashi S, see Hotta Y 43 ,68

Koch KM, see Bank N 85, 86,103

Koch-Weser J 23, 26, 68 Koczorek K, see Bathman A

(48) 146,147, 170 Kohan DE, see Knox FG

93, 95 ,108 Kokko JP, see Higashihara E

97 ,107 Koller PC, see Davies JS (131)

119,173 Komeva FA (294) 164, 166,

172 Komuro K, Boyse EA (295)

138,172 Komuro K, Goldstein G.

Boyse A (296) 141,179 Komuro K, see Scheid MP

(451) 138 ,159 ,185 Konda S, Stockert E, Smith

RT (297) 126,127, 180

Kondo T, see Moore PF (374) 147, 182

Konopka EA, see Goble FC (215) 151,176

Kontiainen S, Feldman M (298) 180

Kook AI, Trainin N (299, 300) 158,180

Kook AI, Yakir Y, Trainin N (301) 138, 180

Kook AJ, see Trainin M (512) 188

Kopeyan C, Martinez G, Rochat H 6, 69

Kopeyan C, see Martinez G 6, 69

Kopeyan C, see Miranda F 6, 70

Kopeyan C, see Rochat H 6,72

Kopin IJ, see Moss J 26, 70 Kopin IJ, see Thoa NB

26, 73 Koppenh6fer E, Schmidt H

10, 69 Korth M 58, 69 Koutsaimanis KG, see Brown

PR 96,104 Kovacz G, see Hochman PS

(257) 146,178 Kover G, see Oliw E 97,110 Kowanski A, see Beitens IZ

100, 103 Kozima T, see Kakisawa H

6, 68 Kphn L, see Wecker E (532)

123,157,189 Kramer HJ, see Dusing R

97,106 Kramer K, see Keck W

84,108 Krayer O 4, 64, 69 Krayer O, Acheson GH

3 , 4 , 2 3 , 6 9 Krayer O, George HW 4, 69 Krayer O, Meilman E 4, 69 Krayer O, see Moe GK 19, 70 Kreifner D 16, 42, 69 Kremshead JT, see North JR

(392) 183 Kretchmer RR, Perez-Tamayo

R (302) 120, 180 Kreth HW, Williamson A (303)

180 Krinsbeek AM (304) 180 Krisbeek AM, Astaldi GCB,

Blankwater MJ, Zijlstra JJ, Levent LA, Astaldi A (307) 134,180

Krohn PL (305) 147, 155, 180

Page 207: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

206 A u t h o r l n d e x

Krohn PL, see Billingham RE (58) 147,170

Kruck F, see Stumpe KO 93, 112

Krtiger J, Goldstein AL, Waks- manBH (306) 118,137, 180

Ku DD, Akera T, Frank M, Brody TM 42,.43, 69

Ku DD, see Akera T 42, 43, 64

Kuchel O, see Faucheux B 99,106

Kumazawa Z, Iriye R 6, 69 Kunau RT Jr, Lameire NH

86, 108 Kunau RT Jr, Webb JL, Bor-

man SC 86, 91,108 Kunau RT Jr, see Stein JH

92,112 Kupchan SM, By AW 4, 5, 69 Kupchan SM, Flacke W 4, 69 Kupchan SM, Zimmerman JH,

Alfonso A 4, 69 Kuschinsky W, Wahl M,

Wunderlich P, Thurau K 83,108

Laanes T, see Bates RW (47) 163,170

Labadie GW, see Ceglowski WS (19) 144, 171

Labat M, Moroz C (308) 180 Lackner LH, see Barton LJ

91,103 Lacombe M, Pleau F, Dardenne

MA, BachJF (309) 143, 180

Lacour B, see Chanard J 85,105 Lacy FB, see Jamison RL

81 ,107 Lalone R, see Davidman M

79, 80, 94, 105 Lalone RC, see Levinsky NG

79,109 Lalurniere G, see Carriere S

99,105 Lameire N, Matthys E, Mussche

M, Ringoir S, Leusen I 88,108

Lameire NH, see Kunau RT Jr 86, 108

Lameire NH, see Osgood RW 88, 110

Lampen M, see Pollak A (419) 184

Lance EM, Medawar PB (310) 180

Land W, see Bathmann A (48) 146, 147,170

Landwehr DM, Klose RM, Giebisch G 91,109

Lane P, see Philipps SM (405) 135,184

Lang FC, see Marchand GR 77,109

Langer SZ, Adler-Graschinsky E, Almeida AP, Diniz CR 44, 69

Langman RE, see Lee KC (317) 119,180

Lappe M, see Graft RJ (238) 146 ,151 ,177

Laragh JH, see Sealey JE 96,112

Larsson C, see Oliw W 97,110 Laskov R (311) 180 Lasmoler F, see Kelemen H

(284) 143,179 Lassiter WF, see Cortney MA

90, 91,105 Lauler DP, see Espiner EA

95,106 Lauler DP, see McDonald M

96,109 Lauler DP, see McDonald KM

98,109 Lauler DP, see Schrier RW

84, 86,111, 112 Laval F, see Deschaux P (141)

140,173 Law LW (312, 313) 134,180 Law LW, Goldstein AL, White

A (315) 117 ,137 ,180 Law LW, Tranin N, Levey RH

(314,571) 133, 136, 180 190

Law LW, see Levey RH (320) 134,180

Lawson Y, see Munro AJ (384) 124,183

Lazdunski M 64 Lazdunski M, Balerna M, Bar-

hanin J, Chicheportiche R, Fosset M, Frelin C, Jacques Y, Lombet A, Pouyss6gur J, Renaud JF, Romey G, Schweitz H, Vincent JP 3, 69

Lazdunski M, see Fosset M 14, 37, 53, 54, 55, 67

Lazdunski M, see Martinez G 6, 69

Lazdunski M, see Pouss6gur J 12,71

Lazdunski M, see Romey G 11, 12, 13, 37, 47, 48, 55, 72

Lazzari J, see Arbel ER 17, 21, 22, 49, 64

Leblond PC, see Eartly H (164) 164,174

Lederer WJ, see Kass RS 18, 68 Lee CO, Kang DH, Sokol JH,

Lee KS 56, 69

Lee JB, see Attallah AA 97,103

Lee JS 85,109 Lee KC (316) 149,180 Lee KC, Langman RE, Paltken

VH, Diener E (317) 119, 180

Lee KS, see Lee CO 56, 69 Leeber DA, Murdaugh HV,

Davis BB 90, 109 Lefkowitz I, see Watson J

(584) 124, 191 Lehmkuhl D, see Sperelakis

N 53, 73 Leicht R, Meves H, WellhSrner

HH 13, 69 Lennane RJ, Carey RM, Good-

win TJ, Peart WS 101,109 Lennane RJ, Peart WS, Carey

RM, Shaw J 101,109 Lennox ES, see Tucker DF

(514) 121,188 Lenoir MC, see Fosset M

14, 37, 53, 54, 55, 67 Leonhardt H, see Comsa J

(117-120, 123, 125) 117, 140, 147, 148,151 154, 155, 156, 172, 173

Leskovits S, see McGillivray MW (331) 181

Leuchars E, Gross AM, Dukor P (318) 133,180

Leuchars E, see Cross AM (127) 118, 134, 161,173

Leuchars E, see Davies JS (131,132) 119, 173

Leuchars E, see Doenhoff MJ (145) 125, 173

Leuchars E, see Miller JFAP (369) 182

Leusen I, see Lameire N 88,108

Levasseur P, see Bach JF (31) 169

Levent LA, see Krisbeek AM (307) 134,180

Levert LA, see Blankwater MJ (63) 137,170

Levey RH, Medawar PB (319) 146,180

Levey RH, Trainin N, Law LW (320) 134,180

Levey RH, see Burleson R (80) 133,171

Levey RH, see Dunn TD (155) 159,174

Levey RH, see Law LW (314, 571) 133,136, 180, 190

Levine DZ, see Schnermann J 94, 111

Levinsky NG, Lalone RC 79, 109

Page 208: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 20 7

Levinsky N, see Auld R 93,103

Levinsky NG, see Bruns FJ 78, 79, 81,104

Levinsky N, see Davidman M 79, 80, 94,105

Levinsky NG, see Kamm DE 88, 89, 108

Levinsky NG, see Migdal S 78,110

Levinthal BG, see Lipman MF (322) 156,180

Levitzky L, see Beitens IZ 100, 103

Levitt MF, see Stein RM 90,112

Levo Y, see Trainin M (511) 139, 188

Levy J, see Feldman M (189) 175

Levy M 93,109 Lewy JE, Windhager EE

82, 109 Lewy JE, see Windhager EE

82, 113 Lewis WJ, Cheever EV, Van-

derlaanWD (321) 163,164, 180

Liacopoulos-Briot M, see Biozzi G (59) 170

Lichardus B, Pearce JW 96,106

Lichardus B, see Pearce JW 98,110

Liebhaber SA, see Gershon RK (206) 121,176

Lifson N, see Hakum AA 85,107

Lily F, see Zissblatt M (558) 137, 190

Linker-Israeli M, see Trainin M (505,507) 117,139,188

Lipham E, see Allison M 100, 103

Lipman MF, Halteman RH, Levinthal BG, Percy S, Thomson E (322) 156,180

Lipman MF, see Thompson EB (495) 157,187

Lissitzky S, see Couraud F 37, 46, 54, 55, 66

Lissitzky S, see Fayet G 45, 67

Lissitzky S, see Miranda F 6,70

Lissitzky S, see Roehat H 6,72

List PH, H6rhammer L 5, 69 Litvac G (323) 121,181 Loeb JH, see Kimberg DV

(290) 157,179

Lohmann-Mathes ML, Fischer H (324) 121,135,181

Lombet A, see Lazdunski M 3, 69

Lonai P, Clark WR, Feldman M (326) 120, 181

Lonai P, Feldman M (325) 181

Lonai P, Rotter V, Mogilnes B, Trainin N (327) 121, 139, 181

Loot F, Amstutz H, H~igg LB, Mayor KS, Roelants GE (328) 126,181

Lovenberg W, see Alexander RW 99,103

Lovingood CG, see Allen HL (9) 155,168

Low PA, Wu Ch, Narahashi T 12, 69

Lowe DA, Bush BMH, Ripley SH 12, 69

Lowe DA, see Donatsch P 12, 66

Lowitz HD, see Stumpe KO 85,112

Loyning EW 77,109 Lucas Z J, see Walter SM

(527) 124,188 Lucharskaya LM, see Sergeev

AV (464) 165,186 LuckeyTD (329) 116,137,

138,143,144,155,168,181 Luckey TD, Venugopal B

(330) 138,143,181 Liicke-Huhle C, see Ruthen-

stroth-Baur W (441) 125, 185

Lundh H, see Redfern P 13, 71

Lundin PM, see Knutson F (293) 162,179

Lundquist LF, see Bjornboe M (62) 117, 155,170

Luton JP, see Strauch G (480) 164,186

Luttermann JW, see Schafer LA (447) 138,185

Lynch RE, see Knox FG 89,108

Lynch RE, see Schneider EG 80, 92, 111

Machleidt W, see Wunderer G 6,74

Maddox DA, Price DC, Rector FC Jr 84,109

Mahrota ND, see Talwar GP (490) 162,187

Maires RC, see Potvorski EF (422) 125,184

Maisin HF (336) 181 Makman MH, Dvoskin B,

White A (337,338) 181 Makman MH, Nakagawa S,

Dvoskin B, White A (340) 157, 181

Makman MH, Nakagawa S, White A (339) 157,181

Malakian A, see Colley DG (110) 172

Malgren J, see Schellein Y (452) 162, 185

Malkiel S, Hargis BJ (341) 146, 155,181

Man MK, see Dardenne M (129) 142, 173

Mandi B (573) 160, 190 Mandin H, Israelit AH, Rector

FC Jr, Seldin DW 80, 109 Manganaro A, see Goldstein G

(231) 141,177 Mangos JA, see Gertz KH

90, 106 Manley OT, see Marine D

(344) 161,181 Mannick JA, Egdahl RH

(342) 124,181 Manuel J, see Brunner KT

(78) 122,171 Marandola P, see Buscarini L

(81) 135,171 Marchalomis J J, Cone RE,

Rolley RT (343) 158, 181 Marchand GR 87, 99, 94,109 Marchand GR, Burke T J, Haas

JA, Romero JC, Knox FG 77,109

Marchand GR, Ott CE, Lang FC, Greger RF, Knox FG 77, 109

Marchand GR, see Diaz-Buxo JA 89,105

Marchant T, see Davies JS (132) 173

Mariani T, see Duquesnoy RJ (159) 154,174

Marine D, Manley OT, Bau- man EJ (344) 161,181

Marine D, see Jaff~ HL (267) 145, 178

Markham RB, White A, Goldstein AL (345) 147, 181

Marsh D J, see Quinn MD 87,111

Marshall RA, see Schrier RW 86,111

Martin PC, see Ellison EH (170) 155,174

Martin WJ, Miller JFAP (346) 134,181

Page 209: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

208 A u t h o r Index

Martinez C, Delmasso AP, Blaese M, Good RA (347) 117,181

Martinez C, Kersey B, Paper- master W, Good RA (348) 117,181

Martinez C, see Delmasso AP (134,135) 117,133,173

Martinez C, see Good RA (234) 121,177

Martinez C, see Stutman O (485) 187

Martinez C, see Yunis L (553) 134,189

Martinez D, Field A, Schwann H, Tyrell AA, Hilleman MR (574) 142, 143,190

Martinez F J, see Buckalew VM Jr 96,104

Martinez G, Kopeyan C, Schweitz H, Lazdunski M 6, 69

Martinez G, see Kopeyan C 6,69

Martinez-Maldonado M, see Rector FC Jr 90,111

Martino JA, Earley LE 76, 77, 82, 86,109

Martino JA, see Earley LE 85, 106

Maxtino L de, see Primus FJ (423) 137,184

Marx L, see Kemp T (286) 179

Mason DT, see Fill JR Jr 99,106

Mason DW, see Hunt SW (262) 126, 178

Massry SG, see Better OS 102, 104

Massry SG, see Melman A 102, 109

Math6 G, see Kiger M (289) 135,179

Mathieu A, see Carriere S 81,105

Matsuda K, Hoffman BF, Ellner CN, Katz M, Brooks CMcC 19, 69

Matsuda K, Hoshi T, Kame- yama S 40, 41, 70

Matsumoto T, see Braun W (74) 158,171

Matsumura M, Takaori S 39, 41, 70

Matsuo T, see Shibata S 48, 49, 72

Matthys E, see Lameire N 88,108

Maul VA, see Zaalberg OBVD (554) 189

Maunsbach AB, Boulpaep EL 84, 109

Maximov A (349) 141,181 Mayer MM, see Eisen HN

(166) 146,174 Mayopoulou-Symvoulidou

MG, see Mountokalakis T 97,110

Mayor KS, see Loor F (328) 126,181

Mayor-Withery KS, see Roe- lants GE (435) 126,134, 185

McAllister RE, Noble D, Tsien RW 15, 70

McCaniel MC, see Hooper JS (258) 136,178

McCarthy DA, see Swain HH 21,43, 73

McDonald J, see Bahlmann JS 96,103

McDonald KM, Rosenthal A, Schrier RW, Galicich J, Lauler DP 98,109

McDonald KM, see Schrier RW 84, 86,111, 112

McDonald M, Schrier RW, Lauler DP 96,109

McDonald R, see Primus FJ (423) 137,184

McDonald S J, Wardener HE de 85,109

McDonald TF, Sachs HG 36, 70

McDonald TF, Sachs HG, DeHaan RL 36, 37, 70

McDonald TF, Trautwein W 15, 70

McDonald TF, see DeHaan RL 36, 66

McDonald TF, see Trautwein W 51, 73

McDonald W, see Claman H (101) 119,172

McDougal JL, Shen FW, Elster P (572) 122,190

McDowell EC, see Smith PE (471) 163,186

McGillivray MW, Jones VE, LeskovitsS (331) 181

McGregor DD, Gowans JL (332) 120,181

McGregor DD, see Gowans JL (236,237) 117,120,163, 177

McGuigan JAS, see Bassingth- waighte JB 27, 65

McLane-Vega LA, see Hanson RC 101,107

McLean MJ, Sperelakis N 36, 70

McManus JP, Whitfield JF (333, 334) 144, 158,162, 181

McManus JP, see Rixon RH (431) 185

McManus JP, see Whitfield JF (539) 150, 157,189

McMaster PD, Franzl RB (335) 146,181

McNaughton PA, see Baker PF 52, 53, 64

McNeil JS, see Schrier RW 89,111

Medawar PB (350) 120,182 Medawar PB, Sparrow EM

(351) 134 ,135 ,143 ,146 , 152, 155,182

Medawar PB, see Billingham RE (58) 147,170

Medawar PB, see Lance EM (310) 180

Medawar PB, see Levey RH (319) 146,180

Meilman E, see Krayer O 4, 69

Meissner A, see Honerjfiger P 42

Melder B, see Dusing R 97,106

Mellors T, see Perri WL (403) 183

Melman A, Massry SG 102,109

Mendez, see Zipes 21 Mendoza SA, see Hurley JK

99,107 Merikas G, see Mountokalakis

T 97,110 Merlet-Benichou C, Rouffig-

nac C de 99,109 Merrile JP, see Carpenter CB

(87) 135,171 Meshalova AM, Frazinova JB

(352) 146,182 Metalnikov S, see Kepinov L

(288) 150,179 MetcalfD (353-355) 146,182 Meres H, see Leicht R 13, 69 Michclen HS, see Ford LF

(193) 125,175 Michoud P, see Diezi J

92, 106 Migdal S, Alexander EA, Bruns

FJ, Riley AL, Levinsky NG 78,110

Migeon C J, see Beitens IZ 100,103

Milcu S, Potop J (356) 135, 144,182

Milcu S, Potop J, Boer V, Oli- niciN (357) 135,182

Page 210: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 209

Milcu S, see Potop J (421) 117,145,184

Milland G, see Kelemen H (284) 143,179

Miller and Good 128 Miller HC, Esselmann WJ

(358) 133, 138,164,182 Miller HC, Schniege SK, Rule

A (359) 138,182 Miller HC, see Esselman WJ

(566) 124,190 Miller JFAP (360-362) 117,

118,120,133,182 Miller JFAP, Brugh PM de,

Grant GA (371) 117,182 Miller JFAP, Doak SMA, Cross

MA (367) 118,182 Miller JFAP, Grant GA, Roe

FJC (368) 117,182 Miller JFAP, Leuchars E,

Cross AM, Dukor P (369) 182

Miller JFAP, Mitchell GF (363-365) 118,119,134, 182

Miller JFAP, Osoba D (366) 182

Miller JFAP, Osoba D, Dukor P (370) 182

Miller JFAP, see Cross AM (127) 118,134,161,173

Miller JFAP, see Martin WJ (346) 134,181

Miller RG, see Gorczynski RM (235) 123,177

Milliez P, see Papanicolaou N 97,110

Mills IH, see Mtlnck O 77,110 Mills IH, see Wardener HE de

79, 87, 94, 95, 96, 97,113 Miranda F, Kopeyan C, Rochat

H, Rochat C, Lissitzky S 6, 70

Miranda F, see Fayet G 45, 67 Miranda F, see Rochat H 6, 72 Miranda F, see Zlotkin E

44, 74 Misanko BS, Bengele HH,

Solomon S 100,110 Mitchell GF, see Miller JFAP

(363-365) 118,119,134, 182

Mitchison MA (372) 120, 182 Mitchison MA, see Raft MC

(427) 125,184 Miura Y, see Hashimoto K

6, 49, 67 Miyamoto H, Racker E 56, 70 Moe GK, Krayer O 19, 70 Moeschlin S, Baguerra R,

Baguerra J (373), 146,155, 182

Mogilnes B, see Lonai P (327) 121,139,181

Money WL, see Perri WL (403) 183

Mongo KG, see Roulet MJ 57, 72

Moore DH, see Eisen HN (166) 146,174

Moore JW, see Narahashi T 31, 70

Moore PF, Kondo T, Oliver RJ (374) 147,182

Moorhead JW, see Claman H (103) 172

Morad M, Goldman Y 57, 70 Morad M, Trautwein W 57, 70 Morad M, see Cleeman L

28, 66 Morales-Aguilera A, Vaughan

Williams EM 43, 70 Mordin AA, see Jerne NK

(273) 117,179 Morel G, see Deschaux P (142)

165, 173 Morgan G, see Scriabine A

49, 72 Morgan T, Berliner RW

90, 91,110 Morita Y, Munck A (375)

157,182 Moroz C, see Labat M (308)

180 Morris AA, see Scriabine A

49, 72 Morrison SL, see Tener GSL

(582) 191 Mosher KM, Young DA,

Munck A (376,377) 157, 182, 183

Mosier DE, Coppleson LW (378) 183

Mosier DE, Pierce W (379) 119,134,183

Moss J, Thoa NB, Kopin IJ 26, 70

Moth W, see Kapteina FW 101,108

Mountain JM (380) 148,183 Mountokalakis T, Karambasis

T, Mayopoulou-Symvo ulidou MG, Merikas G 97,110

Mouton D, see Biozzi G (59) 170

Mowbray JF (381) 135,183 Mozhayeva GN, Naumov AP,

Negulyaev YA, Nosyreva ED 10,41, 70

Miiller JFAP, see Basten A (44) 170

MuUane JF, Gliedman ML 103,110

Mullins LJ 35, 70

Mumludahl KE, see Zahnd GR (555) 164,190

Munck A (382) 183 Munck A, Brink-Johnson T

(383) 156,157,183 Munck A, see Kattwinkel J

(281) 157,179 Munck A, see Morita Y (375)

157,182 Munck A, see Mosher KM

(376,377) 157,182, 183 Munck A, see Wira C (546)

156,189 Munck O, Bono E de, Mills IH

77,110 Munro A, see Waldmann H

(526) 123,188 Munro AJ, Taussig MJ, Camp-

beel R, Williams H, Lawson Y (384) 124,183

Munson R, Westermark B, Glaser L 12, 70

Muramatsu I, see Fujiwara M 12, 50, 61, 67

Murdaugh HV, see Leeber DA 90, 109

Mussche M, see Lameire N 88,108

Muzzoli M, see Fabris N (174) 154, 175

Myers TS, see Brown GL (77) 148, 157,171

Mylle M, see Cortney MA 90, 91,105

Nachtigal D, see Eisental A (167) 122, 174

Nadeau A, see Zahnd GR (555) 164,190

Nagareda CS, see Kaplan HS (278) 179

Nagy E (575) 154,190 Najarian JS, Feldman M (385,

386) 120, 123,183 Nakagawa S, see Makman MH

(339, 340) 157,181 Nakamura J, see Rotter V

(438,439) 139,185 Nakanishi K, see Kakisawa H

6, 68 Nakao S, Namba Y, Hanaoka

M (387) 126,183 Namba Y, see Nakao S (387)

126,183 Narahashi T 3, 13, 31, 70 Narahashi T, Anderson NC,

Moore JW 31, 70 Narahashi T, Seyama I 10, 70 Narahashi T, Shapiro BI,

Deguchi T, Scuka M, Wang CM 11, 70

Narahashi T, see Low PA 12, 69

Page 211: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

210 A u t h o r I n d e x

Narahashi T, see Ohta M 4, 71

Narahashi T, see Starkus JG 10,73

Nase S, see Raft MC (427) 125,184

Naumov AP, see Mozhayeva GN 10, 41, 70

Nazanine J, see Robert A (432) 148,185

Nedred J, Touton M, Clark WR (388) 121,183

Negulyaev YA, see Mozhayeva GN 10,41, 70

Nenninger M, see Diezi J 91,106

Neu H, see Comsal J (124) 140, 144, 149,155,161, 162, 173

New W, Trautwein W 34, 51, 70

Newson S, Darrach M (389) 147, 148,155,183

Nicholas DP, see Daugharty TM 79, 80, 83,105

Niedergerke R 55, 70 Nielsen EL (390) 163,183 Nielsen S, see Wortis HH (549)

117, 133,189 Nishimoto AY, see Philipson

KD 56, 71 Nissen OI 79, 110 Noble D, see McAlhster RE

15, 70 Noma A, Yanagihara K,

Irisawa H 16, 42, 71 Nomttra M, see Abe T (1)

147,148,168 Norden SK, Young DA (391)

157,183 Nordin AA, see Cerrottini JC

(94) 121,172 North JR, Kremshead JT,

Askonas BA (392) 183 Norton TR, see Shibata S

48, 49, 72 Norton TR, see Tanaka M

6,73 Nosyreva ED, see Mozhayeva

GN 10, 41, 70 Notargiacomo MV, see Velas-

quez MT 77, 78,112 Nutbourne DM, Howse JD,

Schrier RW, Talner LB, Ventom MG, Verroust PJ, Wardener HE de 96,110

Obika LFO, Fitzgerald EM, Gleason SD, Zueker A, Schneider EG 101,110

Ochi R, see Hashimoto K 6, 49, 67

Ochwadt B, see Stumpe KO 85,112

Ohta M, Narahashi T, Keeler RF 4, 71

Ohta M, see Attwell D 15, 22, 64

Ojeda C, see Attwell D 15, 22, 64

Olinici N, see Milcu S (357) 135,182

Oliver R J, see Moore PF (374) 147,182

Oliw E, Kover G, Larsson C, Anggard E 97,110

Opitz W-D, see Dusing R 97,106

Orias O, see Brooks CMcC 19, 65

Orkand RK, see Tang CM 12,73

Orloff J, see Burg MB 90,105

Orosz CG (393) 124,183 Ortt EM, see Carey RM

101,105 Osgood RA, see Stein JH

92,112 Osgood RW, Lameire NH,

Sorkin MI, Stein JH 88,110

Osgood RW, Reineck HJ, Stein JH 81, 87, 88, 92, 110

Osgood RW, see Reineck HJ 92,111

Osgood RW, see Stein JH 78, 80, 91,112

Osoba D (394,395) 152, 153,183

Osoba D, see Miller JFAP (366, 370) 182

Ott CE, Haas JA, Cuche J-L, Knox FG 83,110

Ott CE, see Diaz-Buxo JA 89,105

Ott CE, see Knox FG 83, 90,108

Ott CE, see Marchand GR 77,109

Ottenger B, see Germuth FG (203) 146,155,1 76

Owen JJ, see Wortis HH (549) 117, 133,189

Owen JT, Raft MC (396) 183 Oyama J, see Germuth FG

(203) 146,155,176 Oyama J, see Hanan R (246)

119,178 Ozminski K, see Comsa J

(125) 140 ,141 ,155 ,173

Pagel HD, see Gertz KH 90,106

Paimre M, see Feinstein MB 31,67

Pakovits M, see Fachet J (177, 178) 159, 175

Paltken VH, see Lee KC (317) 119, 180

Pandian MR, Talwar GP (397) 154, 162,183

Pandit H, see Bentzel CJ 84,104

Pane WE, see Stobo JD (479) 143, 186

Pangburn PC, see Kenny JF (287) 151,179

Pantelouris S (398) 118,183 Papanicolaou N, Safar M,

Hornych A, Fontaliran F, Weiss Y, Bariety J, Milliez P 97,110

Papermaster BW, see Good RA (234) 121,177

Papermaster W, see Martinez C (348) 117, 181

Papiernik M, see Bach JF (31) 169

Papiernik M, see Daxdenne M (128) 162,173

Pappano AJ 36, 71 Pappano AJ, see Iijima T

36, 68 Pappano A J, see Sperelakis N

12, 36,53,54, 73 Papper S, Belsky JL, Bleifer

KH 85,110 Pardos P, see Strauch G (480)

164, 186 Parish CR, see Globerson A

(214) 127,176 Parma R, see Reineck HJ

92,111 Parott DMV, see East J (165)

134, 174 Parrillo E (576) 146,190 Parrott D, Sousa M de (399)

125, 183 Parrott D, Sousa M de, East J

(400) 125, 183 Passo SS, Thornborough JR,

Rothboller AB 101,110 Pastoriza-Munoz R, see Bello-

ReussE 98,103 Paulsen F, see 8chellein Y

(452) 162, 185 Paznino MM, Ihle JM, Gold-

stein AL (401) 137,183 Pearce JW, Lichardus B

98,110 Pearee JW, Sonnenberg H

98,110 Pearce JW, Sonnenberg H,

Veress AT, Ackerman U 96,110

Page 212: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 21 1

Pearce JW, see Bengele HH 96, 98,104

Peaxce JW, see Lichardus B 96,106

Pearce JW, see Veress AT 95,112

Peart WS, see Lennane RJ 101,109

Pelletier CL, see Clement DL 99,105

Pena A, Dwoskin B, White A (402) 183

Peper K, Trautwein W 40, 41, 71

Percy S, see Lipman MF (322) 156, 180

Perez-Tamayo R, see Kxetsch- mer RR (302) 120, 180

Perlman P, Holm C (404) 184 Perri WL, Faulk M, Shapiro E,

Mellors T, Money WL (403) 183

Pesardo PC, see Baroni C (38) 154, 169

Peterson DF, see Blair RW 4, 65

Pfitzenmaler K, see Rollinghoff MA (437) 122,185

Philipp EM, see Comsa J (121) 137, 140, 144,173

Philipps SM, Carpenter CB, Lane P (405) 135,184

Philipson KD, Nishimoto AY 56, 71

Phillips RA, see Gorczynski RM (235) 123,177

Photopoulos K, see Fischel EE (191) 146,175

Piantanelli L, see Fabris N (174) 154,175

Pierce JC, see Archer OK (12) 117, 168

Pierce JC, see Good RA (234) 121,177

Pierce W, see Mosier DE (379) 119,134,183

PierpaoliW (406) 119,184 Pierpaoli W, Baroni C, Fabin

M, Sorkin E (413) 154,184 Pierpaoli W, Besedowsky HO

(407, 408) 140,160, 184 Pierpaoli W, Bianchi E, Sorkin

E (415) 118,160,184 Pierpaoli W, Fabris H, Sorkin

E (414) 184 Pierpaoli W, Sorkin E (409-

412) 117, 160, 184 Pierpaoli W, see Bianchi E

(55) 160,170 Pierpaoli W, see Fabris N

(175) 154, 156,175

Pierpaoli W, see Sorkin E (475) 160, 163,186

Pietro S Di, see Doria G (146) 123,174

Pilanke LM, see A1-Adra AR (559) 122, 190

Pillat B, see Heistracher P 17, 18 ,40 ,41 ,42 ,67

Pinder M, see Humber DP (570) 152,190

Pitkins DH (416) 148,184 Pitlick PT, see Hurley JK

99,107 Pitts B JR 56, 71 Playfair JHL, see Roitt IM

(436) 119,185 Pleau F, see Lacombe M (309)

143, 180 Pleau JM, Dardenne M, Bioquet

Y, Bach JF (417) 142, 184 Pleau JM, see Bach JF (32)

142, 169 Pleau JM, see Dardenne M

(129) 142,173 Plescia O, Yamamoto I, Shima-

wara T, Fert C (418) 158, 184

Pollak A, HLrnmerling W, Lampen M, Harveirs E de (419) 184

Polo R Di 51, 52, 66 Polo R Di, Beaug~ L 52, 53, 66 Pollen DW, Scott AC, Wallace

WFM 62, 71 Ponce Zumino A, see Ruiz-

CerettiE 16, 72 Pora E, Toma V, Wittenberger

C, Rusdea D (420) 141, 184

Pottier A, see Deschaux P (139) 173

Portius HJ, Repke K 36, 71 Potkay S, Gilmore JP 101,110 Potop J, Milcu S (421) 117,

145,184 Potop J, see Milcu S (356,

357) 135,144, 182 Potvorski EF, Makes RC

(422) 125,184 Poujeol R, Bonvalet JP, Rouf-

fignac C de 81,111 Poujeol P, see Chabardes D

81,105 Pouyss6gur J, Jacques Y, Laz-

dunski M 12, 71 Pouyss6gur J, see Lazdunski M

3, 69 Prahn RT, see Algire GH (8)

120,168 Pratt KR, see Fauci AS (567)

148,190

Prezansky J, see Axelrod AE (23) 165, 167, 169

Price DC, see Maddox DA 84,109

Primus F J, Martino L de, McDonald R, Hansen HJ (423) 137,184

Proppe D, see Alsen C 46, 64 Prucksunand P, see Keck W

84, 108 Pujade-Lauraine C, see Cha-

nard J 85,105 Purkerson M, see Bricker NS

96,104 Puschett JB, see Agus ZS

98,103 Puscbett JB, see Buckalew

VM 85,104 Puschett JB, see Buckalew

VM Jr 90, 104

Quinn MD, Marsh DJ 87,111 Quint AL, see Hardy MA

(248) 137,178 Quint J, see Goldstein AL

(219) 137,176

Racker E, see Miyamoto H 56, 70

RaffMC (424) 125,184 Raft MC, Cantor H (425)

184 Raft MC, Nase S, Mitchison

MA (427) 125,184 Raft MC, Wortis HH (426)

125, 184 Raft MC, see Owen JT (396)

183 Rathmayer W, B~ress L 11, 71 Rathmayer W, see Bergmann C

11, 65 Ravens U 46, 47, 51, 59, 61,

71 Reckard CR (428) 120,184 Rector FC Jr, Giesen GV, Kill F,

Seldin DW 79, 90, 94,111 Rector FC Jr, Sellman JC,

Martinez-Maldonado M, Seldin DW 90, 111

Rector FC Jr, see Barratt LJ 79, 80,103

Rector FC Jr, see Barton LJ 91,103

Rector FC Jr, see Blantz RC 78,104

Rector FC Jr, see Brunner FP 90,104

Rector FC Jr, see Eknoyan G 90, 106

Rector FC Jr, see Herrea- Acosta J 80, 107

Page 213: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

212 A u t h o r Index

Rector FC Jr, see Maddox DA 84, 109

Rector FC Jr, see Mandin H 80, 109

Rector FC Jr, see Wallin JD 76, 78,112

Redfern P, Lundh H, Thesleff S 13,71

Reeves JP, Sutko JL 56, 71 Rega MJ, see Braun W (73)

158, 171 Reichman ME (577) 152, 190 Reif AE, Allen JMV van (429)

125, 185 Reilly R, see Thompson JS

(497) 149, 156,187 Reinberg T, see Alsen C

46, 64 Reineck H J, Parma R, Barnes

JL, Osgood RW 92,111 Reineck H J, see Osgood RW

81, 87, 88, 92, 110 Reiter M 5, 18, 23, 28, 29, 32,

56, 57, 58, 60, 64, 71 Reiter M, Stickel F J, Weber S

61, 71 Reiter M, see Ebner F 60, 66 Reiter M, see Honerj~iger P

18, 23, 24, 25, 26, 28, 29, 30, 31, 32, 34, 35, 38, 39, 59, 60, 61, 62, 67, 68

Reiter M, see Seibel K 60, 72 Renaud JF, see Lazdunski M

3, 69 Renaud JF, see Romey G

12, 37, 47, 48, 55, 72 Renne T, see Senon B (463)

135, 186 Rennels EG, see Carsner RL

(88) 163,171 Repke D, see Katz AM 51, 68 Repke K, see Portius HJ

36, 71 Restoff WD v, see Keck W

84, 108 Reuter H 15, 71 Reuter H, Scholz H 15, 32, 71 Reuter H, Seitz N 52, 71 Reuter H, see Baer M 31, 37,

59, 64 Reuter H, see Beeler GW

15, 31, 51, 61, 65 Reuter H, see Beresewicz A

60, 65 Reuter H, see Gettes LS

18, 67 Reuter H, see Glitsch HG

53, 55, 67 Reuter JH, see Kleinman LI

99,108 Revenko SV, see Khodorov

BI 9, 68

Rho YM, see Touraine JL (502) 154,187

Richardson BP, see Donatsch P 12,66

Richer G, Hornych A 84,111 Riddle O, see Bates RW (47)

163, 170 Riley AL, see Bruns FJ

78, 79, 81,104 Riley AL, see Migdal S

78,110 Ringoir S, see Lameire N

88,108 Ripley SH, see Lowe DA

12,69 Ritchi JM 3, 71 Ritter MA (430) 149,150,

185 Rixon RH, Whitfield JF,

McManus JP (431) 185 Rixon RH, see Whitfield JF

(539) 150, 157,189 Robb CA, see Schneider EG

101,111 Robbins JB, see Tanz RD

41 ,73 Robert A, Nazanine J (432)

148,185 Roberts S, White A (433)

145,185 Robey G (434) 143,144, 185 Robinson RR, see Burke TJ

84,105 Rochat C, see Miranda F 6, 70 Rochat C, see Rochat H 6, 72 Rochat H, Rochat C, Kopeyan

C, Miranda F, Lissitzky S, Edman P 6, 72

Rochat H, see Couraud F 37, 46, 54, 55, 66

Rochat H, see Kopeyan C 6,69

Rochat H, see Miranda F 6, 70 Rochat H, see Zlotkin E

44, 74 Roe FJC, see Miller JFAP

(368) 117, 182 Roe J, see Daly JJ 101,105 Roelants GE, Mayor-Withery

KS (435) 126,134,185 Roelants GE, see Loor F (328)

126,181 Roesel OF, see Bottoner GD

(68) 157,171 Roiff IM, see Jones B (275)

121,179 Roitt IM, Torrigiani G, Greaves

MF, Brostoff J, Playfair JHL (436) 119, 185

Roitt JM, see Kappas A (279) 152,179

Rojas E, Rudy B 31, 72

Rojas E, see Bergmann C 11, 65

Rola-Pleszczinski M, see Thong YA (498) 157, 187

Rolley RT, see Marchalomis JJ (343) 158, 181

Rollinghoff MA, Pfitzenmaier K,Wagner H (437) 122,185

Romero JC, see Marchand GR 77, 109

Romey G, Abita JP, Schweitz H, Wunderer G, Lazdunski M 11,72

Romey G, Jacques Y, Schweitz H, Fosset M, Lazdunski M 12, 13, 72

Romey G, Renaud JF, Fosset M, Lazdunski M 12, 37, 47, 48, 55, 72

Romey G, see Lazdunski M 3, 69

Roosa RA, see Defendi V (133) 117,173

Rosen MR, Danilo P 18, 72 Rosenberry TL, see Bartels-

Bernal E 38, 64 Rosenfeld C, see Kayibanda B

(283) 124,179 Rosenstreich DL, see Wahl SJ

(523) 157,188 Rosenthal A, see McDonald

KM 98,109 Rosenthal J, Simone PG,

Silbergleit A 97,111 Ross SB, Kelder D 26, 72 Rossio JL, see Goldstein AL

(225) 137,177 Rothboller AB, see Passo SS

101,110 Rothlauf MW, see Brown GL

(77) 148,157,171 Rotter V, Globerson A, Naka-

mura J, Trainin M (438,439) 139, 185

Rotter V, see Lonai P (327) 121,139,181

Rotter V, see Trainin M (511) 139,188

Rouffignac C de, Bonvalet JP 81,111

Rouffignac C de, see Chabardes D 81,105

Rouffignac C de, see Merlet- Benichou C 99,109

Rouffignac C de, see Poujeol R 81,111

Roulet M J, Mongo KG, Vassort G, Ventura-Clapier R 57, 72

Rubin AS, Carpenter CR (440) 123,185

Rude E, see Gisler R (211) 123,176

Page 214: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 213

Rudolf M, see Brunner KT (78) 122, 171

Rudolph AM, see Barger AC 76,103

Rudy B, see Rojas E 31, 72 Ruiz-Ceretti E, Ponce Zumino

A 16,72 Rule A, see Miller HC (359)

138, 182 Rumrich G, Ullrich KJ

83,111 Rusdea D, see Pora E (420)

141,184 Ruthenstroth-Baur W, Liicke-

Huhle C (441) 125,185

Sabolovic D, see Wioland M (545) 125,189

Sabolevic EB, Dumont F (442) 125, 185

Sachs HG, see De Haan RL 36, 66

Sachs HG, see McDonald TF 36, 37, 70

Safar M, see Papanicolaou N 97,110

Sakakibara J, see Hotta Y 43, 68

Saldanha LF, see Gonick HC 96,107

Salomon JC, see Bach JF (33) 142, 143, 149,169

Sand H, Haynes RC (443) 157,185

Sanders GC, King DW (444) 185

Sano T, see Yamagishi S 16, 74

Sato K 86,111 Sato VL, Waksal SD, Herzen-

berg LA (445) 134, 185 Sattler RW, see Alsen C 46, 64 Savart M, Daniel-Lamaziere

JM (446) 156,185 Sayana R, see Tatwar GP

(490) 162, 187 Scala VA Di, see Holmes EW .

98, 107 Scala VA, see Kinney MJ

78, 108 Schafer LA, Goldstein AL,

Luttermann JW, Heisler EM (447) 138, 185

SchaUer RT, Stevenson JK (448) 133,185

Schaumburg BP (449) 156, 185

Scheid M, see Schlesinger M (461) 141,186

Scheid MP, Goldstein G, Ham- merfing W, Boyse EA (450) 136,141,185

Scheid MP, Hoffman MK, KomuoK (451) 138,159, 185

ScheUein Y, Hesselj5 R, Paul- sen F, Malgren J (452) 162, 185

Schellekens PG, see Astaldi G (21) 143,169

Schenkel-Hulligex L, see Gisler R (209, 210) 154,176

Schimpl A, Wecker E (453, 454,455) 123,186

Schimpl A, see Wecker E (532) 123,157,188

Schlesinger M (456,457) 125,126,186

Schlesinger M, Goldstein G (458) 186

Schlesinger M, Goldstein G, Scheid M, Boyse EA (461) 141,186

Schlesinger M, Shlonai-Kor- zash Z, Israel E (460) 186

Schlesinger M, Yaron T (459) 186

Schmidmeier E, see Schner- mann J 94,111

Schmidt H, Schmitt 0 10, 72 Schmidt H, see Adam KR

10, 64 Schmidt H, see KoppenhSfer

E 10,69 Schmidt RF 17, 40, 41, 72 Schmitt 0, see Schmidt H

10,72 Schneebeli G, see Dougherty

TF (151) 149,174 Schneebeli GL, see Goldstein

AL (220) 136,176 Schneider EG, Davis JO, Robb

CA, Baumber JS, Johnson JA, Wright FS 101,111

Schneider EG, Dresser TP, Lynch RE, Knox FG 98, 111

Schneider EG, Goldsmith RS, Arnaud CD, Knox FG 98,111

Schneider EG, Lynch RE, Willis LR, Knox FG 80,111

Schneider EG, see Hanson RC 101,107

Schneider EG, see Knox FG 83, 89, 90,108

Schneider EG, see Obika LFO 101,110

Schnermann J 91,111 Schnermann J, Davis JM,

Wunderlich P, Levine DZ, Horster M 94,111

Schnermann J, Hermle M, Schmidmeier E, Dalheim H 94,111

Schnermann J, Wright FS, Davis JM, Stackelberg W v, Grill G 94, 111

Schnermann J, see Dev B 94,105

Schniege SK, see Miller HC (359) 138, 182

Scholz H 58, 61, 72 Scholz H, Yazikof E de 61, 72 Scholz H, see Glitsch HG

53, 55, 67 Scholz H, see Reuter H

15, 32, 71 Schrek B (462) 149,186 Schrier RW, Earley LE

84,111 Schrier RW, Fein RL, McNeil

JS, Cirksena WJ 89,111 Schrier RW, McDonald KM,

Marshall RA, Lauler DP 86,111

Schrier RW, McDonald KM, Wells RE, Lauler DP 84,112

Schrier RW, see Holzgreve H 83,107

Schrier RW, see McDonald KM 98, 109

Schrier RW, see McDonald M 96,109

Schrier RW, see Nutbourne DM 96,110

Schultze RG, see Bricker NS 96,104

Schwann H, see Martinez D (574) 142, 143,190

Schwartz N, see Viscoper JR 96,112

Schwartz-Porsche D, see Kapteina FW 101,108

Schwarz JA, see Comsa J (123, 124) 117, 140, 144, 149, 154, 155,161,162,173

Schweissfurth R, see Comsa J (122) 173

Schweitz H, see Lazdunski M 3, 69

Schweitz H, see Martinez G 6, 69

Schweitz H, see Romey G 11, 12, 13, 72

Scinader JW, see Wagner H (521) 121, 134,188

Scott AC, see Pollen DW 62, 71

Scriabine A, Arman CG van, Morgan G, Morris AA, Ben- nett CD, Bohidar NR 49, 72

Scuka M, see Narahashi T 11, 70

Sculof RS, see Hooper JS (258) 136,178

Page 215: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

214 Au tho r Index

Sealey JE, Kirshman D, Laragh JH 96,112

Seely JF, see Dirks JH 91,106 Selbel K, Karema E, Takeya K,

Reiter M 60, 72 Seifen E 19, 72 Seitz N, see Reuter H 52, 71 Sekerin CE, see Abraham AD

(2) 156,157,168 Seldin DW, see .Barratt LJ

79, 80,103 Seldin DW, see Barton LJ

91,103 Seldin DW, see Blantz RC

78, 104 Seldin DW, see Brunner FP

90, 104 Seldin DW, see Eknoyan G

90, 106 Seldin DW, see Herrera-Acosta

J 80, 107 Seldin DW, see Mandin H

80, 109 Setdin DW, see Rector FC Jr

79, 90, 94, 111 Seldin DW, see Wallin JD

76, 78,112 Sellman JC, see Rector FC Jr

90, 111 Senesky D, see Agus ZS

98,103 Senon B, Renne T, Sermlar R,

Delor B, Dubois JB, Thierry C (463) 135, 18_6

Sergeev AV, Bykovskaya SM, Lucharskaya LM (464) 165, 186

Seriguchi DG, see Shibata S 48, 73

Sermlar R, see Senon B (463) 135,186

Sethi KK, Brandis H (465) 123,186

Sevcik C, see Villegas J 12, 74 Sevensen C, see Thompson JS

(497) 149, 156,187 Seyama I 42, 60, 72 Seyama I, see Narahashi T

10, 70 Shafner JB, see Arnason BG

(15) 117,169 Shanes AM 8, 17, 72 Shanks RG, see Howe R

62, 68 Shapiro BI, see Narahashi T

11, 70 Shapiro E, see Perri WL (403)

183 Sharp GWG, see Di Bona DR

84, 85,105 Shaskar JR, Bottoner GD

(466) 156,186

Shaw J, see Lennane RJ 101,109

Shear L, Kleinerman J, Gabuzda GJ 101,112

Shen FW, see Cantor H (86) 127, 171

Shen FW, see McDougal JL (572) 122, 190

Shepherd JT, see Clement DL 99,105

Sherman JD, see Wong FM (548) 189

Shibata S, Izumi T, Seriguchi DG, Norton TR 48, 73

Shibata S, Norton TR, Izumi T, Matsuo T, Katsuki S 48, 49, 72

Shibata S, see Shimizu T 17, 48, 49, 73

Shigenobu K, Sperelakis N 36, 73

Shigenobu K, see Sperelakis N 36, 73

Shigeto N, Irisawa H 16, 73 Shimawara T, see Plescia O

(418) 158, 184 Shimizu T, Iwamura N,

Toyama J, Yamada K, Shibata S 17, 48, 49, 73

Shirai N, see Hotta Y 43, 68 Shlonai-Korzash Z, see Schle-

singer M (460) 186 Shotzberger GS, Albuquerque

EX, Daly JW 39, 73 Shuyser M (467) 156,186 Silbergleit A, see Rosenthal J

97,111 Silvestroni AE, see Goldstein

G (232) 141,177 Simone PG, see Rosenthal J

97,111 Simonsen M (468) 117,186 Sinclair MR, Elliott EV (469)

117,186 Sinclair MR, see Elliott EV

(168) 146,174 SininskiA (470) 160, 186 Sjodin K, see Delmasso AP

(135) 173 Sj6din K, see Wilson R (543)

117,189 Slate D, see Hardy MA (248)

137,178 Slater FD, see Goldstein AL

(224) 136,164,177 Small M, see Trainin M (506,

509,510) 117,138,139, 188

Smith JR, see Carey RM 101,105

Smith PE, McDowell EC (471) 163,186

Smith RT, see Konda S (297) 126, 127, 180

Smith SB, see Isakovic K (264) 120, 178

SneUGD (472) 151, 163, 186 Snell GD, see Graft R.I (238)

146, 151, 177 Sokol JH, see Lee CO 56, 69 Solle H, see Stumpe KO

93,112 Solomon GE (473) 148,186 Solomon S, see Bengele HH

99,104 Solomon S, see Misanko BS

100, 110 Solomon S, see Sonnenberg H

83,112 Sonnenberg H 92, 112 Sonnenberg H, Solomon S

83, 112 Sonnenberg H, see Pearce JW

96, 98,110 Sonnenberg H, see Wilson DR

92, 113 Sopori ML, Alter B J, Bach FH,

Bach ML (474) 124,186 Sordelli A, see Houssay BA

(260) 150, 178 Sorkin E, Pierpaoli W, Fabris

N, Bianchi F (475) 160, 163, 186

Sorkin E, see Arrenbrecht S (16) 155,162, 169

Sorkin E, see Besedowsky H (54) 147, 160, 164,167, 170

Sorkin E, see Bianchi E (55) 160, 170

Sorkin E, see Fabris N (175) 154, 156, 175

Sorkin E, see Pierpaoli W (410-415) 117, 118, 154, 160,184

Sorkin MI, see Osgood RW 88,110

Sousa de 128 Sousa M de, see Paxrott D

(399, 400) 125,183 Sparks JC, see Susic D

97,112 Sparrow E (476) 147,186 Sparrow EM, see Medawar PB

(351) 134, 135,143,146, 152, 155,182

Sperelakis N, Lehmkuhl D 53,73

Sperelakis N, Pappano AJ 12, 36, 53, 54, 73

Sperelakis N, Shigenobu K 36, 73

Sperelakis N, see McLean MJ 36, 70

Page 216: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Author Index 215

Sperelakis N, see Shigenobu K 36, 73

Spielmau WS, see Knox FG 93, 95,108

Spitzer A, Windhager EE 82, 112

Spitzer A, see Goldsmith DI 99,106

Spitzer A, see Windhager EE 82, 113

Sprent J, see Basten A (44) 170

Staber F, see Gisler R (211) 123, 176

Stackelberg W v, see Schner- mann J 94, 111

StLrnpfli R, see Adam KR 10, 64

Stark E, see Fachet J (177) 159, 175

Starkus JG, Narahashi T 10,73

Staughton RCD, see Byrom NA (82) 138, 171

Stavy L, see Cohen JT (109) 148, 172

Steichen JJ, Kleinman LI 100, 112

Stein JH, Osgood RW, Boon- jaren S, Ferris T 91,112

Stein JH, Osgood RW, Ferris TF 78, 80, 112

Stein JH, Osgood R.A, Kunau RT Jr 92, 112

Stein JH, see Kirschenbaum MA 97, 108

Stein JH, see Osgood RW 81, 87, 88, 92, 110

Stein RM, Abramson RG, Kahn T, Levitt MF 90,112

Steinhardt RA, see Baker PF 51, 52, 55, 64

Stern K, Davidsohn J (477) 151,186

Stetson CA (478) 120,186 Stevenson JK, see Sehaller RT

(448) 133, 185 Stickel FJ, see Reiter M 61, 71 Stiffel C, see Biozzi G (59)

170 Stimson WH, Hunter IC (578)

152, 191 Stitsch RD, see Bottoner GD

(68) 157,171 St. Louis P J, see Sulakhe PV

56, 73 Stobo JD, Pane WE (479)

143, 186 Stoekert E, see Konda S (297)

126, 127,180 Stoerk HC, see Bjornboe M

(61) 146,170

Stoerk HC, see Eisen HN (166) 146,174

Stokes JB, see Higashihara E 97,107

Stoner RD, see Hess MW (256) 117,178

St Pierre R, see Waksal D (524) 127, 134,188

St Pierre RL, see WiUis-Carr JJ (540) 165,167, 189

Strand JC, see Knox FG 93, 95,108

Strandhoy JW, Williamson HE 101,112

Strandhoy JW, see Knox FG 83, 90,108

Strass P, see Bathmann A (48) 146,147,170

St~auch G, Pardos P, Luton JP, Bricaine H (480) 164, 186

Strauss MB, Earley LE 95,112 Strichartz GR, see Tang CM

12,73 Strieder N, see Khuri RN

91,108 Stumpe KO, Lowitz HD,

Ochwadt B 85,112 Stumpe KO, Solle H, Klein H,

Kruck F 93,112 Stutman (481,482) 126,127,

187 Stutman O (579, 580,581)

127,140,191 Stutman O, Good RA (483,

484) 117,137,187 Stutman O, Yunis EJ, Good

RA (486,487) 133, 134, 140,187

Stutman O, Yunis E J, Martinez C, Good RA (485) 187

Stutman O, see Dardenne M (128) 162, 173

Suckling EE, see Brooks CMcC 19, 65

Suki WN, see Eknoyan G 90,106

Sulakhe PV, St Louis PJ 56, 73 Sunshine GH, Baseh RS, Cof-

fey RG, Cohen KW, Gold- stein G (488) 141,187

Susie D, Sparks JC 97,112 Sutherland EW, Hayes RC

(489) 157,187 Sutko JL, see Reeves JP

56, 71 Swain HH, McCarthy DA

21, 43, 73 Swart AC, see Blankwater MJ

(63) 137,170 Svedmyr EAJ, see Goldstein P

(233) 177

Svetmoldavski GY, see Zinzar SM (557) 117,190

Szymik M, see Buntner B (79) 160, 171

Takaori S, see Matsumura M 39, 41, 70

Takatsuki K, see Azar NA (24) 117,169

Takeya K, see Hotta Y 43, 68 Takeya K, see Seibel K 60, 72 Talmadge DW, see Claman HM

(104) 119, 172 Talner LB, see Clarkson EM

96,105 Talner LB, see Nutbourne DM

96,110 Talwar GP, Hanjan SHS, Kid-

vaz Z, Gupta PD, Mahrota ND, Sayana R, Bhattarai R (490) 162, 187

Talwar GP, see Pandian MR (397) 154, 162, 183

Tanaka M, Hanin M, Yasunobu KT, Norton TR 6, 73

Tang CM, Strichartz GR, Orkand RK 12, 73

Tanz RD 41, 73 Tanz RD, Robbins JB, Kemple

KL, Allen PA 41, 73 Tart M 31, 73 Tarr RR, see Eisen HN (166)

146,174 Tasuda M, Greet MA (491)

164, 187 Taub RH, see Wong FM (548)

189 Taussig M J, see Munro AJ

(384) 124,183 Taylor G, see Jennings J (272)

157, 179 Taylor RB (492, 493) 117,

119, 187 Taylor RB, Allison AC (494)

187 Tazieff-Depierre F, see Cora-

boeufE 44, 45, 66 Tener GSL, Morrison SL,

Habicht GS (582) 191 Thesleff S, see Redfern P

13, 71 Thierry C, see Dubois JB

(463) 135,186 Thoa NB, Wooten GF, Axel-

rod J, Kopin IJ 26, 73 Thoa NB, see Moss J 26, 70 Thodenius K, see Aperia A

99, 103 Thomas L, see Weismann G

(534, 535) 157,189 Thompson EB, Lippman MF

(495) 157, 187

Page 217: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

216 Author Index

Thompson E, see Lippman MF (322) 156, 180

Thompson JS, Crawford MK, Reilly R, Sevensen C (497) 149, 156, 187

Thompson JS, Furth R van (496) 151,187

Thong YA, Hensen SA, Vin- cent MM, Rola-Pleszczinski M, Walsh JB, Bellanti JA (498) 157, 187

Thronborough JR, see Passo SS 101,110

Thurau K, see Horster M 81,107

Thurau K, see Kuschinsky W 83,108

Thureau GB, see Goldstein AL (225) 137,177

Thurman GB, Barr PS, Gold- steinAL (500) 187

Thurman GB, Brosio JL, Gold- stein AL (499) 126,187

Thurman GB, see Hooper JS (258) 136,178

Tokuyama T, Daly J, Witkop B 5 , 7 3

Toma V, see Pora E (420) 141,184

Torgyan S (501) 150, 187 Torrigiani G, see Roitt IM

(436) 119,185 Touraine F, see Tottraine JL

(502) 154,187 Touraine JL, Incefy GS, Gold-

stein AL, Good RA (503) 138, 187

Touraine JL, Incefy GS, Tou- raine F, Rho YM, Good RA (502) 154, 187

Touton M, see Nedred J (388) 121,183

Toyama J, see Shimizu T 17, 48, 49, 73

Trainin M (504) 116,188 Trainin M, Burger M, Kaye

AM (508) 138, 188 Trainin M, Burger M, Linker-

IsraeliM (507) 139,188 Trainin M, Kook AJ, Albuia M,

Umiel T (512) 188 Trainin M, Levo Y, Rotter V

(511) 139,188 Trainin M, Linker-Israeli M

(505) 117, 139, 188 Trainin M, Small M (506)

138, 188 Trainin M, Small M, Globerson

A (509) 117, 139,188 Trainin M, Small M, Kimhi Y

(510) 139,188

Trainin M, see Rotter V (438, 439) 139,185

Trainin N, see Dunn TD (155) 159,174

Trainin N, see Kook AI (299, 300,301) 138,158,180

Tranin N, see Law LW (314, 571) 133,136,180, 190

Trainin N, see Levey RH (320) 134,180

Trainin N, see Lonai P (327) 121,139,181

Trainin N, see Umiel T (516) 139,188

Trautwein W 3, 7, 15, 59, 73 Trautwein W, McDonald TF,

TripathiO 51, 73 Trautwein W, see McDonald

TF 15, 70 Trautwein W, see Morad M

57, 70 Trautwein W, see New W

34, 51, 70 Trautwein W, see Peper K

40, 41, 71 Trevino DL, see Bello-Reuss E

99,103 Tripathi O, see Trautwein W

51, 73 Triplett RF, see Claman H

(102) 118,172 Troy JL, see Brenner BM

80, 82,104 Trygzynski EW, see Wexler BC

(538) 189 Tse Hy (513) 127,188 Tsien RW, see Kass RS 18, 68 Tsien RW, see McAllister RE

15, 70 Tucci JR, see Espiner EA

95,106 Tucker BJ, Blantz RC 87,112 Tucker DF, Dennert G, Lennox

ES (514) 121. 188 Tursz T, see Bach JF (33)

142, 143,149,169 Twisk MJ, see Zaalberg OBVD

(554) 189 Tyan HL, Cole LJ, Davies WE

(515) 118,188 Tylor P, see Donatsch P

12, 66 Tyrell AA, see Martinez D

(574) 142, 143,190 Tyssebotn I, see Clausen G

81,105

Ueki IF, see Brenner BM 82,104

Ueki IF, see Daugharty TM 79, 80, 83,105

Ulbricht W 3, 7, 8, 14, 20, 22, 23, 29, 64, 73, 74

Ullmann TD, see Viscoper JR 96, 112

Ullrich K J, see Rumrich G 83, 111

Umiel T, Trainin N (516) 139,188

Umiel T, see Globerson A (213) 140, 176

Umiel T, see Trainin M (512) 188

Urakawa N, see Ito K 59, 68 Urquhard J, see Yates FE

(550) 160, 189

Valiant K, see Fachet J (177, 178) 159,175

Vanderlaan WD, see Lewis WJ (321) 163, 164,180

Vann DC (517) 123,188 VassaUe M, Bhattacharyya M

22, 74 Vassort G, see Horarkova M

19, 20, 23, 34, 55, 59, 68 Vassort G, see Roulet MJ

57, 72 Vaughan JH, see Fischel EE

(191) 146,175 Vaughan Williams EM, see

Morales-Aguilera A 43, 70 Vaux de St Cyr C, see Axnason

BG (15) 117,169 Velasquez MT, Notargiacomo

MV, Cohn JN 77, 78, 112 Ventom MG, see Bahlmann JS

96,103 Ventom MG, see Nutbourne

DM 96,110 Ventura-Clapier R, see Roulet

MJ 57, 72 Venugopal B, see Luckey TD

(330) 138, 143,181 Veress AT, Pearce JW 95,112 Veress AT, see Pearce JW

96,110 Verroust PJ, see Nutbourne

DM 96, 110 Vessey SH (518) 148,188 Villegas J, Sevcik C, Baxnola

FV, Villegas R 12, 74 Villegas R, see Villegas J

12,74 Vincent JP, see Lazdunski M

3, 69 Vincent MM, see Thong YA

(498) 157,187 Viscoper JR, Czaczkes JW,

Schwartz N, Ullmann TD 96,112

Visscher TL (519) 149, 188

Page 218: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

A u t h o r I n d e x 217

Wachter E, see B6ress L 6, 65 Wachter E, see Wunderer G

6,74 Wagner H (520) 121,188 Wagner H, Feldman M, Boyle

W, Scinader JW (521) 121 ,134 ,188

Wagner H, Harris AW, Feld- man M (522) 188

Wagner H, see Rollinghoff MA (437) 122, 185

Wahl M, see Kuschinsky W 83, 108

Wahl SJ, Altmann LC, Rosen- streich DL (523) 157,188

Waksal D, Cohen JR, Waksal HW, Wekerle H, St Pierre R, Feldman M (524) 127,134, 188

Waksal HW, see Waksal D (524) 127 ,134 ,188

Waksal SD, see Sato VL (445) 134, 185

Waksman B, see Colley DG (110) 172

Waksman BH, Arnason BG, Jankovic BD (525) 117, 188

Waksman BH, see Arnason BG (14) 117,168

Waksman BH, see Isakovic K (264) 120, 178

Waksman BH, see Kriiger J (306) 118, 137,180

Waldek JF, see Hellig H (253) 146,178

Waldmann H, Munro A (526) 123,188

Walker BR, see Buckalew VM Jr 90,104

Walker SM, Lucas ZJ (527) 124,188

Wallace WFM, see Pollen DW 62, 71

Wallin JD, Blantz RC, Katz MA, Andreucci VE, Rector FC Jr, Seldin DW 76, 78, 112

Waltin JD, see Barratt LJ 79, 80 ,103

Wallis T, see Doenhoff MJ (145) 125,173

Wallis V, see Davies JS (131, 132) 119,173

Walsh JB, see Thong YA (498) 157, 187

Waltman SR, Brude RM, Benios J (583) 152, 191

Walton M, Fozzard HA 15, 74 Wang CM, see Narahashi T

11, 70

Wara W, Ammann AJ (528) 138,189

Wara W, Goldstein AL, Doyle H, Ammann AJ (529) 137, 188

Wardener HE de, Mills IH, Clapham WF, Hayter CJ 79, 87, 94, 95, 96, 97 ,113

Wardener HE de, see Bahl- mann JS 96,103

Wardener HE de, see Brown PR 96,104

Wardener HE de, see Clarkson EM 96,105

Wardener HE de, see McDonald SJ 85,109

Wardener HE de, see Nut- bourne DM 96,110

Warnick JE, see Albuquerque EX 13, 64

Warnick JE, see Kayaalp SO 37, 68

Wathsman BH, see Ha Ty (243) 120, 137,177

Watson J, Aarden LA, Lefko- witzI (584) 124,191

Watson J, see Hoffmann MK (569) 124,190

Watts HG (530) 158,188 Weaver JM, see Algire GH (8)

120,168 Webb D, see Braun W (75) 171

Webb D, see Winchurch R (544) 189

Webb DR (531) 158,188 Webb JL, see Kunau RT Jr

86, 91,108 Weber S, see Reiter M 61, 71 Webster GD, see Bovee KC

77,104 Wecker E, Schimpl A, Hiinig T,

KphnL (532) 123,157,188 Wecker E, see Schimpl A

(453,454,455) 123,186 Weidmann S, see Wood EH

34, 74 Weigl WO, see Chiller JM (98)

120, 172 Weil V, see Elliott EV (169)

125,174 Weingart R, see Kass RS

18, 68 Weinman E J, see Knight TF

90,108 Weismann G, Thomas L (534,

535) 157,189 Weismann JL (533) 125,126,

189 Weit~ C, see Adam KR 10, 64 Weiss Y, see Papanicolaou N

97, 110

Wekerle H (536) 127,132, 189

Wekerle H, Ketelsen UP (585) 133,191

Wekerle H, Ketelsen UP, Ernst M (586) 133, 191

Wekerle H, see Waksal D (524) 127, 134,188

WellhiSrner HH. see Leicht R 13, 69

Wells RE, see Schrier RW 84,112

Welt LG, see Blythe WB 96,104

Wennersten C, see Arnason BG (14) 117,168

Werthamer S, Hicks C, Amarat L (537) 157,189

Westermark B, see Munson R 12, 70

Wexler BC, Dolgin AE, Tryg- zynskiEW (538) 189

Whalen G, see Fauci AS (567) 148,190

Whitaker JM, see Gruber KA 96, 107

White A, see Asanuma Y (17) 169

White A, see Bach JF (30) 137, 142,169

White A, see Blecher M (64) 157,170

White A, see Chase J (96) 146,172

White A, see Dougherty TF (148, 149) 174

White A, see Goldstein AL (218-224) 116,136, 137, 138,164,176, 177

White A, see Hardy MA (248) 137,178

White A, see Klein JJ (292) 179

White A, see Law LW (315) 117, 137,180

White A, see Makman MH (337-340) 157,181

White A, see Markham RB (345) 147,181

White A, see Pena A (402) 183 White A, see Roberts S

(433) 145,185 White A, see Zissblatt M

(558) 137,190 White RG, see Askonas BA

(19) 117,169 Whitehead RH, see Fox CA

(195) 146,175 Whitfield JF, McManus JP,

Rixon RH (539) 150, 157, 189

Page 219: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

218 A u t h o r I n d e x

Whitfield JF, see McManus JP (333,334) 144, 158, 162, 181

Whitfield JF, see Rixon RH (431) 185

Wiederholt M, see Khuri RN 91,108

Wiesner K, Kao W, Jay EWK 6,74

Wigzell H, see Goldstein P (233) 177

Wijemans P, see Astaldi A (20) 159, 169

Wijemans PS, see Astadi G (21) 143,169

Wilkes B, see Aisenberg AC (7) 133, 134, 168

Williams AF, see Hunt SW (262) 126,178

Williams H, see Munro AJ (384) 124, 183

Williams K, see Azar NA (24) 117, 169

Williams RD, see Allen HL (9) 155,168

Williams RD, see Ellison EH (170) 155,174

Williamson A, see Kreth HW (303) 180

Williamson HE, see Strandhoy JW 101,112

Willis LR, see Knox FG 83, 90, 108

Witlis LR, see Schneider EG 80, 111

Willis-Cart J J, St Pierre RL (540) 165 ,167 ,189

Wilson DB (541) 120,189 Wilson DB, Billingham RE

(542) 120, 189 Wilson DR, Sonnenberg H

92, 113 Wilson R, Sj6din K, Bealmar

M (543) 117,189 Winchurch R, Ischizuka M,

Webb D, Braun W (544) 189

Winchurch R, see Braun W (75) 171

Windhager EE, Lewy JE, Spitzer A 82 ,113

Windhager EE, see Giebisch G 91, 106

Windhager EE, see Lewy JE 82, 109

Windhager EE, see Spitzer A 82, 112

Wioland M, Sabolovic D, Burg C (545) 125,189

Wira C, Munck A (546) 156,189

Wistar R, Hildeman WH (547) 148,189

Witkop B, see Daly J 37, 66 Witkop B, see Tokuyama T

5,73 Wittenberger C, see Pora E

(420) 141,184 Wolf H, see Kaufmann R

18, 68 Wolgast M, see Kallskog O

87,108 Wong FM, Taub RH, Sherman

JD, Dameshek W (548) 189 Wood EH, HHeppner RL, Weld-

mann S 34, 74 Wooten GF, see Thoa NB

26, 73 Wortis HH, Nielsen S, Owen

JJ (549) 117,133,189 Wortis HH, see Raft MC (426)

125,184 Wright FS, see Davis BB

89, 105 Wright FS, see Johnston CI

96 ,107 Wright FS, see Knox FG

84, 96, 108 Wright FS, see Schneider EG

101,111 Wright FS, see Schnermann J

94,111 Wu CH, see Low PA 12, 69 Wunderer G, Eulitz M 6, 74 Wunderer G, Fritz H, Wachter

E, Machleidt W 6, 74 Wunderer G, see B6ress L

6, 65 Wunderer G, see Romey G

11,72 Wunderlich P, see Kuschinsky

W 83,108 Wunderlich P, see Schnermann

J 94, 111

Yakir Y, see Kook AI (301) 138,180

Yamabe H, see Alexander RW 99, 103

Yamada K, see Shimizu T 17, 48, 49, 73

Yamagishi S, Sano T 16, 74 Yamamoto I, see Plescia O

(418) 158,184 Yanagihara K, see Noma A

16, 42, 71

Yanai M, see Kakisawa H 6, 68

Yarger WE, see Harris RH 92, 107

Yaron T, see Schlesinger M (459) 186

Yasunobu KT, see Tanaka M 6,73

Yates FE, Urquhard J, Herbst AL (550) 160,189

Yates FE, see Barger AC 76,103

Yazikof E de, see Scholz H 61,72

Young DA (551) 157,189 Young DA, see Mosher KM

(376,377) 157,182, 183 Young DA, see Norden SK

(391) 157,183 Young RH, Hopkins P, Esparza

A (552) 120, 189 Yunis EJ, see Stutman O

(485-487) 133,134, 140, 187

Yunis L, Hillgard HR, Marti- nez C, Good RA (553) 134, 189

Zaalberg OBVD, Maul VA, Twisk MJ (554) 189

Zahnd GR, Nadeau A, Mumlu- dahl KE (555) 164, 190

Zatz MM, see Goldstein AL (222) 136,177

Zetterstrom R, see Aperia A 99, 103

Zijlstra J J, see Krisbeek AM (307) 134, 180

Ziller K (556) 1.25,190 Zimmerman JH, see Kupchan

SM 4, 69 Zinkernagl RM (587) 131,

191 Zinkernagl RM, Althage A

(588) 131,132, 191 Zinzar SM, Svetmoldavski GY

(557) 117,190 Zipes, Mendez 21 Zissblatt M, Goldstein AL,

Lily F, White A (558) 137, 190

Zlotkin E, Miranda F, Rochat H 44, 74

Zollinger RM, see Ellison EH (170) 155,174

Zucker A, see Obika LFO 101,110

Page 220: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Subject Index

aconine 6 aconitine, action on Na channels 10 - , cardiac actions of 3, 39-42 - , chemistry of 5 activation of Na channels 7, 8, 11, 16

- variables 8 active state of contractile elements 57 action potential, prolongation of 38, 39, 41,

47, 48, 49, 50 adaptation syndrome 148 adenohypophyseal deficiency 163 adenohypophysis and immune response 153,

154, 160 adrenal cortex and immune response

145-149 and thymectomy 159

- deficiency 149 adrenalectomy 146 adrenaline 60, 61 adrenergic nerve fibres, intracardiac 31 - pathways 98 #-adrenoceptor agonists 58 after-depolarization 8, 17, 18, 28, 29, 40 age-related natriuretic response 100 aldosterone and immunity 147

- secretion and natriuresis 95 aldosteronism, primary 95 alimentary factors and immune functions

165 alloantigenic markers 130 allograft rejection 117,120,123,124,133,

135,137,139,140,141,146,147,150, 151,155

p-aminohippurate, extraction ratio of 77 anthoplettrin A 4, 6 - , cardiac actions of 48, 49 - , kinetics of Na channels 12 antibody production 117, 118, 135,137,

145,146,150,155 antidiuretic hormone and natriuresis 97 antigen binding regions 131 - receptor 132 - recognition 131,132 - , Thy-1 129 antigenic markers 126,129,138,141,143 anti-growth hormone antiserum 162, 163 anti-lymphocyte serum 139 antithymosin antiserum 137 anti-Toxoplasma factor 123 arrhythmogenesis 37, 41

arrhythmogenic effect of batrachotoxin - - coral toxin 50 arteriovenous fistula 93 aspirin and natriuresis 97 ATP 52 atrium, veratrine actions 19, 20 ATXII, see sea anemone toxin azathioprine test 142

37

batrachotoxin 5, 59 - , action on Na channel 9

, on node of Ranvier 9, 10 , arrhythmogenic action 37

- , binding of 39 - , cardiac actions 37-39 - , lethal dose 37 B cell precursors 140

- cells and thymosin 137 - lymphocytes 126,129 benzocaine 22 benzopyrene tumor 133 Bezold-Jarisch effect 3 blood flow, intrarenal distribution of 77-79

, medullary 77 , renal, and vasodilators 76

bradycardia 44

Ca ++ channels 12 - concentration, intracellular 35 - influx 46 - and Na channels 14 - , oscillatory release 18 - uptake by sarcoplasmicreticulum 23, 24 cAMP, see cyclic AMP cancer development 144, 145 carbachol on sinoatrial node 16 cardiac action potentials 15-18 - cells in culture and ATXII 47

- - - , ceveratrum actions 36, 37 - - - , scorpion toxin actions 45,46

- preparations, Nai-Ca o exchange 53-56 - reflexes 3,4 cardioactive steroids, Na pump inhibition by

55, 56 castration 151 catecholamines and immune response 158 - and sodium excretion 99 - andTTX 32, 33 cell interaction, immunological 124 cevacine 9

Page 221: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

220 Subject Index

cevadine 5, 9, 28 - , chronotropic effect 19 ceveratrum alkaloids, action on Na channel 7

, cardiac actions of 19 ft. , chemistry of 4 , circulatory effects 4 , pharmacology of 3, 4 , positive inotropic effect 24, 25, 29 ft.,

60 choline 8 clonal selection theories 130 cobalt 54 collecting duct, dilution in 91 concanavalin A 121,125,143 coral toxin 6, 12, 50 cortical nephrons, sodium delivery from 92 corticosteroids and immune response 145 ff.,

156,157 - , nuclear receptor for 156 - and nucleic acid synthesis 157

- andprotein synthesis 157 - and thymus 160 corticotropin 140 - and immune response 155,156,157 cortisol 146, 148 cross-circulation experiments and sodium

excretion 96 cyclicAMP 58,124,141,157,158

increasing agents 60, 61 - nucleotides in myocardial cells 36 eyclophosphamide 122 cytolytic activity 120 cytostatic activity 120 cytotoxic activity 121 - cells 127

D 600 54 deoxycorticosterone 89,146,147 deoxynucleotidyl-transferase 137,141 dihydro-ouabain 58 - , inhibition of the Na pump by 61 - , positive inotropic effect 60 - , potentiation of veratridine 31 - and TTX 32 differentiation markers 129 diterpenoids 6 DOCA escape 93 - -saline treated rats 94 dopamine &hydroxylase 99 dye-dilution technique 77 dwarf mouse 118,163

estradiol 151, 152 ethacrynic acid 89 extracellular fluid, volume expansion, chronic

93 , , and natriuresis 87, 89 , , and phosphaturia 98 , , response of perinatal kidney to

99, 100 , , and sodium xeabsorption 90, 91,

94, 95

fermcyanide technique 80 fetus, immunostimulant influence 153 filtration fraction 78, 79 9 a-fluorohydrocortisone 94, 95 folio acid deficiency 165 fractionalreabsorption 83, 84, 85, 91

gastrointestinal Na receptor 101 gating mechanism 7 germine 5, 8 germine-3-acetate 9 - , chronotropic effect 19 germitetrine 25 germitrine 5, 58

- on action potential 28, 29 - , positive inotropic effect 24, 29 ff., 60 - andTTX 32, 33 germ-line hypothesis 132 GFR and fluid expansion 79, 80, 81 - , intrarenal distribution of 80 glomerular filtration rate 94

and sodium excretion 79 - -tubular balance 90 gonads and immune response 151-153 goniopora toxin 6, 12, 50, 61 graft immune reactions 120,121,123 graft-vs-host reaction 117

- - test 139,140,143 growth hormone and immune response 155,

156,162 - - receptors 162 gryanotoxins 6 - , action on Na channel 10 - , cardiac actions 42, 43 guanethidine 99

Hanssen'stechnique 79, 81 heart failure and Na excretion 93 - , membrane currentsin 15-18 helper cell differentiation 124 - cells 122, 127,129,131 - factors 131 hemagglutinin 151

- production 154 hematocrit and sodium excretion 84 hemodflution 78 hemolysin production 118,146 Henle loop and natriuresis 90, 91 hepatorenal syndrome 101,102 h gate 7, 11 histamine 58 hormonal action in immune response 156 ff. - factors, influence on sodium absorption

94-99 - interactions 159 hydrostatic pressure, capillary 84, 85

, peritubular and Na absorption 85, 86 , serosal 85

hypernatremia 89 hypersensitivity, delayed-type 129,130 hypophyseal hormones and immune response

154-156

Page 222: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Subject Index 221

hypophysectomy andthymus 162

IgG antibodies 146 IgM antibodies 123 immune response and adrenal cortex 145 fL,

156,157 - - , alimentary influences 165 - - , cell-to-cell interaction 118,119,123,

124 and gonads 151 153

- - , hormonal coordination in 166,167 - - , hormone mechanisms in 156 ff.

and hypophysis 153-156 - - , organization and generation of 127 ft.

andthymus 117 ft. and thyroid 150,151

- system, cellular communications 130 immunodeficiency 117 immunostimuiant effect 145 immunotolerance 119 inactivation gate 40

- of Nachannel 7, 8, 11, 16 - time constant 20 indomethacin and kidney 97 inert-gas washout 77 inotropic effect, positive 24, 25, 29 ff., 39,

42, 43, 44, 46, 48, 49, 56, 60 , , chain of events 63

- - , - , presynaptic 31 interstitial pressure and Na absorption 86 ionic selectivity, Na channels 9, 10 isometric contraction 57, 58

jerveratrum alkaloids and alkamines 4 juxtameduUary nephron function 92

K ÷ accumulation 28 - , extracellular and inotropy 61 killer ceils 129 killing assisting factor 124 klinotropic effect, positive 23, 39, 42, 43,

46, 49

lldocaine 14 llpopolysaccharides 124 lithium ions 8, 20, 54 liver and sodium reabsorption 101 lymph nodes, thymus-dependent zones 125 lymphocyte differentiation markers 129, 130 - stimulating hormone 143,144 lymphocytes, see also B and T cells

- in bone marrow, see also B cells 126 - , corticoidreceptors 157 - and cyclic AMP 158 - and growth hormone 162 - , immunological functions of 128, 129 - , influence of adrenocortical hormones on

146 ff. - , intracellular enzymes 125 lympholine synthesis 157 lymphotoxines 124 lysosomal enzymes 157

major histocompatibility complex 129 antigens 131,132

manganese 54 mediator substance for immune reaction

124,130 mesaconitine 40 metopyrone 148 m-gate 7, 9, 20 microcatheterization studies 92 microsphere techniques 78 mineralcorticoids 93 - and sodium excretion 95 myoblasts 45, 47

Na ÷ see also sodium Na-Ca exchange 18, 35, 51 ff.

- - , sarcolemmal 57 Na-K-ATPase and ceveratrum alkaloids 36 natriuresis 80, 82, 83,101

- of hypertensive patients 85 - , see also sodium excretion natriuretic hormone 95, 96 neuroblastoma cells 13, 14 neuromuscular block 141 nucleic acids and cortisol 157

oncotic pressure and sodium absorption 82, 83, 84, 85

oscillation of membrane potential 28 oscillatory after-potentials 18, 41 ouabain 53, 54 ovalb umin 155

pacemaker cells, hyperpolarization of 16 palytoxin 59 parathyroid hormone and natriuresis 97, 98 perinatal kidney, responses of 99 peritubular capillary, permeability surface

area 87 phosphatase, alkaline 125 phosphaturia 98 phosphodiesterase inhibitors 58 phytohemagglutinin 125, 143 plaque-forming cells 121,123, 126,133,

137,149,150 - cellassay 117,118 plasma cells 130

- protein and natriuresis 82, 83, 84 polyomavirus 117,134 polypeptide toxins 6 polyribonucleotides 158 pregnancy and immune response 153 pressure, oncotic, peritubular 78 procaine 22 progesterone implants 152 propranolol 26 - , effect on Na channels 43, 62 prostaglandin synthesis inhibitors 158 prostaglandins and sodium excretion 97 prothymocytes 141 protoveratrine 25, 28, 30, 37 proximal tubule, altered permeability of 84

Page 223: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

222 S u b j e c t I n d e x

proximal tubule, sodium reabsorpt ion in Purkinje fibres, aconit ine actions 40

- - , ba t rachotoxin action 37, 38 , veratrine actions 21, 22

puromycin 157 pyridoxal deficiency 165

Ranvier node 7, 10, 11, 20 reabsorpt ion coefficient 87 refractory period 48, 49 relaxation t ime 23, 57, 58 renal sodium absorpt ion, see under sodium

76 renin-angiotensin sys tem 93 repolarization, delayed 17 - , early 17 reserpine 44, 47 RNA 124 - polymerase activity 157 rosette-forming ceil test 117

- cells 137, 138, 142

83

saline infusion 76, 77 sarcoma graft rejection 145 - rejection 137 saxitoxin 2, 13 ,58 scorpion toxins 6, 54 - - , act ion on Na channel 10, 11 - - , act ion on nerve fibres 10 - - , cardiac actions o f 4 4 - 4 6

- - , p resynap t icac t ion of 59 sea anemone toxins 6, 46, 61 - - - , act ion on N a c h a n n e l 11, 12 - - - , cardiac actions 4 6 - 4 9 secretin 77 single nephron glomerular fi l tration rate

80, 81, 94 sinoatrial node, effects o f ceveratrum 19 sinus tachycardia 19 slow inward current 15, 61 sodium absorpt ion, dependency on plasma Na

88 - 9 0 and glomerular filtration rate 7 9 - 8 1

, hemodynamics influencing 7 6 - 7 9 - - , intestinal 84, 85 - - , neurohumora l effects upon 98, 99 - - , physical factors influencing 8 2 - 9 0 - accumulat ion, intracellular 54, 56 - channel-gate toxins, see also individual

toxins antagonists to 13, 14 ar rhythmias produced by 18 cardiac action of 15 ft. and cardiac reflexes 3, 4 chemistry o f 4 - 6 competi t ive interactions 14 definition of 3 and isometric contract ion 57 kinetics o f Na channels 13 mode of act ion o f 7 ff. receptors for 13

- channels acon i t ineac t ion 41

- - and BTX 38 - - in cardiac action potential 1 5 - 1 8 - - , effects of toxins on 3

, exci tat ion-concentrat ion coupling, role in 50, 51

- - and grayanotoxin 43 , inactivation o f 49

- - and scorpion toxin 45 , silent 12, 1 3 , 4 8 , TTX-insensitive 13

- c o n c e n t r a t i o n , intracellular 31, 34, 35 - excretion, age-related 100 - - and anesthesia 84

, gas t ro in tes t ina lcontrol of 1 0 1 , 1 0 2 - - and renal blood flow 76, 77 - , extracellular and inotropy 60 - , f rac t ionalreabsorpt ion 83, 84, 85, 93 - inactivation 4 4 , 4 7 - ion receptor 101 - influx and positive inotropic effect 63, 64 - i o n s a n d Ca 2+release 51 - permeabili ty changes 7, 8

- in plasma and natriuresis 88, 89 - p u m p 36, 52

inhibit ion 56, 61 , s t imulat ion o f 43

- reabsorption, micropuncture studies 91, 92

- - , proximal 78 - - , s egmenta l tubu la r 9 0 - 9 3 - retent ion, chronic model 93 spinal cord section and natriuresis 98 spironolactone 147 spleen cells, killer activity 146 - - , transfer o f 134 - extracts 137 Starling forces 86 stress and immune response 148, 149 superficial nephron, filtration fraction 79 suppressor T cells 1 2 1 , 1 2 7 , 1 2 9 , 1 3 0

T cell replacing factor 131 - cell-B-cell interaction, mechan i sm of

1 2 2 - 1 2 4 , 130, 131 - cells, antigen recognit ion 131

and B cells, dist inction of 1 2 5 , 1 2 6 cortisol-resistant 126 immunocompe ten t 127 immunological funct ions 128, 129 invasion of 133 killer 129 matura t ion of 126 ,127 , 143 secretion of mediator substance 123 subpopulat ions in 125, 126, 127

testosterone 1 5 1 , 1 5 2 tetracaine 14 te t rodotoxin 2, 8, 12, 13, 15, 16, 19, 20, 28,

47, 48, 49, 50 - and bat rachotoxin action 38

, blockade of sarcolemmal Na channels by 58, 59

- and development 36

Page 224: Reviews of 92 Physiolog3~ Biochemistry and Pharmacology

Subject Index 223

- andgrayanotoxin 42,43 - insensitive Na channel 36 - , mode of action 31 - , negative inotropic action 18

and Purkinje fibres 22 - , veratridine antagonism 32, 33, 34 theophyUine 58,60,61 thymectomy 147 - , effects on lymphocytes 125 - and hormones 159 - , immunological consequences of 117 - , neuromuscular transmission in 141 - , substitutive therapy for 133 ff. thymic culture supernatant, injection of 134

- extracts 135 ff. - factor in serum 142 - grafts 133,134 - hormone 155

, homeostatic 140,141 - humoralfactor 138,139,140 - hypertrophy 149 - nurse cells 133 thymin 141 thymocytes 127 - , transfusion of 134 thymopoietin 141,159 thymosin, actions of injected 136 ft. - , activity tested in vitro 138 - , amino acid sequence of 136 thymosterines 145 thymus-adenohypophysis interaction 162 ff.

- -adrenalinteractions 161,162 - , generation of antigen diversity 132 - , lipidic extracts from 144, 145 - , morphology of 128 - , peptitic extracts from 136-144 - , polypeptide fraction 144 - , role of, in immunity 116 ff., 149,154

, , inimmunotolerance 119,120 - -thyroid interactions 161 thyreotropin 156,163 thyroid hormone and sodium transport 98

- and immune response 150, 151 thyroxine 163,164

injection 150,151,154 transmitter release 11, 26 tuberculin 150

tubular surface area 90 tubule, distal, role in natriuresis 90 ff.

- geometry and sodium reabsorption 90 tubuloglomerular feedback 94 tumor development 144, 145 tumors, experimental 117

urine reinfusion 92

vasopressin 89 vena cava obstruction 93 ventricular muscle, aconitine actions 40, 41

and batrachotoxin 38, 39 - , veratridine actions 23 ff.

- myocardium, action potential 15 veracevine 5, 8, 24 veratridine 5, 11, 58

, action on Na channel 7 ff - and Ca ++ 14 - and Cainflux 53, 54 - , cardiac actions 19ff. - in cultured cardiac cells 36 - , mechanism of inotropic effect 29 ft. - and noradrenaline release 26

- in pancreas 12 - on Ranvier node 7 - , reserpine-like effect 26 - and silent Na channels 12 - andTTX 32, 33, 34 - and ventricular action potential 26, 27 veratrine 4 - , action on action potential 19 - , actions onatrium 19-21 - , positive inotropic effect 20, 22, 23 ff., 60 - relaxation time 57 - , ventricular actions 23 ff. veratrum alkaloids 4 volume expansion, extracellular 76, 77, 84,

85, 86 see also under extracellular

Walker sarcoma grafts 145 washout hypothesis, medullary 78 wasting 133,139,140

zygadenine 24